
Journal Menu
► ▼ Journal Menu-
- JCM Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserNeed Help?
Announcements
1 December 2023
Journal of Clinical Medicine | Collaboration Established with the Italian Society of Thoracic Endoscopy (SIET)
|
In September 2023, the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) has established a cooperation with the Italian Society of Thoracic Endoscopy (SIET). As part of this collaboration, all members of SIET will enjoy a discount on the Article Processing Charge (APC) when submitting articles to JCM. The collaboration goes beyond the discount benefit offered to members and includes other services as well as cross-promotions. Italian Society of Thoracic Endoscopy was founded as an Italian organization in 1980. However, it now has members from all over the European continent. SIET is a dynamic and young scientific society that plays a leading role in endoscopy and minimally invasive thoracic surgery. |
SIET is a professional organization whose functions are highly relevant to the scope of JCM. We look forward to collaborating with SIET and publishing state-of-the-art research from its members in this field.
For more information about societies cooperated with JCM, please visit: https://www.mdpi.com/journal/jcm/societies.
30 November 2023
MDPI Insights: The CEO's Letter #6 - MDPI Spain Summit and ResearchGate

Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
MDPI Spain Summit
Stefan Tochev (CEO, MDPI) gives the opening speech at the MDPI Spain Summit.
On Friday 10 November 2023 I was in Barcelona, Spain, to deliver the opening presentation and participate in a panel at MDPI’s Spain Summit, a two-day event, inspired by our salon events in China.
With 16 Editors-in-Chief (EiCs) and 20 Editorial Board Members (EBMs) in attendance, the event, organized by our conference team and Barcelona office, featured presentations on open access (OA), MDPI, and publishing market trends in Spain.
The event provided a great opportunity to engage with stakeholders from various MDPI journals, including Nutrients, Vaccines, Buildings, IJMS, and others. We were able to gather feedback and have open conversations around manuscript quality, the peer-review process, and journal development, as well as accreditation agencies.
The main objective of this Summit was to bring together Editors representing MDPI journals across various disciplines within Spanish universities and research centers, primarily from the Barcelona area. The aim was to facilitate an open and fruitful discussion regarding the development of their journals, the future of OA in Spain, and to provide meaningful interactions and networking opportunities.
Connecting with Editorial Board Members
Stefan Tochev in conversation with Summit participants: "Our EBMs are passionate about the journals they serve."
Interacting with our EBMs in person provides a valuable opportunity to show how important it is to us to connect with them, hear their perspectives on their journals and learn more about their own experience collaborating with MDPI.
From my conversations, it was clear that our EBMs are passionate about the journals they serve. I know the advice they provide may sometimes involve just small tweaks, but these can lead to important improvements. As the saying goes, small hinges swing open big doors.
As at November 2023, MDPI has over 6,300 EBMs affiliated with Spanish institutions, with more than 30 of them serving as EiCs or section EiCs. Furthermore, over 68,000 Spanish scholars have contributed as reviewers in MDPI journals.
Open Access in Spain
In 2023, Spain implemented legislation mandating immediate OA for all publicly funded research, aligning with the EU’s Plan S initiative to expedite the transition to OA. The Spanish government also approved a four-year, €23.8 million annual budget for the first national OA strategy, aiming to make publicly funded research freely accessible upon publication. This strategy aims to strengthen the quality and transparency of research in Spain, and to help promote movement towards a digital, low-carbon economy.
For further details of Spain's OA policy and the history of government mandates, click here.
Spain has already seen a notable decline in subscription-only articles, decreasing by 62% over a 10-year period, while gold OA increased by 42%. Green OA slightly decreased, suggesting a shift towards publishing in gold OA journals rather than traditional subscription-based ones. Here are some statistics from Scopus.
A big thank-you to the various MDPI teams, including our conference team and the Barcelona office, for organizing this very successful event!
MDPI colleagues from various offices gathered to host and support the first MDPI Spain Summit, in Barcelona, Spain.
I think this type of gathering has the potential to become an annual event in various locations. For example, Manchester could be an option, as we have over 30 EiCs and over 3,000 EBMs in the UK, a top market for MDPI that publishes high-quality research.
Impactful Research
769 Editorial Board Members of MDPI Journals Recognized as Highly Cited Researchers in 2023
Congratulations to our 769 Editorial Board Members from 40 countries/territories who have been awarded Highly Cited Researcher status for 2023 by Clarivate. This recognition is based on their outstanding scientific research contributions and significant influence in various fields, as evidenced by Web of Science data.
Click here to view the full list of 769 Editorial Board Members.
Clarivate's Highly Cited ResearchersTM list identifies individuals with exceptional impact in scientific and social science domains over the past decade. Their papers rank in the top 1% of citations in 21 fields analysed in ‘Essential Science Indicators,’ showcasing their substantial influence.
This year, 7,125 Highly Cited Researcher 2023 designations were issued to 6,849 individuals from 67 countries, representing just 1 in 1,000 researchers worldwide.
These researchers demonstrate exceptional influence, representing a small fraction of contributors pushing the boundaries of knowledge, contributing to global well-being, sustainability, and security.
Congratulations to these scholars for their remarkable achievement: we are honoured to have them on board with our journals!
Inside MDPI
Corporate Marketing and Communications Strategy Session
Members of MDPI’s Corporate Marketing & Communications team.
For the past few years, I have led the Corporate Marketing & Communications department in our annual strategy session.
This typically involves 2–3 days of focused sessions covering key topics including budgeting, hiring targets, campaign reviews, and planning for the upcoming year, department strategy, and structure.
We are constantly exploring ways to optimize the Corporate Marketing & Communications department to support MDPI’s primary objectives and better convey the MDPI story while serving the scholarly community.
The strategy session also serves as a team-building activity, during which the team voted on bowling!
Strategy Session
In this strategy session, we looked at how to align our teams in order to better streamline our content with our campaigns, build a dedicated marketing team to strategically support our core MDPI products, expand our communications teams and functionalities to focus on company-critical campaigns and press releases, align our new brand design system with our marketing initiatives, set up a community and engagement team to support various teams with their outreach and communication efforts, and increase our use of data in the evaluation of campaign performance.
To grow in these areas, we will be hiring for various positions, including those of Public Relations Manager, Communications Manager, Internal Communications Manager, Campaign Manager, Marketing Associate, and Editorial Engagement Manager.
I am grateful for the way our Corporate Marketing & Communications department has grown and gelled over the years, and I look forward to supporting the department teams and their ideas for the future.
Coming Together for Science
ResearchGate and MDPI Partner to Boost the Visibility of Open Access Content through Journal Home
Stefan Tochev (CEO, MDPI) and Sören Hofmayer (Co-Founder and Chief Strategy Officer, ResearchGate) meet in Berlin, Germany to take their ongoing discussion further.
When I assumed the role of CEO at MDPI, my primary focus was to initiate the building of essential partnerships and collaborations within our industry. After all, I am a firm believer in achieving our goals by helping others achieve theirs and focusing on co-opetition wherever there is an opportunity. I first touched on the notion of co-opetition in MDPI Insights: The CEO's Letter #3, particularly when discussing collaborations with Elsevier.
In light of this, Sören Hofmayer (Co-Founder and Chief Strategy Officer at ResearchGate) and I connected recently to continue a discussion that had been ongoing for months. I was quickly brought up to speed and felt there was an opportunity for MDPI journals to pilot the Journal Home service that ResearchGate had launched. This would provide a new way for MDPI to engage with authors and readers and amplify the visibility of our journals.
While I receive many offers and opportunities for discussions with vendors, I am a firm believer that timing is everything, and in this case, the time for us is now. Sören and I met in person during my recent visit to Berlin and decided to proceed with piloting ten MDPI journals with the Journal Home service.
The press release below provides further details.
Press Release: Berlin (Germany) and Basel (Switzerland), 15 November 2023
ResearchGate, the professional network for researchers, and MDPI, the largest open access publisher in the world and a pioneer in open access publishing, today announced a partnership that will see ten of MDPI’s open access journals benefit from an enhanced presence on ResearchGate through its innovative Journal Home offering.
This new partnership will expand the reach and visibility of MDPI’s participating flagship journals with ResearchGate’s highly relevant community of more than 25 million researchers globally.
Around 210,000 version-of-record articles from these 10 titles will be readily available on ResearchGate, including the full archive material and all new articles as they are published. These journals also benefit from enhanced brand visibility, with dedicated journal profiles, prominent representation on all associated article pages and all relevant touchpoints across the ResearchGate network – keeping the journals top-of-mind with their reader and author audiences. All articles covered by the new partnership will automatically be added to the authors’ publication records in ResearchGate. This not only reduces MDPI authors’ needs for direct management but also offers them valuable insights into the impact of their work, including data about readership and citations.
Closing Thoughts
November is Men’s Health Awareness Month
Stefan Tochev (CEO, MDPI) listening to music as he writes at a coffee shop in Basel, Switzerland.
November is dedicated to raising awareness of various men’s health issues. I have been fortunate to have positive male role models in my life, and I strive to share my experiences with others.
I used to take part in Movember, growing my moustache throughout November to raise awareness and funds and to help “change the face of men’s health.” With male family and friends impacted by physical and mental health issues, I have recently become more interested in men’s overall well-being.
Men often face stigma involving the perceived need always to be strong and have things figured out. Recently, I’ve had meaningful conversations with male friends and colleagues about issues we rarely discuss, and it was a positive experience.
Various factors impact men’s health and well-being, all too easily leading to risky health behaviours including a lack of health awareness, poor health education, and negative, culturally induced, behaviour patterns in our work and personal lives. I hope we can break down these barriers in our work environment.
Healthy men help build healthy families and a healthy society
Men are less likely than women to seek help with their physical and mental health struggles. This is a reminder to prioritize your overall well-being. I hope that as men, we will continue to open up to one another, becoming vulnerable in order to share what we are going through. By sharing and by supporting each other, we can learn and grow together. You are not alone, and when you fall, you can still get up and stand tall.
From one broski to another, you are loved and appreciated. I hope this mindset carries into December and beyond.
Mindfulness
Our content team recently released a handful of articles on mindfulness, a practice that I believe provides a good opportunity for stress release and self-reflection:
Chief Executive Officer
MDPI AG
28 November 2023
Journal of Clinical Medicine | Highly Cited Papers in the Section “Gastroenterology & Hepatopancreatobiliary Medicine”

Journal of Clinical Medicine (JCM, ISSN: 2077-0383) publishes high-quality original research, reviews, and systematic reviews that contribute to advancing clinical health and medicine. As JCM is of open access format, you have free and unlimited access to the full text of all the articles published in it.
We welcome you to read the highly cited papers published in 2022 in the Section “Gastroenterology & Hepatopancreatobiliary Medicine”.
1. “Extra-Intestinal Manifestations of Celiac Disease: What Should We Know in 2022?”
by Marilena Durazzo, Arianna Ferro, Isabella Brascugli, Simone Mattivi, Sharmila Fagoonee and Rinaldo Pellicano
J. Clin. Med. 2022, 11(1), 258; https://doi.org/10.3390/jcm11010258
Available online: https://www.mdpi.com/2077-0383/11/1/258
2. “The Coexistence of Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus”
by Marcin Kosmalski, Sylwia Ziółkowska, Piotr Czarny, Janusz Szemraj and Tadeusz Pietras
J. Clin. Med. 2022, 11(5), 1375; https://doi.org/10.3390/jcm11051375
Available online: https://www.mdpi.com/2077-0383/11/5/1375
3. “The Feasibility of Liver Biopsy for Undefined Nodules in Patients under Surveillance for Hepatocellular Carcinoma: Is Biopsy Really a Useful Tool?”
by Matteo Renzulli, Anna Pecorelli, Nicolò Brandi, Stefano Brocchi, Francesco Tovoli, Alessandro Granito, Gianpaolo Carrafiello, Anna Maria Ierardi and Rita Golfieri
J. Clin. Med. 2022, 11(15), 4399; https://doi.org/10.3390/jcm11154399
Available online: https://www.mdpi.com/2077-0383/11/15/4399
4. “Current Status and Future Perspectives of Artificial Intelligence in Colonoscopy”
by Yu Kamitani, Kouichi Nonaka and Hajime Isomoto
J. Clin. Med. 2022, 11(10), 2923; https://doi.org/10.3390/jcm11102923
Available online: https://www.mdpi.com/2077-0383/11/10/2923
5. “Real-World Evidence of the Effectiveness and Safety of Ustekinumab for the Treatment of Crohn’s Disease: Systematic Review and Meta-Analysis of Observational Studies”
by Cristina Rubín de Célix, María Chaparro and Javier P. Gisbert
J. Clin. Med. 2022, 11(14), 4202; https://doi.org/10.3390/jcm11144202
Available online: https://www.mdpi.com/2077-0383/11/14/4202
6. “Ulva pertusa, a Marine Green Alga, Attenuates DNBS-Induced Colitis Damage via NF-κB/Nrf2/SIRT1 Signaling Pathways”
by Alessio Ardizzone, Alessia Filippone, Deborah Mannino, Sarah Adriana Scuderi, Giovanna Casili, Marika Lanza, Laura Cucinotta, Michela Campolo and Emanuela Esposito
J. Clin. Med. 2022, 11(15), 4301; https://doi.org/10.3390/jcm11154301
Available online: https://www.mdpi.com/2077-0383/11/15/4301
7. “COVID-19 Pneumonia and Gut Inflammation: The Role of a Mix of Three Probiotic Strains in Reducing Inflammatory Markers and Need for Oxygen Support”
by Angela Saviano, Annalisa Potenza, Valentina Siciliano, Carmine Petruzziello, Claudia Tarli, Alessio Migneco, Flavia Nasella, Francesco Franceschi and Veronica Ojetti
J. Clin. Med. 2022, 11(13), 3758; https://doi.org/10.3390/jcm11133758
Available online: https://www.mdpi.com/2077-0383/11/13/3758
8. “Mechanisms Leading to Gut Dysbiosis in COVID-19: Current Evidence and Uncertainties Based on Adverse Outcome Pathways”
by Laure-Alix Clerbaux, Julija Filipovska, Amalia Muñoz, Mauro Petrillo, Sandra Coecke, Maria-Joao Amorim and Lucia Grenga
J. Clin. Med. 2022, 11(18), 5400; https://doi.org/10.3390/jcm11185400
Available online: https://www.mdpi.com/2077-0383/11/18/5400
9. “Experience with Rifabutin-Containing Therapy in 500 Patients from the European Registry on Helicobacter pylori Management (Hp-EuReg)”
by Olga P. Nyssen, Dino Vaira, Ilaria Maria Saracino, Giulia Fiorini, María Caldas, Luis Bujanda, Rinaldo Pellicano, Alma Keco-Huerga, Manuel Pabón-Carrasco, Elida Oblitas Susanibar et al.
J. Clin. Med. 2022, 11(6), 1658; https://doi.org/10.3390/jcm11061658
Available online: https://www.mdpi.com/2077-0383/11/6/1658
10. “Suppurative Thrombosis of the Portal Vein (Pylephlebits): A Systematic Review of Literature”
by Dorde Jevtic, Tatjana Gavrancic, Ivana Pantic, Terri Nordin, Charles W. Nordstrom, Marina Antic, Nikola Pantic, Marija Kaljevic, Bojan Joksimovic, Milan Jovanovic et al.
J. Clin. Med. 2022, 11(17), 4992; https://doi.org/10.3390/jcm11174992
Available online: https://www.mdpi.com/2077-0383/11/17/4992
Access more Section information here.
21 November 2023
769 Editorial Board Members of MDPI Journals Achieve Highly Cited Researcher Recognition in 2023

We extend our sincere congratulations to the 769 Editorial Board Members of our journals – from 40 different countries/territories – who have been recognized as Highly Cited Researchers for the year 2023 by Clarivate. They are being recognized for their high-quality scientific research achievements and outstanding contributions to their professional fields, as indicated by Web of Science data.
Clarivate's annual list of Highly Cited ResearchersTM identifies the most highly cited scientists for the past decade who stand out for their significant and broad influence in various scientific and social science domains. Their impactful papers are among the top 1 per cent in the citation distribution of one or more of 21 fields analyzed in the "Essential Science Indicators", distinguishing them as hugely influential among their peers.
This year, 7,125 Highly Cited Researcher 2023 designations were issued to 6,849 individuals from 67 countries, representing just 1 in 1,000 researchers worldwide.
This means that these researchers have demonstrated an incredible level of significant and broad influence in their chosen field or fields over the last decade. They represent a small fraction of the researcher population whose contributions disproportionately push the boundaries of knowledge, enhancing global well-being, sustainability, and security.
Congratulations to the scholars for their noteworthy achievement – we are honored to have them on board with our journals!
Abate, Antonio |
Jaiswal, Amit K. |
Shen, Zexiang |
15 November 2023
2023 Journal of Clinical Medicine Editorial Board Meeting of Section “Endocrinology & Metabolism” Held on 5 and 18 September 2023

It is our great pleasure to share the news that the 2023 Journal of Clinical Medicine (JCM) Editorial Board Meeting of Section “Endocrinology & Metabolism” was held on 5 and 18 September 2023, conducted by the Section Editor-in-Chief, Prof. Dr. Didac Mauricio.
The meeting started with a presentation about the journal and Section “Endocrinology & Metabolism” development with the following information presented:
- Journal history, publication statistics, distribution of scholars (2018–2023), open access benefits, journal awards, conference sponsorship, promotion on social media;
- Section aims and scope, Editorial Board Member distribution and decision-making statistics, Section statistics, highly cited papers.
The meeting mainly discussed keyword expansion and revision of the Section website, as well as other topics such as Academic Editor decisions, Section title, Section competitiveness, manuscript processing flow, Special Issue series, and feature paper invitations. Based on the discussion, some keywords may be added to the Section website, such as therapy of obesity, diabetes, metabolic bone diseases/disorders, prevention of endocrine diseases, pediatric endocrinology, etc. We will keep an eye out for more proposals and maintain regular communication with the Editorial Board Members to further the Section's growth.
This Section Editorial Board online meeting aims to increase support for the Section's and the journal's next development. We would like to thank every Editorial Board Member and the academics for their support again. We look forward to receiving more support and suggestions and making common progress.
Attendee list (in no particular order):
Part I (5 September 2023):
- Dr. Didac Mauricio, Hospital de la Sant Creu i Sant Pau, Barcelona, Spain; University of Vic & Central University of Catalonia, Barcelona, Spain; Instituto de Salud Carlos III, Barcelona, Spain;
- Dr. Luigi Uccioli, University of Rome Tor Vergata, Rome, Italy;
- Dr. Brian Tomlinson, Macau University of Science and Technology, Macau; The Chinese University of Hong Kong, Hong Kong;
- Sheyu Li, West China Hospital of Sichuan University, Chengdu, China.
Part II (18 September 2023):
- Dr. Didac Mauricio, Hospital de la Sant Creu i Sant Pau, Barcelona, Spain; University of Vic & Central University of Catalonia, Barcelona, Spain; Instituto de Salud Carlos III, Barcelona, Spain;
- John Griffith Jones, University of Coimbra, Coimbra, Portugal;
- Dr. Gyanendra Tripathi, University of Derby, Derby, UK;
- Dr. Alejandro Gugliucci, Touro University California, Vallejo, CA, USA;
- Dr. Neveen Agnes Therese Hamdy, Leiden University Medical Center, University of Leiden, Leiden, the Netherlands;
- Dr. Cees Noordam, Centre for Paediatric Endocrinology Zurich (PEZZ), Zurich, Switzerland; Radboud University Medical Centre, Nijmegen, the Netherlands;
- Ishwarlal Jialal, UCDAVIS School of Medicine, Sacramento, CA, USA.
The latest official CiteScore (2022 Scopus data) of the Journal of Clinical Medicine (ISSN: 2077-0383) is 5.4, ranking 137/830 (Q1) in the area of “General Medicine”. The current Impact Factor of JCM is 3.9 (2022), ranking 58/167 (Q2) in the category “Medicine, General & Internal”.
To access more journal statistics please click here.
To access more Section information, please visit the following link: https://www.mdpi.com/journal/jcm/sections/Endocrinology_Metabolism.
9 November 2023
Interview with Dr. Francesco Restelli—Winner of the JCM 2023 Travel Award

Name: Dr. Francesco Restelli
Affiliation: 1. Neurovascular Unit and Revascularization Unit, the Foundation IRCCS Neurological Institute “C. Besta,” Milan, Italy;
2. Italian Society of Neurosurgery and the European Association of Neurosurgical Societies.
We wish to congratulate Dr. Francesco Restelli on winning the JCM 2023 Travel Award. Dr. Francesco Restelli, MD., is an attending neurosurgeon of the Neurovascular Unit and the Revascularization Unit at the Foundation IRCCS Neurological Institute “C. Besta” in Milano. Dr. Restelli’s expertise includes cerebrovascular disorders (aneurysm, AVM, cavernomas, and moyamoya disease and stroke), brain, skull base, and intramedullary tumors.
He is a member of the Italian Society of Neurosurgery and the European Association of Neurosurgical Societies. Dr. Restelli received his medical degree and neurosurgery residency at the University of Milano. He completed a neurosurgical fellowship at the Arkansas Neuroscience Institute in Little Rock, Arkansas.
Dr. Restelli's research activities include the development of new visualization techniques during surgical approaches for oncological and vascular disease, particularly involving intraoperative fluorescence, developing new surgical techniques for cerebral revascularization, and anatomical studies of neurosurgical approaches. In the last five years, he has won five international awards related to neurosurgical research, and he is the author and co-author of over 40 peer-reviewed articles and four book chapters.
The following is an interview with Dr. Francesco Restelli:
1. How does it feel to receive this recognition for your work?
It was an honor; I feel very good because, for a researcher, having your work recognized that it is good enough to win a prize, is wonderful.
2. Where do you obtain journal award participation information?
My mentor, Prof. Dr. Francesco Acerbi, here at our neurological institute, suggested I apply for this recognition. Our group recently published many papers in your journal, and he probably received some emails about it. So, he was the one who suggested I apply.
3. Have you promoted it at a conference? In addition to promoting at the conference, how do you prefer to share the journal with your community?
In 2023, emails and notes on social media are the mainstream way for scientific diffusion. So I think that these ways would be my preferred ones.
4. How did winning this award impact your career, and what do you hope to do?
This kind of award is fundamental to my professional career and future. We are now working on the future steps of our project and trying to push it to the next clinical level.
5. Could you please briefly introduce your research direction for those who may not be familiar with it?
Confocal microscopy is a new technique that obtains images intraoperatively at the microscopic level during surgeries without needing standings or fixations using classical histological techniques. So basically, with this machine, the operator can obtain intraoperatively virtual histological images during the surgery an infinite number of times. So you can check inside and outside the tumor area, at the tumor bed, etc. Of course, in neurological surgery, as in my case, this aspect could have a significant role in the near future, as the microscopic vision of tumor tissue, particularly at the margins of resection of the intra-axial or glial tumor, could increase the extent of resection, leading to an increase in postoperative survival, hopefully.
6. What inspired you to follow this line of research?
Our group at Besta Institute, headed by Dr. Ferroli and Dr. Acerbi, has been very active in intraoperative imaging surgery in the last 20–25 years. So, following this path was a natural, consecutive step.
7. What do you think sets your research apart from others?
I think that our study was the first available in the literature where a machine's ability, named CONVIVO, was studied prospectively and blindly. For instance, similar works have been performed in recent years by different groups, but almost every study was characterized by not completely controlled designs or a low number of patients. For instance, only gliomas were often included in the surgical cohorts. Furthermore, in similar works, the analysis at the margins of the tumors has always been uncontrolled, with consecutively poor results in accuracy, sensitivity, sensitivity, and specificity.
8. How do you see your research findings impacting the field of clinical medicine and other related research areas?
Confocal microscopy has been widely used in medical clinical fields in recent years, such as gastroenterology, dermatology, gynecology, and neurosurgery. It is a wonderful technology because it permits physicians, clinicians, and surgeons to have live histological images during a procedure, an exam, an endoscopy, or surgery. I think this aspect may have very relevant insights in all the fields of clinical medicine, but especially for neurosurgery, where we all need to check the difference between a normal brain and a pathologic brain, and this difference during surgery is not always easy to find. Hence, having a machine that permits the physician to check whether tissue is pathologic is very interesting.
9. What are the next steps for this research?
We just concluded a 75-patient prospective study and presented the results at several international meetings. I think the two consecutive steps would be creating a common and worldwide shared database to increase the amount of collected data regarding rarer pathologies, not just metastasis and gliomas because for pathologies that are encountered less frequently, the data are still suboptimal. The other aspect is that we still need to study the real effectiveness of this kind of technology regarding the extent of resection, especially in intra-axial tumors. This aspect is just hypothesized for now, but we need to keep going and create a clinical protocol to check the difference in the extent of resection and overall survival in patients, considering if they are operated on with the aid of CONVIVO.
10. Do you have any advice for aspiring researchers in the field?
I have some advice. First, this is a very interesting field, but it requires physicians and surgeons to increase their skill in visualizing histological images. In Italy, for example, a neurosurgical resident's ability to analyze histological images is not commonly requested (and tested) in the residency program. So, regarding this aspect, I suggest that other researchers keep their minds open. I think the more a professional figure can analyze different aspects of his proper research, from the histological image analysis to the statistical analysis, the more comprehensive and interesting ideas could become because the researcher has the instruments to talk with everyone and share ideas.
A second piece of advice that I would give everyone is not to hesitate to contact colleagues worldwide to take a tour and look at their work. In scientific papers, it very often is impossible to present all those clinical, blurred, and accessory aspects that represent ingredients necessary for good clinical results, regardless of the main theme of the research. Once again, keep your mind open and travel.
11. What is your opinion of the open access model of publishing?
Science is based on information sharing, which is the only way to improve research. Therefore, every option that permits authors to increase the diffusion of their thinking and work should always be welcomed.
You can find more information about JCM Awards at the following link: https://www.mdpi.com/journal/jcm/awards. To request further information, please contact the JCM Editorial Office ([email protected]).
Journal of Clinical Medicine Editorial Office
1 November 2023
MDPI Insights: The CEO's Letter #5 - OA Week, UK, and Strategy

Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
Open Access Week 2023 – the Global Drive to Open Continues
As the world's largest open-access (OA) publisher, we believe that unrestricted access to research findings is the cornerstone of transparency, efficiency, and quality control across scientific disciplines. At MDPI, we provide free, immediate access to scientific papers, empowering scientists to examine, validate, replicate, and build upon existing results. This minimizes redundancy, optimizes resources, and fosters innovative approaches.
International OA Week, held from 23 to 29 October 2023, provided a unique opportunity to link the global movement toward open sharing and open science with the progress of policy changes at the local level. Our mission, during OA Week and all the year round, is to offer educational resources highlighting the benefits of open-access publishing. The MDPI Blog is a valuable resource for information on open access and open science.
Core principles of OA publishing
Accessibility, transparency, and collaboration are core principles of OA publishing. OA aims to break down barriers that have traditionally restricted research access, ensuring that knowledge is available to all, regardless of financial situation or institutional affiliations. Our commitment to diverse pathways for OA publishing worldwide includes discounts for researchers. You can learn more about how MDPI supports scientific communities here.
One of the key strengths of OA publishing is its ability to facilitate interdisciplinary research. By removing paywalls and promoting knowledge-sharing across disciplines, OA encourages collaboration and innovation. Researchers from various fields can access and build upon each others’ work, fostering a holistic approach to addressing complex global challenges.
OA holds the potential to democratize knowledge, advance science, and drive positive societal change.
Policy driving change
Governments, institutions, and funding agencies have recognized the transformative potential of OA and have implemented policies to promote it. These policies often require publicly funded research to be made openly accessible, accelerating the growth of OA repositories and journals. Check out our spotlights on OA policies in the US, EU and China.
OA publishing is continuously evolving, with community-driven models and technologies shaping its future. Initiatives such as “Plan S” and “cOAlition S” promote OA publishing from the perspective of national funders, requiring grantees to publish their research openly. A new policy announced by the US administration last year mandates that, with effect from January 2026, all US federally funded research should be freely and immediately available after publication.
Additionally, preprint servers such as MDPI's Preprints.org, which allow researchers to share their findings before formal peer review, have gained popularity, enhancing the speed at which new knowledge is disseminated. The rise of blockchain technology is also being explored to ensure transparency and authenticity in scholarly publishing.
For more than two decades, OA publishing has been revolutionizing academic publishing by promoting accessibility, transparency, and collaboration. Its support for interdisciplinary research, evolving policies, and innovative practices all contribute to its growing influence in the global research community. As OA continues to expand, it holds the potential to democratize knowledge, advance science, and drive positive societal change.
MDPI is proud to lead the transition to open access.
Read more:
Impactful Research
Spotlight on Smart Cities
Smart cities will serve as a cornerstone for future human development. Their implementation will help us tackle many of the significant challenges we are facing – climate change, ageing populations, waste management, public safety, travel, and so on. Recognising the importance of this multifaceted field, MDPI launched the inaugural issue of Smart Cities in 2018 to provide an advanced forum for research into smart technology and society. Here we take a look at how this journal has developed, and its impact in this exciting field.
As at 30 October, 2023, Smart Cities has published 421 papers and has an Impact Factor of 6.4. It also has a CiteScore of 8.5, and more than one quarter of its published papers – 124 – have been cited 10 times or more.
Highly cited papers in Smart Cities
Below are several highly cited papers recently published in Smart Cities. Citation metrics are current as at 31 October 2023.
1. “Introducing the “15-Minute City”: Sustainability, Resilience and Place Identity in Future Post-Pandemic Cities”
Authors: Carlos Moreno, Zaheer Allam, Didier Chabaud, Catherine Gall and Florent Pratlong
Smart Cities 2021, 4(1), 93-111; https://doi.org/10.3390/smartcities4010006
Citations: Crossref (338), Scopus (366), Web of Science (270), Google Scholar (710)
The paper discusses the socio-economic impacts of the COVID-19 on cities, including increasing inequalities and rising unemployment. It introduces the concept of the "15-Minute City," a form of "chrono-urbanism," as a response to the challenges posed by the pandemic.
2. “A Review on Electric Vehicles: Technologies and Challenges”
Authors: Julio A. Sanguesa, Vicente Torres-Sanz, Piedad Garrido, Francisco J. Martinez and Johann M. Marquez-Barja
Smart Cities 2021, 4(1), 372-404; https://doi.org/10.3390/smartcities4010022
Citations: Crossref (359), Scopus (363), Web of Science (268), Google Scholar (558)
This paper provides an overview of the progress in Electric Vehicles (EVs), focusing on battery technology, charging methods, and emerging research challenges. It also analyzes the global EV market and its future outlook.
3. “IoT in Smart Cities: A Survey of Technologies, Practices and Challenges”
Authors: Abbas Shah Syed, Daniel Sierra-Sosa, Anup Kumar and Adel Elmaghraby
Smart Cities 2021, 4(2), 429-475; https://doi.org/10.3390/smartcities4020024
Citations: Crossref (121), Scopus (151), Web of Science (91), Google Scholar (215)
This paper gives an overview of the Internet of Things (IoT) in the context of Smart Cities, discussing the fundamental components, technologies, architectures, networking technologies, and artificial algorithms that underpin IoT-based Smart City systems.
4. “Artificial Intelligence Techniques in Smart Grid: A Survey”
Authors: Olufemi A. Omitaomu and Haoran Niu
Smart Cities 2021, 4(2), 548-568; https://doi.org/10.3390/smartcities4020029
Citations: Crossref (76), Scopus (94), Web of Science (57), Google Scholar (120)
This survey paper reviews the utilization of artificial intelligence (AI) techniques in the context of the smart grid. It covers various applications of AI in load forecasting, power grid stability assessment, fault detection, and security issues in the smart grid and power systems.
5. “The Metaverse as a Virtual Form of Smart Cities: Opportunities and Challenges for Environmental, Economic, and Social Sustainability in Urban Futures”
Authors: Zaheer Allam, Ayyoob Sharifi, Simon Elias Bibri, David Sydney Jones and John Krogstie
Smart Cities 2022, 5(3), 771-801; https://doi.org/10.3390/smartcities5030040
Citations: Crossref (72), Scopus (75), Web of Science (43), Google Scholar (176)
This paper discusses the concept of the Metaverse, a virtual world introduced by Meta (formerly Facebook), and its potential impact on urban life. It explores how emerging technologies such as AI, Big Data, IoT, and Digital Twins could reshape urban design and services in the context of the Metaverse.
Testimonial
“It was indeed a great and pleasant experience with MDPI regarding our recent publication. The submission process was very straightforward and less time-consuming than the norm. The review process was very fast compared to many other open access journals, which is praiseworthy. The support from the Editorial Office during the revision process was highly useful as well. We look forward to publishing with MDPI in the future, and I will most definitely recommend MDPI to my colleagues and collaborators.” – Dr. Luís Rosa, University of Minho
Article in Smart Cities: Mobile Networks and Internet of Things Infrastructures to Characterize Smart Human Mobility
Inside MDPI
MDPI Manchester office, UK Visit
Allie Shi (Editorial Director, MDPI), Stefan Tochev (CEO, MDPI), Jamie Anderson (Manchester Office Manager, MDPI), Michael O’Sullivan (Senior Scientific Officer, MDPI), Hushneara Akhtar, and Becky Castellon (IOAP Team Lead, MDPI), dining out in Manchester, UK.
In October, I visited MDPI’s new office in Manchester. During the visit, I connected with our English Editing (EE) managers, Scientific Officer, members of the Editorial team, the Marketing team, and IOAP Team Lead.
Our Manchester office focuses primarily on EE services and provides local support for the UK market. Additionally, we regularly visit Editorial Board members and participate in local conferences.
I would like to thank Jamie Anderson, Manchester Office Manager, and her team, for their deep commitment to our Manchester staff and to MDPI’s impact on the UK market.
The UK by numbers
The UK is a hub for the world’s top universities, making it a key market for MDPI and the publishing world in general. It is home to two of the top-five-ranked universities globally, 11 in the top 100, and 15 in the top 200.
As a result, the UK plays a key role in MDPI’s global market. As at October 2023, it ranks as the seventh-largest contributor to the total number of papers published by MDPI. We have 3,500 Editorial Board members affiliated with UK institutions, including 34 serving as Editors-in-Chief (EiCs). Our commitment to collaboration with institutions is evident in the UK, where we have successfully established some 60 Institutional Open Access Program (IOAP) agreements with esteemed institutions, such as the University of Oxford, the University of Cambridge, Imperial College London, the University of Edinburgh, and more.
According to InCites Dataset + ESCI for the period 2018–2022, as at October 2023, nearly 65% of UK papers are now published as OA. Just over 10% of total OA publications are by UK authors. UK papers are known for their high quality, with an average of 11 citations per paper. Furthermore, 2.16% of UK papers are in the top 1% of cited papers, and 14.61% are in the top 10% of cited papers, showcasing their impact.
We are currently hiring EEs in various locations worldwide.
English Editing at MDPI
Our English Editing (EE) department consists of two main branches, Quality Control and Learning and Development, reflecting our priorities. We are continuously enhancing the quality of our English Editing services and have raised the relevant standards, which now extend to company-wide communications. English editors participate in international interviews, conduct English assessments, and provide colleagues with presentations on ways to improve their use of written and spoken English.
While expanding, the EE department has proactively refocused its efforts on the quality of our work and how the English Editing department can benefit the company more broadly. We currently have approximately 140 full-time English Editors based across five offices worldwide, supplemented by over 700 freelance English editors.
Our Manchester office serves as the hub for the EE Department, with EE Managers situated there, except for Kurtis Jackson, who serves as the Head of EE and is located in our Basel office. Manchester EEs play a critical role in establishing and developing EE teams in our other offices, overseeing management and recruitment. The EE department plays a vital role in MDPI’s operations, as it is the department that touches every published paper. If this work interests you, I encourage you to explore our available EE positions, whether you are seeking full-time or freelance opportunities.
Testimonials
“MDPI provides an excellent service compared to any other previously used services. It delivers fast and high-quality results but at an affordable price.” – Ardha Apriyanto, University of Potsdam
“In my role as a professor, I consider that MDPI Author Services offer an excellent quality in the editing of Western academic writing while maintaining the required standards of clarity, precision and rigor. Additionally, delivery times are fast compared to other available services.” – Jesus Insuasti, University of Nariño
Read more:
Coming Together for Science
STM and Frankfurt Book Fair
Attending STM
MDPI has been a proud sponsor of the STM Conference for several years. The STM Conference is a dynamic event featuring interactive sessions, expert panellists, idea-sharing, and ample networking opportunities. On 16 October, the event kicked off with arrival drinks, sponsored by MDPI, followed by a welcoming dinner, providing a great chance to connect and network with industry professionals. The following day was filled with speakers, sessions, and further opportunities to connect. STM exemplifies the collaborative spirit of the scientific community, with session topics including achieving open, visible, and impactful research at scale; maintaining research integrity in a rapidly changing world; and exploring the impact of ever-evolving technology in the scholarly community.
Meeting with Web of Science
On a personal note, one of the highlights of STM was a candid and productive conversation with Nandita Quaderi, Editor-in-Chief and SVP at Web of Science. During our discussion, we talked about MDPI, Web of Science, the IJERPH delisting, and ways of moving forward. This open conversation aimed at fostering better collaboration for the future.
“We discussed ways to improve our communication and collaboration.”
I appreciated our frank discussion and felt that Nandita wholeheartedly supports open access. She also expressed her appreciation for the monthly CEO Letter, which she sees as a way to add personality to the MDPI brand and provide insight into the great work we do at MDPI. While we highlighted the positives, we also discussed ways to improve our communication and collaboration moving forward. This meeting alone made the trip worthwhile, and I hope Nandita doesn’t mind my sharing that she found our chat to be “the most honest and constructive discussion” she’s had with someone from MDPI in recent years.
75th Frankfurt Book Fair
Jelena Milojevic (Book Editor, MDPI), Jovana Dubajic (Book Editor, MDPI), Evan Escamilla (Project Manager, MDPI), Laura Wagner (Head of Books, MDPI), and Jenny Knowles (Commissioning Editor, MDPI), at the Frankfurt Book Fair in Frankfurt am Main, Germany.
For the 75th time, the Frankfurter Buchmesse opened its doors in October to celebrate exciting stories and their authors. If you haven’t yet had the chance to visit the Frankfurt Book Fair, I highly recommend it. It’s the largest book fair in the world, attracting thousands of visitors from around the globe. This is the place to gain valuable industry insights from top-class publishing professionals, connect with publishers directly, and learn about the latest trends in publishing.
MDPI Books
Our Books team was also present at the Frankfurt Book Fair, networking and learning from various panels. Did you know that our MDPI Books department publishes OA Books?
The book publishing program includes monographs, book series, edited books and reprints of special issues and topical collections, among other book types.
If you have a book proposal you would like to discuss, please feel free to contact our Books team to understand the benefits and methods of publishing your next book with the OA model.
Closing Thoughts
MDPI Strategy Meeting
As the newly appointed CEO, this is my first year leading the MDPI Senior Management Strategy session. I saw it as an opportunity to explore what MDPI has the potential to become in the next five years. Guided by the vision of its founder and President, Dr. Shu-kun Lin, the company has accomplished remarkable feats over the past 27 years and currently holds the position as the world’s third-largest academic publisher, following Springer Nature and Elsevier.
Our primary objective is to build upon the milestones of the past decades and consolidate MDPI’s position as well-established publishing brand. The two-day meeting emphasized the importance of communicating MDPI’s values more actively via its brand and adopting a straightforward yet impactful approach to managing MDPI as a mature academic publisher.
“Our primary objective is to consolidate MDPI’s position as well-established publishing brand”
As the world’s number one open-access publisher, MDPI has long been a game-changer in the scholarly community, serving millions of authors. The challenge in being a trailblazer is the need to continuously improve and at the same time explore the next blue-ocean strategy, while also maintaining the smooth operation of the business. Our collection model, featuring guest-curated thematic topics in the form of Special Issues, has disrupted the industry. Other publishers closely study us and attempt to replicate our models. The future of this collection model is something we are actively addressing – while, of course, looking ahead to what comes next!
Chief Executive Officer
MDPI AG
24 October 2023
JCM 2023 Best Ph.D. Thesis Award—Open for Applications

The Journal of Clinical Medicine (JCM, ISSN: 2077-0383) is inviting applications for the JCM 2023 Ph.D. Thesis Award. This prize will be awarded to a Ph.D. student or recently qualified Ph.D. fellow who has produced a highly anticipated thesis with great academic potential. The applications will be assessed by an evaluation committee led by the Editors-in-Chief, Dr. Emmanuel Andrès and Prof. Dr. Michael G. Hennerici.
Eligibility and requirements:
- The candidate must be a Ph.D. student or recently qualified Ph.D. fellow who has produced a highly anticipated thesis with great academic potential;
- The Ph.D. thesis must be their original work;
- The Ph.D. thesis must be defended in 2023.
Required application documents:
- An executive summary of the Ph.D. thesis in English of around 3000 words;
- A letter from the Ph.D. supervisor recommending the candidate for consideration for this award;
- The candidate’s CV, including a list of publications connected with the thesis;
- An electronic copy of the Ph.D. thesis;
- A scanned copy of the Ph.D. diploma (or certificate of studying at a school or research institute as a Ph.D. student going to graduate or participate in graduation thesis defenses).
Selection criteria:
- Quality of resume and publications;
- Relevance of the candidate and research description;
- Novelty of the candidate’s Ph.D. thesis;
- Strength of the recommendation letter;
- Anticipated academic potential;
- Originality and impact of the research.
Prizes:
- CHF 800;
- Certificate;
- Offer to publish one paper free of charge in JCM after peer review before the end of 2024.
The application deadline is 30 April 2024. The winner will be announced on the JCM website by the end of June 2024.
JCM Editorial Office
19 October 2023
Open Access Week 2023 – the Global Drive to Open Continues

MDPI has been a strong proponent of the open access publishing model right from the beginning. As one of the pioneering fully open access publishers, we firmly believe that unrestricted access to research findings forms the foundation for better transparency, efficiency, and quality control across all scientific disciplines.
In December 2022, we reached a significant milestone by surpassing one million articles published. That is one million articles freely available to all, to circulate and build upon!
Offering free and immediate access to scientific papers empowers scientists to examine, validate, replicate, and expand upon existing results. This not only helps prevent redundancy and optimizes how resources are used but also paves the way for innovative new approaches.
The International Open Access Week takes place from 23 to 29 October 2023, providing a unique opportunity to connect the global movement towards open sharing and open science with the progress of policy transformations at the local level.
Our goal, during Open Access Week as well as throughout the year, is to offer resources for educating people about the benefits of open access publishing. The MDPI Blog offers a wealth of information around open access and open science.
Promoting the values of accessibility, transparency, and collaboration
Open access publishing embodies the fundamental values of democratizing knowledge and fostering global accessibility. It aims to break down barriers that have traditionally limited access to scholarly work, ensuring that knowledge is available to all, regardless of their financial or institutional affiliations.
Discounts are part of our commitment to ensuring there are diverse pathways to Open Access publishing for researchers worldwide. MDPI supports scientific communities in several different ways.
One of the key strengths of open access publishing lies in its ability to facilitate interdisciplinary research. By removing paywalls and promoting the sharing of knowledge across disciplines, OA encourages collaboration and innovation. Researchers from diverse fields can access and build upon each other's work, fostering a holistic approach to addressing complex global challenges.
Funders' policies are getting aligned with open science
Governments, institutions, and funding agencies have recognized the transformative potential of open access and have implemented policies to promote it. These policies often mandate that publicly funded research should be made openly accessible. Such initiatives have accelerated the growth of open access repositories and journals, reinforcing the commitment to open access principles. Check our spotlights on OA policies in the US, EU and China.
Open access publishing is continually evolving, with innovative and community-driven models and technologies shaping its future. Initiatives like "Plan S" and "cOAlition S" promote the adoption of OA publishing from the national funders’ perspective by requiring grantees to publish their research openly. A new policy announced by the US administration last year requires that, as of January 2026, all US federally funded research be made freely and immediately available after publication.
Additionally, preprint servers such as MDPI's Preprints.org, which allow researchers to share their findings before formal peer review, have gained popularity, enhancing the speed at which new knowledge is disseminated. The rise of blockchain technology is also being explored to ensure transparency and authenticity in scholarly publishing.
For more than twenty years, open access scholarly publishing has been revolutionizing academia by promoting the values of accessibility, transparency, and collaboration. Its support for interdisciplinary research, evolving policies, and innovative practices all contribute to its growing influence in the global research community. As open access continues to expand, it holds the potential to democratize knowledge, advance science, and drive positive societal change.
MDPI is proud to be a leader in the transition to open access.
18 October 2023
Meet Us at Neuroscience 2023, 11–15 November 2023, Washington, DC, USA

Neuroscience 2023 will be held from 11 to 15 November 2023 in Washington, DC, USA. The conference is organized by the Society for Neuroscience.
The conference will gather scientists, clinicians, and decision makers from around the world, creating a platform for the communication of knowledge and the sharing of groundbreaking research on the brain as well as nervous system. As stated in the introduction to the conference, you can “Present new research. Exchange ideas. Expand collaborations. Strengthen your career.”
As one of the exhibitors of Neuroscience 2022 last year, MDPI will be a part of Neuroscience 2023 this year, and looks forward to meeting our scholars as well as new friends, hoping to impress you with our open access publishing model face-to-face.
The following MDPI journals will be represented:
- Brain Sciences.
- JCM.
- Cells.
- NeuroSci.
- J. Intell.
- Neuroglia.
- JPM.
- Biomedicines.
- Clinics and Practice.
- Diagnostics.
- Neurology International.
- Pathophysiology.
- Psych.
If you are attending this conference, please feel free to start an online conversation with us. Our delegates look forward to meeting you in person at the booth and answering any questions that you may have. For more information about the conference, please visit the following link: https://www.sfn.org/meetings/neuroscience-2023.
17 October 2023
JCM 2024 Travel Award—Open for Applications

We are pleased to announce that the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) will grant a Travel Award to two junior scientists. The applications will be assessed by an Evaluation Committee consisting of senior scholars from the JCM Editorial Board.
This award provides financial support for the winners to hold a presentation, present a poster, or both, at an international conference in the field of clinical medicine in 2024.
Candidate requirements:
- Postdoctoral fellows or Ph.D. students;
- Plans to attend an international conference in 2024 (oral presentation or poster).
Required application documents:
- Information of the conference the applicant is planning to attend and the abstract that will be submitted;
- CV and list of publications;
- Justification letter describing the focus of the research (max. 800 words);
- Letter of recommendation from the supervisor, research director, or department head, which also confirms the applicant’s status as a postdoctoral fellow/Ph.D. student.
The winners (two awardees) will each be awarded CHF 800 and a certificate.
Please submit your applications for the JCM 2024 Travel Award online by 31 December 2023.
JCM Editorial Office
16 October 2023
Journal of Clinical Medicine | Global Day against Pain 2023

The Global Day against Pain, celebrated every year on the third Monday of October, is supported by the World Health Organization (WHO), which considers that the “treatment of pain and palliative care form an integral part of the right to enjoy good health”.
To further explore the related research on the 2023 Global Day against Pain, the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) has gathered open access academic articles on the topic of pain. We hope to share new scientific knowledge in this field with the world on this special day.
Article Collection:
1. “New Generation Gepants: Migraine Acute and Preventive Medications”
by David Moreno-Ajona, María Dolores Villar-Martínez and Peter J. Goadsby
J. Clin. Med. 2022, 11(6), 1656; https://doi.org/10.3390/jcm11061656
Available online: https://www.mdpi.com/2077-0383/11/6/1656
2. “Endometriosis, an Ongoing Pain—Step-by-Step Treatment”
by Sylvia Mechsner
J. Clin. Med. 2022, 11(2), 467; https://doi.org/10.3390/jcm11020467
Available online: https://www.mdpi.com/2077-0383/11/2/467
3. “Novel Therapies for the Treatment of Neuropathic Pain: Potential and Pitfalls”
by Pottathil Shinu, Mohamed A. Morsy, Anroop B. Nair, Abdulaziz K. Al Mouslem, Katharigatta N. Venugopala, Manoj Goyal, Monika Bansal, Shery Jacob and Pran Kishore Deb
J. Clin. Med. 2022, 11(11), 3002; https://doi.org/10.3390/jcm11113002
Available online: https://www.mdpi.com/2077-0383/11/11/3002
4. “Effect of Preoperative Anxiety on Postoperative Pain after Craniotomy”
by Lucía Valencia, Ángel Becerra, Nazario Ojeda, Ancor Domínguez, Marcos Prados, Jesús María González-Martín and Aurelio Rodríguez-Pérez
J. Clin. Med. 2022, 11(3), 556; https://doi.org/10.3390/jcm11030556
Available online: https://www.mdpi.com/2077-0383/11/3/556
5. “Platelet-Rich Plasma Releasate versus Corticosteroid for the Treatment of Discogenic Low Back Pain: A Double-Blind Randomized Controlled Trial”
by Koji Akeda, Kohshi Ohishi, Norihiko Takegami, Takao Sudo, Junichi Yamada, Tatsuhiko Fujiwara, Rui Niimi, Takeshi Matsumoto, Yuki Nishimura, Toru Ogura et al.
J. Clin. Med. 2022, 11(2), 304; https://doi.org/10.3390/jcm11020304
Available online: https://www.mdpi.com/2077-0383/11/2/304
6. “Knee Pain from Osteoarthritis: Pathogenesis, Risk Factors, and Recent Evidence on Physical Therapy Interventions”
by Jean-Philippe Berteau
J. Clin. Med. 2022, 11(12), 3252; https://doi.org/10.3390/jcm11123252
Available online: https://www.mdpi.com/2077-0383/11/12/3252
7. “State-of-the-Art Review on Immersive Virtual Reality Interventions for Colonoscopy-Induced Anxiety and Pain”
by Marcel-Alexandru Găină, Andreea Silvana Szalontay, Gabriela Ștefănescu, Gheorghe Gh Bălan, Cristina Mihaela Ghiciuc, Alexandra Boloș, Alexandra-Maria Găină and Cristinel Ștefănescu
J. Clin. Med. 2022, 11(6), 1670; https://doi.org/10.3390/jcm11061670
Available online: https://www.mdpi.com/2077-0383/11/6/1670
8. “Different Machine Learning Approaches for Implementing Telehealth-Based Cancer Pain Management Strategies”
by Marco Cascella, Sergio Coluccia, Federica Monaco, Daniela Schiavo, Davide Nocerino, Mariacinzia Grizzuti, Maria Cristina Romano and Arturo Cuomo
J. Clin. Med. 2022, 11(18), 5484; https://doi.org/10.3390/jcm11185484
Available online: https://www.mdpi.com/2077-0383/11/18/5484
9. “Effect of a Craniosacral Therapy Protocol in People with Migraine: A Randomized Controlled Trial”
by Elena Muñoz-Gómez, Marta Inglés, Marta Aguilar-Rodríguez, Sara Mollà-Casanova, Núria Sempere-Rubio, Pilar Serra-Añó and Gemma V. Espí-López
J. Clin. Med. 2022, 11(3), 759; https://doi.org/10.3390/jcm11030759
Available online: https://www.mdpi.com/2077-0383/11/3/759
10. “Factors Influencing Pain Management of Patients with Osteoarthritis: A Cross-Sectional Study”
by Gyöngyi Anna Mezey, Zsuzsanna Máté and Edit Paulik
J. Clin. Med. 2022, 11(5), 1352; https://doi.org/10.3390/jcm11051352
Available online: https://www.mdpi.com/2077-0383/11/5/1352
11. “Association between Metformin Use and Risk of Total Knee Arthroplasty and Degree of Knee Pain in Knee Osteoarthritis Patients with Diabetes and/or Obesity: A Retrospective Study”
by Shibo Chen, Guangfeng Ruan, Muhui Zeng, Tianyu Chen, Peihua Cao, Yan Zhang, Jia Li, Xiaoshuai Wang, Shengfa Li, Su’an Tang et al.
J. Clin. Med. 2022, 11(16), 4796; https://doi.org/10.3390/jcm11164796
Available online: https://www.mdpi.com/2077-0383/11/16/4796
12. “The Importance of Nutrition as a Lifestyle Factor in Chronic Pain Management: A Narrative Review”
by Ömer Elma, Katherine Brain and Huan-Ji Dong
J. Clin. Med. 2022, 11(19), 5950; https://doi.org/10.3390/jcm11195950
Available online: https://www.mdpi.com/2077-0383/11/19/5950
13. “Chronic Pain and Emotional Stroop: A Systematic Review”
by Lidia Amaro-Díaz, Casandra I. Montoro, Laura R. Fischer-Jbali and Carmen M. Galvez-Sánchez
J. Clin. Med. 2022, 11(12), 3259; https://doi.org/10.3390/jcm11123259
Available online: https://www.mdpi.com/2077-0383/11/12/3259
14. “Reduction of Thoracic Hyper-Kyphosis Improves Short and Long Term Outcomes in Patients with Chronic Nonspecific Neck Pain: A Randomized Controlled Trial”
by Ibrahim Moustafa Moustafa, Tamer Mohamed Shousha, Lori M. Walton, Veena Raigangar and Deed E. Harrison
J. Clin. Med. 2022, 11(20), 6028; https://doi.org/10.3390/jcm11206028
Available online: https://www.mdpi.com/2077-0383/11/20/6028
15. “Trends in the Management of Headache Disorders in US Emergency Departments: Analysis of 2007–2018 National Hospital Ambulatory Medical Care Survey Data”
by Seonkyeong Yang, Yulia Orlova, Abigale Lipe, Macy Boren, Juan M. Hincapie-Castillo, Haesuk Park, Ching-Yuan Chang, Debbie L. Wilson, Lauren Adkins and Wei-Hsuan Lo-Ciganic
J. Clin. Med. 2022, 11(5), 1401; https://doi.org/10.3390/jcm11051401
Available online: https://www.mdpi.com/2077-0383/11/5/1401
Access more articles here.
Call for Papers:
1. Special Issue “Low Back Pain Management: Clinical Advances and Perspectives”
Guest Editor: Dr. Maryse Fortin
Submission Deadline: 20 December 2023
2. Special Issue “Neuropathic Pain Management and Deep Brain Stimulation in Clinical Practice”
Guest Editor: Dr. Sylvie Raoul
Submission Deadline: 20 December 2023
3. Special Issue “Pain and Rheumatology”
Guest Editors: Prof. Dr. Giustino Varrassi, Prof. Dr. Piercarlo Sarzi-Puttini and Prof. Dr. Stefano Coaccioli
Submission Deadline: 31 December 2023
Access more Special Issues here.
Special Issue Books:
1. “Chronic Pain: Clinical Updates and Perspectives”
2. “Lifestyle and Chronic Pain”
Access more Special Issue books here.
13 October 2023
Meet Us at the 34th Annual Meeting of the Japanese Society of Clinical Sports Medicine, 11–12 November 2023, Tokyo, Japan

MDPI will be attending the 34th Annual Meeting of the Japanese Society of Clinical Sports Medicine, which will be held from 11 to 12 November in Tokyo, Japan.
The theme of this academic conference is "Cooperation and Evolution". As many academic conferences have been held online due to the coronavirus pandemic, we are now realizing that one of the most important aspects of academic conferences is the face-to-face exchange of information inside and outside the academic venue. This academic conference will aim to promote the future progress of sports medicine by disseminating the research results of each person who has made progress during the coronavirus pandemic and by bringing together many participants for full discussions.
The following MDPI journals will be represented:
- Sports;
- Medicina;
- JPM;
- Nutrients;
- JCM;
- IJERPH;
- STD;
- Geriatrics.
If you are planning to attend this conference, please feel free to stop by our booth and chat with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://www.34rinspo.jp/index.html.
12 October 2023
Journal of Clinical Medicine | World Sight Day 2023—“Love Your Eyes at Work”

World Sight Day, held annually on the second Thursday of October, is a global event meant to draw attention to blindness and vision impairment. This year’s theme is “Love your eyes at work”.
To further explore related research on World Sight Day 2023, the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) has brought together open access academic articles from the Section “Ophthalmology”. We hope to share new scientific knowledge in the field of eye health with the world on this special day.
Article Collection:
1. “Managing Neovascular Age-Related Macular Degeneration in Clinical Practice: Systematic Review, Meta-Analysis, and Meta-Regression”
by Daniele Veritti, Valentina Sarao, Valentina Soppelsa, Carla Danese, Jay Chhablani and Paolo Lanzetta
J. Clin. Med. 2022, 11(2), 325; https://doi.org/10.3390/jcm11020325
Available online: https://www.mdpi.com/2077-0383/11/2/325
2. “Vision-Threatening Ocular Adverse Events after Vaccination against Coronavirus Disease 2019”
by Mihyun Choi, Min-Hwan Seo, Kwang-Eon Choi, Sukyeon Lee, Boyoon Choi, Cheolmin Yun, Seong-Woo Kim and Yong Yeon Kim
J. Clin. Med. 2022, 11(12), 3318; https://doi.org/10.3390/jcm11123318
Available online: https://www.mdpi.com/2077-0383/11/12/3318
3. “Scleral Buckling: A Review of Clinical Aspects and Current Concepts”
by Matteo Fallico, Pietro Alosi, Michele Reibaldi, Antonio Longo, Vincenza Bonfiglio, Teresio Avitabile and Andrea Russo
J. Clin. Med. 2022, 11(2), 314; https://doi.org/10.3390/jcm11020314
Available online: https://www.mdpi.com/2077-0383/11/2/314
4. “The Dual Effect of Rho-Kinase Inhibition on Trabecular Meshwork Cells Cytoskeleton and Extracellular Matrix in an In Vitro Model of Glaucoma”
by Juliette Buffault, Françoise Brignole-Baudouin, Élodie Reboussin, Karima Kessal, Antoine Labbé, Stéphane Mélik Parsadaniantz and Christophe Baudouin
J. Clin. Med. 2022, 11(4), 1001; https://doi.org/10.3390/jcm11041001
Available online: https://www.mdpi.com/2077-0383/11/4/1001
5. “Meibomian Gland Density: An Effective Evaluation Index of Meibomian Gland Dysfunction Based on Deep Learning and Transfer Learning”
by Zuhui Zhang, Xiaolei Lin, Xinxin Yu, Yana Fu, Xiaoyu Chen, Weihua Yang and Qi Dai
J. Clin. Med. 2022, 11(9), 2396; https://doi.org/10.3390/jcm11092396
Available online: https://www.mdpi.com/2077-0383/11/9/2396
6. “Subretinal Injection Techniques for Retinal Disease: A Review”
by Cristina Irigoyen, Asier Amenabar Alonso, Jorge Sanchez-Molina, María Rodríguez-Hidalgo, Araceli Lara-López and Javier Ruiz-Ederra
J. Clin. Med. 2022, 11(16), 4717; https://doi.org/10.3390/jcm11164717
Available online: https://www.mdpi.com/2077-0383/11/16/4717
7. “Post Penetrating Keratoplasty Ectasia: Incidence, Risk Factors, Clinical Features, and Treatment Options”
by Antonio Moramarco, Lorenzo Gardini, Danilo Iannetta, Piera Versura and Luigi Fontana
J. Clin. Med. 2022, 11(10), 2678; https://doi.org/10.3390/jcm11102678
Available online: https://www.mdpi.com/2077-0383/11/10/2678
8. “Choroidal Thickness in Different Patterns of Diabetic Macular Edema”
by Rida Amjad, Cheong-Ah Lee, Hafiz Muhammad Umer Farooqi, Hina Khan and Dong-Guk Paeng
J. Clin. Med. 2022, 11(20), 6169; https://doi.org/10.3390/jcm11206169
Available online: https://www.mdpi.com/2077-0383/11/20/6169
9. “360° Ab-Interno Schlemm’s Canal Viscodilation with OMNI Viscosurgical Systems for Open-Angle Glaucoma—Midterm Results”
by Giacomo Toneatto, Marco Zeppieri, Veronica Papa, Laura Rizzi, Carlo Salati, Andrea Gabai and Paolo Brusini
J. Clin. Med. 2022, 11(1), 259; https://doi.org/10.3390/jcm11010259
Available online: https://www.mdpi.com/2077-0383/11/1/259
10. “A Comprehensive Update on Retinal Vasculitis: Etiologies, Manifestations and Treatments”
by Aniruddha Agarwal, Anne Rübsam, Lynn zur Bonsen, Francesco Pichi, Piergiorgio Neri and Uwe Pleyer
J. Clin. Med. 2022, 11(9), 2525; https://doi.org/10.3390/jcm11092525
Available online: https://www.mdpi.com/2077-0383/11/9/2525
11. “In Vitro Chromatic Performance of Three Presbyopia-Correcting Intraocular Lenses with Different Optical Designs”
by Diego Montagud-Martínez, Vicente Ferrando, Anabel Martínez-Espert, Salvador Garcia-Delpech, Juan A. Monsoriu and Walter D. Furlan
J. Clin. Med. 2022, 11(5), 1212; https://doi.org/10.3390/jcm11051212
Available online: https://www.mdpi.com/2077-0383/11/5/1212
12. “Long-Term Outcomes of a Kahook Dual Blade Procedure Combined with Phacoemulsification in Japanese Patients with Open-Angle Glaucoma”
by Kentaro Iwasaki, Hiroshi Kakimoto, Yusuke Orii, Shogo Arimura, Yoshihiro Takamura and Masaru Inatani
J. Clin. Med. 2022, 11(5), 1354; https://doi.org/10.3390/jcm11051354
Available online: https://www.mdpi.com/2077-0383/11/5/1354
13. “Myopia Control Effect Is Influenced by Baseline Relative Peripheral Refraction in Children Wearing Defocus Incorporated Multiple Segments (DIMS) Spectacle Lenses”
by Hanyu Zhang, Carly S. Y. Lam, Wing-Chun Tang, Myra Leung, Hua Qi, Paul H. Lee and Chi-Ho To
J. Clin. Med. 2022, 11(9), 2294; https://doi.org/10.3390/jcm11092294
Available online: https://www.mdpi.com/2077-0383/11/9/2294
14. “Dry Eye Parameters and Lid Geometry in Adults Born Extremely, Very, and Moderately Preterm with and without ROP: Results from the Gutenberg Prematurity Eye Study”
by Achim Fieß, Clara Hufschmidt-Merizian, Sandra Gißler, Ulrike Hampel, Eva Mildenberger, Michael S. Urschitz, Fred Zepp, Bernhard Stoffelns, Norbert Pfeiffer and Alexander K. Schuster
J. Clin. Med. 2022, 11(10), 2702; https://doi.org/10.3390/jcm11102702
Available online: https://www.mdpi.com/2077-0383/11/10/2702
15. “Pharmacological Treatment in Presbyopia”
by Andrzej Grzybowski and Varis Ruamviboonsuk
J. Clin. Med. 2022, 11(5), 1385; https://doi.org/10.3390/jcm11051385
Available online: https://www.mdpi.com/2077-0383/11/5/1385
Access more articles here.
Call for Papers:
1. “Latest Advances in the Diagnosis and Management of Vitreo-Retinal Disorders”
Guest Editor: Prof. Dr. Takeshi Iwase
Submission Deadline: 15 November 2023
2. “Current Update and Perspectives in Corneal Disorders”
Guest Editors: Dr. Domenico Schiano-Lomoriello and Dr. Anna Maria Roszkowska
Submission Deadline: 25 November 2023
3. “Clinical Presentation and Management of Eye Infections”
Guest Editor: Dr. Reza Razaghi
Submission Deadline: 18 December 2023
Access more Special Issues here.
Special Issue Books:
1. “Advances in Glaucoma Surgery”
2. “Current Challenges and Advances in Cataract Surgery”
3. “Intraocular Pressure and Ocular Hypertension”
Access more Special Issue books here.
12 October 2023
Journal of Clinical Medicine | World Arthritis Day 2023

World Arthritis Day (WAD) is a global awareness day held annually on 12 October. It aims to increase the knowledge of all audiences of the existence as well as impact of rheumatic and musculoskeletal diseases (RMDs). RMDs comprise over 200 diseases and syndromes, which are usually progressive and associated with pain.
To further explore the related research on World Arthritis Day 2023, the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) has gathered open access academic research on rheumatic and musculoskeletal diseases. We hope to share interesting and up-to-date scientific knowledge in this field.
Article Collection:
1. “Secondary Osteoporosis and Metabolic Bone Diseases”
by Mahmoud M. Sobh, Mohamed Abdalbary, Sherouk Elnagar, Eman Nagy, Nehal Elshabrawy, Mostafa Abdelsalam, Kamyar Asadipooya and Amr El-Husseini
J. Clin. Med. 2022, 11(9), 2382; https://doi.org/10.3390/jcm11092382
Available online: https://www.mdpi.com/2077-0383/11/9/2382
2. “Autologous Microfragmented Adipose Tissue for the Treatment of Knee Osteoarthritis: Real-World Data at Two Years Follow-Up”
by Daniele Screpis, Simone Natali, Luca Farinelli, Gianluca Piovan, Venanzio Iacono, Laura de Girolamo, Marco Viganò and Claudio Zorzi
J. Clin. Med. 2022, 11(5), 1268; https://doi.org/10.3390/jcm11051268
Available online: https://www.mdpi.com/2077-0383/11/5/1268
3. “Induction and Maintenance Treatment of Lupus Nephritis: A Comprehensive Review of Meta-Analyses”
by Jae Il Shin, Han Li, Seoyeon Park, Jae Won Yang, Keum Hwa Lee, Yongsuk Jo, Seongeun Park, Jungmin Oh, Hansol Kim, Hyo Jin An et al.
J. Clin. Med. 2022, 11(2), 343; https://doi.org/10.3390/jcm11020343
Available online: https://www.mdpi.com/2077-0383/11/2/448
4. “Lifestyle Factors and Their Influence on Rheumatoid Arthritis: A Narrative Review”
by Christoph Schäfer and Gernot Keyßer
J. Clin. Med. 2022, 11(23), 7179; https://doi.org/10.3390/jcm11237179
Available online: https://www.mdpi.com/2077-0383/11/23/7179
5. “Systemic Scleroderma—Definition, Clinical Picture and Laboratory Diagnostics”
by Piotr Gałecki, Jerzy Samochowiec, Magdalena Mikułowska and Agata Szulc
J. Clin. Med. 2022, 11(9), 2299; https://doi.org/10.3390/jcm11092299
Available online: https://www.mdpi.com/2077-0383/11/9/2299
6. “Systemic Lupus Erythematosus and Lung Involvement: A Comprehensive Review”
by Jae Il Shin, Keum Hwa Lee, Seoyeon Park, Jae Won Yang, Hyung Ju Kim, Kwanhyuk Song, Seungyeon Lee, Hyeyoung Na, Yong Jun Jang, Ju Yun Nam et al.
J. Clin. Med. 2022, 11(22), 6714; https://doi.org/10.3390/jcm11226714
Available online: https://www.mdpi.com/2077-0383/11/22/6714
7. “Osteoarthritis: Pathogenesis, Animal Models, and New Regenerative Therapies”
by Tomasz Szponder, Michał Latalski, Anna Danielewicz, Katarzyna Krać, Aleksandra Kozera, Beata Drzewiecka, Dominika Nguyen Ngoc, Dominika Dobko and Joanna Wessely-Szponder
J. Clin. Med. 2023, 12(1), 5; https://doi.org/10.3390/jcm12010005
Available online: https://www.mdpi.com/2077-0383/12/1/5
8. “Unraveling the Signaling Secretome of Platelet-Rich Plasma: Towards a Better Understanding of Its Therapeutic Potential in Knee Osteoarthritis”
by Cristina Del Amo, Arantza Perez-Valle, Leire Atilano and Isabel Andia
J. Clin. Med. 2022, 11(3), 473; https://doi.org/10.3390/jcm11030473
Available online: https://www.mdpi.com/2077-0383/11/3/473
9. “Knee Pain from Osteoarthritis: Pathogenesis, Risk Factors, and Recent Evidence on Physical Therapy Interventions”
by Jean-Philippe Berteau
J. Clin. Med. 2022, 11(12), 3252; https://doi.org/10.3390/jcm11123252
Available online: https://www.mdpi.com/2077-0383/11/12/3252
10. “Short- and Long-Term Effectiveness of Low-Level Laser Therapy Combined with Strength Training in Knee Osteoarthritis: A Randomized Placebo-Controlled Trial”
by Martin Bjørn Stausholm, Ingvill Fjell Naterstad, Patricia Pereira Alfredo, Christian Couppé, Kjartan Vibe Fersum, Ernesto Cesar Pinto Leal-Junior, Rodrigo Álvaro Brandão Lopes-Martins, Jon Joensen and Jan Magnus Bjordal
J. Clin. Med. 2022, 11(12), 3446; https://doi.org/10.3390/jcm11123446
Available online: https://www.mdpi.com/2077-0383/11/12/3446
11. “Curcumin: Useful add-on for Rheumatic Diseases?”
by Stylianos Tomaras, Gernot Keyßer and Eugen Feist
J. Clin. Med. 2022, 11(10), 2908; https://doi.org/10.3390/jcm11102908
Available online: https://www.mdpi.com/2077-0383/11/10/2908
12. “Factors Influencing Pain Management of Patients with Osteoarthritis: A Cross-Sectional Study”
by Gyöngyi Anna Mezey, Zsuzsanna Máté and Edit Paulik
J. Clin. Med. 2022, 11(5), 1352; https://doi.org/10.3390/jcm11051352
Available online: https://www.mdpi.com/2077-0383/11/5/1352
13. “Effect of Combined Intraosseous and Intraarticular Infiltrations of Autologous Platelet-Rich Plasma on Subchondral Bone Marrow Mesenchymal Stromal Cells from Patients with Hip Osteoarthritis”
by Payal Ganguly, Nicolás Fiz, Maider Beitia, Heather E. Owston, Diego Delgado, Elena Jones and Mikel Sánchez
J. Clin. Med. 2022, 11(13), 3891; https://doi.org/10.3390/jcm11133891
Available online: https://www.mdpi.com/2077-0383/11/13/3891
14. “Associations of IL-18 with Altered Cardiovascular Risk Profile in Psoriatic Arthritis and Ankylosing Spondylitis”
by Krzysztof Bonek, Ewa Kuca-Warnawin, Anna Kornatka, Agnieszka Zielińska, Małgorzata Wisłowska, Ewa Kontny and Piotr Głuszko
J. Clin. Med. 2022, 11(3), 766; https://doi.org/10.3390/jcm11030766
Available online: https://www.mdpi.com/2077-0383/11/3/766
15. “The Impacts of the Clinical and Genetic Factors on Chronic Damage in Caucasian Systemic Lupus Erythematosus Patients”
by Fulvia Ceccarelli, Giulio Olivieri, Carmelo Pirone, Cinzia Ciccacci, Licia Picciariello, Francesco Natalucci, Carlo Perricone, Francesca Romana Spinelli, Cristiano Alessandri, Paola Borgiani et al.
J. Clin. Med. 2022, 11(12), 3368; https://doi.org/10.3390/jcm11123368
Available online: https://www.mdpi.com/2077-0383/11/12/3368
Call for Papers:
“Inflammatory Arthritis and Autoimmune Inflammatory Systemic Diseases: From Bench to Bedside and Back”
Guest Editors: Dr. Marco Sebastiani and Prof. Dr. Giovanni Lapadula
Submission Deadline: 25 November 2023
“Clinical Updates on Rheumatoid Arthritis”
Guest Editor: Dr. Francesca Bandinelli
Submission Deadline: 15 February 2024
Access more Special Issues here.
Special Issue Books:
“Diagnostic Imaging of Arthritis”
“Clinical Features and Long-Term Outcomes of Systemic Lupus Erythematosus”
Access more Special Issue books here.
10 October 2023
Journal of Clinical Medicine | World Mental Health Day 2023—“A Universal Human Right”

World Mental Health Day is an annual event held on October 10th to raise awareness of mental health issues worldwide and to mobilize efforts to support mental health. This year's theme is “Mental health is a universal human right”. It provides us with an opportunity to ensure that the human rights and well-being of people with mental illness are respected in all parts of the world.
To further explore the related research on Mental Health Day 2023, the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) has gathered open access academic research on mental health. We hope to share interesting and up-to-date scientific knowledge in this field.
Article Collection:
1. “Intestinal Permeability and Depression in Patients with Inflammatory Bowel Disease”
by Miorita Melina Iordache, Cristina Tocia, Mariana Aschie, Andrei Dumitru, Mihaela Manea, Georgeta Camelia Cozaru, Lucian Petcu, Sabina E. Vlad, Eugen Dumitru and Anca Chisoi
J. Clin. Med. 2022, 11(17), 5121; https://doi.org/10.3390/jcm11175121
Available online: https://www.mdpi.com/2077-0383/11/17/5121
2. “Higher-Level Executive Functions in Healthy Elderly and Mild Cognitive Impairment: A Systematic Review”
by Ilaria Corbo and Maria Casagrande
J. Clin. Med. 2022, 11(5), 1204; https://doi.org/10.3390/jcm11051204
Available online: https://www.mdpi.com/2077-0383/11/5/1204
3. “Multi-Level Processes and Retina–Brain Pathways of Photic Regulation of Mood”
by Julia Maruani and Pierre A. Geoffroy
J. Clin. Med. 2022, 11(2), 448; https://doi.org/10.3390/jcm11020448
Available online: https://www.mdpi.com/2077-0383/11/2/448
4. “Multiple Aspects of Inappropriate Action of Renin–Angiotensin, Vasopressin, and Oxytocin Systems in Neuropsychiatric and Neurodegenerative Diseases”
by Ewa Szczepanska-Sadowska, Agnieszka Wsol, Agnieszka Cudnoch-Jedrzejewska, Katarzyna Czarzasta and Tymoteusz Żera
J. Clin. Med. 2022, 11(4), 908; https://doi.org/10.3390/jcm11040908
Available online: https://www.mdpi.com/2077-0383/11/4/908
5. “Treatment-Resistant Depression in Poland—Epidemiology and Treatment”
by Piotr Gałecki, Jerzy Samochowiec, Magdalena Mikułowska and Agata Szulc
J. Clin. Med. 2022, 11(3), 480; https://doi.org/10.3390/jcm11030480
Available online: https://www.mdpi.com/2077-0383/11/3/480
6. “A Systematic Review and Meta-Analysis of Nature Walk as an Intervention for Anxiety and Depression”
by Simone Grassini
J. Clin. Med. 2022, 11(6), 1731; https://doi.org/10.3390/jcm11061731
Available online: https://www.mdpi.com/2077-0383/11/6/1731
7. “Diagnosis and Management of Functional Tic-Like Phenomena”
by Irene A. Malaty, Seonaid Anderson, Shannon M. Bennett, Cathy L. Budman, Barbara J. Coffey, Keith A. Coffman, Erica Greenberg, Joseph F. McGuire, Kirsten R. Müller-Vahl, Michael S. Okun et al.
J. Clin. Med. 2022, 11(21), 6470; https://doi.org/10.3390/jcm11216470
Available online: https://www.mdpi.com/2077-0383/11/21/6470
8. “Pathways Linking the Big Five to Psychological Distress: Exploring the Mediating Roles of Stress Mindset and Coping Flexibility”
by Luxi Chen, Li Qu and Ryan Y. Hong
J. Clin. Med. 2022, 11(9), 2272; https://doi.org/10.3390/jcm11092272
Available online: https://www.mdpi.com/2077-0383/11/9/2272
9. “Repetitive Transcranial Magnetic Stimulation (rTMS) as a Promising Treatment for Craving in Stimulant Drugs and Behavioral Addiction: A Meta-Analysis”
by Aurélia Gay, Julien Cabe, Ingrid De Chazeron, Céline Lambert, Maxime Defour, Vikesh Bhoowabul, Thomas Charpeaud, Aurore Tremey, Pierre-Michel Llorca, Bruno Pereira et al.
J. Clin. Med. 2022, 11(3), 624; https://doi.org/10.3390/jcm11030624
Available online: https://www.mdpi.com/2077-0383/11/3/624
10. “rTMS Reduces Craving and Alcohol Use in Patients with Alcohol Use Disorder: Results of a Randomized, Sham-Controlled Clinical Trial”
by Maarten Belgers, Philip Van Eijndhoven, Wiebren Markus, Aart H. Schene and Arnt Schellekens
J. Clin. Med. 2022, 11(4), 951; https://doi.org/10.3390/jcm11040951
Available online: https://www.mdpi.com/2077-0383/11/4/951
11. “The Deficit Schizophrenia Subtype Is Associated with Low Adherence to the Mediterranean Diet: Findings from a Case–Control Study”
by Krzysztof Kowalski, Bogna Bogudzińska, Bartłomiej Stańczykiewicz, Patryk Piotrowski, Tomasz Bielawski, Jerzy Samochowiec, Krzysztof Szczygieł, Piotr Plichta and Błażej Misiak
J. Clin. Med. 2022, 11(3), 568; https://doi.org/10.3390/jcm11030568
Available online: https://www.mdpi.com/2077-0383/11/3/568
12. “State-of-the-Art Review on Immersive Virtual Reality Interventions for Colonoscopy-Induced Anxiety and Pain”
by Marcel-Alexandru Găină, Andreea Silvana Szalontay, Gabriela Ștefănescu, Gheorghe Gh Bălan, Cristina Mihaela Ghiciuc, Alexandra Boloș, Alexandra-Maria Găină and Cristinel Ștefănescu
J. Clin. Med. 2022, 11(6), 1670; https://doi.org/10.3390/jcm11061670
Available online: https://www.mdpi.com/2077-0383/11/6/1670
13. “The Impact of Group Emotion Regulation Interventions on Emotion Regulation Ability: A Systematic Review”
by Rebekah Moore, David Gillanders and Simon Stuart
J. Clin. Med. 2022, 11(9), 2519; https://doi.org/10.3390/jcm11092519
Available online: https://www.mdpi.com/2077-0383/11/9/2519
14. “Second-Generation Antipsychotics’ Effectiveness and Tolerability: A Review of Real-World Studies in Patients with Schizophrenia and Related Disorders”
by Michele Fabrazzo, Salvatore Cipolla, Alessio Camerlengo, Francesco Perris and Francesco Catapano
J. Clin. Med. 2022, 11(15), 4530; https://doi.org/10.3390/jcm11154530
Available online: https://www.mdpi.com/2077-0383/11/15/4530
15. “Insomnia Symptoms, Sleep Hygiene, Mental Health, and Academic Performance in Spanish University Students: A Cross-Sectional Study”
by Sara Carrión-Pantoja, Germán Prados, Florian Chouchou, Martha Holguín, Ángela Mendoza-Vinces, Manuela Expósito-Ruiz and Laura Fernández-Puerta
J. Clin. Med. 2022, 11(7), 1989; https://doi.org/10.3390/jcm11071989
Available online: https://www.mdpi.com/2077-0383/11/7/1989
Call for Papers:
“Bipolar Disorder: Clinical Advances and Challenges”
Guest Editors: Dr. Laura Fusar-Poli and Prof. Dr. Andrea Aguglia
Submission Deadline: 31 October 2023
“Clinical Updates on Psychology in Children and Adolescents”
Guest Editor: Dr. Oswald D. Kothgassner
Submission Deadline: 31 December 2023
Access more Special Issues here.
Special Issue Book:
“Recent Advances in Dual Disorders (Addiction and Other Mental Disorders)”
Access more Special Issue books here.
2 October 2023
MDPI Insights: The CEO's Letter #4 - MDPI Presence in China

Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
Open Access in China
It is Saturday, 23 September, and I have just returned from an unforgettable 12-day trip to China, visiting our main offices in Beijing and Wuhan. In the wake of a packed and very enjoyable agenda of internal and external meetings, I would like to use this edition of the CEO Letter to showcase how MDPI supports the scholarly community in China.
Coincidentally, Jack McKenna, Communications Associate from MDPI’s corporate content team, has just released a blog article discussing China’s open access (OA) policy. It is a timely read, providing a concise overview of the development of the OA movement in China and reflecting on its future. I shall draw some content from Jack’s piece and use this edition of the CEO Letter to highlight the various ways in which MDPI is involved in this market. And it would be remiss of me not to include some pictures and highlights from my travels!
Open Access Policy in China
As per Jack’s post, in 2020, China became the world’s leading producer of research articles. Today, China is experiencing a “substantial growth rate in OA [Open Access] publication”. This growth is supported by the State’s commitment to research & development and its policy “requiring the promotion of open science”.
Over the past two decades, there have been gradual developments in China’s OA framework, with repositories and platforms being developed in a consistent manner. Currently, key institutions across China – including the National Science Library, the National Science and Technology Library, and the Natural Science Foundation of China – support OA. The State aims to establish consistent policies across government agencies – a framework for a more encompassing embrace of OA across institutions.
In China, the number of subscription-only articles decreased by nearly 30% over the 10-year period of 2011–2021, while gold OA increased by 22%. Between 2017 and 2020 alone, China published 800,921 academic papers in an OA format.
In 2023, as the leading publisher of academic research, China is pursuing “self-reliance”. Therefore, the State will be establishing consistent policies across government agencies, including those related to OA. Additionally, it will want to ensure that Chinese people can access the research that is supported by Chinese funding and produced by Chinese academics. For this reason, “Open Access is a matter of priority in China”.
MDPI Offices in China
While the history of MDPI begins in Basel, Switzerland, the story of MDPI’s founder is very much rooted in China. Dr. Shu-kun Lin, Founder and President of MDPI, graduated with a BSc from Wuhan University in 1982. He also studied physical chemistry at the Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences (1982–1986; MSc in 1985), and at the University of Louisville, USA (1987–1989). Dr. Lin completed his doctorate in organic chemistry at the Swiss Federal Institute of Technology (ETH-Zürich) in 1992.
Stefan Tochev (CEO, MDPI) at MDPI’s Wuhan office.
In 2002, MDPI’s Basel headquarters moved to Matthäusstrasse 11, 4052 Basel, and Dr. Lin opened an editorial office in Qingdao, China, which launched the journal Marine Drugs in the following year. Below is a list of MDPI’s current offices in China and their respective dates of inauguration:
- 2008: Beijing (Tongzhou, Haidian)
- 2013: Wuhan (Hankou, Guanggu)
- 2019: Tianjin
- 2021: Dalian
- 2021: Nanjing
Our Strength is in Our People
With over 6,000 MDPI staff, across 20 offices in 11 countries, MDPI is able to offer authors responsive and efficient round-the-clock support, enabling a rapid publication process.
In my experience, stakeholders are genuinely surprised when they realize the extent of our global operations. My response is to reiterate that our people are our strength. This is why we have fast and efficient processes and top-notch responsiveness. Our global presence ensures that your manuscript is constantly attended to, rather than sitting on someone’s desk. We prioritize our authors’ needs and act quickly to move things through the various stages of publication. MDPI is built on speed, convenience, and competence, which I believe are core pillars for success in any industry. We continually strive to improve our systems and processes on the basis of these core strengths. We literally have over 6,000 staff worldwide dedicated to serving your needs. It’s not magic: it’s people; it’s real.
Impactful Research
MDPI Awards
To support the academic community, and especially young researchers, and also to enhance communication among scientists, MDPI journals offer various awards in specific fields. We serve the scientific community by funding research to facilitate the development of sustainable global solutions through our annual World Sustainability Award and Emerging Sustainability Leader Award.
In 2022, MDPI made awards totalling over US$1 million in recognition and support of researchers worldwide.
Across our journal catalogue, we have granted over 2,000 awards to recognize and support researchers from all disciplines. Since 2016, these awards have served as a source of recognition, acknowledging the impact of research by heightening the influence of talented individuals. The award types mainly include the Young Investigator Award, the Best PhD Thesis Award, the Best Paper Award, and the Outstanding Reviewer Award.
To learn more about MDPI Awards and to find out which are currently available, please click here.
MDPI Awards to Scholars from China
Since 2021, there have been 23 Best Paper Awards granted to authors affiliated with Chinese institutions, identifying their papers as having high-quality scientific impact. A total of 45 Chinese scholars have received awards such as the Young Investigator Award, the Best PhD Thesis Award, the Outstanding Reviewer Award, and the Tu Youyou Award, among others. Prizes for these awards include MDPI grants for paid publications, totalling over CHF 70,000 for scholars affiliated with Chinese institutions.
MDPI’s Tu Youyou Award
Prof. Tu Youyou (left), Dr. Shu-Kun Lin (President, MDPI).
In 2015, Professor Tu Youyou was awarded the Nobel Prize in Physiology or Medicine “for her discoveries concerning a novel therapy against Malaria.” In order to commemorate Professor Tu’s contributions to human health and to promote the passion and spirit conveyed by her experiences, MDPI in 2016 established the ‘Tu Youyou Award’, which runs biennially to recognize outstanding scholars dedicated to the research of natural products and medicinal chemistry.
The 2022 Tu Youyou Award was granted to Prof. Dr. Xiaoguang Lei of Peking University. Click here to access the interview with the winner.
2015 Nobel Prize for Medicine Awarded to Professor Youyou Tu
Professor Tu’s work was celebrated in a Special Issue from Molecules on the occasion of her 80th birthday. The Special Issue: 'Artemisinin (Qinghaosu): Commemorative Issue in Honor of Professor Youyou Tu on the Occasion of her 80th Anniversary” was created five years before she won the Nobel Prize, highlighting the visibility MDPI provides researchers and their work.
Highly Cited Articles by Chinese Scholars Published in MDPI
Click here to access the most cited MDPI papers published by scholars affiliated with Chinese institutions. This list presents the most influential research from the more than 287,000 MDPI papers published by Chinese scholars. With over 9 million total citations, I encourage you to maximize your visibility and impact by publishing with MDPI, the number one most cited open access publisher.
Read more:
- Tu Youyou Award
- World Sustainability Awards
- Available Awards
Inside MDPI
Stefan Tochev (CEO, MDPI) with the Beijing Marketing team.
Marketing Department in China
During my visit to our offices in Beijing and Wuhan, I had the opportunity to meet with, and to present to, our local marketing teams. These teams are responsible for various journal-related and corporate promotional activities, including newsletters, conferences, seminars, author training, journal awards, content creation, digital marketing, and social media.
I was pleased by the ambition and curiosity of our marketing colleagues. They showed a strong desire to collaborate and acquire knowledge and tactics to effectively market and promote MDPI-journal-related activities. I presented some of the principles and objectives that we apply in the Corporate Marketing and Communications department, and used the opportunity to strengthen our collaborative communications across offices.
Stefan Tochev (CEO, MDPI) with the Wuhan Marketing team.
Coming Together for Science
Collaborations, Scholarships and Meetings
MDPI maintains partnerships with nearly 190 learned societies and over 800 institutions and consortia, helping to facilitate the transition to OA publishing. Our commitment to working with institutions is evident in China, where we have successfully established over 35 Institutional Open Access Programs (IOAP) with esteemed institutions such as the Tsinghua University, Huazhong University of Science and Technology, and Shanghai Jiao Tong University.
Our institutional partnerships, waiver programs, and article processing cost discounts create diverse pathways to OA publishing for researchers worldwide.
Scholarships in China
Since 2021, several MDPI journals (Sensors, Photonics, Coatings, Materials, Energies, and Journal of Fungi) have funded full scholarships for four Master’s and five Ph.D. projects in China. These scholarships align with Tianjin University, Wuhan University of Technology, Central South University, the Chinese Academy of Sciences, and the China University of Petroleum (Beijing).
Meeting with the Society of Chinese University Journals (CUJS)
Prof. Tieming Zhang (President of CUJS, centre) and MDPI colleagues at CUJS office.
I am pleased to have participated in some highly productive meetings during my visit to China, including one with the Society of Chinese University Journals (CUJS). The meeting involved Prof. Tieming Zhang (President of CUJS), Assoc. Prof. Xin Zhang (Vice President and Secretary General), and Dr. Fei Gao (Executive Member of CUJS). Alongside my colleagues Dr. Guoshi Liu, Dr. Giulia Stefenelli, and Anita Sun, I represented MDPI and held an open discussion to address any questions regarding OA and MDPI.
We discussed several methods for collaboration, including a workshop on the future of peer review, MDPI sponsoring a funding grant for early-career researchers, and transitioning journals from diamond to gold OA. I am thankful for the opportunity to have met our colleagues at CUJS in person and feel very confident about our future collaborations in support of OA publishing in China.
MDPI hosts free academic seminars, author training sessions, and academic conferences as part of its commitment to enrich and support the scholarly community. CUJS often stages academic events (e.g., conferences, editor training, and editor competitions), and I believe there are great opportunities for CUJS and MDPI to collaborate accordingly.
Meeting with National Science Library, Chinese Academy of Sciences (NSLC)
Stefan Tochev (CEO, MDPI), Dr. Giulia Stefenelli (Chair of Scientific Officers, MDPI), Anita Sun (PR Manager, MDPI) and Dr. Guoshi Liu (Managing Director, MDPI) at the National Science Library, Chinese Academy of Sciences.
We also visited the NSLC Director, Xiwen Liu, and colleagues Ying Jin, Zhesi Shen, and Sichao Tong. Following our introductions, we gave a presentation on the history and editorial process at MDPI, discussing specific details related to MDPI’s business and data. We highlighted the status of our IOAP collaborations in China and the makeup of our author base, specifically in China, and drew attention to the fact that MDPI has published research by authors from every country in the world. We then discussed the design indicators, calculation methods and implementation purposes of the ‘Early Warning Journal List’ and how we can have open communication to provide any data regarding MDPI journals. I am pleased to report that we reached a consensus on future communications, and am grateful to NSLC for hosting us in their offices.
In-person meetings with stakeholders provide an invaluable opportunity to communicate what MDPI is about and the various ways in which we serve the scholarly community. While digital marketing and online communication are essential, they are no replacement for the understanding and trust that come about through in-person interactions.
The Numbers
As at September 2023, China holds the largest position in MDPI’s global market, ranking as the largest contributor to the total number of papers published by MDPI.
At this point in time, there were more than 847,000 China mainland scholars who have published with MDPI, 51 of whom are Section-Editors-in-Chief (SEiC) of MDPI journals, with seven serving as Editors-in-Chief (EiCs) for journals such as Air, Big Data and Cognitive Computing, Blockchains, Future, Nanoenergy Advances, and Targets.
Our growth and presence in China are a true testament to the service we provide to the scholarly community, and to the relationships we foster through collaborative activities. We look forward to continuing to support the growth of the scholarly community in China, providing a valuable and trusted experience with MDPI.
Closing Thoughts
Final Reflections on our MDPI Offices in Beijing and Wuhan
Stefan Tochev (CEO, MDPI), Dr. Constanze Schelhorn (Indexing Manager, MDPI), Jiale Shang (Admin, Tongzhou, MDPI) at Beijing Capital International Airport, Beijing.
I spent approximately two weeks visiting some of our offices in China, and the first word that comes to mind when describing my experience is ‘hospitality.’ My colleagues and I were met with enthusiasm and delight at the airport by the Tongzhou Admin team (thank you, Jiale Shang, and thank you, Eric Wang, for keeping us organized on this trip!) and were taken care of with great attention. From hotels to transportation, dinners, and meetings, our stay was catered for perfectly.
Perhaps this is where MDPI’s focus on customers and service originates. At our core, we are a service company that provides a publishing platform for its authors. It’s therefore no surprise that authors consistently rate their experience with MDPI very highly.
95% of submitting authors rate their overall experience with the MDPI publication process as Excellent or Good (Springer Nature report 90%).
91% of submitting authors rate their overall experience with the MDPI peer review process as Excellent or Good.
Speed/Efficiency and Editorial Relationship are two key reasons underlying this high satisfaction score. ‘Editorial Relationship’ can be further explored, but in the past month, the most commonly noted aspects were the professionalism, kindness, availability, communicativeness, and personalized assistance provided by our editorial staff throughout the process. These attributes are at the core of our work across all our offices and continents.
Hospitality and Service
Just as our Chinese colleagues strove to keep us engaged by showing us the city sights (thank you, Thea Pan, and Jason Wu from the Wuhan Marketing team!) and sharing a variety of wonderful meals, our editorial staff are committed to serving our authors throughout their publishing journey. Our aim is to place the author at the centre of everything we do, eager to welcome our ‘guests’ and provide them with a pleasant publishing experience.
I asked my colleague Francis Wu (Senior Publisher, Wuhan office) where this hospitality originates. He responded that it is part of Chinese culture. I reflected long and deep on this answer. China is a vast country, and when visitors arrive, hosts want to ensure they feel welcomed and taken care of in order to maximize their time and visit. I can’t think of a better analogy for how I would want our authors to feel when they visit MDPI for their publishing needs. A company culture that prioritizes service, something that goes beyond products and productivity, and focuses on the overall experience. Over 6,000 people, across all MDPI offices, are ready, willing and able to go the extra mile for their colleagues and their customers. This is something I am truly proud of.
Chief Executive Officer
MDPI AG
28 September 2023
Journal of Clinical Medicine | Highly Cited Papers in 2022 in the Section “Stomatology”

The Journal of Clinical Medicine (JCM, ISSN: 2077-0383) is an international, peer-reviewed, open access journal published semimonthly online by MDPI. The International Bone Research Association (IBRA), Italian Resuscitation Council (IRC), Spanish Society of Hematology and Hemotherapy (SEHH), Japan Association for Clinical Engineers (JACE), European Independent Foundation in Angiology/ Vascular Medicine (VAS) and others are all affiliated with JCM, and their members receive a discount on the article processing charges. The Section “Stomatology” is dedicated to publishing high-quality original research, reviews or perspectives that contribute to advancing clinical health and medicine.
The Section “Stomatology” follows the same open access format as the rest of JCM, meaning that you have free and unlimited access to the full texts of all published articles. We invite you to read our most frequently cited papers published in 2022 below:
1. “3D Printing and Virtual Surgical Planning in Oral and Maxillofacial Surgery”
by Adeeb Zoabi, Idan Redenski, Daniel Oren, Adi Kasem, Asaf Zigron, Shadi Daoud, Liad Moskovich, Fares Kablan and Samer Srouji
J. Clin. Med. 2022, 11(9), 2385; https://doi.org/10.3390/jcm11092385
Available online: https://www.mdpi.com/2077-0383/11/9/2385
2. “Prevalence and Methods for Assessment of Oropharyngeal Dysphagia in Older Adults: A Systematic Review and Meta-Analysis”
by Thanh-Nhan Doan, Wen-Chao Ho, Liang-Hui Wang, Fei-Chun Chang, Nguyen Thanh Nhu and Li-Wei Chou
J. Clin. Med. 2022, 11(9), 2605; https://doi.org/10.3390/jcm11092605
Available online: https://www.mdpi.com/2077-0383/11/9/2605
3. “The Administration of Hyaluronic Acid into the Temporomandibular Joints’ Cavities Increases the Mandible’s Mobility: A Systematic Review and Meta-Analysis”
by Maciej Chęciński, Maciej Sikora, Kamila Chęcińska, Zuzanna Nowak and Dariusz Chlubek
J. Clin. Med. 2022, 11(7), 1901; https://doi.org/10.3390/jcm11071901
Available online: https://www.mdpi.com/2077-0383/11/7/1901
4. “Lipid Peroxidation Levels in Saliva and Plasma of Patients Suffering from Periodontitis”
by Tanja Veljovic, Milanko Djuric, Jelena Mirnic, Ivana Gusic, Aleksandra Maletin, Bojana Ramic, Isidora Neskovic, Karolina Vukoje and Snezana Brkic
J. Clin. Med. 2022, 11(13), 3617; https://doi.org/10.3390/jcm11133617
Available online: https://www.mdpi.com/2077-0383/11/13/3617
5. “Nonsurgical Periodontal Treatment Options and Their Impact on Subgingival Microbiota”
by Susanne Schulz, Jamal M. Stein, Anne Schumacher, David Kupietz, Sareh S. Yekta-Michael, Florian Schittenhelm, Georg Conrads, Hans-Günter Schaller and Stefan Reichert
J. Clin. Med. 2022, 11(5), 1187; https://doi.org/10.3390/jcm11051187
Available online: https://www.mdpi.com/2077-0383/11/5/1187
6. “Malignant Transformation Rate of Oral Submucous Fibrosis: A Systematic Review and Meta-Analysis”
by Vignesh Murthy, Petros Mylonas, Barbara Carey, Sangeetha Yogarajah, Damian Farnell, Owen Addison, Richard Cook, Michael Escudier, Marcio Diniz-Freitas and Jacobo Limeres et al.
J. Clin. Med. 2022, 11(7), 1793; https://doi.org/10.3390/jcm11071793
Available online: https://www.mdpi.com/2077-0383/11/7/1793
7. “Clinical Outcome and Comparison of Regenerative and Apexification Intervention in Young Immature Necrotic Teeth—A Systematic Review and Meta-Analysis”
by Pratima Panda, Lora Mishra, Shashirekha Govind, Saurav Panda and Barbara Lapinska
J. Clin. Med. 2022, 11(13), 3909; https://doi.org/10.3390/jcm11133909
Available online: https://www.mdpi.com/2077-0383/11/13/3909
8. “Home Oral Care Domiciliary Protocol for the Management of Dental Erosion in Rugby Players: A Randomized Clinical Trial”
by Andrea Butera, Simone Gallo, Maurizio Pascadopoli, Giuseppe Alessandro Scardina, Sofia Pezzullo and Andrea Scribante
J. Clin. Med. 2022, 11(16), 4893; https://doi.org/10.3390/jcm11164893
Available online: https://www.mdpi.com/2077-0383/11/16/4893
9. “Comparison between Ecological Momentary Assessment and Questionnaire for Assessing the Frequency of Waking-Time Non-Functional Oral Behaviours”
by Rosaria Bucci, Daniele Manfredini, Francesca Lenci, Vittorio Simeon, Alessandro Bracci and Ambrosina Michelotti
J. Clin. Med. 2022, 11(19), 5880; https://doi.org/10.3390/jcm11195880
Available online: https://www.mdpi.com/2077-0383/11/19/5880
10. “Autonomous Robotic Surgery for Immediately Loaded Implant-Supported Maxillary Full-Arch Prosthesis: A Case Report”
by Shuo Yang, Jiahao Chen, An Li, Ping Li and Shulan Xu
J. Clin. Med. 2022, 11(21), 6594; https://doi.org/10.3390/jcm11216594
Available online: https://www.mdpi.com/2077-0383/11/21/6594
11. “Effects of the Dental Caries Preventive Procedure on the White Spot Lesions during Orthodontic Treatment—An Open Label Randomized Controlled Trial”
by Yudai Shimpo, Yoshiaki Nomura, Toshiko Sekiya, Chihiro Arai, Ayako Okada, Kaoru Sogabe, Nobuhiro Hanada and Hiroshi Tomonari
J. Clin. Med. 2022, 11(3), 854; https://doi.org/10.3390/jcm11030854
Available online: https://www.mdpi.com/2077-0383/11/3/854
12. “Chewing Patterns and Muscular Activation in Deep Bite Malocclusion”
by Maria Grazia Piancino, Alessandro Tortarolo, Laura Di Benedetto, Vito Crincoli and Deborah Falla
J. Clin. Med. 2022, 11(6), 1702; https://doi.org/10.3390/jcm11061702
Available online: https://www.mdpi.com/2077-0383/11/6/1702
13. “Primary Orbital Reconstruction with Selective Laser Melting (SLM) of Patient-Specific Implants (PSIs): An Overview of 96 Surgically Treated Patients”
by Majeed Rana, Henriette L. Moellmann, Lara Schorn, Julian Lommen, Madiha Rana, Max Wilkat and Karsten Hufendiek
J. Clin. Med. 2022, 11(12), 3361; https://doi.org/10.3390/jcm11123361
Available online: https://www.mdpi.com/2077-0383/11/12/3361
14. “One Third of Patients before Endoprosthesis Implantation Show an Oral Focus as Potential Source of Infectious Complication—The Value of Pre-Operative Dental Risk Stratification in a German Cohort”
by Gerhard Schmalz, Florentine Reuschel, Markus Bartl, Laura Schmidt, Janine Runge, Rainer Haak, Szymon Goralskiandreas Roth and Dirk Ziebolz
J. Clin. Med. 2022, 11(13), 3686; https://doi.org/10.3390/jcm11133686
Available online: https://www.mdpi.com/2077-0383/11/13/3686
15. “Update on the Accuracy of Conventional and Digital Full-Arch Impressions of Partially Edentulous and Fully Dentate Jaws in Young and Elderly Subjects: A Clinical Trial”
by Maximiliane Amelie Schlenz, Julian Maximilian Stillersfeld, Bernd Wöstmann and Alexander Schmidt
J. Clin. Med. 2022, 11(13), 3723; https://doi.org/10.3390/jcm11133723
Available online: https://www.mdpi.com/2077-0383/11/13/3723
16. “Clinical, Microbiologicaland Biochemical Impact of the Surgical Treatment of Peri-Implantitis—A Prospective Case Series”
by Fernando Luengo, Myroslav Solonko, Javier Sanz-Esporrín, Ignacio Sanz-Sánchez, David Herrera and Mariano Sanz
J. Clin. Med. 2022, 11(16), 4699; https://doi.org/10.3390/jcm11164699
Available online: https://www.mdpi.com/2077-0383/11/16/4699
17. “In Vitro Accuracy of Digital and Conventional Impressions for Full-Arch Implant-Supported Prostheses”
by Rani D’haese, Tom Vrombaut, Herman Roeykens and Stefan Vandeweghe
J. Clin. Med. 2022, 11(3), 594; https://doi.org/10.3390/jcm11030594
Available online: https://www.mdpi.com/2077-0383/11/3/594
18. “Non-Interventional Prospective Observational Study of Platelet Rich Fibrin as a Therapy Adjunctive in Patients with Medication-Related Osteonecrosis of the Jaw”
by Sebastian Blatt, Maximilian Krüger, Peer W. Kämmerer, Daniel G. E. Thiem, Philipp Matheis, Anne-Katrin Eisenbeiß, Jörg Wiltfang, Bilal Al-Nawas and Hendrik Naujokat
J. Clin. Med. 2022, 11(3), 682; https://doi.org/10.3390/jcm11030682
Available online: https://www.mdpi.com/2077-0383/11/3/682
19. “Quality of Life in Patients with End-Stage Renal Disease Undergoing Hemodialysis”
by Elżbieta Dembowska, Aleksandra Jaroń, Ewa Gabrysz-Trybek, Joanna Bladowska, Szymon Gacek and Grzegorz Trybek
J. Clin. Med. 2022, 11(6), 1584; https://doi.org/10.3390/jcm11061584
Available online: https://www.mdpi.com/2077-0383/11/6/1584
20. “What Does Bone Corticalization around Dental Implants Mean in Light of Ten Years of Follow-Up?”
by Marcin Kozakiewicz, Małgorzata Skorupska and Tomasz Wach
J. Clin. Med. 2022, 11(12), 3545; https://doi.org/10.3390/jcm11123545
Available online: https://www.mdpi.com/2077-0383/11/12/3545
26 September 2023
Journal of Clinical Medicine | Issue Cover Articles in 2021
The articles below have been selected as 2021 Issue Cover Articles by the Editorial Office of the Journal of Clinical Medicine (JCM, ISSN: 2077-0383). These articles are from multiple fields within the scope of the Journal of Clinical Medicine, and we hope they can provide insights and references for scholars in related fields.
![]() |
1. “Retinal Microcirculation and Cytokines as Predictors for Recurrence of Macular Edema after Intravitreal Ranibizumab Injection in Branch Retinal Vein Occlusion” by Hidetaka Noma, Kanako Yasuda, Tatsuya Mimura, Noboru Suganuma and Masahiko Shimura J. Clin. Med. 2021, 10(1), 58; https://doi.org/10.3390/jcm10010058 Available online: https://www.mdpi.com/2077-0383/10/1/58 |
![]() |
2. “Pravastatin Promotes Endothelial Colony-Forming Cell Function, Angiogenic Signaling and Protein Expression In Vitro” by Nadia Meyer, Lars Brodowski, Katja Richter, Constantin S. von Kaisenberg, Bianca Schröder-Heurich and Frauke von Versen-Höynck. J. Clin. Med. 2021, 10(2), 183; https://doi.org/10.3390/jcm10020183 Available online: https://www.mdpi.com/2077-0383/10/2/183 |
![]() |
3. “Ventricular Assist Device-Specific Infections” by Yue Qu, Anton Y. Peleg and David McGiffin. J. Clin. Med. 2021, 10(3), 453; https://doi.org/10.3390/jcm10030453 Available online: https://www.mdpi.com/2077-0383/10/3/453 |
![]() |
4. “Functional and Structural Characterization of Nucleic Acid Ligands That Bind to Activated Coagulation Factor XIII” by Nasim Shahidi Hamedani, Arijit Biswas, Oliver Rudan, Rosa Tönges, Carlotta Meyring, Fabian Tolle, Günter Mayer, Johannes Oldenburg, Jens Müller and Bernd Pötzsch. J. Clin. Med. 2021, 10(4), 677; https://doi.org/10.3390/jcm10040677 Available online: https://www.mdpi.com/2077-0383/10/4/677 |
![]() |
5. “Emerging Therapies in Immune Thrombocytopenia” by Sylvain Audia and Bernard Bonnotte. J. Clin. Med. 2021, 10(5), 1004; https://doi.org/10.3390/jcm10051004 Available online: https://www.mdpi.com/2077-0383/10/5/1004 |
![]() |
6. “Degenerative Cervical Myelopathy: Insights into Its Pathobiology and Molecular Mechanisms” by Ji Tu, Jose Vargas Castillo, Abhirup Das and Ashish D. Diwan. J. Clin. Med. 2021, 10(6), 1214; https://doi.org/10.3390/jcm10061214 Available online: https://www.mdpi.com/2077-0383/10/6/1214 |
![]() |
7. “Thyroid Cancer Stem-Like Cells: From Microenvironmental Niches to Therapeutic Strategies” by Elisa Stellaria Grassi, Viola Ghiandai and Luca Persani. J. Clin. Med. 2021, 10(7), 1455; https://doi.org/10.3390/jcm10071455 Available online: https://www.mdpi.com/2077-0383/10/7/1455 |
![]() |
8. “Cardiovascular and Renal Disease in Chronic Critical Illness” by Tyler J. Loftus, Amanda C. Filiberto, Tezcan Ozrazgat-Baslanti, Saraswathi Gopal and Azra Bihorac. J. Clin. Med. 2021, 10(8), 1601; https://doi.org/10.3390/jcm10081601 Available online: https://www.mdpi.com/2077-0383/10/8/1601 |
![]() |
9. “Advanced Microscopy for Liver and Gut Ultrastructural Pathology in Patients with MVID and PFIC Caused by MYO5B Mutations” by Michael W. Hess, Iris M. Krainer, Przemyslaw A. Filipek, Barbara Witting, Karin Gutleben, Ilja Vietor, Heinz Zoller, Denise Aldrian, Ekkehard Sturm and James R. Goldenring et al. J. Clin. Med. 2021, 10(9), 1901; https://doi.org/10.3390/jcm10091901 Available online: https://www.mdpi.com/2077-0383/10/9/1901 |
![]() |
10. “Speckle-Tracking Echocardiography with Novel Imaging Technique of Higher Frame Rate” by Kana Fujikura, Mohammed Makkiya, Muhammad Farooq, Yun Xing, Wayne Humphrey, Mohammad Hashim Mustehsan, Mario J. Garcia and Cynthia C. Taub. J. Clin. Med. 2021, 10(10), 2095; https://doi.org/10.3390/jcm10102095 Available online: https://www.mdpi.com/2077-0383/10/10/2095 |
![]() |
11. “The Non-Coding RNA Landscape in IgA Nephropathy—Where Are We in 2021?” by Izabella Z. A. Pawluczyk, Haresh Selvaskandan and Jonathan Barratt. J. Clin. Med. 2021, 10(11), 2369; https://doi.org/10.3390/jcm10112369 Available online: https://www.mdpi.com/2077-0383/10/11/2369 |
![]() |
12. “Infections as Novel Risk Factors of Atherosclerotic Cardiovascular Diseases: Pathophysiological Links and Therapeutic Implications” by Piotr Szwed, Aleksandra Gąsecka, Mateusz Zawadka, Ceren Eyileten, Marek Postuła, Tomasz Mazurek, Łukasz Szarpak and Krzysztof J. Filipiak. J. Clin. Med. 2021, 10(12), 2539; https://doi.org/10.3390/jcm10122539 Available online: https://www.mdpi.com/2077-0383/10/12/2539 |
![]() |
13. “The Cerebral Effect of Ammonia in Brain Aging: Blood–Brain Barrier Breakdown, Mitochondrial Dysfunction, and Neuroinflammation” by Danbi Jo, Byeong C. Kim, Kyung A. Cho and Juhyun Song. J. Clin. Med. 2021, 10(13), 2773; https://doi.org/10.3390/jcm10132773 Available online: https://www.mdpi.com/2077-0383/10/13/2773 |
![]() |
14. “Genetic Susceptibility to Acute Kidney Injury” by Christian Ortega-Loubon, Pedro Martínez-Paz, Emilio García-Morán, Álvaro Tamayo-Velasco, Francisco J. López-Hernández, Pablo Jorge-Monjas and Eduardo Tamayo. J. Clin. Med. 2021, 10(14), 3039; https://doi.org/10.3390/jcm10143039 Available online: https://www.mdpi.com/2077-0383/10/14/3039 |
![]() |
15. “Understanding Chronic Venous Disease: A Critical Overview of Its Pathophysiology and Medical Management” by Miguel A. Ortega, Oscar Fraile-Martínez, Cielo García-Montero, Miguel A. Álvarez-Mon, Chen Chaowen, Fernando Ruiz-Grande, Leonel Pekarek, Jorge Monserrat, Angel Asúnsolo and Natalio García-Honduvilla et al. J. Clin. Med. 2021, 10(15), 3239; https://doi.org/10.3390/jcm10153239 Available online: https://www.mdpi.com/2077-0383/10/15/3239 |
![]() |
16. “Decoding the Myeloid-Derived Suppressor Cells in Lymphoid Malignancies” by Iosif Papafragkos, Efrosyni Markaki, Christina Kalpadakis and Panayotis Verginis. J. Clin. Med. 2021, 10(16), 3462; https://doi.org/10.3390/jcm10163462 Available online: https://www.mdpi.com/2077-0383/10/16/3462 |
![]() |
17. “Obstructive Sleep Apnea and Cardiac Arrhythmias: A Contemporary Review” by Balint Laczay and Michael D. Faulx. J. Clin. Med. 2021, 10(17), 3785; https://doi.org/10.3390/jcm10173785 Available online: https://www.mdpi.com/2077-0383/10/17/3785 |
![]() |
18. “RBM20-Related Cardiomyopathy: Current Understanding and Future Options” by Jan Koelemen, Michael Gotthardt, Lars M. Steinmetz and Benjamin Meder. J. Clin. Med. 2021, 10(18), 4101; https://doi.org/10.3390/jcm10184101 Available online: https://www.mdpi.com/2077-0383/10/18/4101 |
![]() |
19. “Vaccination for Respiratory Infections in Patients with Heart Failure” by Nicolas Girerd, Nicolas Chapet, Camille Roubille, Jérôme Roncalli, Muriel Salvat, Frédéric Mouquet, Nicolas Lamblin, Jean-Pierre Gueffet, Thibaud Damy and Michel Galinier et al. J. Clin. Med. 2021, 10(19), 4311; https://doi.org/10.3390/jcm10194311 Available online: https://www.mdpi.com/2077-0383/10/19/4311 |
![]() |
20. “The Microbiota-Gut-Brain Axis as a Key to Neuropsychiatric Disorders: A Mini Review” by Katarzyna Stopińska, Maria Radziwoń-Zaleska and Izabela Domitrz. J. Clin. Med. 2021, 10(20), 4640; https://doi.org/10.3390/jcm10204640 Available online: https://www.mdpi.com/2077-0383/10/20/4640 |
![]() |
21. “The Emerging Role of Gut Microbiota in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Current Evidence and Potential Therapeutic Applications” by Angelica Varesi, Undine-Sophie Deumer, Sanjana Ananth and Giovanni Ricevuti. J. Clin. Med. 2021, 10(21), 5077; https://doi.org/10.3390/jcm10215077 Available online: https://www.mdpi.com/2077-0383/10/21/5077 |
![]() |
22. “Imaging of Gastric Carcinomatosis” by Raquel Saiz Martínez, Clarisse Dromain and Naik Vietti Violi. J. Clin. Med. 2021, 10(22), 5294; https://doi.org/10.3390/jcm10225294 Available online: https://www.mdpi.com/2077-0383/10/22/5294 |
![]() |
23. “The Impact of COVID-19 Pandemic on Management and Outcome in Patients with Heart Failure” by Zahi Abu Ghosh, Donna R. Zwas, Andre Keren, Gabby Elbaz-Greener, Vered Israeli, Offer Amir and Israel Gotsman. J. Clin. Med. 2021, 10(23), 5577; https://doi.org/10.3390/jcm10235577 Available online: https://www.mdpi.com/2077-0383/10/23/5577 |
![]() |
24. “Advances in Diagnostic Imaging for Cardiac Sarcoidosis” by Osamu Manabe, Noriko Oyama-Manabe, Tadao Aikawa, Satonori Tsuneta and Nagara Tamaki. J. Clin. Med. 2021, 10(24), 5808; https://doi.org/10.3390/jcm10245808 Available online: https://www.mdpi.com/2077-0383/10/24/5808 |
JCM announces the Best Paper Award each year. If your paper has been highly cited and downloaded, you will have an advantage in applying for this award. Please find more details of the JCM Best Paper Award recipients at the following link: https://www.mdpi.com/journal/jcm/awards/2320.
Journal of Clinical Medicine Editorial Office
25 September 2023
Meet Us at the Gerontological Society of America (GSA) 2023 Annual Scientific Meeting, 8–12 November 2023, Tampa, Florida, USA

MDPI will attend the Gerontological Society of America (GSA) 2023 Annual Scientific Meeting. The Gerontological Society of America is the oldest and largest interdisciplinary organization devoted to research, education, and practice in the field of aging.
The GSA 2023 Annual Scientific Meeting draws professionals in the field of aging on a global scale. Attendees represent specialties including geriatrics, biological sciences, nursing, nutrition, medicine, social work, economics, policy, psychology, and more. The Annual Scientific Meeting offers an extensive amount of stimulating and high-level scholarship, from a diverse variety of aging research disciplines. It is this new, enriching knowledge that will inform policy, practice, and research for years to come.
The following MDPI journals will be represented:
- Healthcare;
- Medicina;
- Epidemiologia;
- Nutrients;
- JCM;
- JPM;
- IJERPH;
- Nursing Reports;
- Geriatrics;
- Life;
- BioMedInformatics;
- Behavioral Sciences;
- Societies;
- JAL.
If you plan on attending this conference, please feel free to stop by our booth #119 and start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have.
For more information about the conference, please visit https://www.gsa2023.org.
20 September 2023
Meet Us at the 109th Radiological Society of North America Scientific Assembly and Annual Meeting (RSNA 2023), 26–29 November 2023, Chicago, USA

Conference: RSNA 2023
Organization: The Radiological Society of North America
Date: 26–29 November 2023
Place: McCormick Place, 2301 S. Lake Shore Drive, Chicago, IL 60616 USA
Booth: #1103
The Radiological Society of North America (RSNA) is a non-profit organization. RSNA’s annual meeting provides radiology professionals and industry partners with endless opportunities to learn, connect, exchange ideas, and see the latest technology in action. This year’s theme—Leading through Change—focuses on how radiology professionals can be intentional and proactive while leading teams and organizations through change.
The following MDPI journals will be represented as exhibitors:
- Diagnostics;
- JPM;
- Tomography;
- JCM;
- Osteology;
- Radiation;
- Cancers.
If you are attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions you may have. For more information about the conference, please visit the following website: https://www.rsna.org/annual-meeting.
18 September 2023
Meet Us at the 82nd Annual Meeting of the Japan Neurosurgical Society, 25–27 October 2023, Tokyo, Japan

The 82nd Annual Meeting of the Japan Neurosurgical Society will be held from 25 to 27 October 2023 in Tokyo, Japan. The conference is organized by the Department of Neurosurgery, University of Tokyo.
The areas of interest include the following:
- Vascular disorders;
- Brain tumor;
- Spine and the spinal cord;
- Function;
- Pediatric;
- Neurotrauma;
- Education and society.
The following MDPI journals will be represented:
- Clinical Medicine;
- Brain Sciences;
- Neuroglia;
- Neurology International;
- NeuroSci.
If you are attending this conference, please talk to us online. Our delegates look forward to meeting you in person at booth #No. 14 and answering any questions that you may have. For more information about the conference, please visit the following link: http://jns2023.umin.jp/index.html.
14 September 2023
Journal of Clinical Medicine | Highly Cited Papers in 2021–2022 in the Section “Pulmonology”

The Journal of Clinical Medicine (JCM, ISSN: 2077-0383) is an international, peer-reviewed, open access journal published semimonthly online by MDPI. The International Bone Research Association (IBRA), Italian Resuscitation Council (IRC), Spanish Society of Hematology and Hemotherapy (SEHH), Japan Association for Clinical Engineers (JACE), European Independent Foundation in Angiology/Vascular Medicine (VAS) and others are all affiliated with JCM, and their members receive a discount on the article processing charges. The Section “Pulmonology” is dedicated to publishing high-quality original research, reviews or perspectives that contribute to advancing clinical health and medicine.
The Section “Pulmonology” follows the same open access format as the rest of JCM, meaning that you have free and unlimited access to the full texts of all published articles. We invite you to read our most frequently cited papers published in 2021 and 2022 below:
1. “Post-COVID-19 Pulmonary Fibrosis: Novel Sequelae of the Current Pandemic”
by Shiva Rattan Ambardar, Stephanie L. Hightower, Nikhil A. Huprikar, Kevin K. Chung, Anju Singhal and Jacob F. Collen
J. Clin. Med. 2021, 10(11), 2452; https://doi.org/10.3390/jcm10112452
Available online: https://www.mdpi.com/2077-0383/10/11/2452
2. “Asthma and Obesity: Two Diseases on the Rise and Bridged by Inflammation”
by Marina Bantulà, Jordi Roca-Ferrer, Ebymar Arismendi and César Picado
J. Clin. Med. 2021, 10(2), 169; https://doi.org/10.3390/jcm10020169
Available online: https://www.mdpi.com/2077-0383/10/2/169
3. “Interstitial Lung Disease at High Resolution CT after SARS-CoV-2-Related Acute Respiratory Distress Syndrome According to Pulmonary Segmental Anatomy”
by Elisa Baratella, Barbara Ruaro, Cristina Marrocchio, Natalia Starvaggi, Francesco Salton, Fabiola Giudici, Emilio Quaia, Marco Confalonieri and Maria Assunta Cova
J. Clin. Med. 2021, 10(17), 3985; https://doi.org/10.3390/jcm10173985
Available online: https://www.mdpi.com/2077-0383/10/17/3985
4. “Management Challenges in Chronic Obstructive Pulmonary Disease in the COVID-19 Pandemic: Telehealth and Virtual Reality”
by Sebastian Rutkowski
J. Clin. Med. 2021, 10(6), 1261; https://doi.org/10.3390/jcm10061261
Available online: https://www.mdpi.com/2077-0383/10/6/1261
5. “Chronic Obstructive Pulmonary Disease: Epidemiology, Biomarkers and Paving the Way to Lung Cancer”
by Klára Szalontai, Nikolett Gémes, József Furák, Tünde Varga, Patrícia Neuperger, József Á. Balog, László G. Puskás and Gábor J. Szebeni
J. Clin. Med. 2021, 10(13), 2889; https://doi.org/10.3390/jcm10132889
Available online: https://www.mdpi.com/2077-0383/10/13/2889
6. “Electronic Cigarette Aerosol Is Cytotoxic and Increases ACE2 Expression on Human Airway Epithelial Cells: Implications for SARS-CoV-2 (COVID-19)”
by Kielan Darcy McAlinden, Wenying Lu, Parisa Vahidi Ferdowsi, Stephen Myers, James Markos, Josie Larby, Collin Chia, Heinrich C. Weber, Greg Haug, Mathew Suji Eapen et al.
J. Clin. Med. 2021, 10(5), 1028; https://doi.org/10.3390/jcm10051028
Available online: https://www.mdpi.com/2077-0383/10/5/1028
7. “The Aggregate Index of Systemic Inflammation (AISI): A Novel Prognostic Biomarker in Idiopathic Pulmonary Fibrosis”
by Angelo Zinellu, Claudia Collu, Mouhamad Nasser, Panagiotis Paliogiannis, Sabrina Mellino, Elisabetta Zinellu, Julie Traclet, Kais Ahmad, Arduino Aleksander Mangoni, Ciriaco Carru et al.
J. Clin. Med. 2021, 10(18), 4134; https://doi.org/10.3390/jcm10184134
Available online: https://www.mdpi.com/2077-0383/10/18/4134
8. “The Gustave Roussy Immune (GRIm)-Score Variation Is an Early-on-Treatment Biomarker of Outcome in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Pembrolizumab”
by Edoardo Lenci, Luca Cantini, Federica Pecci, Valeria Cognigni, Veronica Agostinelli, Giulia Mentrasti, Alessio Lupi, Nicoletta Ranallo, Francesco Paoloni, Silvia Rinaldi et al.
J. Clin. Med. 2021, 10(5), 1005; https://doi.org/10.3390/jcm10051005
Available online: https://www.mdpi.com/2077-0383/10/5/1005
9. “Spontaneous Breathing and Evolving Phenotypes of Lung Damage in Patients with COVID-19: Review of Current Evidence and Forecast of a New Scenario”
by Roberto Tonelli, Alessandro Marchioni, Luca Tabbì, Riccardo Fantini, Stefano Busani, Ivana Castaniere, Dario Andrisani, Filippo Gozzi, Giulia Bruzzi, Linda Manicardi et al.
J. Clin. Med. 2021, 10(5), 975; https://doi.org/10.3390/jcm10050975
Available online: https://www.mdpi.com/2077-0383/10/5/975
10. “Coagulative Disorders in Critically Ill COVID-19 Patients with Acute Distress Respiratory Syndrome: A Critical Review”
by Chiara Robba, Denise Battaglini, Lorenzo Ball, Alberto Valbusa, Italo Porto, Roberta Della Bona, Giovanni La Malfa, Nicolò Patroniti, Iole Brunetti, Maurizio Loconte et al.
J. Clin. Med. 2021, 10(1), 140; https://doi.org/10.3390/jcm10010140
Available online: https://www.mdpi.com/2077-0383/10/1/140
11. “Telomeres in Interstitial Lung Disease”
by Carmel J. W. Stock and Elisabetta A. Renzoni
J. Clin. Med. 2021, 10(7), 1384; https://doi.org/10.3390/jcm10071384
Available online: https://www.mdpi.com/2077-0383/10/7/1384
12. “Elexacaftor/Tezacaftor/Ivacaftor in Patients with Cystic Fibrosis Homozygous for the F508del Mutation and Advanced Lung Disease: A 48-Week Observational Study”
by Vincenzo Carnovale, Paola Iacotucci, Vito Terlizzi, Carmela Colangelo, Lorenza Ferrillo, Angela Pepe, Michela Francalanci, Giovanni Taccetti, Serena Buonaurio, Assunta Celardo et al.
J. Clin. Med. 2022, 11(4), 1021; https://doi.org/10.3390/jcm11041021
Available online: https://www.mdpi.com/2077-0383/11/4/1021
13. “COVID-19 Patients Presenting with Post-Intubation Upper Airway Complications: A Parallel Epidemic?”
by Grigoris Stratakos, Nektarios Anagnostopoulos, Rajaa Alsaggaf, Evangelia Koukaki, Katerina Bakiri, Philip Emmanouil, Charalampos Zisis, Konstantinos Vachlas, Christina Vourlakou and Antonia Koutsoukou
J. Clin. Med. 2022, 11(6), 1719; https://doi.org/10.3390/jcm11061719
Available online: https://www.mdpi.com/2077-0383/11/6/1719
14. “Etiologic Classification of Diffuse Parenchymal (Interstitial) Lung Diseases”
by Matthias Griese
J. Clin. Med. 2022, 11(6), 1747; https://doi.org/10.3390/jcm11061747
Available online: https://www.mdpi.com/2077-0383/11/6/1747
15. “Intestinal Inflammation and Alterations in the Gut Microbiota in Cystic Fibrosis: A Review of the Current Evidence, Pathophysiology and Future Directions”
by Rachel Y. Tam, Josie M. van Dorst, Isabelle McKay, Michael Coffey and Chee Y. Ooi
J. Clin. Med. 2022, 11(3), 649; https://doi.org/10.3390/jcm11030649
Available online: https://www.mdpi.com/2077-0383/11/3/649
16. “Clinical Characteristics of Macrolide-Refractory Mycoplasma pneumoniae Pneumonia in Korean Children: A Multicenter Retrospective Study”
by Yun Jung Choi, Eun Hee Chung, Eun Lee, Chul-Hong Kim, Yong Ju Lee, Hyo-Bin Kim, Bong-Seong Kim, Hyung Young Kim, Yoojung Cho, Ju-Hee Seo et al.
J. Clin. Med. 2022, 11(2), 306; https://doi.org/10.3390/jcm11020306
Available online: https://www.mdpi.com/2077-0383/11/2/306
17. “Oncological Outcomes of Robotic Lobectomy and Radical Lymphadenectomy for Early-Stage Non-Small Cell Lung Cancer”
by Filippo Tommaso Gallina, Riccardo Tajè, Daniele Forcella, Felicita Corzani, Virna Cerasoli, Paolo Visca, Cecilia Coccia, Federico Pierconti, Isabella Sperduti, Fabiana Letizia Cecere et al.
J. Clin. Med. 2022, 11(8), 2173; https://doi.org/10.3390/jcm11082173
Available online: https://www.mdpi.com/2077-0383/11/8/2173
18. “Refractory Mycoplasma pneumoniae Pneumonia in Children: Early Recognition and Management”
by Lin Tong, Shumin Huang, Chen Zheng, Yuanyuan Zhang and Zhimin Chen
J. Clin. Med. 2022, 11(10), 2824; https://doi.org/10.3390/jcm11102824
Available online: https://www.mdpi.com/2077-0383/11/10/2824
19. “A Comprehensive Systematic Review and Meta-Analysis of the Association between the Neutrophil-to-Lymphocyte Ratio and Adverse Outcomes in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease”
by Angelo Zinellu, Elisabetta Zinellu, Maria Carmina Pau, Ciriaco Carru, Pietro Pirina, Alessandro G. Fois and Arduino A. Mangoni
J. Clin. Med. 2022, 11(12), 3365; https://doi.org/10.3390/jcm11123365
Available online: https://www.mdpi.com/2077-0383/11/12/3365
20. “Are Oropharyngeal Dysphagia Screening Tests Effective in Preventing Pneumonia?”
by Ikuko Okuni and Satoru Ebihara
J. Clin. Med. 2022, 11(2), 370; https://doi.org/10.3390/jcm11020370
Available online: https://www.mdpi.com/2077-0383/11/2/370
13 September 2023
Journal of Clinical Medicine Indexed in the Polish Ministry of Education and Science List
We are pleased to inform you that the open access Journal of Clinical Medicine (JCM, ISSN: 2077-0383; IF: 3.9, CiteScore 5.4) has been indexed within the Polish Ministry of Education and Science list of scientific journals and reviewed materials from international conferences. For publishing with JCM, Polish scholars will receive 140 Ministerial Points in the following disciplines related to medicine:
- Biomedical engineering;
- Medical biology;
- Pharmaceutical sciences;
- Medical sciences;
- Science of physical culture;
- Health sciences;
- Family studies;
- Food and nutrition technology;
- Biotechnology;
- Chemical sciences;
- Veterinary medicine.
JCM is an international, peer-reviewed, open access journal of clinical medicine, published semimonthly online by MDPI. We warmly welcome you to consider JCM as the platform for publishing your work. You can contact the JCM Editorial Office at [email protected].
JCM Editorial Office
13 September 2023
Journal of Clinical Medicine | Collection of Papers from the Winners of Best Paper Awards
We invite you to read the best papers published in 2022 below:
1. “Racial Disparities-Associated COVID-19 Mortality among Minority Populations in the US”
by Donald J. Alcendor
J. Clin. Med. 2020, 9(8), 2442; https://doi.org/10.3390/jcm9082442
Available online: https://www.mdpi.com/2077-0383/9/8/2442
2. “Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence”
by Celestino Sardu, Jessica Gambardella, Marco Bruno Morelli, Xujun Wang, Raffaele Marfella and Gaetano Santulli
J. Clin. Med. 2020, 9(5), 1417; https://doi.org/10.3390/jcm9051417
Available online: https://www.mdpi.com/2077-0383/9/5/1417
3. “Estimation of the Transmission Risk of the 2019-nCoy and Its Implication for Public Health Interventions”
by Biao Tang, Xia Wang, Qian Li, Nicola Luigi Bragazzi, Sanyi Tang, Yanni Xiao and Jianhong Wu
J. Clin. Med. 2020, 9(2), 462; https://doi.org/10.3390/jcm9020462
Available online: https://www.mdpi.com/2077-0383/9/2/462
In addition, we have collected all papers from the Best Paper Award’s authors community from 2019 to 2023, as listed below. You are welcome to read and share them.
1. “BK Polyomavirus Virus Glomerular Tropism: Implications for Virus Reactivation from Latency and Amplification during Immunosuppression”
by Donald J. Alcendor
J. Clin. Med. 2019, 8(9), 1477; https://doi.org/10.3390/jcm8091477
Available online: https://www.mdpi.com/2077-0383/8/9/1477
2. “Inositol 1,4,5-Trisphosphate Receptors in Human Disease: A Comprehensive Update”
by Jessica Gambardella, Angela Lombardi, Marco Bruno Morelli, John Ferrara and Gaetano Santulli
J. Clin. Med. 2020, 9(4), 1096; https://doi.org/10.3390/jcm9041096
Available online: https://www.mdpi.com/2077-0383/9/4/1096
3. “Modulation of SERCA in Patients with Persistent Atrial Fibrillation Treated by Epicardial Thoracoscopic Ablation: The CAMAF Study”
by Celestino Sardu, Gaetano Santulli, Germano Guerra, Maria Consiglia Trotta, Matteo Santamaria, Cosimo Sacra, Nicola Testa, Valentino Ducceschi, Gianluca Gatta, Michele D' Amico et al.
J. Clin. Med. 2020, 9(2), 544; https://doi.org/10.3390/jcm9020544
Available online: https://www.mdpi.com/2077-0383/9/2/544
4. “Efficacy of the New Inotropic Agent Istaroxime in Acute Heart Failure”
by Imma Forzano,Pasquale Mone, Gaetano Mottola, Urna Kansakar, Luigi Salemme, Antonio De Luca, Tullio Tesorio, Fahimeh Varzideh and Gaetano Santulli
J. Clin. Med. 2022, 11(24), 7503; https://doi.org/10.3390/jcm11247503
Available online: https://www.mdpi.com/2077-0383/11/24/7503
5. “Long-Term Prognosis among COVID-19 Patients: The Predictive Role Played by Hyperinflammation and Arrhythmic Disorders in Fatal Outcome”
by Domenico Cozzolino, Ciro Romano, Celestino Sardu, Riccardo Nevola, Giuseppina Rosaria Umano, Luca Rinaldi, Luigi Elio Adinolfi, Christian Catalini, Aldo Marrone and Maurizio Municinò et al.
J. Clin. Med. 2023, 12(17), 5691; https://doi.org/10.3390/jcm12175691
Available online: https://www.mdpi.com/2077-0383/12/17/5691
6. “Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study”
by Raffaele Galiero, Vittorio Simeon, Giuseppe Loffredo, Alfredo Caturano, Luca Rinaldi, Erica Vetrano, Giulia Medicamento, Maria Alfano, Domenico Beccia and Chiara Brin
J. Clin. Med. 2022, 11(20), 6121; https://doi.org/10.3390/jcm11206121
Available online: https://www.mdpi.com/2077-0383/11/20/6121
7. “Effect of Hyperglycemia on COVID-19 Outcomes: Vaccination Efficacy, Disease Severity, and Molecular Mechanisms”
by Celestino Sardu, Raffaele Marfella, Francesco Prattichizzo, Rosalba La Grotta, Giuseppe Paolisso and Antonio Ceriello
J. Clin. Med. 2022, 11(6), 1564; https://doi.org/10.3390/jcm11061564
Available online: https://www.mdpi.com/2077-0383/11/6/1564
8. “Point-of-Care Diagnostic Tests for Detecting SARS-CoV-2 Antibodies: A Systematic Review and Meta-Analysis of Real-World Data”
by Matteo Riccò, Pietro Ferraro, Giovanni Gualerzi, Silvia Ranzieri, Brandon Michael Henry, Younes Ben Said, Natalia Valeryevna Pyatigorskaya, Elena Nevolina, Jianhong Wu, Nicola Luigi Bragazzi et al.
J. Clin. Med. 2020, 9(5), 1515; https://doi.org/10.3390/jcm9051515
Available online: https://www.mdpi.com/2077-0383/9/5/1515
9. “Forecasting COVID-19-Associated Hospitalizations under Different Levels of Social Distancing in Lombardy and Emilia-Romagna, Northern Italy: Results from an Extended SEIR Compartmental Model”
by Chiara Reno, Jacopo Lenzi, Antonio Navarra, Eleonora Barelli, Davide Gori, Alessandro Lanza, Riccardo Valentini, Biao Tang and Maria Pia Fantini
J. Clin. Med. 2020, 9(5), 1492; https://doi.org/10.3390/jcm9051492
Available online: https://www.mdpi.com/2077-0383/9/5/1492
6 September 2023
Recap of Awards Granted to Scholars in 2022

MDPI is committed to supporting the academic community, nurturing talent and advancing science. Awards are an important part of the research landscape and play a vital role in helping academics gain recognition, especially young researchers as they embark on new research avenues.
In 2022, our journals presented a total number of 394 Awards, including Travel Awards, Young Investigator Awards, Best PhD Thesis Awards, Best Paper Awards, and Outstanding Reviewer Awards, with several winners announced for some of the awards. The total prize sum amounted to just under 580,000 Swiss francs (CHF), or approximately 650,000 US dollars. Overall, more than 720 scholars were awarded.
The majority of the awards were dedicated to young researchers in relatively early stages of their careers. This encompassed 66 of the afore-mentioned Travel Awards, 60 Young Investigator Awards, supporting research projects and conference attendance, as well as 51 Best PhD Thesis Awards. Additionally, 113 Best Paper Awards were given by our journals. The selection committees were entrusted with identifying the most impactful and novel research and review articles published in their journal within a given year.
MDPI will continue its support and recognition for the academic community moving forward, sponsoring new awards across disciplines. To learn more about all the awardees and their research projects in your field of study, please visit the following pages:
To explore more MDPI awards, please click here.
30 August 2023
MDPI Insights: The CEO's Letter #3 - Sustainability and Co-opetition

Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
Our Commitment to Sustainability
As a pioneer in academic open access publishing since 1996, MDPI has always been dedicated to facilitating scientific exchange across all disciplines. Our approach to open science is guided by principles such as Open Access (OA), Timeliness and Efficiency, Simplicity, High-Quality Service, Flexibility, and a commitment to Sustainability. This commitment involves preserving published papers for the long term and supporting the future of science through partnerships, sponsorships, and awards.
In this edition of the CEO Letter, I will delve into MDPI’s various sustainability initiatives. As a leader in OA publishing, we are able to provide the public with a significant amount of environment-related content at no cost.
MDPI and the Sustainable Development Goals (SDGs)
In 2020, the SDG Publishers Compact was launched to accelerate implementation of the SDGs by promoting content that informs, develops, and inspires action. MDPI joined this initiative in 2021 and subsequently launched the MDPI SDG Hub in 2022, offering free access to recent research within the scope of each of the 17 SDGs. We also support authors from underrepresented communities by waiving publication charges for selected SDG-related papers. Detailed sustainability practices and supported publications are available in the report under each Goal page.
“More than 80% of MDPI articles and reviews published in 2022 relate to the Sustainable Development Goals.” [source: InCites, Accessed on 21.08.2023]
As at August 2023, MDPI boasts 14 journals dedicated to sustainability-related topics. Our first journal in this area, Sustainability, has published over 29,000 articles on the SDGs, accumulating over 240,000 citations (source: InCites, as at 1 January 2023). These journals serve as vital platforms for researchers to share insights and address environmental challenges. In addition:
MDPI journals specializing in sustainability-related topics:
- 2009: Sustainability
- 2012: Resources
- 2013: Climate
- 2014: Environments
- 2016: Recycling
- 2019: Clean Technologies
- 2020: Sustainable Chemistry
- 2021: Wind, Biomass, Conservation, Pollutants, Solar
- 2022: Waste, Microplastics
Read more:
Impactful Research
Highly Cited Articles in Sustainability
In 2022, content published in Sustainability and indexed in Journal Citation Reports (JCR) received nearly 190,000 citations. This highlights the fact that Sustainability publishes highly cited research articles related to environmental sciences and SDG-related topics such as climate action.
We are pleased to share that Sustainability received a 2022 CiteScore of 5.8, marking a 16% increase from the 2021 metric. Specifically, the CiteScore positions Sustainability as follows: Q1 (27 out of 163) in the “Environmental Science (miscellaneous)” category, and Q1 (101 out of 779) in the “Geography Planning and Development” category. For additional journal statistics, please visit here.
“Sustainability received a 2022 CiteScore of 5.8”
While MDPI journals such as Climate and Atmosphere have a distinct focus on atmosphere pollution and its impact on climate processes, journals like Sustainability, Environments, Water, Remote Sensing, and IJERPH publish content related to climate change. These journals have published over 32,300 articles related to SDG 13: Climate Action.
Highly Cited Papers in Sustainability
Below are several highly cited papers published in Sustainability over the past three years. Citation metrics are current as at 15 August 2023.
1. “A Global Assessment: Can Renewable Energy Replace Fossil Fuels by 2050?”Authors: Jerry L. Holechek, Hatim M. E. Geli, Mohammed N. Sawalhah, and Raul Valdez
Sustainability 2022, 14(8), 4792; https://doi.org/10.3390/su14084792
Citations: Crossref (97), Scopus (91), Web of Science (82), Google Scholar (125)
This paper addresses one of the most significant challenges of climate change – achieving Net Zero Carbon by 2050. The meta-analysis suggests that while difficult, this transition is possible through the concerted application of pathways, lifestyle changes, and global cooperation.
2. “Anxiety and the Ecological Crisis: An Analysis of Eco-Anxiety and Climate Anxiety”Author: Panu Pihkala
Sustainability 2020, 12(19), 7836; https://doi.org/10.3390/su12197836
Citations: Crossref (144), Scopus (121), Web of Science (159), Google Scholar (382)
This paper has received substantial media attention, including coverage by The Guardian, BBC, Vice, and CNBC. An interview with Dr. Panu Pihkala, a leading interdisciplinary researcher on the topic, can be found on MDPI’s podcast: Insight Faster, Episode 1.
3. “Impact of Climate Change on Agriculture and Its Mitigation Strategies: A Review”Authors: Gurdeep Singh Malhi, Manpreet Kaur, and Prashant Kaushik
Sustainability 2021, 13(3), 1318; https://doi.org/10.3390/su13031318
Citations: Crossref (207), Scopus (221), Web of Science (186), Google Scholar (355)
This paper reviews literature on climate change, addressing its causes, future projections, impact on agriculture, including plant physiology, growth, productivity, pest infestation, and the economic implications of mitigation strategies.
4. “Impacts of Plastic Pollution on Ecosystem Services, Sustainable Development Goals, and Need to Focus on Circular Economy and Policy Interventions”Authors: Rakesh Kumar, Anurag Verma, Arkajyoti Shome, Rama Sinha, Srishti Sinha, Prakash Kumar Jha, Ritesh Kumar, Pawan Kumar, Shubham, Shreyas Das, Prabhakar Sharma, and P. V. Vara Prasad
Sustainability 2021, 13(17), 9963; https://doi.org/10.3390/su13179963
Citations: Crossref (134), Scopus (136), Web of Science (113), Google Scholar (184)
This review aims to assess the adverse effects of plastic pollution on ecosystems, link the management of plastic with the SDGs, and propose policy measures using transdisciplinary approaches. Empowering communities to reduce plastic use is crucial. Addressing global plastic pollution is a priority.
Sustainability is an international, cross-disciplinary, open access journal that explores environmental, cultural, economic, and social sustainability of human beings. It provides a forward-looking platform for research on sustainability and sustainable development, and is published semi-monthly online by MDPI. Sustainability is affiliated with The Canadian Urban Transit Research & Innovation Consortium (CUTRIC) and The International Council for Research and Innovation in Building and Construction (CIB).
Read more:
- Testimonials: See what our editors and authors say about Sustainability.
Inside MDPI
President of Ireland Authors Editorial in MDPI Journal Sustainability
It’s a very special occasion when the president of a country takes the initiative to write an editorial for a journal. Michael D. Higgins, President of the Republic of Ireland, has contributed his insights to a forthcoming Special Issue in Sustainability:
This Special Issue, focusing on “making sustainable development happen” at grassroots levels, allows for perspectives from, and on, the major world faiths, exploring how challenges have been conceptualised and addressed, in addition to case studies of faith-based sustainability initiatives in practice.
The experience of faith institutions and communities in translating theological and moral commitments to sustainable development into action is now a topic we must examine with urgency; one on which I am so glad this Special Issue focuses.
As President of Ireland, I very much support this Special Issue of Sustainability. It is my great hope that the contents of the papers contained herein will assist in making sustainable development happen at grassroots levels across the world so that we can cooperate together, people of faith and of none, to ensure a just, inclusive and sustainable future for all on our fragile planet.
Read the completed editorial here:
Special Issue “Faith and Sustainable Development: Exploring Practice, Progress and Challenges among Faith Communities and Institutions”: Foreword by the President of Ireland
Author: Michael D. Higgins
Sustainability 2023, 15(12), 9683; https://doi.org/10.3390/su15129683
Coming Together for Science
The World Sustainability Forum 2023
The World Sustainability Forum (WSF) is a biennial MDPI event focused on sustainability. WSF 2023 marks the tenth anniversary of the conference series, taking place on 14 September. For the first time, the event will be hosted as a 24-hour conference across three locations – Singapore, Basel in Switzerland, and Toronto in Canada – alongside virtual streaming.
This unique format allows us to span three time zones, providing live coverage of critical sustainability-related topics throughout the day:
- The Singapore Hub, chaired by Professor Horn Mun Cheah and Associate Professor Renee Tan, will explore “Sustainability for Social and Community Impact”.
- The Basel Hub, chaired by Prof. Dr. Anet Režek Jambrak and Dr. Lela Mélon, will delve into “Sustainability in the industry, and at university and corporate settings”.
- The Toronto Hub, led by Dr. Umberto Berardi, will discuss “The Sustainable Built Environment”.
MDPI Sustainability Foundation: Recognizing Excellence in Sustainability Research
The MDPI Sustainability Foundation supports researchers through two sustainability-focused awards:
- The World Sustainability Award, amounting to USD 100,000, is given to senior researchers.
- The Emerging Sustainability Leader Award, valued at USD 20,000, sponsored by the journal Sustainability, is presented to early-career researchers.
The winners of the Sustainability Foundation will be formally awarded during the WSF2023 on 14 September. Interviews with the award winners and finalists are available below.
2023 World Sustainability Award Winners
Interviews with 2023 Emerging Sustainability Leader Award Finalists
- Dr. Bahareh Kamranzad
- Dr. Youjin Kim
- Dr. Julia Lohmann
As a hybrid event, WSF23 provides scholars with the option to attend in person at one of the conference sites or, for a more sustainable approach, virtually. All sessions will be recorded and archived for future access. Registration is open until 3 September 2023, with in-person and virtual tickets available here.
Read more:
Closing Thoughts
“Co-opetition”: Collaboration Plus Healthy Competition – A Visit to Elsevier
I firmly believe in fostering collaboration and at the same time promoting healthy competition within the academic publishing industry. The market offers ample room for publishers and related companies to provide valuable services and products that enrich the academic community. While MDPI is recognized for its efficient and streamlined processes –thanks to our over 6,000 colleagues, in-house tools, and initiatives that support the author journey – our ethos has always involved learning from and collaborating with other organizations.
MDPI’s Interaction with Elsevier
In January 2023, I had a brief conversation with Judy Verses, President of Global Academic and Government Markets at Elsevier, following her participation in a panel discussion at the Academic Publishers Europe event in Berlin. One of the highlights for me was Judy’s insight into the impact of research, particularly her emphasis on the role of collaboration, including policy and showing the impact of research to influence on funding decisions.
“Such collaborations drive forward-looking strategies to elevate our support for the scholarly community”
Judy and I resumed our discussion in August, when I visited Elsevier's office to review current projects, such as our recent agreement with Science Direct and the continued indexing of MDPI journals in Scopus (indexing database owned by Elsevier). We also explored possible opportunities for the future, including a potential collaboration to expand MDPI’s Scilit data infrastructure. This endeavour aims to aggregate and provide access to scholarly metadata encompassing journal articles, conference papers, books, preprints, and more. While these discussions are ongoing, the underlying principle remains that such collaborations drive forward-looking strategies to elevate our services and support for the scholarly community.
It was great that Judy and I acknowledged the merits of 'co-opetition,' a concept based of the belief that fostering cooperation alongside healthy competition can lead to shared advancements for both individual companies and the industry at large.
‘Fully OA’ Organizations Dedicated to Open Access
MDPI proudly aligns with the ‘Fully OA’ group, a collaborative initiative comprising nine organizations dedicated to Open Access. Our monthly meetings, including an OASPA representative, serve as platforms to share non-confidential information, resources, and projects. These gatherings also facilitate discussions on topics relevant to fully OA organizations. Occasionally, joint actions spring from these interactions, such as collaborative blog posts on pertinent subjects and joint statements, such as a recent response to the House Appropriations Committee.
This display of cooperation among competing entities forms a strategic alliance focused on nurturing the best interests of the OA publishing model.
As I wrap up this third edition of the CEO Letter, I encourage you to seize opportunities for collaboration and contribute to advancing our shared academic culture. As the African proverb has it, “If you want to go fast, go alone; if you want to go far, go together.”
Chief Executive Officer
MDPI AG
28 August 2023
JCM 2023 Young Investigator Award—Open for Nominations
We are pleased to announce that the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) is now inviting nominations for the JCM 2023 Young Investigator Award. This prize will be given to one young investigator in recognition of their excellence in the field of clinical medicine.
The prize:
- CHF 2000 (Swiss francs);
- Option to publish one paper free of charge in the JCM after peer review before the end of 2024;
- An electronic certificate.
Eligibility and requirements:
- Must have received their Ph.D. no more than 10 years prior to 31 December 2023;
- Must have produced ground-breaking research and made a significant contribution to the advancement of clinical medicine;
- Candidates must be nominated by senior scientists.
Nomination deadline: 31 December 2023
You can find more information about this award and how to nominate here (https://www.mdpi.com/journal/jcm/awards/2254). To request further information, please contact the JCM Editorial Office ([email protected]).
Journal of Clinical Medicine Editorial Office
25 August 2023
Meet Us at the American Congress of Rehabilitation Medicine (ACRM) 100th Annual Conference, 30 October–2 November 2023, Atlanta, USA

MDPI will attend the American Congress of Rehabilitation Medicine (ACRM) 100th Annual Conference. The 2023 annual meeting of ACRM is the world’s largest interdisciplinary rehabilitation research event. Rehabilitation professionals and community members from around the globe are encouraged to join. With 150+ inter-professional groups at ACRM, including community groups, committees, and task forces, the 100th anniversary conference is planning 4 powerful plenaries, 15+ symposia, 300+ educational sessions, symposia and lectures, and 600+ scientific papers and digital poster presentations, etc.
To enhance patient care, the presentation of science by researchers is required, and to inform and improve research, feedback from the clinicians is required. The aim of the ACRM 100th annual conference is to encourage attendees to join the discussions and collaborations in order to help move the field of physical medicine and rehabilitation forward.
The following MDPI journals will be represented:
If you plan on attending this conference, please feel free to stop by our booth #413 and start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit https://conference.acrm.org/.
23 August 2023
Journal of Clinical Medicine | Google Scholar Metrics Released
We are pleased to announce that the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) ranked 17th under the subcategory “Health & Medical Sciences (general)” in the latest released 2023 Google Scholar Metrics on 19 July 2023. The latest release covers articles published from 2018 to 2022 and includes citations from all articles that were indexed in Google Scholar as of July 2023 (source: 2023 Google Scholar Metrics).
The h5-index of the Journal of Clinical Medicine is 125, and the h5-median is 178. We express our gratitude to all the editors, reviewers, authors, and readers of the Journal of Clinical Medicine. Thank you for all your support for the journal.
You are welcome to browse the most cited publications over the last 5 years here.
Please feel free to contact us at [email protected] if you have any questions or suggestions for the Journal of Clinical Medicine.
Supplementary explanations:
- Scholar Metrics provide an easy way for authors to quickly gauge the visibility and influence of recent articles in scholarly publications;
- h5-index: the h5-index is the h-index for articles published in the last 5 complete years. H articles published in 2018-2022 have at least h citations each;
- h5-median: the h5-median for a publication is the median number of citations for the articles that make up its h5-index.
18 August 2023
Meet Us at the American Academy of Pediatrics 2023 National Conference & Exhibition, 20–24 October 2023, Washington, USA

MDPI will attend the American Academy of Pediatrics 2023 National Conference & Exhibition. This event will be held in Washington D.C. for five days from Friday, 20 October, to Tuesday, 24 October 2023.
The following MDPI journals will be represented:
- Children;
- JCM;
- Medicina;
- Healthcare;
- IJERPH;
- JPM;
- Clinpract;
- Diagnostics;
- Medicines.
If you plan on attending this conference, please stop by our booth and speak with us. Our delegates look forward to meeting you in person and answering any questions that you may have.
For more information about the conference, please visit https://aapexperience.org/.
18 August 2023
MDPI’s 2022 Young Investigator Awards in Medicine and Pharmacology—Winners Announced

MDPI’s Young Investigator Awards recognize promising young researchers, acknowledge their contributions, and enhance communication among scientists. We are proud to present the winners for the year 2022 in medicine and pharmacology. The winners were selected by the journals’ Award Evaluation Committee.
We would like to warmly congratulate the awarded young investigators for their outstanding contributions. MDPI will continue to provide support and recognition to the academic community.
- Yuyan Jiang, Stanford University, USA
- Billy Wai-Lung Ng, Chinese University of Hong Kong, China
- Ashleigh Poh, The Olivia Newton-John Cancer Research Institute, Australia
- Miranda Fidler-Benaoudia, University of Calgary, Canada
- Bishal Gyawali, Queen’s University, Canada
- Shahnawaz Anwer, Hong Kong Polytechnic University, Hong Kong
- Jan Bednarsch, Universitätsmedizin Berlin, Germany
- Anda Mihaela Naciu, Fondazione Policlinico Universitario Campus Bio-Medico, Italy
- Jerome Lechien, University of Mons, Belgium
- Daniele Bertoglio, University of Antwerp, Belgium
- Gregor Fuhrmann, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany
- Haley Adcox, Virginia Commonwealth University, USA
About MDPI Awards:
In order to support the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and a form of recognition, help to promote the influence of talented individuals who have made outstanding achievements and are making significant contributions to the advancement of their fields.
For more MDPI awards, please click here.
18 August 2023
MDPI’s 2022 Travel Awards in Medicine and Pharmacology—Winners Announced

We are proud to recognize the winners of MDPI’s 2022 Travel Awards in medicine and pharmacology category for their outstanding presentations.
MDPI journals regularly offer Travel Awards to encourage talented junior scientists to present their research at academic conferences in specific fields, which helps to enhance their influence.
The winners mentioned below were carefully selected by the journal editors based on an outline of their research and the work to be presented at an academic conference.
We would like to congratulate the winners of the 2022 Travel Awards and wish them success with their future research endeavors. MDPI will continue to enhance communication among scientists.
- Filip Jansåker, Lund University, Lund, Sweden
- Vanessa Silva, University of Trás-os-Montes and Alto Douro, Portugal
- Diego de Miguel Perez, Icahn School of Medicine at Mount Sinai, USA
- Luigi Russo, Italian Institute of Technology (IIT), Italy
- Sneha Sethi, University of Adelaide, Australia
- Xiyin Wang, Indiana University School of Medicine, USA
- Sonia Nath, University of Adelaide, Australia
- Konstantina Kritikou, Carol Davila University of Medicine and Pharmacy, Romania
- Adrien Holzgreve, The University Hospital of Munich, Germany
- Antonella Padella, Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST S.r.l., Italy
- Susanna Cooper, St. George’s University of London, UK
- Renée Tillie, Maastricht University Medical Center, the Netherlands
- Max Lennart Eckstein, University of Bayreuth, Germany
- Lorenzo Bertani, University of Pisa, Italy
- Yuxue Cao, University of Queensland, Australia
- Flávia Sousa, Italian Institute of Technology, Italy
About MDPI Awards:
In order to support the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and form ot recognition, help to promote the influence of talented individuals who have made outstanding achievements and are making significant contributions to their fields.
See more MDPI awards, please click here.
18 August 2023
MDPI’s 2022 Outstanding Reviewer Awards in Medicine and Pharmacology—Winners Announced

In order to acknowledge our reviewers, who so generously dedicate their time to reviewing papers and demonstrate diligence, professionalism, and timeliness when reviewing manuscripts, MDPI journals regularly offer outstanding reviewer awards to scholars who participate in the peer-review process.
We are proud to recognize the winners for the year 2022 in medicine and pharmacology for their outstanding contributions among the extensive competition by presenting them with an Outstanding Reviewer Award.
We would like to take this opportunity to congratulate all of the winners on their achievements. MDPI will continue to provide support and recognition to the academic community.
- Maxime Pichon, Centre Hospitalier Universitaire de Poitiers, France
- Violeta Popovici, Ovidius University of Constanta, Romania
- Yosra A. Helmy, University of Kentucky, USA
- Antonio G. Solimando, Aldo Moro University of Bari, Italy
- Linlin Guo, The Ohio State University Medical Center, USA
- Ravindra Deshpande, Wake Forest School of Medicine, USA
- Songli Zhu, Fred Hutchinson Cancer Research Center, USA
- Antonella Argentiero, IRCCS Istituto Tumori “Giovanni Paolo II” of Bari, Italy
- Camelia Coada, Alma Mater Studiorum-University of Bologna, Italy
- Chenghui Li, University of Arkansas for Medical Sciences, USA
- Laurentiu Pop, University of Texas Southwestern Medical Center, USA
- Muhammad Fazal Ijaz, Dongguk University, Republic of Korea
- Rafał Watrowski, University of Freiburg, Germany
- Ruben C. Petreaca, The Ohio State University, USA
- Ruchi Roy, Rush University Medical Center, USA
- Salvatore Cocuzza, University of Catania, Italy
- Santosh Kumar Singh, Morehouse School of Medicine, USA
- Sergei Boichuk, Kazan State Medical University, Russia
- Simon John Christoph Soerensen, Stanford University, USA
- Takuya Koie, Gifu University, Japan
- Teresa Rubio-Tomás, Foundation for Research and Technology Hellas, Greece
- Teruki Nii, Kyushu University, Japan
- Tomasz Marjanski, Medical University of Gdansk, Poland
- Kristen Haase, The University of British Columbia, Canada
- Ravi Ramjeesingh, Nova Scotia Cancer Centre and Dalhousie University, Canada
- Makoto Endo, Kyushu University, Japan
- Tefera Tadesse, Addis Ababa University, Ethiopia
- Ravi Ramjeesingh, Nova Scotia Cancer Centre and Dalhousie University, Canada
- Ryuichi Ohta, Unnan City Hospital, Japan
- Henry Sutanto, Cardiovascular Research Institute Maastricht, the Netherlands
- José-María Sánchez-González, University of Seville, Spain
- Emmanouil Kapetanakis, General Hospital of Piraeus “Tzaneio”, Greece
- Eleonora Topino, Libera Università Maria Santissima Assunta (LUMSA), Italy
- Rodolfo Reda, Sapienza University of Rome, Italy
- Giulio Francesco Romiti, Sapienza University of Rome, Italy
- Maria Gabriella Melchiorre, IRCCS INRCA—National Institute of Health and Science on Ageing, Italy
- James Walter, 1Hines VA Hospital, USA; 2 Loyola Medical Center, USA
- Vasiliki Tsigkou, Sotiria Hospital, Greece
- Flavia Zacconi, Pontificia Universidad Católica de Chile, Chile
- Bhupendra Prajapati, Ganpat University, India
- Van-An Duong, Gachon University, Republic of Korea
- Ashish Agrawal, Indian Institute of Technology (BHU), India
- Aydin Eresen, University of California Irvine, USA
About MDPI Awards:
In order to support the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and form of recognition, help to promote the influence of talented individuals who have made outstanding achievements and are making significant contributions to their fields.
See more MDPI awards, please click here.
18 August 2023
MDPI’s 2022 Best PhD Thesis Awards in Medicine and Pharmacology—Winners Announced

MDPI’s Best PhD Thesis Awards aim to recognize young scholars who are deemed to have produced the most outstanding PhD thesis in their fields of research and to encourage them to continue their outstanding work and further contributions to their field.
We would like to congratulate the winners of the 2022 Best PhD Thesis Awards in medicine and pharmacology and wish them success with their future research endeavors. MDPI will continue to enhance communication among scientists.
- “Uncovering Novel Prognostic and Predictive Epigenetic Biomarkers in Malignant Testicular Germ Cell Tumors”
by João Pedro da Silva Machado Lobo, University of Porto, Portugal
- “Metastatic Recurrence in Colorectal Cancer Arises from Residual EMP1+ Cells”
by Adrià Cañellas Socias, University of Barcelona, Spain
- “Investigating Novel Aspects of the Blood–Brain Barrier Using High-Resolution Electron Microscopy”
by Shireen Mentor, University of Cape Town, South Africa
- “An Epidemiological Approach to Study The Interplay between Genome, Epigenome and Exposome in Women”
by Roberta Magnano San Lio, University of Catania, Italy
- “Intravitreal Liposomes as Ocular Drug Delivery Systems: Vitreal Interactions, Retinal Permeation and Drug Release Characteristics”
by Shirin Tavakoli, University of Helsinki, Finland
- “Microbiome-Mediated Colonization Resistance: Defense against Enteropathogens and Multi-Drug Resistant Organisms”
by Quinten Ducarmon, Leiden University Medical Center, the Netherlands
About MDPI Awards:
In order to support the academic community, especially young researchers, and enhance communication among scientists, MDPI journals offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and form of recognition, help to promote the influence of talented individuals who have made outstanding achievements and are making significant contributions to their fields.
For more MDPI awards, please click here.
18 August 2023
MDPI’s Best Paper Awards in Medicine and Pharmacology—Winners Announced in 2022

The purpose of our Best Paper Awards is to promote and recognize the most impactful contributions published within MDPI journals.
The editors of each journal carefully selected review and research papers through a rigorous evaluative process based on criteria such as the scientific merit, overall impact, and quality of presentation of the papers published in the journal.
We are honored to present the winners for the year 2022 in medicine and pharmacology, who were selected amongst extensive competition, and congratulate the authors for their outstanding scientific publications. MDPI will continue to provide support and recognition to the academic community.
- “Development and Challenges of Antimicrobial Peptides for Therapeutic Applications”
by Charles H. Chen and Timothy K. Lu
Antibiotics 2020, 9(1), 24; https://doi.org/10.3390/antibiotics9010024
- “Antimicrobial Usage and Resistance in Companion Animals: A Cross-Sectional Study in Three European Countries”
by Philip Joosten, Daniela Ceccarelli, Evelien Odent, Steven Sarrazin, Haitske Graveland, Liese Van Gompel, Antonio Battisti, Andrea Caprioli, Alessia Franco, Jaap A. Wagenaar et al.
Antibiotics 2020, 9(2), 87; https://doi.org/10.3390/antibiotics9020087
- “Management of Peri-Implantitis Lesions without the Use of Systemic Antibiotics: A Systematic Review”
by Ahsen Khan, Ankit Goyal, Scott D. Currell and Dileep Sharma
Dent. J. 2020, 8(3), 106; https://doi.org/10.3390/dj8030106
- “Associations among Primary Stability, Histomorphometric Findings, and Bone Density: A Prospective Randomized Study after Alveolar Ridge Preservation with a Collagen Cone”
by Sigmar Schnutenhaus, Werner Götz, Jens Dreyhaupt, Heike Rudolph, Ralph G. Luthardt and Cornelia Edelmann
Dent. J. 2020, 8(4), 112; https://doi.org/10.3390/dj8040112
- “Novel Prefrontal Synthesis Intervention Improves Language in Children with Autism”
by Andrey Vyshedskiy, Edward Khokhlovich, Rita Dunn, Alexander Faisman, Jonah Elgart, Lisa Lokshina, Yuriy Gankin, Simone Ostrovsky, Lauren deTorres, Stephen M. Edelson et al.
Healthcare 2020, 8(4), 566; https://doi.org/10.3390/healthcare8040566
- “The Effects of Long-Term 40-Hz Physioacoustic Vibrations on Motor Impairments in Parkinson’s Disease: A Double-Blinded Randomized Control Trial”
by Abdullah Mosabbir, Quincy J. Almeida and Heidi Ahonen
Healthcare 2020, 8(2), 113; https://doi.org/10.3390/healthcare8020113
- “Racial Disparities-Associated COVID-19 Mortality among Minority Populations in the US”
by Donald J. Alcendor
J. Clin. Med. 2020, 9(8), 2442; https://doi.org/10.3390/jcm9082442
- “Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence”
by Celestino Sardu, Jessica Gambardella, Marco Bruno Morelli, Xujun Wang, Raffaele Marfella and Gaetano Santulli
J. Clin. Med. 2020, 9(5), 1417; https://doi.org/10.3390/jcm9051417
- “Estimation of the Transmission Risk of the 2019-nCoy and Its Implication for Public Health Interventions”
by Biao Tang, Xia Wang, Qian Li, Nicola Luigi Bragazzi, Sanyi Tang, Yanni Xiao and Jianhong Wu
J. Clin. Med. 2020, 9(2), 462; https://doi.org/10.3390/jcm9020462
- “Molecular and Cellular Mechanisms Affected in ALS”
by Laura Le Gall, Ekene Anakor, Owen Connolly, Udaya G. Vijayakumar, William J. Duddy and Stephanie Duguez
J. Pers. Med. 2020, 10(3), 101; https://doi.org/10.3390/jpm10030101
- “Postulated Adjuvant Therapeutic Strategies for COVID-19”
by Anderson O. Ferreira, Hudson C. Polonini and Eli C. F. Dijkers
J. Pers. Med. 2020, 10(3), 80; https://doi.org/10.3390/jpm10030080
- “Evidences of CTLA-4 and PD-1 Blocking Agents-Induced Cardiotoxicity in Cellular and Preclinical Models”
by Vincenzo Quagliariello, Margherita Passariello, Domenica Rea, Antonio Barbieri, Martina Iovine, Annamaria Bonelli, Antonietta Caronna, Gerardo Botti, Claudia De Lorenzo and Nicola Maurea
J. Pers. Med. 2020, 10(4), 179; https://doi.org/10.3390/jpm10040179
- "Manufacturing Considerations for the Development of Lipid Nanoparticles Using Microfluidics”
by Carla B. Roces, Gustavo Lou, Nikita Jain, Suraj Abraham, Anitha Thomas, Gavin W. Halbert and Yvonne Perrie
Pharmaceutics 2020, 12(11), 1095; https://doi.org/10.3390/pharmaceutics12111095
- “Development of Remdesivir as a Dry Powder for Inhalation by Thin Film Freezing”
by Sawittree Sahakijpijarn, Chaeho Moon, John J. Koleng, Dale J. Christensen and Robert O. Williams III
Pharmaceutics 2020, 12(11), 1002; https://doi.org/10.3390/pharmaceutics12111002
- “Skin Wound Healing Process and New Emerging Technologies for Skin Wound Care and Regeneration”
by Erika Maria Tottoli, Rossella Dorati, Ida Genta, Enrica Chiesa, Silvia Pisani and Bice Conti
Pharmaceutics 2020, 12(8), 735; https://doi.org/10.3390/pharmaceutics12080735
- “The Role of Hospital and Community Pharmacists in the Management of COVID-19: Towards an Expanded Definition of the Roles, Responsibilities, and Duties of the Pharmacist”
by Nicola Luigi Bragazzi, Muhammad Mansour, Alessandro Bonsignore and Rosagemma Ciliberti
Pharmacy 2020, 8(3), 140; https://doi.org/10.3390/pharmacy8030140
- “Association of a Novel Medication Risk Score with Adverse Drug Events and Other Pertinent Outcomes Among Participants of the Programs of All-Inclusive Care for the Elderly”
by David L. Bankes, Hubert Jin, Stephanie Finnel, Veronique Michaud, Calvin H. Knowlton, Jacques Turgeon and Alan Stein
Pharmacy 2020, 8(2), 87; doi.org/10.3390/pharmacy8020087
About MDPI Awards:
In order to support the academic community, especially young researchers, and enhance communication among scientists, MDPI journals regularly offer various awards to researchers in specific fields. These awards, serving as a source of inspiration and form of recognition, help to promote the influence of talented individuals who have made outstanding achievements and are making significant contributions to their fields.
See more MDPI awards, please click here.
18 August 2023
Journal of Clinical Medicine | Call for Special Issue Proposals and Recruiting Guest Editors

Journal of Clinical Medicine (JCM, ISSN: 2077-0383) is an international, peer-reviewed, open access journal of clinical medicine, published semi-monthly online by MDPI. JCM supports scientific innovations and clinical medicine research within the whole field and its related fields. The journal is indexed within Scopus, SCIE (Web of Science), PubMed, PMC, Embase, CAPlus / SciFinder, and other databases. For more details, please see the following link: https://www.mdpi.com/journal/jcm.
The JCM editorial team is pleased to announce this open call for Special Issue proposals, which offers a group of authors the opportunity to work on an interconnected set of papers on an innovative topic. We are soliciting high-quality proposals that will be evaluated in a continuous selection process throughout the year.
If you would like to propose a Special Issue topic for this journal, please visit the following link and then complete and submit the form: https://www.mdpi.com/journalproposal/sendproposalspecialissue/jcm, and contact the JCM Editorial Office ([email protected]). Our editors will respond to you as soon as possible.
The duties of Guest Editors are as follows:
- Refining the Special Issue’s title and scope, as well as providing a short introduction (100–200 words) and 5–10 keywords to set up the Special Issue’s website;
- Inviting contributors with the assistance of the in-house editor to achieve a publication target (e.g., 10 papers);
- Supervising the peer review process of the Special Issue, conducting a pre-review check, making final decisions based on at least two review reports that we have collected, etc.
- You will be offered an opportunity to publish one of your papers free of charge in an open access format, in addition to having the chance to provide the waivers to the papers that you invited for your Special Issue;
- A printed book of the Special Issue can be sent to you if more than 10 papers are published by the end of the Special Issue. See more information at https://www.mdpi.com/books;
- It is an ideal venue for networking and communicating with scholars in the research community, as well as a chance to mark you as influential within your discipline. The relationships you develop will last beyond the publication of your Special Issue, establishing a network for future collaboration;
- You can freely organize or promote your own conferences by using our platform SciForum.
The Editorial Office will set up the Special Issue’s website, arrange the promotional materials, assist with the invitations for paper contributions, and take care of the administrative tasks associated with peer review.
Please do not hesitate to contact the Editorial Office ([email protected]) for further details and clarification.
We look forward to receiving your proposals.
Journal of Clinical Medicine Editorial Office
28 July 2023
Journal of Clinical Medicine | World Hepatitis Day in 2023—“We’re not waiting”

World Hepatitis Day (WHD), held on 28 July every year, aims to raise global awareness of hepatitis—a group of infectious diseases known as hepatitis A, B, C, D, and E—and encourage prevention, diagnosis, and treatment, where we bring the world together under a single theme to raise awareness of the global burden of viral hepatitis and to influence real change. In 2023, the theme is “We’re not waiting”, and we call on people around the world to take action because hepatitis can’t wait.
To further explore the related research on the World Hepatitis Day 2023, Journal of Clinical Medicine (JCM, ISSN: 2077-0383) has gathered open access academic research on the topic of hepatitis. We hope to share new scientific knowledge in the field of hepatitis with the world on this special day.
Article Collections:
1. "CD8+ T Cell Responses during HCV Infection and HCC"
by Maike Hofmann, Catrin Tauber, Nina Hensel and Robert Thimme
J. Clin. Med. 2021, 10(5), 991; https://doi.org/10.3390/jcm10050991
2. "Hepatocellular Carcinoma Recurrence after Hepatitis C Virus Therapy with Direct-Acting Antivirals. A Systematic Review and Meta-Analysis"
by Leonardo Frazzoni, Usama Sikandar, Flavio Metelli, Sinan Sadalla, Giuseppe Mazzella, Franco Bazzoli, Lorenzo Fuccio and Francesco Azzaroli
J. Clin. Med. 2021, 10(8), 1694; https://doi.org/10.3390/jcm10081694
3. "Laboratory Profile of COVID-19 Patients with Hepatitis C-Related Liver Cirrhosis"
by Bianca Cerbu, Mirela Loredana Grigoras, Felix Bratosin, Iulia Bogdan, Cosmin Citu, Adrian Vasile Bota, Madalina Timircan, Melania Lavinia Bratu, Mihaela Codrina Levai and Iosif Marincu
J. Clin. Med. 2022, 11(3), 652; https://doi.org/10.3390/jcm11030652
4. "Tracking Down the Epigenetic Footprint of HCV-Induced Hepatocarcinogenesis"
by Tom Domovitz and Meital Gal-Tanamy
J. Clin. Med. 2021, 10(3), 551; https://doi.org/10.3390/jcm10030551
5. "Immunological Mechanisms for Hepatocellular Carcinoma Risk after Direct-Acting Antiviral Treatment of Hepatitis C Virus Infection"
by Pil Soo Sung and Eui-Cheol Shin
J. Clin. Med. 2021, 10(2), 221; https://doi.org/10.3390/jcm10020221
6. "Rapid Decline of Serum Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) in Non-Cirrhotic Patients with Chronic Hepatitis C Infection Receiving Direct-Acting Antiviral Therapy"
by Jonathan Grimm, Georg Peschel, Martina Müller, Doris Schacherer, Reiner Wiest, Kilian Weigand and Christa Buechler
J. Clin. Med. 2021, 10(8), 1621; https://doi.org/10.3390/jcm10081621
7. "Day-4 Lille Score Is a Good Prognostic Factor and Early Predictor in Assessing Therapy Response in Patients with Liver Cirrhosis and Severe Alcoholic Hepatitis"
by Camelia Gianina Foncea, Ioan Sporea, Raluca Lupușoru, Tudor Voicu Moga, Felix Bende, Roxana Șirli and Alina Popescu
J. Clin. Med. 2021, 10(11), 2338; https://doi.org/10.3390/jcm10112338
8. "Hepatitis C: A Pharmacological Therapeutic Update"
by Sonia Santander Ballestín, David Gómez Martín, Sara Lorente Pérez and María José Luesma Bartolomé
J. Clin. Med. 2021, 10(8), 1568; https://doi.org/10.3390/jcm10081568
9. "Zinc Administration and Improved Serum Markers of Hepatic Fibrosis in Patients with Autoimmune Hepatitis"
by Kei Moriya, Norihisa Nishimura, Tadashi Namisaki, Hiroaki Takaya, Yasuhiko Sawada, Hideto Kawaratani, Kosuke Kaji, Naotaka Shimozato, Shinya Sato, Masanori Furukawa et al.
J. Clin. Med. 2021, 10(11), 2465; https://doi.org/10.3390/jcm10112465
10. "Association between Visceral Adipose Tissue and Non-Alcoholic Steatohepatitis Histology in Patients with Known or Suspected Non-Alcoholic Fatty Liver Disease"
by Ilkay S. Idilman, Hsien Min Low, Tolga Gidener, Kenneth Philbrick, Taofic Mounajjed, Jiahui Li, Alina M. Allen, Meng Yin and Sudhakar K. Venkatesh
J. Clin. Med. 2021, 10(12), 2565; https://doi.org/10.3390/jcm10122565
11. "Transplantation of Organs from Hepatitis C Virus-Positive Donors under Direct-Acting Antiviral Regimens"
by Muhammad Nauman Zahid
J. Clin. Med. 2022, 11(3), 770; https://doi.org/10.3390/jcm11030770
12. "Extrahepatic Manifestations of Chronic HBV Infection and the Role of Antiviral Therapy"
by Cesare Mazzaro, Luigi Elio Adinolfi, Gabriele Pozzato, Riccardo Nevola, Ada Zanier, Diego Serraino, Pietro Andreone, Roberta Fenoglio, Savino Sciascia, Valter Gattei et al.
J. Clin. Med. 2022, 11(21), 6247; https://doi.org/10.3390/jcm11216247
13. "Use of a Deep Learning Approach for the Sensitive Prediction of Hepatitis B Surface Antigen Levels in Inactive Carrier Patients"
by Hiroteru Kamimura, Hirofumi Nonaka, Masaya Mori, Taichi Kobayashi, Toru Setsu, Kenya Kamimura, Atsunori Tsuchiya and Shuji Terai
J. Clin. Med. 2022, 11(2), 387; https://doi.org/10.3390/jcm11020387
14. "Micro-Elimination of Hepatitis C among Patients with Kidney Disease by Using Electronic Reminder System—A Hospital-Based Experience"
by Pei-Yuan Su, Wei-Wen Su, Yu-Chun Hsu, Shu-Yi Wang, Ping-Fang Chiu and Hsu-Heng Yen
J. Clin. Med. 2022, 11(2), 423; https://doi.org/10.3390/jcm11020423
15. "Hepatitis B Core-Related Antigen Is Useful for Predicting Phase and Prognosis of Hepatitis B e Antigen-Positive Patients"
by Han Ah Lee, Hyun Woong Lee, Younhee Park, Hyon-Suk Kim and Yeon Seok Seo
J. Clin. Med. 2022, 11(6), 1729; https://doi.org/10.3390/jcm11061729
Access more articles:
https://www.mdpi.com/search?journal=jcm.
Call for Paper:
"Clinical Advances in Viral Hepatitis"
Guest Editor: Prof. Dr. Calvin Q. Pan
Submission Deadline: 30 September 2023
"New Advances in Management of Hepatitis B Virus (HBV) Infection"
Guest Editors: Dr. Maryam Moini and Dr. Scott K. Fung
Submission Deadline: 25 November 2023
Access more Special Issues:
https://www.mdpi.com/journal/jcm/special_issues?section_id=491&search=&sort=deadline&view=open&page_count=100.
Special Issue Book:
“Chronic HCV Infection: Clinical Advances and Eradication Perspectives”
Access more Special Issue books:
https://www.mdpi.com/books/search?type=Reprint%20Book&journal_facet=Journal%20of%20Clinical%20Medicine.
27 July 2023
Journal of Clinical Medicine | Highly Cited Papers in 2021 and 2022 from the Section “Endocrinology & Metabolism”

The Journal of Clinical Medicine (JCM, ISSN: 2077-0383) is an international, peer-reviewed, open access journal published semimonthly online by MDPI. The International Bone Research Association (IBRA), Italian Resuscitation Council (IRC), Spanish Society of Hematology and Hemotherapy (SEHH), Japan Association for Clinical Engineers (JACE), European Independent Foundation in Angiology/ Vascular Medicine (VAS) and others are all affiliated with JCM, and their members receive a discount on the article processing charges. Section “Endocrinology & Metabolism” is dedicated to publishing high-quality original research, reviews or perspectives that contribute to advancing clinical health and medicine.
Section "Endocrinology & Metabolism" follows the same open access format as the rest of JCM, meaning that you have free and unlimited access to the full texts of all published articles. We invite you to read our most frequently cited papers published in 2021 and 2022 below:
1. "Retinal Vascular Endothelial Cell Dysfunction and Neuroretinal Degeneration in Diabetic Patients"
by Malgorzata Mrugacz, Anna Bryl and Katarzyna Zorena
J. Clin. Med. 2021, 10(3), 458; https://doi.org/10.3390/jcm10030458
Available online: https://www.mdpi.com/2077-0383/10/3/458
2. "The Role of Innate and Adaptive Immune Cells in the Pathogenesis and Development of the Inflammatory Response in Ulcerative Colitis"
by Aleksandra Kałużna, Paweł Olczyk and Katarzyna Komosińska-Vassev
J. Clin. Med. 2022, 11(2), 400; https://doi.org/10.3390/jcm11020400
Available online: https://www.mdpi.com/2077-0383/11/2/400
3. "Advances in Osteoporotic Bone Tissue Engineering"
by Cosmin Iulian Codrea, Alexa-Maria Croitoru, Cosmin Constantin Baciu, Alina Melinescu, Denisa Ficai, Victor Fruth and Anton Ficai
J. Clin. Med. 2021, 10(2), 253; https://doi.org/10.3390/jcm10020253
Available online: https://www.mdpi.com/2077-0383/10/2/253
4. "Testosterone and Bone Health in Men: A Narrative Review"
by Kazuyoshi Shigehara, Kouji Izumi, Yoshifumi Kadono and Atsushi Mizokami
J. Clin. Med. 2021, 10(3), 530; https://doi.org/10.3390/jcm10030530
Available online: https://www.mdpi.com/2077-0383/10/3/530
5. "The Role of Extracellular Matrix Components in Inflammatory Bowel Diseases"
by Alicja Derkacz, Paweł Olczyk, Krystyna Olczyk and Katarzyna Komosinska-Vassev
J. Clin. Med. 2021, 10(5), 1122; https://doi.org/10.3390/jcm10051122
Available online: https://www.mdpi.com/2077-0383/10/5/1122
6. "Effects of Hyperglycemia and Diabetes Mellitus on Coagulation and Hemostasis"
by Xiaoling Li, Nina C. Weber, Danny M. Cohn, Markus W. Hollmann, J. Hans DeVries, Jeroen Hermanides and Benedikt Preckel
J. Clin. Med. 2021, 10(11), 2419; https://doi.org/10.3390/jcm10112419
Available online: https://www.mdpi.com/2077-0383/10/11/2419
7. "Screening for Gestational Diabetes Mellitus in Early Pregnancy: What Is the Evidence?"
by Lore Raets, Kaat Beunen and Katrien Benhalima
J. Clin. Med. 2021, 10(6), 1257; https://doi.org/10.3390/jcm10061257
Available online: https://www.mdpi.com/2077-0383/10/6/1257
8. "Bone Metabolism and RANKL/OPG Ratio in Rheumatoid Arthritis Women Treated with TNF-α Inhibitors"
by Agnieszka Jura-Półtorak, Anna Szeremeta, Krystyna Olczyk, Aleksandra Zoń-Giebel and Katarzyna Komosińska-Vassev
J. Clin. Med. 2021, 10(13), 2905; https://doi.org/10.3390/jcm10132905
Available online: https://www.mdpi.com/2077-0383/10/13/2905
9. "Macrophages, Low-Grade Inflammation, Insulin Resistance and Hyperinsulinemia: A Mutual Ambiguous Relationship in the Development of Metabolic Diseases"
by Gerhard Paul Püschel, Julia Klauder and Janin Henkel
J. Clin. Med. 2022, 11(15), 4358; https://doi.org/10.3390/jcm11154358
Available online: https://www.mdpi.com/2077-0383/11/15/4358
10. "The Immune-Centric Revolution in the Diabetic Foot: Monocytes and Lymphocytes Role in Wound Healing and Tissue Regeneration—A Narrative Review"
by Laura Rehak, Laura Giurato, Marco Meloni, Andrea Panunzi, Giada Maria Manti and Luigi Uccioli
J. Clin. Med. 2022, 11(3), 889; https://doi.org/10.3390/jcm11030889
Available online: https://www.mdpi.com/2077-0383/11/3/889
11. "Clinical Effectiveness and Safety of Once-Weekly GLP-1 Receptor Agonist Dulaglutide as Add-On to Metformin or Metformin Plus Insulin Secretagogues in Obesity and Type 2 Diabetes"
by Maria Mirabelli, Eusebio Chiefari, Vera Tocci, Patrizia Caroleo, Stefania Giuliano, Emanuela Greco, Raul Miguel Luque, Luigi Puccio, Daniela Patrizia Foti, Antonio Aversa et al.
J. Clin. Med. 2021, 10(5), 985; https://doi.org/10.3390/jcm10050985
Available online: https://www.mdpi.com/2077-0383/10/5/985
12. "Etiology and Diagnosis of Permanent Hypoparathyroidism after Total Thyroidectomy"
by Antonio Sitges-Serra
J. Clin. Med. 2021, 10(3), 543; https://doi.org/10.3390/jcm10030543
Available online: https://www.mdpi.com/2077-0383/10/3/543
13. "The Influence of Multidrug-Resistant Bacteria on Clinical Outcomes of Diabetic Foot Ulcers: A Systematic Review"
by Gianmarco Matta-Gutiérrez, Esther García-Morales, Yolanda García-Álvarez, Francisco Javier Álvaro-Afonso, Raúl Juan Molines-Barroso and José Luis Lázaro-Martínez
J. Clin. Med. 2021, 10(9), 1948; https://doi.org/10.3390/jcm10091948
Available online: https://www.mdpi.com/2077-0383/10/9/1948
14. "Biochemical Markers for the Diagnosis of Mitochondrial Fatty Acid Oxidation Diseases"
by Pedro Ruiz-Sala and Luis Peña-Quintana
J. Clin. Med. 2021, 10(21), 4855; https://doi.org/10.3390/jcm10214855
Available online: https://www.mdpi.com/2077-0383/10/21/4855
15. "Effect of Physical Activity, Smoking, and Sleep on Telomere Length: A Systematic Review of Observational and Intervention Studies"
by Rocío Barragán, Carolina Ortega-Azorín, Jose V. Sorlí, Eva M. Asensio, Oscar Coltell, Marie-Pierre St-Onge, Olga Portolés and Dolores Corella
J. Clin. Med. 2022, 11(1), 76; https://doi.org/10.3390/jcm11010076
Available online: https://www.mdpi.com/2077-0383/11/1/76
16. "Primary Hyperparathyroidism: A Narrative Review of Diagnosis and Medical Management"
by Karel Dandurand, Dalal S. Ali and Aliya A. Khan
J. Clin. Med. 2021, 10(8), 1604; https://doi.org/10.3390/jcm10081604
Available online: https://www.mdpi.com/2077-0383/10/8/1604
17. "MiR-126 Is an Independent Predictor of Long-Term All-Cause Mortality in Patients with Type 2 Diabetes Mellitus"
by Justyna Pordzik, Ceren Eyileten-Postuła, Daniel Jakubik, Pamela Czajka, Anna Nowak, Salvatore De Rosa, Aleksandra Gąsecka, Agnieszka Cieślicka-Kapłon, Piotr Sulikowski, Krzysztof J. Filipiak et al.
J. Clin. Med. 2021, 10(11), 2371; https://doi.org/10.3390/jcm10112371
Available online: https://www.mdpi.com/2077-0383/10/11/2371
18. "Crosstalk between Tryptophan Metabolism via Kynurenine Pathway and Carbohydrate Metabolism in the Context of Cardio-Metabolic Risk—Review"
by Małgorzata Kiluk, Janina Lewkowicz, Dariusz Pawlak and Anna Tankiewicz-Kwedlo
J. Clin. Med. 2021, 10(11), 2484; https://doi.org/10.3390/jcm10112484
Available online: https://www.mdpi.com/2077-0383/10/11/2484
19. "Changes in Body Composition Are Associated with Metabolic Changes and the Risk of Metabolic Syndrome"
by Yun Hwan Oh, Seulggie Choi, Gyeongsil Lee, Joung Sik Son, Kyae Hyung Kim and Sang Min Park
J. Clin. Med. 2021, 10(4), 745; https://doi.org/10.3390/jcm10040745
Available online: https://www.mdpi.com/2077-0383/10/4/745
20. "How to Assess Diabetic Kidney Disease Progression? From Albuminuria to GFR"
by Clara García-Carro, Ander Vergara, Sheila Bermejo, María A. Azancot, Ana I. Sánchez-Fructuoso, M. Dolores Sánchez de la Nieta, Irene Agraz and María José Soler
J. Clin. Med. 2021, 10(11), 2505; https://doi.org/10.3390/jcm10112505
Available online: https://www.mdpi.com/2077-0383/10/11/2505
27 July 2023
Journal of Clinical Medicine | Highly Cited Papers in 2021 and 2022 from the Section “Nephrology & Urology”

The Journal of Clinical Medicine (JCM, ISSN: 2077-0383) is an international, peer-reviewed, open access journal published semimonthly online by MDPI. The International Bone Research Association (IBRA), Italian Resuscitation Council (IRC), Spanish Society of Hematology and Hemotherapy (SEHH), Japan Association for Clinical Engineers (JACE), European Independent Foundation in Angiology/ Vascular Medicine (VAS) and others are all affiliated with JCM, and their members receive a discount on the article processing charges. Section “Nephrology & Urology” is dedicated to publishing high-quality original research, reviews or perspectives that contribute to advancing clinical health and medicine.
Section "Nephrology & Urology" follows the same open access format as the rest of JCM, meaning that you have free and unlimited access to the full texts of all published articles. We invite you to read our most frequently cited papers published in 2021 and 2022 below:
1. “Serological Response to Three, Four and Five Doses of SARS-CoV-2 Vaccine in Kidney Transplant Recipients”
by Bilgin Osmanodja, Simon Ronicke, Klemens Budde, Annika Jens, Charlotte Hammett, Nadine Koch, Evelyn Seelow, Johannes Waiser, Bianca Zukunft, Friederike Bachmann et al.
J. Clin. Med. 2022, 11(9), 2565; https://doi.org/10.3390/jcm11092565
Available online: https://www.mdpi.com/2077-0383/11/9/2565
2. “Therapeutic Advances in Diabetic Nephropathy”
by Hanny Sawaf, George Thomas, Jonathan J. Taliercio, Georges Nakhoul, Tushar J. Vachharajani and Ali Mehdi
J. Clin. Med. 2022, 11(2), 378; https://doi.org/10.3390/jcm11020378
Available online: https://www.mdpi.com/2077-0383/11/2/378
3. “Negative Impact of the COVID-19 Pandemic on Kidney Disease Management—A Single-Center Experience in Romania”
by Adrian Vasile Mureșan, Eliza Russu, Emil Marian Arbănași, Réka Kaller, Ioan Hosu, Eliza Mihaela Arbănași and Septimiu Toader Voidăzan
J. Clin. Med. 2022, 11(9), 2452; https://doi.org/10.3390/jcm11092452
Available online: https://www.mdpi.com/2077-0383/11/9/2452
4. “IgA Vasculitis and IgA Nephropathy: Same Disease?”
by Evangeline Pillebout
J. Clin. Med. 2021, 10(11), 2310; https://doi.org/10.3390/jcm10112310
Available online: https://www.mdpi.com/2077-0383/10/11/2310
5. “Immune System Dysfunction and Inflammation in Hemodialysis Patients: Two Sides of the Same Coin”
by Susanna Campo, Antonio Lacquaniti, Domenico Trombetta, Antonella Smeriglio and Paolo Monardo
J. Clin. Med. 2022, 11(13), 3759; https://doi.org/10.3390/jcm11133759
Available online: https://www.mdpi.com/2077-0383/11/13/3759
6. “Enhanced Recovery after Surgery: History, Key Advancements and Developments in Transplant Surgery”
by Henry John Golder and Vassilios Papalois
J. Clin. Med. 2021, 10(8), 1634; https://doi.org/10.3390/jcm10081634
Available online: https://www.mdpi.com/2077-0383/10/8/1634
7. “Aberrantly Glycosylated IgA1 in IgA Nephropathy: What We Know and What We Don’t Know”
by Yukako Ohyama, Matthew B. Renfrow, Jan Novak and Kazuo Takahashi
J. Clin. Med. 2021, 10(16), 3467; https://doi.org/10.3390/jcm10163467
Available online: https://www.mdpi.com/2077-0383/10/16/3467
8. “Perirenal Adipose Tissue—Current Knowledge and Future Opportunities”
by Adriana Grigoraș, Raluca Anca Balan, Irina-Draga Căruntu, Simona Eliza Giușcă, Ludmila Lozneanu, Roxana Elena Avadanei, Andreea Rusu, Laura Adriana Riscanu and Cornelia Amalinei
J. Clin. Med. 2021, 10(6), 1291; https://doi.org/10.3390/jcm10061291
Available online: https://www.mdpi.com/2077-0383/10/6/1291
9. “Targeting Oxidative Stress in Septic Acute Kidney Injury: From Theory to Practice”
by Connie P. C. Ow, Anton Trask-Marino, Ashenafi H. Betrie, Roger G. Evans, Clive N. May and Yugeesh R. Lankadeva
J. Clin. Med. 2021, 10(17), 3798; https://doi.org/10.3390/jcm10173798
Available online: https://www.mdpi.com/2077-0383/10/17/3798
10. “Evolution of SARS-CoV-2-Neutralizing Antibodies after Two Standard Dose Vaccinations, Risk Factors for Non-Response and Effect of a Third Dose Booster Vaccination in Non-Responders on Hemodialysis: A Prospective Multi-Centre Cohort Study”
by Frank-Peter Tillmann, Lars Figiel, Johannes Ricken, Hermann Still, Christoph Korte, Grete Plassmann and Philipp von Landenberg
J. Clin. Med. 2021, 10(21), 5113; https://doi.org/10.3390/jcm10215113
Available online: https://www.mdpi.com/2077-0383/10/21/5113
11. “Antibody Response to mRNA Vaccines against SARS-CoV-2 with Chronic Kidney Disease, Hemodialysis, and after Kidney Transplantation”
by Lukas Buchwinkler, Claire Anne Solagna, Janosch Messner, Markus Pirklbauer, Michael Rudnicki, Gert Mayer and Julia Kerschbaum
J. Clin. Med. 2022, 11(1), 148; https://doi.org/10.3390/jcm11010148
Available online: https://www.mdpi.com/2077-0383/11/1/148
12. “Donor-Derived Cell-Free DNA in Kidney Transplantation as a Potential Rejection Biomarker: A Systematic Literature Review”
by Adrian Martuszewski, Patrycja Paluszkiewicz, Magdalena Król, Mirosław Banasik and Marta Kepinska
J. Clin. Med. 2021, 10(2), 193; https://doi.org/10.3390/jcm10020193
Available online: https://www.mdpi.com/2077-0383/10/2/193
13. “Urinary Microbiome Characteristics in Female Patients with Acute Uncomplicated Cystitis and Recurrent Cystitis”
by Jeong-Ju Yoo, Hee Bong Shin, Ju Sun Song, Minjung Kim, Jina Yun, Zisun Kim, Yoo Min Lee, Sang Wook Lee, Kwang Woo Lee, Woong bin Kim et al.
J. Clin. Med. 2021, 10(5), 1097; https://doi.org/10.3390/jcm10051097
Available online: https://www.mdpi.com/2077-0383/10/5/1097
14. “Pathogenesis of IgA Nephropathy: Current Understanding and Implications for Development of Disease-Specific Treatment”
by Barbora Knoppova, Colin Reily, R. Glenn King, Bruce A. Julian, Jan Novak and Todd J. Green
J. Clin. Med. 2021, 10(19), 4501; https://doi.org/10.3390/jcm10194501
Available online: https://www.mdpi.com/2077-0383/10/19/4501
15. “Drug-Induced Acute Kidney Injury: A Study from the French Medical Administrative and the French National Pharmacovigilance Databases Using Capture-Recapture Method”
by Anne-Lise Rolland, Anne-Sophie Garnier, Katy Meunier, Guillaume Drablier and Marie Briet
J. Clin. Med. 2021, 10(2), 168; https://doi.org/10.3390/jcm10020168
Available online: https://www.mdpi.com/2077-0383/10/2/168
16. “Angiotensin-(1-7)—A Potential Remedy for AKI: Insights Derived from the COVID-19 Pandemic”
by Samuel N. Heyman, Thomas Walther and Zaid Abassi
J. Clin. Med. 2021, 10(6), 1200; https://doi.org/10.3390/jcm10061200
Available online: https://www.mdpi.com/2077-0383/10/6/1200
17. “Effects of Probiotics, Prebiotics, and Synbiotics on Uremic Toxins, Inflammation, and Oxidative Stress in Hemodialysis Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials”
by Thi Thuy Uyen Nguyen, Hyeong Wan Kim and Won Kim
J. Clin. Med. 2021, 10(19), 4456; https://doi.org/10.3390/jcm10194456
Available online: https://www.mdpi.com/2077-0383/10/19/4456
18. “A Review of Current and Emerging Trends in Donor Graft-Quality Assessment Techniques”
by Natalia Warmuzińska, Kamil Łuczykowski and Barbara Bojko
J. Clin. Med. 2022, 11(3), 487; https://doi.org/10.3390/jcm11030487
Available online: https://www.mdpi.com/2077-0383/11/3/487
19. “Nomograms in Urologic Oncology: Lights and Shadows”
by Alessandro Morlacco, Daniele Modonutti, Giovanni Motterle, Francesca Martino, Fabrizio Dal Moro and Giacomo Novara
J. Clin. Med. 2021, 10(5), 980; https://doi.org/10.3390/jcm10050980
Available online: https://www.mdpi.com/2077-0383/10/5/980
20. “Podocyte Autophagy in Homeostasis and Disease”
by Qisheng Lin, Khadija Banu, Zhaohui Ni, Jeremy S. Leventhal and Madhav C. Menon
J. Clin. Med. 2021, 10(6), 1184; https://doi.org/10.3390/jcm10061184
Available online: https://www.mdpi.com/2077-0383/10/6/1184
27 July 2023
MDPI Insights: The CEO's Letter #2 - Open Peer-Review and IJERPH

Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
Open Peer Review Reports
Continuing the topic of openness from my inaugural monthly CEO letter, in these Opening Thoughts, I highlight the growth and importance of open peer-review reports at MDPI. Open peer reports align with the principles of open science, making the publishing process more transparent and facilitating rigorous peer review.
MDPI journals operate an open peer-review option by default, allowing authors to publish review reports and author responses (often referred to as open reports) together with the published paper. Publishing the reviewer reports and author responses together with the article provides greater transparency and trust for readers, as this allows them to track the editorial decision-making process. Open peer-review also encourages reviewers and editors to provide high-quality comments, as these will be made public if the article is accepted for publication.
Start and Growth of Open Peer Review at MDPI
The MDPI journal Life was a pioneer in offering this opportunity to its authors in 2014. The first MDPI article with peer-review reports openly published was a review by the Nobel Laureate Werner Arber, in which the review reports were published as supplementary material. By 2018, open peer-review was available across all MDPI journals. As such, MDPI authors have embraced the open peer-review model, providing a steady increase in the number of MDPI articles. As of 2023, approximately one-third (34.0%) of MDPI articles were published with open review reports.
As at July 2023, the percentage of MDPI articles published with open peer review has increased to 36.2% of the total papers published in 2023 so far, indicating ongoing growth in adoption.
Open peer review continues to play a critical role in the assessment of the peer-review process in Life. For further insights, please see the recent editorial by Dr. Pabulo Henrique Rampelotto, the former Editor-in-Chief of Life, who spearheaded the implementation of the open peer-review process.
Benefits of Open Peer Review
The benefits of open peer review include increased transparency, trust and constructive feedback. To promote open communication further and increase the robustness of the peer-review process, we encourage reviewers to sign their reports so that their name appears on the review report (this process is referred to as open identity). The default option is for reviewers to remain anonymous; however, by signing the reports, reviewers receive direct credit for their contribution to the peer-review process and show their commitment towards open science.
As the leading open access publisher, MDPI remains committed to promoting open peer-review and encourages authors to choose this approach. Our goal is to provide a rigorous and transparent peer-review process that benefits the scientific community, and we believe that open peer-review is a vital step in fostering openness and collaboration in scientific communication.
Impactful Research
MDPI Papers Cited in the News – IJERPH edition
Every month, our corporate marketing team compiles data from Altmetrics to create a list of MDPI papers that have been cited in the news. This list continues to grow as renowned news outlets regularly reference research published by MDPI in their articles.
During 2022, a total of 111,965 MDPI research papers were mentioned in prominent news outlets such as National Geographic, The Washington Post, Forbes, The Guardian, the BBC, CNN, Time, and Harvard Business Review.
Highly Cited Journal Publications
IJERPH, known for publishing impactful research, received the most news mentions among all MDPI journals in 2022, based on Altmetrics data:
- International Journal of Environmental Research and Public Health: 3509 mentions
- Nutrients: 2698 mentions
- International Journal of Molecular Sciences: 1701 mentions
- Journal of Clinical Medicine: 1131 mentions
- Viruses: 1111 mentions
These numbers show the recognition and impact of the articles published in IJERPH. For a more detailed view of the journal’s most cited and viewed papers, you can visit here. In total, IJERPH has garnered over 28,000 mentions in prominent news outlets, and as at July 2023, an impressive count of over 17,000 papers cited 10 times or more. These figures highlight the impactful contribution of IJERPH publications to the scientific community.
Example of Recent Mentions
During May and June 2023, a noteworthy selection of articles from IJERPH was cited in news articles, including:
The Washington Post: “Bringing nature inside can improve your health. Here’s how to do it.”
IJERPH paper: “Physiological Benefits of Viewing Nature: A Systematic Review of Indoor Experiments”
Harvard Business Review: “How to Take Better Breaks at Work, According to Research”
IJERPH paper: “Canine-Assisted Therapy Improves Well-Being in Nurses”
National Geographic: “Lyme disease is spreading fast—but a vaccine may be on the way”
IJERPH paper: “Range Expansion of Tick Disease Vectors in North America: Implications for Spread of Tick-Borne Disease”
Inside MDPI
MDPI Develops an Artificial Intelligence Tool to Enhance the Peer-Review Process
At MDPI, we believe that rigorous peer-review is the corner-stone of high-quality academic publishing. We are grateful to the scholars who generously dedicate their time to peer-review articles submitted to MDPI journals. Their contributions are invaluable to the advancement of science.
Peer-review is a critical part of the publication process, ensuring that MDPI upholds the highest quality standards for the papers we publish. Every manuscript submitted to our journals undergoes a comprehensive peer-review process conducted by subject-matter experts.
To further enhance our peer-review process, our Data Analytics team has developed an Artificial Intelligence (AI) tool designed to support the selection of reviewers. This proprietary tool utilizes Natural Language Processing (NLP), a specially designed AI language model, to extract information from the title and abstract of submitted papers. It then searches our database for similar manuscripts and suggests potential reviewers based on this analysis. Integrated with MDPI's submission system (SuSy), the AI tool cross-references the suggested candidates with our reviewer database to verify their invitation status and availability.
The goal of this tool is to provide better targeted peer-review invitations, reducing the number of emails sent for each paper and increasing the efficiency of our editorial staff.
In the near future, our Data Analytics team plans to deploy similar AI projects to improve other critical aspects of our services, offering an enhanced experience to our authors and readers.
Click here to learn about MDPI’s review process, including procedures, responsibilities, and benefits.
Read more:
Coming Together for Science
The Future of IJERPH
On 5 July 2023, Prof. Dr. Paul B. Tchounwou, the founding Editor-in-Chief of IJERPH, along with five Section Editors in Chief (Prof. Dr. Germán Vicente-Rodríguez, Prof. Dr. Karl Goodkin, Prof. Dr. William A. Toscano, Prof. Dr. Jimmy T. Efird, and Prof. Dr. William Douglas Evans), gathered in Basel to discuss the future of the journal. The meeting provided an opportunity to address the recent decision by The Web of Science to delist IJERPH due to the journal failing the Content Relevance criterion, and propose best strategies that will ensure high scientific rigor as well as a clear scope and aim of IJERPH, going forward.
While the delisting is disappointing for IJERPH, as well as for our authors, academic editors, and the entire scientific community supporting our journal, we see it as an opportunity to reflect and prepare for the future direction of the journal.
Since its launch in 2004, IJERPH’s vision and mission have evolved to be more complete and comprehensive in engaging scientific communities. In light of this, we will refresh the journal’s aims and scope, ensuring they align with the organic expansion of IJERPH. Additionally, we will restructure the journal sections into broader categories, encouraging collaborative research and transdisciplinary approaches for authors. This is designed to foster collaboration and knowledge exchange among diverse fields, contributing to a holistic understanding of health promotion and disease prevention. We are confident that these next steps will enhance the scientific strength and societal impact of our journal.
Journal Achievements
In addition to the productive discussions, we took the time to celebrate some of the remarkable achievements of IJERPH, which I highlight below:
- Founded by Prof. Dr. Paul B. Tchounwou in 2004
- Indexed in PubMed in 2008
- Received its first Impact Factor in 2012
- Published its 5000th paper in 2017
- Over 60,000 papers published as at June 30, 2023
- 131,628,173 paper views in 2018–2022
- Over 28,000 mentions in prominent news outlets
- 17,000 papers cited 10 times or more as at June 30, 2023
- No.1 journal in the 2022 Google Scholar Metrics in the category of Public Health
- Awarded several editions of Young Investigator Awards, Travel Awards, and Outstanding Reviewer Awards since 2018.
These achievements showcase the journal’s significant contributions to the field and its impact on global health. We are proud of the exceptional work accomplished by the IJERPH team and look forward to building upon this success in the years to come.
Closing Thoughts
MDPI’s Impact in Spain
During the past month, I had the opportunity to visit our new office building in Barcelona, where I met with our local colleagues to discuss the ways we serve the scholarly community, particularly in Spain. The multi-functional office plays a vital role in supporting various business needs, including editorial, design, conference management, data analytics, journal relationship management, publishing partnerships, and collaborations with societies.
Spain holds a significant position in MDPI’s global market, ranking as the fourth-largest contributor to the total number of papers published by MDPI as at July 2023, ranking next to Italy, the USA, and China, with Germany completing the top five.
The Numbers
Out of the 1,680,000 total MDPI articles published as at 25 July, almost 80,000 articles are contributed by Spanish authors, representing nearly 40,000 unique authors affiliated with Spanish institutions. Remarkably, over 6,300 of these authors hold editorial board member (EBM) positions within MDPI journals, with 30 of them serving as Editors-in-Chief (EiCs).
Our commitment to working with institutions is very evident in Spain, where we have successfully established over 40 Institutional Open Access Programs (IOAP) with esteemed institutions such as the University of Barcelona, the Autonomous University of Barcelona, Pompeu Fabra University, the University of Navarre, and Complutense University of Madrid.
Over the past five years, we have successfully organized eight in-person conferences in Barcelona, attracting over 1,150 registrations, with two forthcoming events scheduled for 2024. Barcelona's excellent connectivity to international airports makes it easily accessible to participants from around the world. Its welcoming atmosphere provides us with the perfect environment for knowledge-sharing, networking, and contributing to the local economy.
Our growth and presence in Spain are a true testament to the incredible service we provide to the scholarly community and the relationships we foster through responsive and collaborative communication. We look forward to continuing to support Spanish scholars, providing them a valuable and trusted experience with MDPI, the leader in open access publishing.
Testimonials
I close this letter as I did in the first edition, by sharing testimonials from our stakeholders. Here are a few IJERPH testimonials from a Spanish guest editor and an author:
Guest Editor
“I want to thank the kindness, attention and professionalism of the MDPI team throughout the editorial process of the Special Issue. I believe that it is a very professional and quality editorial process.”
- Professor Víctor Arufe-Giráldez, University of A Coruña
Special Issue in International Journal of Environmental Research and Public Health: Physical Activity in Childhood and Adolescence
Special Issue in International Journal of Environmental Research and Public Health: Physical Education: Present and Future
__
Author
“I want to thank the rigor of the revisions made to the manuscripts to improve their quality, the support to the authors for the editor assignment system they have and the follow-up they carry out, for the speed in answering and in carrying out the entire process of the revision, and for doing all this at an affordable price.”
- Dr. María Paz García-Caro, University of Granada
Article in International Journal of Environmental Research and Public Health: Factors Associated with Suicide Attempts and Suicides in the General Population of Andalusia (Spain)
Chief Executive Officer
MDPI AG
19 July 2023
Journal of Clinical Medicine | Highly Cited Papers in 2021 and 2022 from the Section “Cardiology”

The Journal of Clinical Medicine (JCM, ISSN: 2077-0383) is an international, peer-reviewed, open access journal published semimonthly online by MDPI. The International Bone Research Association (IBRA), Italian Resuscitation Council (IRC), Spanish Society of Hematology and Hemotherapy (SEHH), Japan Association for Clinical Engineers (JACE), European Independent Foundation in Angiology/ Vascular Medicine (VAS) and others are all affiliated with JCM, and their members receive a discount on the article processing charges. Section “Cardiology” is dedicated to publishing high-quality original research, reviews or perspectives that contribute to advancing clinical health and medicine.
Section "Cardiology" follows the same open access format as the rest of JCM, meaning that you have free and unlimited access to the full texts of all published articles. We invite you to read our most frequently cited papers published in 2021 and 2022 below:
1. "Epidemiological Impact of Myocarditis"
by Ainoosh Golpour, Dimitri Patriki, Paul J. Hanson, Bruce McManus and Bettina Heidecker
J. Clin. Med. 2021, 10(4), 603; https://doi.org/10.3390/jcm10040603
Available online: https://www.mdpi.com/2077-0383/10/4/603
2. "Systemic Inflammation and COVID-19 Mortality in Patients with Major Noncommunicable Diseases: Chronic Coronary Syndromes, Diabetes and Obesity"
by Andreea-Luciana Buicu, Simona Cernea, Imre Benedek, Corneliu-Florin Buicu and Theodora Benedek
J. Clin. Med. 2021, 10(8), 1545; https://doi.org/10.3390/jcm10081545
Available online: https://www.mdpi.com/2077-0383/10/8/1545
3. "Predictors and Prognostic Implications of Cardiac Arrhythmias in Patients Hospitalized for COVID-19"
by Maura M. Zylla, Uta Merle, Johannes A. Vey, Grigorios Korosoglou, Eva Hofmann, Michael Müller, Felix Herth, Werner Schmidt, Erwin Blessing, Christoph Göggelmann et al.
J. Clin. Med. 2021, 10(1), 133; https://doi.org/10.3390/jcm10010133
Available online: https://www.mdpi.com/2077-0383/10/1/133
4. "A Review of the Molecular Mechanisms Underlying Cardiac Fibrosis and Atrial Fibrillation"
by Grażyna Sygitowicz, Agata Maciejak-Jastrzębska and Dariusz Sitkiewicz
J. Clin. Med. 2021, 10(19), 4430; https://doi.org/10.3390/jcm10194430
Available online: https://www.mdpi.com/2077-0383/10/19/4430
5. "Clinical Factors Associated with Atrial Fibrillation Detection on Single-Time Point Screening Using a Hand-Held Single-Lead ECG Device"
by Giuseppe Boriani, Pietro Palmisano, Vincenzo Livio Malavasi, Elisa Fantecchi, Marco Vitolo, Niccolo’ Bonini, Jacopo F. Imberti, Anna Chiara Valenti, Renate B. Schnabel and Ben Freedman
J. Clin. Med. 2021, 10(4), 729; https://doi.org/10.3390/jcm10040729
Available online: https://www.mdpi.com/2077-0383/10/4/729
6. "Exercise Training in Post-COVID-19 Patients: The Need for a Multifactorial Protocol for a Multifactorial Pathophysiology"
by Gaia Cattadori, Silvia Di Marco, Massimo Baravelli, Anna Picozzi and Giuseppe Ambrosio
J. Clin. Med. 2022, 11(8), 2228; https://doi.org/10.3390/jcm11082228
Available online: https://www.mdpi.com/2077-0383/11/8/2228
7. "Clinical Characteristics, Exercise Capacity and Pulmonary Function in Post-COVID-19 Competitive Athletes"
by Klara Komici, Antonio Bianco, Fabio Perrotta, Antonio Dello Iacono, Leonardo Bencivenga, Vito D'Agnano, Aldo Rocca, Andrea Bianco, Giuseppe Rengo and Germano Guerra
J. Clin. Med. 2021, 10(14), 3053; https://doi.org/10.3390/jcm10143053
Available online: https://www.mdpi.com/2077-0383/10/14/3053
8. "Impact of COVID-19 Pandemic on Remote Monitoring of Cardiac Implantable Electronic Devices in Italy: Results of a Survey Promoted by AIAC (Italian Association of Arrhythmology and Cardiac Pacing)"
by Massimiliano Maines, Pietro Palmisano, Maurizio Del Greco, Donato Melissano, Silvana De Bonis, Stella Baccillieri, Gabriele Zanotto, Antonio D’Onofrio, Renato Pietro Ricci, Roberto De Ponti et al.
J. Clin. Med. 2021, 10(18), 4086; https://doi.org/10.3390/jcm10184086
Available online: https://www.mdpi.com/2077-0383/10/18/4086
9. "The Role of Uric Acid in Acute and Chronic Coronary Syndromes"
by Alessandro Maloberti, Marco Biolcati, Giacomo Ruzzenenti, Valentina Giani, Filippo Leidi, Massimiliano Monticelli, Michela Algeri, Sara Scarpellini, Stefano Nava, Francesco Soriano et al.
J. Clin. Med. 2021, 10(20), 4750; https://doi.org/10.3390/jcm10204750
Available online: https://www.mdpi.com/2077-0383/10/20/4750
10. "Frailty in Acute and Chronic Coronary Syndrome Patients Entering Cardiac Rehabilitation"
by Francesco Giallauria, Anna Di Lorenzo, Elio Venturini, Mario Pacileo, Antonello D’Andrea, Umberto Garofalo, Felice De Lucia, Crescenzo Testa, Gianluigi Cuomo, Gabriella Iannuzzo et al.
J. Clin. Med. 2021, 10(8), 1696; https://doi.org/10.3390/jcm10081696
Available online: https://www.mdpi.com/2077-0383/10/8/1696
11. "Clinical Significance of Carotid Intima-Media Complex and Carotid Plaque Assessment by Ultrasound for the Prediction of Adverse Cardiovascular Events in Primary and Secondary Care Patients"
by Anna Kabłak-Ziembicka and Tadeusz Przewłocki
J. Clin. Med. 2021, 10(20), 4628; https://doi.org/10.3390/jcm10204628
Available online: https://www.mdpi.com/2077-0383/10/20/4628
12. "Validation of Noninvasive Remote Dielectric Sensing System to Quantify Lung Fluid Levels"
by Teruhiko Imamura, Wataru Gonoi, Masakazu Hori, Yohei Ueno, Nikhil Narang, Hiroshi Onoda, Shuhei Tanaka, Makiko Nakamura, Naoya Kataoka, Ryuichi Ushijima et al.
J. Clin. Med. 2022, 11(1), 164; https://doi.org/10.3390/jcm11010164
Available online: https://www.mdpi.com/2077-0383/11/1/164
13. "Fibrin Clot Properties in Atherosclerotic Vascular Disease: From Pathophysiology to Clinical Outcomes"
by Michał Ząbczyk, Joanna Natorska and Anetta Undas
J. Clin. Med. 2021, 10(13), 2999; https://doi.org/10.3390/jcm10132999
Available online: https://www.mdpi.com/2077-0383/10/13/2999
14. "Diabetes Mellitus and Heart Failure"
by Filippos Triposkiadis, Andrew Xanthopoulos, Alexandra Bargiota, Takeshi Kitai, Niki Katsiki, Dimitrios Farmakis, John Skoularigis, Randall C. Starling and Efstathios Iliodromitis
J. Clin. Med. 2021, 10(16), 3682; https://doi.org/10.3390/jcm10163682
Available online: https://www.mdpi.com/2077-0383/10/16/3682
15. "Acute Coronary Syndrome in the Older Patient"
by Sergio García-Blas, Alberto Cordero, Pablo Diez-Villanueva, Maria Martinez-Avial, Ana Ayesta, Albert Ariza-Solé, Gemma Mateus-Porta, Manuel Martínez-Sellés, David Escribano, Ana Gabaldon-Perez et al.
J. Clin. Med. 2021, 10(18), 4132; https://doi.org/10.3390/jcm10184132
Available online: https://www.mdpi.com/2077-0383/10/18/4132
16. "Association between Lung Fluid Levels Estimated by Remote Dielectric Sensing Values and Invasive Hemodynamic Measurements"
by Teruhiko Imamura, Masakazu Hori, Yohei Ueno, Nikhil Narang, Hiroshi Onoda, Shuhei Tanaka, Makiko Nakamura, Naoya Kataoka, Mitsuo Sobajima, Nobuyuki Fukuda et al.
J. Clin. Med. 2022, 11(5), 1208; https://doi.org/10.3390/jcm11051208
Available online: https://www.mdpi.com/2077-0383/11/5/1208
17. "Current Knowledge and Future Challenges in Takotsubo Syndrome: Part 2—Treatment and Prognosis"
by Francesco Santoro, Adriana Mallardi, Alessandra Leopizzi, Enrica Vitale, Elias Rawish, Thomas Stiermaier, Ingo Eitel and Natale D. Brunetti
J. Clin. Med. 2021, 10(3), 468; https://doi.org/10.3390/jcm10030468
Available online: https://www.mdpi.com/2077-0383/10/3/468
18. "Current Knowledge and Future Challenges in Takotsubo Syndrome: Part 1—Pathophysiology and Diagnosis"
by Elias Rawish, Thomas Stiermaier, Francesco Santoro, Natale D. Brunetti and Ingo Eitel
J. Clin. Med. 2021, 10(3), 479; https://doi.org/10.3390/jcm10030479
Available online: https://www.mdpi.com/2077-0383/10/3/479
19. "Coronary Microvascular Dysfunction: PET, CMR and CT Assessment"
by Elisabetta Tonet, Graziella Pompei, Evelina Faragasso, Alberto Cossu, Rita Pavasini, Giulia Passarini, Matteo Tebaldi and Gianluca Campo
J. Clin. Med. 2021, 10(9), 1848; https://doi.org/10.3390/jcm10091848
Available online: https://www.mdpi.com/2077-0383/10/9/1848
20. "Radiological Cardiothoracic Ratio in Evidence-Based Medicine"
by Krystian Truszkiewicz, Rafał Poręba and Paweł Gać
J. Clin. Med. 2021, 10(9), 2016; https://doi.org/10.3390/jcm10092016
Available online: https://www.mdpi.com/2077-0383/10/9/2016
11 July 2023
MDPI’s Newly Launched Journals in June 2023
With the first issue released in June 2023, five new MDPI journals disseminating multi-disciplinary science are due to launch, which will cover the subjects of medicine & pharmacology, biology and physical sciences.
The newly launched journals will be overseen by professional Editorial Board Members and Editors to ensure an accurate and rapid publication, rigorous peer review and broad visibility.
Please feel free to browse and discover more about the new journals below.
Journal | Founding Editor-in-Chief | Journal topics (selected) |
![]() |
Prof. Dr. Jun Ma, Peking University, China| Editorial | view inaugural issue | growth and development; diet and nutrients; school health promotion policies and practices; child health and care; adolescent health and wellbeing | view journal scope | submit an article |
![]() |
Prof. Dr. Bernd Rehm, Griffith University, Australia | Editorial | view inaugural issue | DNA and gene synthesis; synthetic transcription factors; protein engineering; viral engineering; metabolic engineering | view journal scope | submit an article |
![]() |
Prof. Dr. Varsha Gandhi, University of Texas MD Anderson Cancer Center, USA | Editorial | view inaugural issue | lymphatics; cancers associated with lymphocytes and lymphoblasts; lymphatic tissues; lymphoma; lymphoid leukemia | view journal scope | submit an article |
![]() |
Dr. Bradley Turner, University of Melbourne, Australia | Editorial | view inaugural issue | multiple sclerosis; amyotrophic lateral sclerosis; primary lateral sclerosis; atherosclerosis; systemic sclerosis | view journal scope | submit an article |
![]() |
Prof. Dr. Clemens Burda, Case Western Reserve University, USA | Editorial | view inaugural issue | Gamma ray, X-ray, and UV–Vis spectroscopies; NIR/mid-infrared/Raman spectroscopy; microwave and THz spectroscopy; high-resolution gas-phase atomic, molecular, and cluster spectroscopy; MS, NMR, and EPR spectroscopy | view journal scope | submit an article |
We wish to thank everyone who has supported the development of open access publishing. You are welcome to submit an application to the New Journal Committee ([email protected]) if you would like to create more new journals.
4 July 2023
Journal of Clinical Medicine Webinar | Geriatric Surgery: State of the Art, Held on 13 July 2023

On 13 July 2023, MDPI and the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) organized the webinar titled Geriatric Surgery: State of the Art.
The webinar provided a comprehensive overview of the current advancements and best practices in the field of geriatric surgery. The webinar was designed to address the unique challenges and considerations involved in surgical interventions for older adults, who are often faced with complex medical conditions and age-related physiological changes, including frailty and futility. Participants gained a deeper understanding of how to implement evidence-based practices to improve outcomes in this vulnerable patient population.
You can watch the recorded webinar at the following link: https://www.youtube.com/watch?v=vKnbDPDMyBw.
Webinar Chairs and Keynote Speakers:
- Prof. Dr. Fausto Catena (Chair), Department of General and Emergency Surgery, “M. Bufalini” Hospital, Cesena, Italy;
- Dr. Belinda De Simone (Co-Chair), 1Department of General minimally invasive surgery, Guastalla Hospital, AUSL Reggio Emilia, Reggio Emilia, Italy; 2Unit of general and bariatric surgery, Clinique St Louis, Poissy, France;
- Dr. Brian Tian, 1Department of General Surgery, Singapore General Hospital, Singapore; 2Division of Surgical Oncology, National Cancer Centre Singapore, Singapore;
- Dr. Carlo Vallicelli, Department of General, Emergency and Trauma Surgery, Maurizio Bufalini Hospital, Cesena, Italy;
- Dr. Raffaele Bova, Department of General, Emergency and Trauma Surgery, Maurizio Bufalini Hospital, Cesena, Italy.
Relevant Special Issue:
“Geriatric Surgery: State of the Art”
Guest Editor: Prof. Dr. Fausto Catena
3 July 2023
MDPI Insights: The CEO's Letter #1 - Open Access and Impactful Research

Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
The Future is Open, and MDPI is Leading the Way
I strongly believe in a future that embraces openness, where open source, open information, and open access (OA) take center stage. This belief that led me to join MDPI in 2020, and I am honored to have recently been appointed as Chief Executive Officer (CEO). In this capacity, and operating in close liaison with Dr. Lin and MDPI’s senior management, I shall work to build on Dr. Lin’s achievements of the past quarter-century. In this role, I will focus on communication initiatives to promote MDPI's remarkable work and continue to build our company as a trusted leader in OA publishing. For over two decades, MDPI has been at the forefront of reshaping the academic publishing landscape, with OA surpassing subscription-based publishing in 2020. This trajectory is deeply rooted in our history and reflects our unwavering commitment and vision for an open future.
1 Million Published Articles
2023 began with a remarkable achievement for MDPI, as we became the first OA publisher to reach the milestone of 1 million published articles. This represents 2.7 million unique authors who have trusted us with their work, or about a third of all researchers worldwide. As the world's most cited OA publisher, we are proud in sharing these significant milestones.
Our mission remains unchanged: to make science open and accessible to all. We understand the importance of knowledge access, empowering researchers to stay at the forefront of a rapidly changing world. Our diverse range of journals covers a wide spectrum of disciplines, offering cutting-edge insights, trusted tools, and crucial knowledge to address global challenges.
Liberating Science
As the world’s leading OA publisher, MDPI is actively liberating science. We are committed to eliminating the frustrations researchers and the general public face when accessing information, ensuring it is not locked behind paywalls. We firmly believe that everyone has a right to information, and our commitment to open access publishing drives our work.
In this inaugural edition of Insights: The CEO's Letter, I draw inspiration from the upcoming 20th anniversary of the Berlin Declaration on Open Access. Its stated mission reminds us that true impact is achieved when knowledge is widely and readily available to society:
"Our mission of disseminating knowledge is only half complete if the information is not made widely and readily available to society”
Impactful Research
MDPI Publishes Impactful Research: Recognized by Leading Indexing Databases
MDPI journals are indexed in every single top database in the world.
As of June 2023, we have 214 journals indexed within Web of Science, 223 indexed within Scopus, 87 indexed within PubMed and PMC, and 17 indexed within MEDLINE, and these numbers increase every month. We constantly strive to expand the coverage of our journals within leading multi-disciplinary and scope-specific databases, resulting in an incredibly broad range of journals that are indexed within a variety of databases. MDPI has active relationships with approximately 65 well-known databases around the world, and we continue to expand our portfolio every year so that your work can be found, cited, and referenced with ease.
Continued Growth of MDPI Journals
The 2022 Scopus and Web of Science journal citation metrics were officially released in June, and I am pleased to report that 31 MDPI journals received their first CiteScore, taking the total number of journals with a CiteScore to 216. The number of MDPI journals receiving an Impact Factor (IF) also continues to grow with 111 receiving their first, by being covered in the ESCI, bringing our total number of journals with an IF to 208 of which 41 journals received an IF above 4.0. Looking at 2022 CiteScores in the Scopus database, 80% of MDPI journals have a score that ranks them in Q1 or Q2 in at least one subject category.
Publishing impactful science would not be possible without all of our authors, editors and reviewers. Thank you for your contribution and continued support! Together we share the latest scientific insights faster and ensure that your work is accessible to all.
Read more
Inside MDPI
Preprints.org: Clarivate adds the Preprint Citation Index to the Web of Science
At MDPI, we are dedicated to driving the advancement of science. Through our initiative, Preprints.org, researchers can publish their work and gain valuable feedback from the broader research community, ensuring rapid progress in their respective fields. This is particularly crucial during times of health and climate challenges, where timely dissemination of findings is essential.
Increased Visibility for Preprints
I am pleased to share that Clarivate recognizes the significance of preprints and has taken a crucial step to enhance their visibility. Clarivate has added the Preprint Citation Index to the Web of Science, encompassing preprints published not only on Preprints.org but also on other reputable repositories.
Looking ahead, the future of preprints appears promising, bolstered by the recent indexing announcement from the Web of Science. As a result, preprints will receive increased visibility, serving as a valuable resource for staying informed about the latest research developments.
Read more
What are Preprints?
The Pros and Cons of Preprints
Preprints and COVID-19
Preprints—The Future of Open Access Publishing?
Coming Together for Science
The First International Conference on Antioxidants: Sources, Methods, Health Benefits and Industrial Applications
In this edition of ‘Coming Together for Science,’ I am pleased to highlight the First International Conference on Antioxidants organized by our conference team in the beautiful city of Barcelona, Spain. The conference attracted over 130 attendees, who engaged in 42 talks, and 89 poster presentations spread across several sessions.
Working Together
Under the leadership of Prof. Dr. Alessandra Napolitano (Department of Chemical Sciences, University of Naples ‘Federico II’, Naples, Italy) and Prof. Dr. Rosa M. Lamuela Raventos (Department of Nutrition, Food Sciences and Gastronomy, University of Barcelona, Spain) as chairs, and supported by the committee members, 10 invited keynote speakers, poster presenters, and all the attendees, this dedicated group of academics came together to discuss the natural sources, methodologies, health benefits, and industrial applications of antioxidants.
Especially noteworthy is the positive feedback received from attendees, with 94% rating the overall organization of the conference as good or excellent. I particularly love the picture above, capturing the gathering of some of the participants. You can browse through more photos in the event gallery located here.
Managing Events With Sciforum
If you are considering hosting your own academic event, I highly recommend checking out Sciforum, MDPI's event management platform. Sciforum simplifies the entire process, making it easy to host your own event by allowing you to focus on what really matters: Science!
Read more
Closing Thoughts
Stefan Tochev, Dr. Shu-Kun Lin, Dr. Eric O. Freed, Peter Roth, Wynne Wang, Allison Yang
Viruses and Editorial Quality: Acknowledging the Dedication of our Viruses Journal Team
During a June meeting with Dr. Eric O. Freed, the founding and current Editor-in-Chief of our journal Viruses, I was reminded of the exceptional dedication of our editorial board. Meeting with Eric is a pleasure, as he has a strong commitment and clear vision for the journal. Over the course of two days, we gained a deep understanding of the journal’s expectations and focus on strategic growth, editorial board representation, and engagement.
I am pleased to share that Viruses holds a CiteScore of 7.1 (an increase of 7.57% versus the 2021 metric) and an Impact Factor of 4.7. You can view the journal statistics here. Viruses publishes highly cited papers, and is indexed in renowned databases such as Scopus, SCIE (Web of Science), PubMed, and others, and maintains affiliations with prestigious societies. Moreover, the Viruses team has recently announced an exciting upcoming event titled ‘Viruses 2024 – A World of Viruses,’ scheduled to take place in Barcelona, Spain, from 14–16 February 2024.
Testimonials
If you notice my enthusiasm regarding our editorial service, it’s because the surveys and testimonials we receive speak volumes about the experiences of our authors, reviewers, and guest editors who collaborate with MDPI. The purpose of these letters is to highlight the exceptional work that we do and the experiences we create for the scholars – thus, let me end with this testimonial from an author:
“It was a great pleasure to publish in Viruses Special Issue [Emerging Viruses in Aquaculture]. The submission process was easy. Guest editors were very helpful and provided all the guidance and support as needed. The handling of the manuscript by the Editorial Team was very fast, efficient, and professional. The reviewer’s comments were insightful, and the publication processes were remarkably rapid.”
– Ms. Magdalena Stachnik, Państwowy Instytut Weterynaryjny | PIWet
Article in Viruses: Emerging Viral Pathogens in Sturgeon Aquaculture in Poland: Focus on Herpesviruses and Mimivirus Detection
Chief Executive Officer
MDPI AG
29 June 2023
Meet Us at the ESMO Congress 2023, 20–24 October 2023, Madrid, Spain

MDPI will attend the ESMO Congress 2023 as an exhibitor. This conference will be held in Madrid, Spain, from 20 to 24 October 2023.
The ESMO Congress is the most influential oncology platform for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world. They will disseminate the latest cutting-edge data, provide high-quality education and unparalleled networking opportunities for oncologists and other stakeholders from all around the world.
The following MDPI journals will be represented:
- Cancers;
- JCM;
- Cells;
- Diagnostics;
- Medical Sciences;
- Biomedicines;
- Geriatrics;
- Current Oncology;
- Hemato;
- Onco;
- CIMB;
- Healthcare.
If you are attending this conference, please feel free to start a conversation with us at our booth #724. Our delegates look forward to meeting you in person and answering any questions that you may have.
For more information about the conference, please visit https://www.esmo.org/meeting-calendar/esmo-congress-2023.
28 June 2023
2022 Impact Factors for MDPI Journals
The 2022 citation metrics have been released in the Journal Citation Reports (JCR), and we’re pleased to announce the following results for MDPI journals:
We are thrilled to announce that 90% of our ranked MDPI journals, specifically 86 out of 96 (captured in the table below), are performing above average in Q1 or Q2. This year, Clarivate has expanded its Impact Factor (IF) awards to include journals in the Emerging Sources Citation Index (ESCI) and the Arts and Humanities Citation Index (AHCI), providing greater transparency for the full set of journals indexed in the Web of Science Core Collection. As a result, 111 of MDPI journals have received their first IF in 2023, with 37 journals surpassing an IF of 3.0. In total, 208 MDPI journals have been honored with an IF.
Clarivate explains that by "expanding the coverage but holding to highly selective standards, the [Impact Factor] is now a reliable indicator of trustworthiness, as well as a measure of scholarly impact, at the journal level."
Please visit our blog post where we discuss the release of the latest citation metrics with our Indexing Manager, Dr. Constanze Schelhorn, to find out what's different this time around and how to make use of different metrics available.
Journal | Impact Factor | Rank Quartile | Category |
Vaccines | 7.8 | Q1 | Immunology |
Medicine, Research & Experimental | |||
Antioxidants | 7.0 | Q1 | Food Science & Technology |
Biochemistry & Molecular Biology | |||
Chemistry, Medicinal | |||
Cells | 6.0 | Q2 | Cell Biology |
Nutrients | 5.9 | Q1 | Nutrition & Dietetics |
International Journal of Molecular Sciences | 5.6 | Q1 | Biochemistry & Molecular Biology |
Q2 | Chemistry, Multidisciplinary | ||
Journal of Theoretical and Applied Electronic Commerce Research | 5.6 | Q2 | Business |
Biomolecules | 5.5 | Q1 | Biochemistry & Molecular Biology |
Biosensors | 5.4 | Q1 | Chemistry, Analytical |
Instruments & Instrumentation | |||
Q2 | Nanoscience & Nanotechnology | ||
Fractal and Fractional | 5.4 | Q1 | Mathematics, Interdisciplinary Applications |
Marine Drugs | 5.4 | Q1 | Chemistry, Medicinal |
Pharmacology & Pharmacy | |||
Pharmaceutics | 5.4 | Q1 | Pharmacology & Pharmacy |
Nanomaterials | 5.3 | Q1 | Physics, Applied |
Q2 | Chemistry, Multidisciplinary | ||
Materials Science, Multidisciplinary | |||
Nanoscience & Nanotechnology | |||
Cancers | 5.2 | Q2 | Oncology |
Foods | 5.2 | Q1 | Food Science & Technology |
Polymers | 5.0 | Q1 | Polymer Science |
Remote Sensing | 5.0 | Q1 | Geosciences, Multidisciplinary |
Q2 | Remote Sensing | ||
Imaging Science & Photographic Technology | |||
Environmental Sciences | |||
Antibiotics | 4.8 | Q1 | Pharmacology & Pharmacy |
Q2 | Infectious Diseases | ||
Drones | 4.8 | Q2 | Remote Sensing |
Journal of Functional Biomaterials | 4.8 | Q2 | Engineering, Biomedical |
Materials Science, Biomaterials | |||
Biomedicines | 4.7 | Q1 | Pharmacology & Pharmacy |
Q2 | Biochemistry & Molecular Biology | ||
Medicine, Research & Experimental | |||
Journal of Fungi | 4.7 | Q2 | Mycology |
Microbiology | |||
Viruses | 4.7 | Q2 | Virology |
Bioengineering | 4.6 | Q2 | Engineering, Biomedical |
Gels | 4.6 | Q1 | Polymer Science |
Molecules | 4.6 | Q2 | Chemistry, Multidisciplinary |
Biochemistry & Molecular Biology | |||
Pharmaceuticals | 4.6 | Q2 | Pharmacology & Pharmacy |
Chemistry, Medicinal | |||
Toxics | 4.6 | Q1 | Toxicology |
Q2 | Environmental Sciences | ||
Biomimetics | 4.5 | Q1 | Engineering, Multidisciplinary |
Q2 | Materials Science, Biomaterials | ||
Microorganisms | 4.5 | Q2 | Microbiology |
Plants | 4.5 | Q1 | Plant Sciences |
Biology | 4.2 | Q2 | Biology |
Chemosensors | 4.2 | Q2 | Instruments & Instrumentation |
Chemistry, Analytical | |||
Electrochemistry | |||
Membranes | 4.2 | Q2 | Engineering, Chemical |
Materials Science, Multidisciplinary | |||
Chemistry, Physical | |||
Polymer Science | |||
Toxins | 4.2 | Q1 | Toxicology |
Q2 | Food Science & Technology | ||
Metabolites | 4.2 | Q2 | Biochemistry & Molecular Biology |
Batteries | 4.0 | Q2 | Electrochemistry |
Materials Science, Multidisciplinary | |||
Q3 | Energy & Fuels | ||
Catalysts | 3.9 | Q2 | Chemistry, Physical |
Journal of Clinical Medicine | 3.9 | Q2 | Medicine, General & Internal |
Land | 3.9 | Q2 | Environmental Studies |
Sensors | 3.9 | Q2 | Instruments & Instrumentation |
Chemistry, Analytical | |||
Engineering, Electrical & Electronic | |||
Sustainability | 3.9 | Q2 | Environmental Sciences (SCIE) |
Environmental Studies (SSCI) | |||
Q3 | Green & Sustainable Science & Technology (SCIE) | ||
Green & Sustainable Science & Technology (SSCI) | |||
Buildings | 3.8 | Q2 | Construction & Building Technology |
Engineering, Civil | |||
Agronomy | 3.7 | Q1 | Agronomy |
Q2 | Plant Sciences | ||
Fermentation | 3.7 | Q2 | Biotechnology & Applied Microbiology |
Pathogens | 3.7 | Q2 | Microbiology |
Agriculture | 3.6 | Q1 | Agronomy |
Diagnostics | 3.6 | Q2 | Medicine, General & Internal |
Genes | 3.5 | Q2 | Genetics & Heredity |
Journal of Intelligence | 3.5 | Q2 | Psychology, Multidisciplinary |
Lubricants | 3.5 | Q2 | Engineering, Mechanical |
Processes | 3.5 | Q2 | Engineering, Chemical |
Coatings | 3.4 | Q2 | Materials Science, Coatings & Films |
Physics, Applied | |||
Q3 | Materials Science, Multidisciplinary | ||
ISPRS International Journal of Geo-Information | 3.4 | Q2 | Geography, Physical |
Q3 | Computer Science, Information Systems | ||
Remote Sensing | |||
Materials | 3.4 | Q2 | Metallurgy & Metallurgical Engineering |
Physics, Applied | |||
Physics, Condensed Matter | |||
Q3 | Materials Science, Multidisciplinary | ||
Chemistry, Physical | |||
Micromachines | 3.4 | Q2 | Instruments & Instrumentation |
Physics, Applied | |||
Chemistry, Analytical | |||
Q3 | Nanoscience & Nanotechnology | ||
Water | 3.4 | Q2 | Water Resources |
Environmental Sciences | |||
Brain Sciences | 3.3 | Q3 | Neurosciences |
Energies | 3.2 | Q3 | Energy & Fuels |
Fire | 3.2 | Q1 | Forestry |
Q2 | Ecology | ||
Life | 3.2 | Q2 | Biology |
Current Issues in Molecular Biology | 3.1 | Q3 | Biochemistry & Molecular Biology |
Horticulturae | 3.1 | Q1 | Horticulture |
Animals | 3.0 | Q1 | Agriculture, Dairy & Animal Science |
Veterinary Sciences | |||
Insects | 3.0 | Q1 | Entomology |
Atmosphere | 2.9 | Q3 | Meteorology & Atmospheric Sciences |
Environmental Sciences | |||
Electronics | 2.9 | Q2 | Engineering, Electrical & Electronic |
Physics, Applied | |||
Q3 | Computer Science, Information Systems | ||
Forests | 2.9 | Q1 | Forestry |
Inorganics | 2.9 | Q2 | Chemistry, Inorganic & Nuclear |
Journal of Marine Science and Engineering | 2.9 | Q1 | Engineering, Marine |
Q2 | Oceanography | ||
Engineering, Ocean | |||
Metals | 2.9 | Q2 | Metallurgy & Metallurgical Engineering |
Q3 | Materials Science, Multidisciplinary | ||
Tropical Medicine and Infectious Disease | 2.9 | Q2 | Tropical Medicine |
Parasitology | |||
Q3 | Infectious Diseases | ||
Universe | 2.9 | Q2 | Astronomy & Astrophysics |
Physics, Particles & Fields | |||
Healthcare | 2.8 | Q2 | Health Policy & Services (SSCI) |
Q3 | Health Care Sciences & Services (SCIE) | ||
Applied Sciences | 2.7 | Q2 | Engineering, Multidisciplinary |
Physics, Applied | |||
Q3 | Chemistry, Multidisciplinary | ||
Materials Science, Multidisciplinary | |||
Crystals | 2.7 | Q2 | Crystallography |
Q3 | Materials Science, Multidisciplinary | ||
Entropy | 2.7 | Q2 | Physics, Multidisciplinary |
Magnetochemistry | 2.7 | Q2 | Chemistry, Inorganic & Nuclear |
Q3 | Chemistry, Physical | ||
Materials Science, Multidisciplinary | |||
Symmetry | 2.7 | Q2 | Multidisciplinary Sciences |
Actuators | 2.6 | Q2 | Instruments & Instrumentation |
Engineering, Mechanical | |||
Aerospace | 2.6 | Q1 | Engineering, Aerospace |
Behavioral Sciences | 2.6 | Q2 | Psychology, Multidisciplinary |
Current Oncology | 2.6 | Q3 | Oncology |
Machines | 2.6 | Q2 | Engineering, Mechanical |
Q3 | Engineering, Electrical & Electronic | ||
Medicina | 2.6 | Q3 | Medicine, General & Internal |
Separations | 2.6 | Q3 | Chemistry, Analytical |
Minerals | 2.5 | Q2 | Mining & Mineral Processing |
Mineralogy | |||
Geochemistry & Geophysics | |||
Children | 2.4 | Q2 | Pediatrics |
Diversity | 2.4 | Q2 | Biodiversity Conservation |
Q3 | Ecology | ||
Journal of Cardiovascular Development and Disease | 2.4 | Q3 | Cardiac & Cardiovascular Systems |
Mathematics | 2.4 | Q1 | Mathematics |
Photonics | 2.4 | Q3 | Optics |
Veterinary Sciences | 2.4 | Q1 | Veterinary Sciences |
Fishes | 2.3 | Q2 | Marine & Freshwater Biology |
Fisheries | |||
Axioms | 2.0 | Q2 | Mathematics, Applied |
Systems | 1.9 | Q2 | Social Sciences, Interdisciplinary |
Tomography | 1.9 | Q3 | Radiology, Nuclear Medicine & Medical Imaging |
Note: The Journal of Personalized Medicine's Impact Factor was omitted in the original release and will be assigned separately. Please find the data on the journal webpage in due course.
Source: 2022 Journal Impact Factors, Journal Citation Reports TM (Clarivate, 2023)
27 June 2023
Journal of Clinical Medicine | Highly Cited Papers in 2021

The Journal of Clinical Medicine (JCM, ISSN: 2077-0383) is an international, peer-reviewed, open access journal published semimonthly online by MDPI, where you have free and unlimited access to the full text of all of the published articles. The International Bone Research Association (IBRA), Italian Resuscitation Council (IRC), Spanish Society of Hematology and Hemotherapy (SEHH), Japan Association for Clinical Engineers (JACE), European Independent Foundation in Angiology/Vascular Medicine (VAS) and others are all affiliated with JCM, and their members receive a discount on article processing charges.
JCM covers all topics related to clinical and pre-clinical practices and is dedicated to publishing high-quality original research, reviews or perspectives on clinical practice. We invite you to read our most cited papers published in 2021:
1. "Volatile Organic Compounds in Exhaled Breath as Fingerprints of Lung Cancer, Asthma and COPD"
by Ileana Andreea Ratiu, Tomasz Ligor, Victor Bocos-Bintintan, Chris A Mayhew and Bogusław Buszewski
J. Clin. Med. 2021, 10(1), 32; https://doi.org/10.3390/jcm10010032
Available online: https://www.mdpi.com/2077-0383/10/1/32
2. "Denosumab Discontinuation and the Rebound Phenomenon: A Narrative Review"
by Athanasios D. Anastasilakis, Polyzois Makras, Maria P. Yavropoulou, Gaia Tabacco, Anda Mihaela Naciu and Andrea Palermo
J. Clin. Med. 2021, 10(1), 152; https://doi.org/10.3390/jcm10010152
Available online: https://www.mdpi.com/2077-0383/10/1/152
3. "Proposal of the Definition for COVID-19-Associated Coagulopathy"
by Toshiaki Iba, Theodore E. Warkentin, Jecko Thachil, Marcel Levi and Jerrold H. Levy
J. Clin. Med. 2021, 10(2), 191; https://doi.org/10.3390/jcm10020191
Available online: https://www.mdpi.com/2077-0383/10/2/191
4. "Head-to-Head Comparison of Rapid and Automated Antigen Detection Tests for the Diagnosis of SARS-CoV-2 Infection"
by Julien Favresse, Constant Gillot, Maxime Oliveira, Julie Cadrobbi, Marc Elsen, Christine Eucher, Kim Laffineur, Catherine Rosseels, Sandrine Van Eeckhoudt, Jean-Baptiste Nicolas et al.
J. Clin. Med. 2021, 10(2), 265; https://doi.org/10.3390/jcm10020265
Available online: https://www.mdpi.com/2077-0383/10/2/265
5. "Oxidative Stress and Inflammation Biomarker Expression in Obstructive Sleep Apnea Patients"
by Antonino Maniaci, Giannicola Iannella, Salvatore Cocuzza, Claudio Vicini, Giuseppe Magliulo, Salvatore Ferlito, Giovanni Cammaroto, Giuseppe Meccariello, Andrea De Vito, Alice Nicolai et al.
J. Clin. Med. 2021, 10(2), 277; https://doi.org/10.3390/jcm10020277
Available online: https://www.mdpi.com/2077-0383/10/2/277
6. "The Impact of COVID-19 Pandemic and Lockdown Measures on Quality of Life among Italian General Population"
by Maria Stella Epifanio, Federica Andrei, Giacomo Mancini, Francesca Agostini, Marco Andrea Piombo, Vittoria Spicuzza, Martina Riolo, Gioacchino Lavanco, Elena Trombini and Sabina La Grutta
J. Clin. Med. 2021, 10(2), 289; https://doi.org/10.3390/jcm10020289
Available online: https://www.mdpi.com/2077-0383/10/2/289
7. "Skin Barrier Function in Psoriasis and Atopic Dermatitis: Transepidermal Water Loss and Temperature as Useful Tools to Assess Disease Severity"
by Trinidad Montero-Vilchez, María-Victoria Segura-Fernández-Nogueras, Isabel Pérez-Rodríguez, Miguel Soler-Gongora, Antonio Martinez-Lopez, Ana Fernández-González, Alejandro Molina-Leyva and Salvador Arias-Santiago
J. Clin. Med. 2021, 10(2), 359; https://doi.org/10.3390/jcm10020359
Available online: https://www.mdpi.com/2077-0383/10/2/359
8. "Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study"
by Daniele Roberto Giacobbe, Denise Battaglini, Elisa Martina Enrile, Chiara Dentone, Antonio Vena, Chiara Robba, Lorenzo Ball, Michele Bartoletti, Irene Coloretti, Stefano Di Bella et al.
J. Clin. Med. 2021, 10(4), 555; https://doi.org/10.3390/jcm10040555
Available online: https://www.mdpi.com/2077-0383/10/4/555
9. "Therapeutic Features and Updated Clinical Trials of Mesenchymal Stem Cell (MSC)-Derived Exosomes"
by Byung-Chul Lee, Insung Kang and Kyung-Rok Yu
J. Clin. Med. 2021, 10(4), 711; https://doi.org/10.3390/jcm10040711
Available online: https://www.mdpi.com/2077-0383/10/4/711
10. "Prevalence of COVID-19 Vaccine Side Effects among Healthcare Workers in the Czech Republic"
by Abanoub Riad, Andrea Pokorná, Sameh Attia, Jitka Klugarová, Michal Koščík and Miloslav Klugar
J. Clin. Med. 2021, 10(7), 1428; https://doi.org/10.3390/jcm10071428
Available online: https://www.mdpi.com/2077-0383/10/7/1428
11. "Thrombocytopenia and Intracranial Venous Sinus Thrombosis after “COVID-19 Vaccine AstraZeneca” Exposure"
by Marc E. Wolf, Beate Luz, Ludwig Niehaus, Pervinder Bhogal, Hansjörg Bäzner and Hans Henkes
J. Clin. Med. 2021, 10(8), 1599; https://doi.org/10.3390/jcm10081599
Available online: https://www.mdpi.com/2077-0383/10/8/1599
12. "Prevalence and Risk Factors of CoronaVac Side Effects: An Independent Cross-Sectional Study among Healthcare Workers in Turkey"
by Abanoub Riad, Derya Sağıroğlu, Batuhan Üstün, Andrea Pokorná, Jitka Klugarová, Sameh Attia and Miloslav Klugar
J. Clin. Med. 2021, 10(12), 2629; https://doi.org/10.3390/jcm10122629
Available online: https://www.mdpi.com/2077-0383/10/12/2629
13. "Demographic and Clinical Overview of Hospitalized COVID-19 Patients during the First 17 Months of the Pandemic in Poland"
by Robert Flisiak, Piotr Rzymski, Dorota Zarębska-Michaluk, Magdalena Rogalska, Marta Rorat, Piotr Czupryna, Beata Lorenc, Przemysław Ciechanowski, Dorota Kozielewicz, Anna Piekarska et al.
J. Clin. Med. 2022, 11(1), 117; https://doi.org/10.3390/jcm11010117
Available online: https://www.mdpi.com/2077-0383/11/1/117
14. "Relative Reproduction Number of SARS-CoV-2 Omicron (B.1.1.529) Compared with Delta Variant in South Africa"
by Hiroshi Nishiura, Kimihito Ito, Asami Anzai, Tetsuro Kobayashi, Chayada Piantham and Alfonso J. Rodríguez-Morales
J. Clin. Med. 2022, 11(1), 30; https://doi.org/10.3390/jcm11010030
Available online: https://www.mdpi.com/2077-0383/11/1/30
15. "The Role of Antioxidants on Wound Healing: A Review of the Current Evidence"
by Inés María Comino-Sanz, María Dolores López-Franco, Begoña Castro and Pedro Luis Pancorbo-Hidalgo
J. Clin. Med. 2021, 10(16), 3558; https://doi.org/10.3390/jcm10163558
Available online: https://www.mdpi.com/2077-0383/10/16/3558
16. "Nociplastic Pain Criteria or Recognition of Central Sensitization? Pain Phenotyping in the Past, Present and Future"
by Jo Nijs, Astrid Lahousse, Eleni Kapreli, Paraskevi Bilika, İsmail Saraçoğlu, Anneleen Malfliet, Iris Coppieters, Liesbet De Baets, Laurence Leysen, Eva Roose et al.
J. Clin. Med. 2021, 10(15), 3203; https://doi.org/10.3390/jcm10153203
Available online: https://www.mdpi.com/2077-0383/10/15/3203
17. "The Impact of Dental Implant Surface Modifications on Osseointegration and Biofilm Formation"
by Stefanie Kligman, Zhi Ren, Chun-Hsi Chung, Michael Angelo Perillo, Yu-Cheng Chang, Hyun Koo, Zhong Zheng and Chenshuang Li
J. Clin. Med. 2021, 10(8), 1641; https://doi.org/10.3390/jcm10081641
Available online: https://www.mdpi.com/2077-0383/10/8/1641
18. "The Exoscope in Neurosurgery: An Overview of the Current Literature of Intraoperative Use in Brain and Spine Surgery"
by Nicola Montemurro, Alba Scerrati, Luca Ricciardi and Gianluca Trevisi
J. Clin. Med. 2022, 11(1), 223; https://doi.org/10.3390/jcm11010223
Available online: https://www.mdpi.com/2077-0383/11/1/223
19. "Therapeutic Advances in Diabetic Nephropathy"
by Hanny Sawaf, George Thomas, Jonathan J. Taliercio, Georges Nakhoul, Tushar J. Vachharajani and Ali Mehdi
J. Clin. Med. 2022, 11(2), 378; https://doi.org/10.3390/jcm11020378
Available online: https://www.mdpi.com/2077-0383/11/2/378
20. "The Association between Early-Life Gut Microbiota and Long-Term Health and Diseases"
by Anujit Sarkar, Ji Youn Yoo, Samia Valeria Ozorio Dutra, Katherine H. Morgan and Maureen Groer
J. Clin. Med. 2021, 10(3), 459; https://doi.org/10.3390/jcm10030459
Available online: https://www.mdpi.com/2077-0383/10/3/459
21. "Long-Term Outcomes of Patients with Coronavirus Disease 2019 at One Year after Hospital Discharge"
by Modesto M. Maestre-Muñiz, Ángel Arias, Emilia Mata-Vázquez, María Martín-Toledano, Germán López-Larramona, Ana María Ruiz-Chicote, Bárbara Nieto-Sandoval and Alfredo J. Lucendo
J. Clin. Med. 2021, 10(13), 2945; https://doi.org/10.3390/jcm10132945
Available online: https://www.mdpi.com/2077-0383/10/13/2945
22. "The Comparative Clinical Performance of Four SARS-CoV-2 Rapid Antigen Tests and Their Correlation to Infectivity In Vitro"
by Niko Kohmer, Tuna Toptan, Christiane Pallas, Onur Karaca, Annika Pfeiffer, Sandra Westhaus, Marek Widera, Annemarie Berger, Sebastian Hoehl, Martin Kammel et al.
J. Clin. Med. 2021, 10(2), 328; https://doi.org/10.3390/jcm10020328
Available online: https://www.mdpi.com/2077-0383/10/2/328
23. "Multi-Organ Involvement in COVID-19: Beyond Pulmonary Manifestations"
by Vikram Thakur, Radha Kanta Ratho, Pradeep Kumar, Shashi Kant Bhatia, Ishani Bora, Gursimran Kaur Mohi, Shailendra K Saxena, Manju Devi, Dhananjay Yadav and Sanjeet Mehariya
J. Clin. Med. 2021, 10(3), 446; https://doi.org/10.3390/jcm10030446
Available online: https://www.mdpi.com/2077-0383/10/3/446
27 June 2023
Journal of Clinical Medicine | Highly Cited Papers in 2022

The Journal of Clinical Medicine (JCM, ISSN: 2077-0383) is an international, peer-reviewed, open access journal published semimonthly online by MDPI, where you have free and unlimited access to the full text of all of the published articles. The International Bone Research Association (IBRA), Italian Resuscitation Council (IRC), Spanish Society of Hematology and Hemotherapy (SEHH), Japan Association for Clinical Engineers (JACE), European Independent Foundation in Angiology/Vascular Medicine (VAS) and others are all affiliated with JCM, and their members receive a discount on article processing charges.
JCM covers all topics related to clinical and pre-clinical practices and is dedicated to publishing high-quality original research, reviews or perspectives on clinical practice. We invite you to read our most cited papers published in 2022 below:
1. "Female Sex Is a Risk Factor Associated with Long-Term Post-COVID Related-Symptoms but Not with COVID-19 Symptoms: The LONG-COVID-EXP-CM Multicenter Study"
by César Fernández-de-las-Peñas, José D. Martín-Guerrero, Óscar J. Pellicer-Valero, Esperanza Navarro-Pardo, Víctor Gómez-Mayordomo, María L. Cuadrado, José A. Arias-Navalón, Margarita Cigarán-Méndez, Valentín Hernández-Barrera and Lars Arendt-Nielsen
J. Clin. Med. 2022, 11(2), 413; https://doi.org/10.3390/jcm11020413
Available online: https://www.mdpi.com/2077-0383/11/2/413
2. "XR (Extended Reality: Virtual Reality, Augmented Reality, Mixed Reality) Technology in Spine Medicine: Status Quo and Quo Vadis"
by Tadatsugu Morimoto, Takaomi Kobayashi, Hirohito Hirata, Koji Otani, Maki Sugimoto, Masatsugu Tsukamoto, Tomohito Yoshihara, Masaya Ueno and Masaaki Mawatari
J. Clin. Med. 2022, 11(2), 470; https://doi.org/10.3390/jcm11020470
Available online: https://www.mdpi.com/2077-0383/11/2/470
3. "Viscoelastic Hemostatic Assays: A Primer on Legacy and New Generation Devices"
by Oksana Volod, Connor M. Bunch, Nuha Zackariya, Ernest E. Moore, Hunter B. Moore, Hau C. Kwaan, Matthew D. Neal, Mahmoud D. Al-Fadhl, Shivani S. Patel, Grant Wiarda et al.
J. Clin. Med. 2022, 11(3), 860; https://doi.org/10.3390/jcm11030860
Available online: https://www.mdpi.com/2077-0383/11/3/860
4. "Prognostic Factors for Post-COVID-19 Syndrome: A Systematic Review and Meta-Analysis"
by Giuseppe Maglietta, Francesca Diodati, Matteo Puntoni, Silvia Lazzarelli, Barbara Marcomini, Laura Patrizi and Caterina Caminiti
J. Clin. Med. 2022, 11(6), 1541; https://doi.org/10.3390/jcm11061541
Available online: https://www.mdpi.com/2077-0383/11/6/1541
5. "Different Methods to Improve the Monitoring of Noninvasive Respiratory Support of Patients with Severe Pneumonia/ARDS Due to COVID-19: An Update"
by Paolo Pelosi, Roberto Tonelli, Chiara Torregiani, Elisa Baratella, Marco Confalonieri, Denise Battaglini, Alessandro Marchioni, Paola Confalonieri, Enrico Clini, Francesco Salton et al.
J. Clin. Med. 2022, 11(6), 1704; https://doi.org/10.3390/jcm11061704
Available online: https://www.mdpi.com/2077-0383/11/6/1704
6. "Serological Response to Three, Four and Five Doses of SARS-CoV-2 Vaccine in Kidney Transplant Recipients"
by Bilgin Osmanodja, Simon Ronicke, Klemens Budde, Annika Jens, Charlotte Hammett, Nadine Koch, Evelyn Seelow, Johannes Waiser, Bianca Zukunft, Friederike Bachmann et al.
J. Clin. Med. 2022, 11(9), 2565; https://doi.org/10.3390/jcm11092565
Available online: https://www.mdpi.com/2077-0383/11/9/2565
7. "Cytokine Profiles as Potential Prognostic and Therapeutic Markers in SARS-CoV-2-Induced ARDS"
by Francesco Salton, Paola Confalonieri, Giuseppina Campisciano, Rossella Cifaldi, Clara Rizzardi, Daniele Generali, Riccardo Pozzan, Stefano Tavano, Chiara Bozzi, Giulia Lapadula et al.
J. Clin. Med. 2022, 11(11), 2951; https://doi.org/10.3390/jcm11112951
Available online: https://www.mdpi.com/2077-0383/11/11/2951
8. "Efficacy of Oxybrasion in the Treatment of Acne Vulgaris: A Preliminary Report"
by Karolina Chilicka, Aleksandra M. Rogowska, Renata Szyguła, Monika Rusztowicz and Danuta Nowicka
J. Clin. Med. 2022, 11(13), 3824; https://doi.org/10.3390/jcm11133824
Available online: https://www.mdpi.com/2077-0383/11/13/3824
9. "Efficacy of Hydrogen Purification and Cosmetic Acids in the Treatment of Acne Vulgaris: A Preliminary Report"
by Karolina Chilicka, Monika Rusztowicz, Aleksandra M. Rogowska, Renata Szyguła, Binnaz Asanova and Danuta Nowicka
J. Clin. Med. 2022, 11(21), 6269; https://doi.org/10.3390/jcm11216269
Available online: https://www.mdpi.com/2077-0383/11/21/6269
10. "The Role of Innate and Adaptive Immune Cells in the Pathogenesis and Development of the Inflammatory Response in Ulcerative Colitis"
by Aleksandra Kałużna, Paweł Olczyk and Katarzyna Komosińska-Vassev
J. Clin. Med. 2022, 11(2), 400; https://doi.org/10.3390/jcm11020400
Available online: https://www.mdpi.com/2077-0383/11/2/400
11. "Long-Term Outcomes of Implants Placed in Maxillary Sinus Floor Augmentation with Porous Fluorohydroxyapatite (Algipore® FRIOS®) in Comparison with Anorganic Bovine Bone (Bio-Oss®) and Platelet Rich Plasma (PRP): A Retrospective Study"
by Biagio Rapone, Alessio Danilo Inchingolo, Stefano Trasarti, Elisabetta Ferrara, Erda Qorri, Antonio Mancini, Nicola Montemurro, Antonio Scarano, Angelo Michele Inchingolo, Gianna Dipalma et al.
J. Clin. Med. 2022, 11(9), 2491; https://doi.org/10.3390/jcm11092491
Available online: https://www.mdpi.com/2077-0383/11/9/2491
12. "Exercise Training in Post-COVID-19 Patients: The Need for a Multifactorial Protocol for a Multifactorial Pathophysiology"
by Gaia Cattadori, Silvia Di Marco, Massimo Baravelli, Anna Picozzi and Giuseppe Ambrosio
J. Clin. Med. 2022, 11(8), 2228; https://doi.org/10.3390/jcm11082228
Available online: https://www.mdpi.com/2077-0383/11/8/2228
13. "The Risk of Spontaneous Abortion Does Not Increase Following First Trimester mRNA COVID-19 Vaccination"
by Ioana Mihaela Citu, Cosmin Citu, Florin Gorun, Ioan Sas, Felix Bratosin, Andrei Motoc, Bogdan Burlea, Ovidiu Rosca, Daniel Malita and Oana Maria Gorun
J. Clin. Med. 2022, 11(6), 1698; https://doi.org/10.3390/jcm11061698
Available online: https://www.mdpi.com/2077-0383/11/6/1698
14. "Age, Sex and Previous Comorbidities as Risk Factors Not Associated with SARS-CoV-2 Infection for Long COVID-19: A Systematic Review and Meta-Analysis"
by Kin Israel Notarte, Maria Helena Santos de Oliveira, Princess Juneire Peligro, Jacqueline Veronica Velasco, Imee Macaranas, Abbygail Therese Ver, Flos Carmeli Pangilinan, Adriel Pastrana, Nathaniel Goldrich, David Kavteladze et al.
J. Clin. Med. 2022, 11(24), 7314; https://doi.org/10.3390/jcm11247314
Available online: https://www.mdpi.com/2077-0383/11/24/7314
15. "Post-COVID-19 Syndrome: Involvement and Interactions between Respiratory, Cardiovascular and Nervous Systems"
by Valeria Visco, Carolina Vitale, Antonella Rispoli, Carmine Izzo, Nicola Virtuoso, Germano Junior Ferruzzi, Mario Santopietro, Americo Melfi, Maria Rosaria Rusciano, Angelantonio Maglio et al.
J. Clin. Med. 2022, 11(3), 524; https://doi.org/10.3390/jcm11030524
Available online: https://www.mdpi.com/2077-0383/11/3/524
16. "The Predictive Role of NLR and PLR in Outcome and Patency of Lower Limb Revascularization in Patients with Femoropopliteal Disease"
by Eliza Russu, Adrian Vasile Mureșan, Emil Marian Arbănași, Réka Kaller, Ioan Hosu, Septimiu Voidăzan, Eliza Mihaela Arbănași and Cătălin Mircea Coșarcă
J. Clin. Med. 2022, 11(9), 2620; https://doi.org/10.3390/jcm11092620
Available online: https://www.mdpi.com/2077-0383/11/9/2620
17. "Neutrophil-to-Lymphocyte Ratio (NLR) Is a Promising Predictor of Mortality and Admission to Intensive Care Unit of COVID-19 Patients"
by Matteo Regolo, Mauro Vaccaro, Alessandra Sorce, Benedetta Stancanelli, Michele Colaci, Giuseppe Natoli, Mario Russo, Innocenza Alessandria, Massimo Motta, Nicola Santangelo et al.
J. Clin. Med. 2022, 11(8), 2235; https://doi.org/10.3390/jcm11082235
Available online: https://www.mdpi.com/2077-0383/11/8/2235
15 June 2023
Meet Us at the Annual Meeting of American Psychological Association 2023 (APA 2023), 3–5 August 2023, Washington DC, USA

MDPI will attend the Annual Meeting of American Psychological Association 2023 (APA 2023) as an exhibitor. This meeting will be held in Washington DC, USA, from 3 to 5 August 2023.
The Annual Meeting of American Psychological Association is organized by the American Psychological Association annually. The American Psychological Association is the largest scientific and professional organization of psychologists in the United States, with over 146,000 members, including scientists, educators, clinicians, consultants, and students. APA 2023 will provide in-person engagement with psychology professionals (practitioners, researchers, scientists, academicians, students, and others) who seek solutions to the work challenges that they face within the field.
The following MDPI journals will be represented:
- Behavioral Sciences;
- J. Intell.;
- EJIHPE;
- Healthcare;
- JCM;
- Social Sciences;
- Psychoactives;
- Psych;
- Children;
- Psychiatry International.
If you are attending this conference, please feel free to start a conversation with us at our booth #244. Our delegates look forward to meeting you in person and answering any questions that you may have.
For more information about the conference, please visit https://convention.apa.org/.
13 June 2023
Journal of Clinical Medicine Receives an Increased CiteScore of 5.4

We are pleased to inform you that the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) has received an updated CiteScore of 5.4, which is an increase of 22% compared with the 2021 metric. The 2022 CiteScore™ was recently released, and it assesses the scientific influence of journals in the 2019 to 2022 period. JCM’s CiteScore ranks Q1 (137 out of 830) in the "General Medicine" category.
To learn more about journal statistics, please visit https://www.mdpi.com/journal/jcm/stats.
Excellent performance is inseparable from the support and dedication of all journal editors, reviewers, authors, and readers. We would like to take this opportunity to thank all of you who have contributed to the journal.
7 June 2023
Meet Us at the WASOG 2023 Conference, 19–21 June 2023, Stockholm, Sweden

Conference: WASOG 2023
Organization: The World Association of Sarcoidosis and Other Granulomatous Disorders
Date: 19–21 June 2023
Place: Aula Medica, Karolinska Institutet, Stockholm, Sweden
Booth: #7
MDPI will be attending the WASOG 2023 conference, which will be held from 19 to 21 June 2023 at Aula Medica, Karolinska Institutet, Stockholm, Sweden.
WASOG 2023 will offer a creative meeting ground for investigating how novel experimental, theoretical and computational approaches in Sarcoidosis and Interstitial Lung Diseases (ILDs) can improve our understanding of their underlying disease mechanisms. It aims to build an even stronger scientific bridge between different sectors, ultimately closing the knowledge gap and accelerating the development and spread of precision medicine in ILDs.
The following MDPI journals will be represented:
- Biomedicines;
- Clinics and Practice;
- Diagnostics;
- Diseases;
- Genes;
- Healthcare;
- Hematology Reports;
- IJTM;
- JCM;
- Medicines;
- Reports.
Please reach out ([email protected]) if you plan on attending this conference. Our delegates look forward to meeting you in person and answering any questions that you might have.
For more information about the conference, please visit the following website: https://mkon.nu/wasog2023.
25 May 2023
Meet Us at the 60th European Renal Association (ERA) Congress, 15–17 June 2023, Milan, Italy

Conference: 60th European Renal Association (ERA) Congress
Date: 15–17 June 2023
Location: Milan, Italy
MDPI will be attending the 60th ERA Congress as an exhibitor; we welcome researchers from different backgrounds to visit and share their latest ideas with us.
This conference is being organized by the European Renal Association, and it will offer a clearly structured scientific program, combining presentations of cutting-edge research with a broad view of the currently most relevant fields in the prevention, detection, and treatment of kidney disease. At the conference, specialists will share knowledge on the clinical assessment and treatments of renal diseases to improve disease prevention and patients’ quality of life.
The following MDPI journals will be represented:
- JCM;
- JPM;
- Kidney and Dialysis;
- Diagnostics;
- Clinics and Practice;
- Uro;
- Cells;
- BioChem;
- Transplantology.
17 May 2023
Interview with Dr. Jan Bednarsch—Winner of the JCM 2022 Young Investigator Award
We are pleased to announce the winner of the JCM 2022 Young Investigator Award—Dr. Jan Bednarsch.
Name: Dr. Jan Bednarsch
Affiliation: Charité – Universitätsmedizin Berlin, Berlin, Germany
Research Interests: colorectal liver metastases, cholangiocellular carcinoma, hepatocellular carcinoma, liver surgery, pancreatic ductal adenocarcinoma, and pancreas surgery
We would like to thank the award committee for selecting one winner from a large number of exceptional candidates, Dr. Jan Bednarsch. We will continue to reward scholars with the Young Investigator Award to express our acknowledgment of their support for the Journal of Clinical Medicine (JCM, ISSN: 2077-0383). We wish them every success in their careers.
The following is a short interview with Dr. Jan Bednarsch:
- Could you briefly introduce yourself and your current research to our readers?
My name is Jan Bednarsch and I am a consultant surgeon and clinical scientist at RWTH Aachen University in Germany. I studied at Charité University Berlin in Germany, where I also obtained my doctoral degree as a result of clinical research conducted during my time in medical school. Later, I did my surgical training at RWTH Aachen University. Here, I also continued to pursue my research interests in clinical medicine and translational oncology with a focus on surgery. In these terms, I am working on clinical studies (including randomized trials) in hepatobiliary surgery and translational research in cholangiocellular carcinoma, exploring biomarkers and various other topics.
- Why did you choose the current research topic? What attracted you to work on it?
I always had a strong interest in surgery and the theoretical basis of it. Furthermore, I was also very interested in oncology in combination with surgery. Therefore, general surgery with a focus on hepato-biliary-pancreatic surgery seemed like a logical choice for me. As my research interests matched my clinical interests, I enjoy researching topics that have a direct influence on actual clinical work. The thing that most drives me to investigate clinical or translational topics is that the results can immediately be transferred into patient treatment and subsequently improve outcomes or facilitate decision making. Thus, the idea to improve surgical treatment for cancer patients keeps fascinating me and attracts me to continuously work on it.
- How did you overcome difficulties while conducting research?
Being a clinician scientist, time is my most limited resource. One key to success is subsequently developing time efficiency to integrate research time into the “regular” workload as a surgeon working in a large center. It is also essential to work in well-organized interdisciplinary teams as it is not possible to do all the work by oneself. Building an infrastructure that helps to work efficiently, balancing time investment with meaningful scientific output, was therefore most important for me. Additionally, I strongly advise young researchers to collaborate with dedicated scientists from other disciplines, which helps to develop new ideas and approaches. Additionally, organizational support in terms of internal funding, providing opportunities, and off-time is essential to overcoming natural difficulties.
- What is your opinion of the open access model of publishing?
In my mind, open access should be the preferred method of choice when publishing because it gives instant access to publications for researchers all over the world. It is therefore the most democratic and efficient way to distribute research.
- As the winner of this award, is there anything you would like to express?
I, of course, would like to express my gratitude to the Award Committee for their support of my work as well as to the editorial team of the Journal of Clinical Medicine for the excellent and professional handling of research work submitted to them. As such, I can encourage any scientist to consider the Journal of Clinical Medicine for their valuable research.
16 May 2023
Journal of Clinical Medicine | Highly Cited Papers in 2021 and 2022 from the Section “Epidemiology & Public Health”

The Journal of Clinical Medicine (JCM, ISSN: 2077-0383) is an international, peer-reviewed, open access journal published semimonthly online by MDPI. The International Bone Research Association (IBRA), Italian Resuscitation Council (IRC), Spanish Society of Hematology and Hemotherapy (SEHH), Japan Association for Clinical Engineers (JACE), European Independent Foundation in Angiology/ Vascular Medicine (VAS) and others are all affiliated with JCM, and their members receive a discount on article processing charges. The Section “Epidemiology & Public Health” is dedicated to publishing high-quality original research, reviews or perspectives that contribute to advancing global health and medicine, with the goal of creating a global health information source focused on clinical practice.
The Section "Epidemiology & Public Health" follows the same open access format as the rest of JCM, meaning that you have free and unlimited access to the full text of all of the published articles. We invite you to read our most cited papers published in 2021 and 2022 below:
- “Real Time PCR and Culture-Based Virus Isolation Test in Clinically Recovered Patients: Is the Subject Still Infectious for SARS-CoV2?”
by Viviana Manzulli, Giulia Scioscia, Giulio Giganti, Maria Rosaria Capobianchi, Donato Lacedonia, Lorenzo Pace, Dora Cipolletta, Pasquale Tondo, Rosella De Nittis, Valeria Rondinone et al.
Clin. Med. 2021, 10(2), 309; https://doi.org/10.3390/jcm10020309
Available online: https://www.mdpi.com/2077-0383/10/2/309
- “AI and Big Data in Healthcare: Towards a More Comprehensive Research Framework for Multimorbidity”
by Ljiljana Trtica Majnarić, František Babič, Shane O’Sullivan and Andreas Holzinger
Clin. Med. 2021, 10(4), 766; https://doi.org/10.3390/jcm10040766
Available online: https://www.mdpi.com/2077-0383/10/4/766
- “Acceptance and Intake of COVID-19 Vaccines among Older Germans”
by Marta Malesza and Erich Wittmann
Clin. Med. 2021, 10(7), 1388; https://doi.org/10.3390/jcm10071388
Available online: https://www.mdpi.com/2077-0383/10/7/1388
- “Exercise Ventilatory Inefficiency in Post-COVID-19 Syndrome: Insights from a Prospective Evaluation”
by Álvaro Aparisi, Cristina Ybarra-Falcón, Mario García-Gómez, Javier Tobar, Carolina Iglesias-Echeverría, Sofía Jaurrieta-Largo, Raquel Ladrón, Aitor Uribarri, Pablo Catalá, Williams Hinojosa et al.
Clin. Med. 2021, 10(12), 2591; https://doi.org/10.3390/jcm10122591
Available online: https://www.mdpi.com/2077-0383/10/12/2591
- “Risk Factors of Infection, Hospitalization and Death from SARS-CoV-2: A Population-Based Cohort Study”
by Jesús Castilla, Marcela Guevara, Ana Miqueleiz, Fernando Baigorria, Carlos Ibero-Esparza, Ana Navascués, Camino Trobajo-Sanmartín, Iván Martínez-Baz, Itziar Casado and Cristina Burgui
Clin. Med. 2021, 10(12), 2608; https://doi.org/10.3390/jcm10122608
Available online: https://www.mdpi.com/2077-0383/10/12/2608
- “SARS-CoV-2 Infectivity and Severity of COVID-19 According to SARS-CoV-2 Variants: Current Evidence”
by Thi Loi Dao, Van Thuan Hoang, Philippe Colson, Jean Christophe Lagier, Matthieu Million, Didier Raoult, Anthony Levasseur and Philippe Gautret
Clin. Med. 2021, 10(12), 2635; https://doi.org/10.3390/jcm10122635
Available online: https://www.mdpi.com/2077-0383/10/12/2635
- “Diagnostic Accuracy of Rapid Antigen Test Kits for Detecting SARS-CoV-2: A Systematic Review and Meta-Analysis of 17,171 Suspected COVID-19 Patients”
by Shahad Saif Khandker, Nik Haszroel Hysham Nik Hashim, Zakuan Zainy Deris, Rafidah Hanim Shueb and Md Asiful Islam
Clin. Med. 2021, 10(16), 3493; https://doi.org/10.3390/jcm10163493
Available online: https://www.mdpi.com/2077-0383/10/16/3493
- “The Role of Antioxidants on Wound Healing: A Review of the Current Evidence”
by Inés María Comino-Sanz, María Dolores López-Franco, Begoña Castro and Pedro Luis Pancorbo-Hidalgo
Clin. Med. 2021, 10(16), 3558; https://doi.org/10.3390/jcm10163558
Available online: https://www.mdpi.com/2077-0383/10/16/3558
- “Self-Reported Adverse Events of COVID-19 Vaccines in Polish Healthcare Workers and Medical Students. Cross-Sectional Study and Pooled Analysis of CoVaST Project Results in Central Europe”
by Arkadiusz Dziedzic, Abanoub Riad, Sameh Attia, Miloslav Klugar and Marta Tanasiewicz
Clin. Med. 2021, 10(22), 5338; https://doi.org/10.3390/jcm10225338
Available online: https://www.mdpi.com/2077-0383/10/22/5338
- “Female Sex Is a Risk Factor Associated with Long-Term Post-COVID Related-Symptoms but Not with COVID-19 Symptoms: The LONG-COVID-EXP-CM Multicenter Study”
by César Fernández-de-las-Peñas, José D. Martín-Guerrero, Óscar J. Pellicer-Valero, Esperanza Navarro-Pardo, Víctor Gómez-Mayordomo, María L. Cuadrado, José A. Arias-Navalón, Margarita Cigarán-Méndez, Valentín Hernández-Barrera and Lars Arendt-Nielsen
Clin. Med. 2022, 11(2), 413; https://doi.org/10.3390/jcm11020413
Available online: https://www.mdpi.com/2077-0383/11/2/413
- “Post-COVID-19 Syndrome: Involvement and Interactions between Respiratory, Cardiovascular and Nervous Systems”
by Valeria Visco, Carolina Vitale, Antonella Rispoli, Carmine Izzo, Nicola Virtuoso, Germano Junior Ferruzzi, Mario Santopietro, Americo Melfi, Maria Rosaria Rusciano, Angelantonio Maglio et al.
Clin. Med. 2022, 11(3), 524; https://doi.org/10.3390/jcm11030524
Available online: https://www.mdpi.com/2077-0383/11/3/524
- “The Interactive Effects of Post-Traumatic Stress Symptoms and Breathlessness on Fatigue Severity in Post-COVID-19 Syndrome”
by Sari Harenwall, Suzanne Heywood-Everett, Rebecca Henderson, Joanne Smith, Rachel McEnery and Amy R. Bland
Clin. Med. 2022, 11(20), 6214; https://doi.org/10.3390/jcm11206214
Available online: https://www.mdpi.com/2077-0383/11/20/6214
- “Psychological and Cognitive Effects of Long COVID: A Narrative Review Focusing on the Assessment and Rehabilitative Approach”
by Rosaria De Luca, Mirjam Bonanno and Rocco Salvatore Calabrò
Clin. Med. 2022, 11(21), 6554; https://doi.org/10.3390/jcm11216554
Available online: https://www.mdpi.com/2077-0383/11/21/6554
- “Practice of Awake Prone Positioning in Critically Ill COVID-19 Patients—Insights from the PRoAcT–COVID Study”
by Willemke Stilma, Christel M. A. Valk, David M. P. van Meenen, Luis Morales, Daantje Remmelzwaal, Sheila N. Myatra, Antonio Artigas, Ary Serpa Neto, Frederique Paulus, Marcus J. Schultz et al.
Clin. Med. 2022, 11(23), 6988; https://doi.org/10.3390/jcm11236988
Available online: https://www.mdpi.com/2077-0383/11/23/6988
- “Age, Sex and Previous Comorbidities as Risk Factors Not Associated with SARS-CoV-2 Infection for Long COVID-19: A Systematic Review and Meta-Analysis”
by Kin Israel Notarte, Maria Helena Santos de Oliveira, Princess Juneire Peligro, Jacqueline Veronica Velasco, Imee Macaranas, Abbygail Therese Ver, Flos Carmeli Pangilinan, Adriel Pastrana, Nathaniel Goldrich, David Kavteladze et al.
Clin. Med. 2022, 11(24), 7314; https://doi.org/10.3390/jcm11247314
Available online: https://www.mdpi.com/2077-0383/11/24/7314
16 May 2023
Journal of Clinical Medicine | Highly Cited Papers in 2021 and 2022 from the Section “Infectious Diseases”

The Journal of Clinical Medicine (JCM, ISSN: 2077-0383) is an international, peer-reviewed, open access journal published semimonthly online by MDPI. The International Bone Research Association (IBRA), Italian Resuscitation Council (IRC), Spanish Society of Hematology and Hemotherapy (SEHH), Japan Association for Clinical Engineers (JACE), European Independent Foundation in Angiology/ Vascular Medicine (VAS) and others are all affiliated with JCM, and their members receive a discount on article processing charges. The Section “Infectious Diseases” of the journal aims to publish articles describing research results on microbiology, immunology, epidemiology, and related disciplines on the pathogenesis, diagnosis, and treatment of infectious diseases, with a particular focus on the role of infections in the pathogenesis of chronic noninfectious conditions as well as on the treatment of infections as comorbidities of chronic conditions.
The Section “Infectious Diseases” follows the same open access format as the rest of JCM, meaning that you have free and unlimited access to the full text of all of the articles published in our journal. We welcome you to read our most cited papers published in 2021 and 2022, listed below:
- “Proposal of the Definition for COVID-19-Associated Coagulopathy”
by Toshiaki Iba, Theodore E. Warkentin, Jecko Thachil, Marcel Levi and Jerrold H. Levy
Clin. Med. 2021, 10(2), 191; https://doi.org/10.3390/jcm10020191
Avaliable online: https://www.mdpi.com/2077-0383/10/2/191
- “Evidence of Pulmonary Hypertension after SARS-CoV-2 Infection in Subjects without Previous Significant Cardiovascular Pathology”
by Cristina Tudoran, Mariana Tudoran, Voichita Elena Lazureanu, Adelina Raluca Marinescu, Gheorghe Nicusor Pop, Alexandru Silvius Pescariu, Alexandra Enache and Talida Georgiana Cut
Clin. Med. 2021, 10(2), 199; https://doi.org/10.3390/jcm10020199
Avaliable online: https://www.mdpi.com/2077-0383/10/2/199
- “Head-to-Head Comparison of Rapid and Automated Antigen Detection Tests for the Diagnosis of SARS-CoV-2 Infection”
by Julien Favresse, Constant Gillot, Maxime Oliveira, Julie Cadrobbi, Marc Elsen, Christine Eucher, Kim Laffineur, Catherine Rosseels, Sandrine Van Eeckhoudt, Jean-Baptiste Nicolas et al.
Clin. Med. 2021, 10(2), 265; https://doi.org/10.3390/jcm10020265
Avaliable online: https://www.mdpi.com/2077-0383/10/2/265
- “Favipiravir in Therapy of Viral Infections”
by Ryta Łagocka, Violetta Dziedziejko, Patrycja Kłos and Andrzej Pawlik
Clin. Med. 2021, 10(2), 273; https://doi.org/10.3390/jcm10020273
Avaliable online: https://www.mdpi.com/2077-0383/10/2/273
- “Severe COVID-19 Lung Infection in Older People and Periodontitis”
by Ruben Aquino-Martinez and Scarlette Hernández-Vigueras
Clin. Med. 2021, 10(2), 279; https://doi.org/10.3390/jcm10020279
Avaliable online: https://www.mdpi.com/2077-0383/10/2/279
- “When Does the Cytokine Storm Begin in COVID-19 Patients? A Quick Score to Recognize It”
by Stefano Cappanera, Michele Palumbo, Sherman H. Kwan, Giulia Priante, Lucia Assunta Martella, Lavinia Maria Saraca, Francesco Sicari, Carlo Vernelli, Cinzia Di Giuli, Paolo Andreani et al.
Clin. Med. 2021, 10(2), 297; https://doi.org/10.3390/jcm10020297
Avaliable online: https://www.mdpi.com/2077-0383/10/2/297
- “The Prognostic Value of Eosinophil Recovery in COVID-19: A Multicentre, Retrospective Cohort Study on Patients Hospitalised in Spanish Hospitals”
by María Mateos González, Elena Sierra Gonzalo, Irene Casado Lopez, Francisco Arnalich Fernández, José Luis Beato Pérez, Daniel Monge Monge, Juan Antonio Vargas Núñez, Rosa García Fenoll, Carmen Suárez Fernández, Santiago Jesús Freire Castro et al.
Clin. Med. 2021, 10(2), 305; https://doi.org/10.3390/jcm10020305
Avaliable online: https://www.mdpi.com/2077-0383/10/2/305
- “The Comparative Clinical Performance of Four SARS-CoV-2 Rapid Antigen Tests and Their Correlation to Infectivity In Vitro”
by Niko Kohmer, Tuna Toptan, Christiane Pallas, Onur Karaca, Annika Pfeiffer, Sandra Westhaus, Marek Widera, Annemarie Berger, Sebastian Hoehl, Martin Kammel et al.
Clin. Med. 2021, 10(2), 328; https://doi.org/10.3390/jcm10020328
Avaliable online: https://www.mdpi.com/2077-0383/10/2/328
- “’Go To Travel’ Campaign and Travel-Associated Coronavirus Disease 2019 Cases: A Descriptive Analysis, July–August 2020”
by Asami Anzai and Hiroshi Nishiura
Clin. Med. 2021, 10(3), 398; https://doi.org/10.3390/jcm10030398
Avaliable online: https://www.mdpi.com/2077-0383/10/3/398
- “Optimal Allocation of the Limited COVID-19 Vaccine Supply in South Korea”
by Eunha Shim
Clin. Med. 2021, 10(4), 591; https://doi.org/10.3390/jcm10040591
Avaliable online: https://www.mdpi.com/2077-0383/10/4/591
- “Calprotectin, an Emerging Biomarker of Interest in COVID-19: A Systematic Review and Meta-Analysis”
by Raphael Udeh, Shailesh Advani, Luis García de Guadiana Romualdo and Xenia Dolja-Gore
Clin. Med. 2021, 10(4), 775; https://doi.org/10.3390/jcm10040775
Avaliable online: https://www.mdpi.com/2077-0383/10/4/775
- “The Rheumatology Drugs for COVID-19 Management: Which and When?”
by Fabiola Atzeni, Ignazio Francesco Masala, Javier Rodríguez-Carrio, Roberto Ríos-Garcés, Elisabetta Gerratana, Laura La Corte, Manuela Giallanza, Valeria Nucera, Agostino Riva, Gerard Espinosa et al.
Clin. Med. 2021, 10(4), 783; https://doi.org/10.3390/jcm10040783
Avaliable online: https://www.mdpi.com/2077-0383/10/4/783
- “Tocilizumab Improves the Prognosis of COVID-19 in Patients with High IL-6”
by Robert Flisiak, Jerzy Jaroszewicz, Magdalena Rogalska, Tadeusz Łapiński, Aleksandra Berkan-Kawińska, Beata Bolewska, Magdalena Tudrujek-Zdunek, Dorota Kozielewicz, Marta Rorat, Piotr Leszczyński et al.
Clin. Med. 2021, 10(8), 1583; https://doi.org/10.3390/jcm10081583
Avaliable online: https://www.mdpi.com/2077-0383/10/8/1583
- “Post-Acute COVID-19 Neurological Syndrome: A New Medical Challenge”
by Domenico Nuzzo, Sonya Vasto, Luca Scalisi, Salvatore Cottone, Gaetano Cambula, Manfredi Rizzo, Daniela Giacomazza and Pasquale Picone
Clin. Med. 2021, 10(9), 1947; https://doi.org/10.3390/jcm10091947
Avaliable online: https://www.mdpi.com/2077-0383/10/9/1947
- “HGF, IL-1α, and IL-27 Are Robust Biomarkers in Early Severity Stratification of COVID-19 Patients”
by Álvaro Tamayo-Velasco, Pedro Martínez-Paz, María Jesús Peñarrubia-Ponce, Ignacio de la Fuente, Sonia Pérez-González, Itziar Fernández, Carlos Dueñas, Esther Gómez-Sánchez, Mario Lorenzo-López, Estefanía Gómez-Pesquera et al.
Clin. Med. 2021, 10(9), 2017; https://doi.org/10.3390/jcm10092017
Avaliable online: https://www.mdpi.com/2077-0383/10/9/2017
- “Prevalence and Risk Factors of CoronaVac Side Effects: An Independent Cross-Sectional Study among Healthcare Workers in Turkey”
by Abanoub Riad, Derya Sağıroğlu, Batuhan Üstün, Andrea Pokorná, Jitka Klugarová, Sameh Attia and Miloslav Klugar
Clin. Med. 2021, 10(12), 2629; https://doi.org/10.3390/jcm10122629
Avaliable online: https://www.mdpi.com/2077-0383/10/12/2629
- “Predictive Value of Comorbid Conditions for COVID-19 Mortality”
by Iosif Marincu, Felix Bratosin, Iulia Vidican, Andra-Cristina Bostanaru, Stefan Frent, Bianca Cerbu, Mirela Turaiche, Livius Tirnea and Madalina Timircan
Clin. Med. 2021, 10(12), 2652; https://doi.org/10.3390/jcm10122652
Avaliable online: https://www.mdpi.com/2077-0383/10/12/2652
- “The Role of Neuropilin-1 (NRP-1) in SARS-CoV-2 Infection: Review”
by Monika Gudowska-Sawczuk and Barbara Mroczko
Clin. Med. 2021, 10(13), 2772; https://doi.org/10.3390/jcm10132772
Avaliable online: https://www.mdpi.com/2077-0383/10/13/2772
- “COVID-19 and the Endocrine System: A Comprehensive Review on the Theme”
by Giuseppe Lisco, Anna De Tullio, Assunta Stragapede, Antonio Giovanni Solimando, Federica Albanese, Martina Capobianco, Vito Angelo Giagulli, Edoardo Guastamacchia, Giovanni De Pergola, Angelo Vacca et al.
Clin. Med. 2021, 10(13), 2920; https://doi.org/10.3390/jcm10132920
Avaliable online: https://www.mdpi.com/2077-0383/10/13/2920
- “Long-Term Outcomes of Patients with Coronavirus Disease 2019 at One Year after Hospital Discharge”
by Modesto M. Maestre-Muñiz, Ángel Arias, Emilia Mata-Vázquez, María Martín-Toledano, Germán López-Larramona, Ana María Ruiz-Chicote, Bárbara Nieto-Sandoval and Alfredo J. Lucendo
Clin. Med. 2021, 10(13), 2945; https://doi.org/10.3390/jcm10132945
Avaliable online: https://www.mdpi.com/2077-0383/10/13/2945
- “One Year after Mild COVID-19: The Majority of Patients Maintain Specific Immunity, But One in Four Still Suffer from Long-Term Symptoms”
by Andreas Rank, Athanasia Tzortzini, Elisabeth Kling, Christoph Schmid, Rainer Claus, Eva Löll, Roswitha Burger, Christoph Römmele, Christine Dhillon, Katharina Müller et al.
Clin. Med. 2021, 10(15), 3305; https://doi.org/10.3390/jcm10153305
Avaliable online: https://www.mdpi.com/2077-0383/10/15/3305
- “Ambulatory COVID-19 Patients Treated with Lactoferrin as a Supplementary Antiviral Agent: A Preliminary Study”
by Luigi Rosa, Giovanni Tripepi, Enrico Naldi, Marina Aimati, Stefano Santangeli, Francesco Venditto, Marcello Caldarelli and Piera Valenti
Clin. Med. 2021, 10(18), 4276; https://doi.org/10.3390/jcm10184276
Avaliable online: https://www.mdpi.com/2077-0383/10/18/4276
- “A Systematic Review of Persistent Symptoms and Residual Abnormal Functioning following Acute COVID-19: Ongoing Symptomatic Phase vs. Post-COVID-19 Syndrome”
by Glenn Jennings, Ann Monaghan, Feng Xue, David Mockler and Román Romero-Ortuño
Clin. Med. 2021, 10(24), 5913; https://doi.org/10.3390/jcm10245913
Avaliable online: https://www.mdpi.com/2077-0383/10/24/5913
- “Prognostic Factors for Post-COVID-19 Syndrome: A Systematic Review and Meta-Analysis”
by Giuseppe Maglietta, Francesca Diodati, Matteo Puntoni, Silvia Lazzarelli, Barbara Marcomini, Laura Patrizi and Caterina Caminiti
Clin. Med. 2022, 11(6), 1541; https://doi.org/10.3390/jcm11061541
Avaliable online: https://www.mdpi.com/2077-0383/11/6/1541
- “Neutrophil-to-Lymphocyte Ratio (NLR) Is a Promising Predictor of Mortality and Admission to Intensive Care Unit of COVID-19 Patients”
by Matteo Regolo, Mauro Vaccaro, Alessandra Sorce, Benedetta Stancanelli, Michele Colaci, Giuseppe Natoli, Mario Russo, Innocenza Alessandria, Massimo Motta, Nicola Santangelo et al.
Clin. Med. 2022, 11(8), 2235; https://doi.org/10.3390/jcm11082235
Avaliable online: https://www.mdpi.com/2077-0383/11/8/2235
10 May 2023
Meet Us at the ATS (American Thoracic Society) Conference 2023, 21–23 May 2023, Washington DC, USA

Conference: ATS (American Thoracic Society) Conference 2023
Date: 21–23 May 2023
Location: Washington DC, USA
MDPI will be attending ATS 2023 as an exhibitor; we welcome researchers from different backgrounds to visit and share their latest ideas with us.
This conference has been organized by the American Thoracic Society, and it will showcase the latest advances and discoveries in respiratory science, patient care and global respiratory health. At the conference, specialists will share and discuss the latest research and its applications to clinical, basic, and translational science in pulmonary, critical care, and sleep medicine.
The following MDPI journals will be represented:
- JCM;
- Medicina;
- Clinics and Practice;
- JPM;
- Cancers;
- Medicines;
- Healthcare;
- Metabolites;
- Children;
- Brain Sciences.
If you are planning to attend this conference, please do not hesitate to talk with us online. Our delegates look forward to meeting you in person at booth #2606, and answering any questions that you may have. For more information about the conference, please visit the following website: https://conference.thoracic.org/.
5 May 2023
Meet Us at the 20th International Congress of the European Society for Child and Adolescent Psychiatry (ESCAP 2023), 29 June–1 July 2023, Copenhagen, Denmark

Conference: 20th International Congress of the European Society for Child and Adolescent Psychiatry (ESCAP 2023)
Date: 29 June–1 July 2023
Location: Copenhagen, Denmark
MDPI will be attending ESCAP 2023 as an exhibitor; we welcome researchers from different backgrounds to visit and share their latest ideas with us.
This conference is organized by the European Society for Child and Adolescent Psychiatry. The theme of the conference is “Mental health of children and adolescents”. At the conference, specialists will share and discuss the latest research and applications of environmental and chemical substances in relation to society.
The following MDPI journals will be represented:
If you are planning to attend this conference, please do not hesitate to start an online conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://www.escap2023.eu/.
21 April 2023
Journal of Clinical Medicine Webinar | The Future of COVID-19 mRNA Vaccines: Focus on Innate Immunity, 10 May 2023
COVID-19 mRNA vaccines saved millions of lives during the pandemic crisis by efficiently protecting against the severe forms of the disease. However, they were much less efficient in protecting against the infection itself and viral transmission. Furthermore, the immunity induced by these vaccines proved to wane relatively rapidly. To understand these features and possibly improve the efficacy and safety of mRNA vaccines, it is critical to obtain insight into their action on the innate immune system.
During this webinar, we will first review the current knowledge on adjuvants included in protein-based vaccines and their action on the innate immune system. We will then discuss how lipid nanoparticles and nucleoside-modified mRNA—the two major components of currently approved mRNA vaccines—contribute to the activation of the innate immune system required for the induction of protective immunity. Finally, we will consider the consequences of this activation on the immune defenses against other pathogens through the phenomenon of trained immunity.
Date: 10 May 2023 at 10:00 a.m. CEST | 4:00 a.m. EST | 3:00 a.m. CST Asia
Webinar ID: 871 5675 7294
Register now for free!
Speaker/Presentation |
Time in CEST |
Time in EST |
Prof. Dr. Michel Goldman |
10:00—10:05 a.m. |
4:00—4:05 a.m. |
Dr. Nathalie Garçon |
10:05—10:35 a.m. |
4:05—4:35 a.m. |
Dr. Rein Verbeke |
10:35—11:05 a.m. |
4:35—5:05 a.m. |
Dr. Mihai Netea |
11:05—11:35 a.m. |
5:05—5:35 a.m. |
Q&A Session |
11:35—11:55 a.m. |
5:35—5:55 a.m. |
Prof. Michel Goldman |
11:55—12:00 p.m. |
5:55—6:00 a.m. |
Webinar Chairs and Keynote Speakers:
Prof. Dr. Michel Goldman (Chair), Institute for Interdisciplinary Innovation in healthcare, Université libre de Bruxelles, Brussels, Belgium
Dr. Nathalie Garçon (Co-Chair), N3J Consulting, Belgium
Dr. Rein Verbeke, 1 Ghent Research Group on Nanomedicines, Ghent University, Ghent, Belgium; 2 Cancer Research Institute Ghent (CRIG), Ghent, Belgium
Dr. Mihai Netea, 1 Department of Internal Medicine, Radboud Institute of Molecular Life Sciences (RIMLS) and Radboudumc Center for Infectious Diseases (RCI), Radboud University Medical Center, Nijmegen, The Netherlands; 2Department of Immunology and Metabolism, Life and Medical Sciences Institute, University of Bonn, 53115 Bonn, Germany
Relevant Special Issue:
“Learning from COVID-19 Vaccines”
Guest Editor: Prof. Dr. Michel Goldman
After registering, you will receive a confirmation email containing information on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.
Unable to attend? Register anyway and we will let you know when the recording is available to watch.
21 April 2023
Journal of Clinical Medicine | Issue Cover Articles in 2022
The articles below have been selected as 2022 Issue Cover Articles by the Editorial Office of the Journal of Clinical Medicine (ISSN: 2077-0383). These articles are from multiple fields within the scope of the Journal of Clinical Medicine, and we hope they can provide insights and references for scholars in related fields.
![]() |
1. “Iron Deficiency in Heart Failure: Mechanisms and Pathophysiology” by Ridha I. S. Alnuwaysir, Martijn F. Hoes, Dirk J. van Veldhuisen, Peter van der Meer and Niels Grote Beverborg J. Clin. Med. 2022, 11(1), 125; https://doi.org/10.3390/jcm11010125 Available online: https://www.mdpi.com/2077-0383/11/1/125 |
![]() |
2. “Peroral Cholangioscopy-Guided Targeted Biopsy versus Conventional Endoscopic Transpapillary Forceps Biopsy for Biliary Stricture with Suspected Bile Duct Cancer” by Katsunori Sekine, Ichiro Yasuda, Shinpei Doi, Noriyuki Kuniyoshi, Takayuki Tsujikawa, Yuichi Takano, Masatoshi Mabuchi, Kosuke Takahashi, Masashi Kawamoto, Mikiko Takahashi et al. J. Clin. Med. 2022, 11(2), 289; https://doi.org/10.3390/jcm11020289 Available online: https://www.mdpi.com/2077-0383/11/2/289 |
![]() |
3. “Cell Death in AMD: The Rationale for Targeting Fas” by David N. Zacks, Andrew J. Kocab, Joanne J. Choi, Meredith S. Gregory-Ksander, Marisol Cano and James T. Handa J. Clin. Med. 2022, 11(3), 592; https://doi.org/10.3390/jcm11030592 Available online: https://www.mdpi.com/2077-0383/11/3/592 |
![]() |
4. “Comparison of Ultra-Wide Field Photography to Ultra-Wide Field Angiography for the Staging of Sickle Cell Retinopathy” by Héloise Torres-Villaros, Franck Fajnkuchen, Fatima Amari, Lucie Janicot and Audrey Giocanti-Aurégan J. Clin. Med. 2022, 11(4), 936; https://doi.org/10.3390/jcm11040936 Available online: https://www.mdpi.com/2077-0383/11/4/936 |
![]() |
5. “Mitral Paravalvular Leak: Clinical Implications, Diagnosis and Management” by Ignacio Cruz-Gonzalez, Pablo Antunez-Muiños, Sergio Lopez-Tejero and Pedro L. Sanchez J. Clin. Med. 2022, 11(5), 1245; https://doi.org/10.3390/jcm11051245 Available online: https://www.mdpi.com/2077-0383/11/5/1245 |
![]() |
6. “Comparison in Short-Term Safety and Efficacy between New-Generation WATCHMAN FLX and Conventional WATCHMAN 2.5 for Percutaneous Left Atrial Appendage Closure” by Nobuyuki Fukuda, Teruhiko Imamura, Shuhei Tanaka, Naoya Kataoka, Ryuichi Ushijima, Hiroshi Ueno and Koichiro Kinugawa J. Clin. Med. 2022, 11(6), 1618; https://doi.org/10.3390/jcm11061618 Available online: https://www.mdpi.com/2077-0383/11/6/1618 |
![]() |
7. “Ablation Index Predicts Successful Ablation of Focal Atrial Tachycardia: Results of a Multicenter Study” by Paolo Compagnucci, Antonio Dello Russo, Marco Bergonti, Matteo Anselmino, Giulio Zucchelli, Alessio Gasperetti, Laura Cipolletta, Giovanni Volpato, Ciro Ascione, Federico Ferraris et al. J. Clin. Med. 2022, 11(7), 1802; https://doi.org/10.3390/jcm11071802 Available online: https://www.mdpi.com/2077-0383/11/7/1802 |
![]() |
8. “Treatment of Transthyretin Amyloid Cardiomyopathy: The Current Options, the Future, and the Challenges” by Carsten Tschöpe and Ahmed Elsanhoury J. Clin. Med. 2022, 11(8), 2148; https://doi.org/10.3390/jcm11082148 Available online: https://www.mdpi.com/2077-0383/11/8/2148 |
![]() |
9. “Clinical Developmental Cardiology for Understanding Etiology of Congenital Heart Disease” by Hiroyuki Yamagishi J. Clin. Med. 2022, 11(9), 2381; https://doi.org/10.3390/jcm11092381 Available online: https://www.mdpi.com/2077-0383/11/9/2381 |
![]() |
10. “Multimodality Imaging in the Study of the Left Atrium” by Sergio Moral, Marc Abulí, Pau Vilardell, Emilce Trucco, Esther Ballesteros and Ramon Brugada J. Clin. Med. 2022, 11(10), 2854; https://doi.org/10.3390/jcm11102854 Available online: https://www.mdpi.com/2077-0383/11/10/2854 |
![]() |
11. “Pre-Interventional 3D-Printing-Assisted Planning of Flow Disrupter Implantation for the Treatment of an Intracranial Aneurysm” by Guillaume Charbonnier, Panagiotis Primikiris, Benjamin Billottet, Aurélien Louvrier, Sergio Vancheri, Serine Ferhat and Alessandra Biondi J. Clin. Med. 2022, 11(11), 2950; https://doi.org/10.3390/jcm11112950 Available online: https://www.mdpi.com/2077-0383/11/11/2950 |
![]() |
12. “Primary Orbital Reconstruction with Selective Laser Melting (SLM) of Patient-Specific Implants (PSIs): An Overview of 96 Surgically Treated Patients” by Majeed Rana, Henriette L. Moellmann, Lara Schorn, Julian Lommen, Madiha Rana, Max Wilkat and Karsten Hufendiek J. Clin. Med. 2022, 11(12), 3361; https://doi.org/10.3390/jcm11123361 Available online: https://www.mdpi.com/2077-0383/11/12/3361 |
![]() |
13. “Effect of Pneumococcal Vaccine on Mortality and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis” by Vikash Jaiswal, Song Peng Ang, Kriti Lnu, Angela Ishak, Nishan Babu Pokhrel, Jia Ee Chia, Adrija Hajra, Monodeep Biswas, Andrija Matetic, Ravinder Dhatt et al. J. Clin. Med. 2022, 11(13), 3799; https://doi.org/10.3390/jcm11133799 Available online: https://www.mdpi.com/2077-0383/11/13/3799 |
![]() |
14. “Impact of COVID-19 on Subclinical Placental Thrombosis and Maternal Thrombotic Factors” by Marie Carbonnel, Camille Daclin, Morgan Tourne, Emmanuel Roux, Mathilde Le-Marchand, Catherine Racowsky, Titouan Kennel, Eric Farfour, Marc Vasse and Jean-Marc Ayoubi J. Clin. Med. 2022, 11(14), 4067; https://doi.org/10.3390/jcm11144067 Available online: https://www.mdpi.com/2077-0383/11/14/4067 |
![]() |
15. “Sex/Gender- and Age-Related Differences in β-Adrenergic Receptor Signaling in Cardiovascular Diseases” by Daniela Liccardo, Beatrice Arosio, Graziamaria Corbi and Alessandro Cannavo J. Clin. Med. 2022, 11(15), 4280; https://doi.org/10.3390/jcm11154280 Available online: https://www.mdpi.com/2077-0383/11/15/4280 |
![]() |
16. “State-of-the-Art Multimodality Imaging in Sudden Cardiac Arrest with Focus on Idiopathic Ventricular Fibrillation: A Review” by Lisa M. Verheul, Sanne A. Groeneveld, Feddo P. Kirkels, Paul G. A. Volders, Arco J. Teske, Maarten J. Cramer, Marco Guglielmo and Rutger J. Hassink J. Clin. Med. 2022, 11(16), 4680; https://doi.org/10.3390/jcm11164680 Available online: https://www.mdpi.com/2077-0383/11/16/4680 |
![]() |
17. “Carbon Fiber Implants in Orthopaedic Oncology” by Caleb M. Yeung, Abhiram R. Bhashyam, Shalin S. Patel, Eduardo Ortiz-Cruz and Santiago A. Lozano-Calderón J. Clin. Med. 2022, 11(17), 4959; https://doi.org/10.3390/jcm11174959 Available online: https://www.mdpi.com/2077-0383/11/17/4959 |
![]() |
18. “Acute Idiopathic Blind Spot Enlargement Syndrome—New Perspectives in the OCT Era” by Julian A. Zimmermann, Nicole Eter and Julia Biermann J. Clin. Med. 2022, 11(18), 5278; https://doi.org/10.3390/jcm11185278 Available online: https://www.mdpi.com/2077-0383/11/18/5278 |
![]() |
19. “Use of Neuronavigation and Augmented Reality in Transsphenoidal Pituitary Adenoma Surgery” by Miriam H. A. Bopp, Benjamin Saß, Mirza Pojskić, Felix Corr, Dustin Grimm, André Kemmling and Christopher Nimsky J. Clin. Med. 2022, 11(19), 5590; https://doi.org/10.3390/jcm11195590 Available online: https://www.mdpi.com/2077-0383/11/19/5590 |
![]() |
20. “Arthritis in Systemic Lupus Erythematosus: From 2022 International GISEA/OEG Symposium” by Fulvia Ceccarelli, Marcello Govoni, Matteo Piga, Giulia Cassone, Francesco Paolo Cantatore, Giulio Olivieri, Alberto Cauli, Ennio Giulio Favalli, Fabiola Atzeni, Elisa Gremese et al. J. Clin. Med. 2022, 11(20), 6016; https://doi.org/10.3390/jcm11206016 Available online: https://www.mdpi.com/2077-0383/11/20/6016 |
![]() |
21. “Endometriosis in Patients with Mayer-Rokitansky-Küster-Hauser-Syndrome—Histological Evaluation of Uterus Remnants and Peritoneal Lesions and Comparison to Samples from Endometriosis Patients without Mullerian Anomaly” by Sahra Steinmacher, Hans Bösmüller, Massimo Granai, André Koch, Sara Yvonne Brucker and Kristin Katharina Rall J. Clin. Med. 2022, 11(21), 6458; https://doi.org/10.3390/jcm11216458 Available online: https://www.mdpi.com/2077-0383/11/21/6458 |
![]() |
22. “Embolization in Pediatric Patients: A Comprehensive Review of Indications, Procedures, and Clinical Outcomes” by Paolo Marra, Barbaro Di Fazio, Ludovico Dulcetta, Francesco Saverio Carbone, Riccardo Muglia, Pietro Andrea Bonaffini, Clarissa Valle, Fabio Corvino, Francesco Giurazza, Giuseppe Muscogiuri et al. J. Clin. Med. 2022, 11(22), 6626; https://doi.org/10.3390/jcm11226626 Available online: https://www.mdpi.com/2077-0383/11/22/6626 |
![]() |
23. “Risk Factors for Rapid Recurrence of Hyperkalemia following Cessation of Sodium Zirconium Cyclosilicate” by Teruhiko Imamura, Nikhil Narang and Koichiro Kinugawa J. Clin. Med. 2022, 11(23), 7096; https://doi.org/10.3390/jcm11237096 Available online: https://www.mdpi.com/2077-0383/11/23/7096 |
![]() |
24. “Impact of Urinary Incontinence on Physical Function and Respiratory Muscle Strength in Incontinent Women: A Comparative Study between Urinary Incontinent and Apparently Healthy Women” by Sirine Abidi, Amine Ghram, Sameh Ghroubi, Said Ahmaidi, Mohamed Habib Elleuch, Olivier Girard, Theodoros Papasavvas, Jari Laukkanen, Helmi Ben Saad, Beat Knechtle et al. J. Clin. Med. 2022, 11(24), 7344; https://doi.org/10.3390/jcm11247344 Available online: https://www.mdpi.com/2077-0383/11/24/7344 |
30 March 2023
Meet Us at the 29th Congress of the European Association for Cancer Research, 12–15 June 2023, Torino, Italy

Conference: 29th Congress of the European Association for Cancer Research
Date: 12–15 June 2023
Place: Torino, Italy
MDPI will be attending the 29th Congress of the European Association for Cancer Research, held in Torino, Italy, from 12 to 15 June 2023. This conference aims to achieve an in-depth exchange of the latest research results in the field of basic research, clinical application, cutting-edge technology, and industrial development in the field of cancer research over the year. During this conference, MDPI will welcome researchers from different backgrounds to visit and share their latest ideas with us.
The following MDPI journals will be represented:
- Cells;
- Cancers;
- Children;
- CIMB;
- Current Oncology;
- Diagnostics;
- Geriatrics;
- Healthcare;
- JCM;
- Medical Sciences.
If you are attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit https://www.eacr2023.org/.
29 March 2023
Meet Us at the 19th World Congress of Basic & Clinical Pharmacology 2023, 2–7 July 2023, Glasgow, Scotland

This conference organized by the British Pharmacological Society and International Union of Basic and Clinical Pharmacologists (IUPHAR) will be held in Glasgow, Scotland, from 2 July to 7 July 2023. The topic of the conference focuses on pharmacology and drug discovery, research, and development, and the conference will include six days of symposia, keynote lectures, workshops, and debates. Discover the latest in pharmacology research and developments across 10 content themes.
Pharmaceuticals (ISSN: 1424-8247) is a peer-reviewed, open access journal of medicinal chemistry and related drug sciences, published monthly online by MDPI. Pharmaceuticals will participate in this event as an exhibitor together with nine other MDPI journals, among which Pharmaceuticals, Journal of Personalized Medicine and Biomedicines will have journal representatives at our booth.
The following MDPI journals will be represented:
- Pharmaceuticals (leading journal);
- Biomedicines;
- JPM;
- JCM;
- Marine Drugs;
- Children;
- Current Oncology;
- BioMedInformatics;
- JoX;
- Rheumato.
If you are attending this conference, please feel free to start a conversation with us at our booth #A22. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit https://wcp2023.org/ or contact the Pharmaceuticals Editorial Office at [email protected].
16 March 2023
Meet Us at the Chinese Academic Conference on Tumor Biomarker, 7–9 April 2023, Shanghai, China

MDPI will be attending the Chinese Academic Conference on Tumor Biomarker, held in Shanghai, China, from 7 to 9 April 2023. This conference aims to achieve an in-depth exchange of the latest research results in the field of basic research, clinical application, cutting-edge technology, and industrial development in the field of tumor markers over the year. During this conference, MDPI will welcome researchers from different backgrounds to visit and share their latest inspirations with us.
The following MDPI journals will be represented:
- Biomedicines;
- Cancers;
- Cells;
- Diagnostics;
- Current Oncology;
- JPM;
- JCM;
- Onco;
- CIMB;
- BioMedInformatics.
If you plan on attending this conference, feel free to stop by our booth, #B155. Our delegates look forward to meeting you in person to answer any questions you may have.
For more information about the conference, please follow the link below: https://biomarker2022.sciconf.cn/cn/web/index/13496.
13 March 2023
MDPI’s Newly Launched Journals in December 2022
As a leading open access publisher, MDPI provides scholars with a high-quality and rich academic exchange platform by continuously expanding into new and exciting research areas.
In December 2022, MDPI launched five new journals, covering multiple subjects such as life sciences, biology, medicine and pharmacology, social sciences and humanities. These new journals are being edited by established scholars across the world.
Journal |
Founding Editor-in-Chief |
Journal Topics (Selected) |
Prof. Dr. Fabio Gresta, University of Messina, Italy| Editorial | view inaugural issue |
grass/forage/turf production; grassland management; pasture monitoring; grazing and livestock; grass agro-ecosystems| view journal scope | submit an article |
|
Prof. Dr. Christos G. Athanassiou, University of Thessaly, Greece| Editorial | view inaugural issue |
pesticides; fungicides; herbicides; fertilizers; soil conditioners| view journal scope | submit an article |
|
Prof. Dr. Stephen H. Safe, Texas A&M University, USA| Editorial | view inaugural issue |
receptor structure; receptor function; receptor signaling; receptor expression and regulation; receptor interactions with drugs| view journal scope | submit an article |
|
Dr. Jean Jacques Vanden Eynde, University of Mons-UMONS, Belgium| Editorial | view inaugural issue |
drug discovery; medicinal chemistry; preclinical and clinical research; marketed drugs; intellectual property and regulatory affairs| view journal scope | submit an article |
|
Prof. Dr. Heather Kanuka, University of Alberta, Canada| Editorial | view inaugural issue |
higher education; tertiary education; policy and practice in higher education; educational leadership in higher education; educational administration and management in higher education| view journal scope | submit an article |
If you are interested in creating more open access journals with us to publish cutting-edge research, please send your journal proposal application to [email protected].
7 March 2023
Displaying Co-Authors’ Email Addresses on the Webpage of Published Papers
MDPI is pleased to announce that we now display the co-authors’ email addresses in addition to the corresponding author’s email address on the webpage of published papers, protected by Captcha. For more information about this change, please visit the journal’s instructions for authors page.
We believe this change will facilitate academic discussions and advance our cause of open science and research. The corresponding authors are responsible for communicating with their co-authors and indicating in our system (https://susy.mdpi.com/) if co-authors would prefer for their email addresses not to be displayed.
21 February 2023
Meet Us at the 143rd Annual Meeting of the Pharmaceutical Society of Japan, 25–28 March 2023, Sapporo, Japan

Conference: 143rd Annual Meeting of the Pharmaceutical Society of Japan
Date: 25–28 March 2023
Place: Sapporo, Japan
MDPI will be attending the 143rd Annual Meeting of the Pharmaceutical Society of Japan as the exhibitor. This meeting will be held at Hokkaido University, Sapporo, Japan, from 25 to 28 March 2023. The organizing committee comprises the Faculty of Pharmaceutical Sciences, Hokkaido University. The theme of the 143rd annual meeting is "PharmaScience: Integration for Breakthroughs". Through this meeting, we wish to contribute to the progress of research leading to the development of innovative drugs and therapies by bringing together researchers from various research fields.
The following MDPI journals will be represented:
If you are attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit https://confit.atlas.jp/guide/event/pharm143/top.
16 February 2023
Increasing Visibility for Preprints.org – Clarivate adds the Preprint Citation Index to the Web of Science

On 9 February 2023, Clarivate, a global leader in providing trusted insights and analytics, added the Preprint Citation Index to the Web of Science platform, streamlining the research process by allowing researchers to locate and link to preprints alongside other trusted content in the database.
The Preprint Citation Index will act as a bridge to connect cutting-edge preprints with peer-reviewed journal articles published within the Web of Science Core Collection. Alerts can be easily set to monitor new research across several repositories and authors will also be able to include preprints on their Web of Science Research Profile to more accurately display their various research outputs.
As of its launch, the Preprint Citation Index will provide nearly two million preprints from various repositories, including MDPI’s own Preprints.org.
MDPI's Preprints Platform – Preprints.org
To advance Open Science and the fast dissemination of research, MDPI offers researchers a free multidisciplinary preprint platform. Preprints.org accepts submissions from all research areas and offers authors high visibility, permanent archiving, article-level Metrics and immediately citable content by assigning a Digital Object Identifier (DOI) to all preprints.
During submission to any MDPI journal, authors have the option to share their research as a preprint. After an initial screening, the manuscript is available online in 48 hours or less. Once online, preprints can be downloaded, shared, commented on, and cited, providing authors maximum visibility.
We invite you to join the ranks of the over 100k researchers using Preprints.org and share your research.
For more information, please visit Preprints.org.
17 January 2023
Journal of Clinical Medicine | New Section “Clinical Pediatrics” Established
The Journal of Clinical Medicine (ISSN: 2077-0383) editorial team is pleased to announce the launch of a new Section, “Clinical Pediatrics”. The aim of this Section is to offer a platform for pediatric clinicians, physicians, and healthcare professionals to present cutting-edge basic and applied health research and quality clinical services in general and specialty pediatrics. We sincerely welcome your submission to the journal. Our readers are waiting for your contribution in original research on managing health and diagnosing and treating disorders in infants, children, and adolescents. Manuscripts can focus on research, practice, education, administration, or policy.
Topics could include but are not limited to the following:
- Neonatal medicine;
- Genetic and congenital conditions;
- Developmental–behavioral medicine;
- Pediatric surgery;
- Pediatric cardiology;
- Pediatric nephrology;
- Pediatric dermatology;
- Pediatric orthopedics;
- Pediatric stomatology;
- Pediatric infectious diseases;
- Pediatric pulmonary;
- Child and adolescent psychiatry;
- Pediatric neurology;
- Pediatric ophthalmology;
- Childhood cancer;
- Pediatric allergy and immunology;
- Pediatric endocrinology;
- Pediatric gastroenterology.
We are currently recruiting Editorial Board Members (EBMs) for this Section. If you are an active researcher in this field and are passionate about publishing cutting-edge research, please contact us at [email protected]. Alternatively, you may wish to submit your work directly via the following link: https://susy.mdpi.com/user/manuscripts/upload/b407bd95154eb0a526717b8543b30b25?&journal=jcm.
JCM Editorial Office
22 December 2022
Special Issue Mentor Program
We are pleased to announce the launch of a new initiative—the MDPI Special Issue Mentor Program.
This program will enable early career researchers (who must hold a Ph.D. in a related field) to experience editing a Special Issue in MDPI journals, under the mentorship of our experienced Editorial Board Members or other experienced scientists. The mentor program will provide an excellent opportunity for early career scientists to gain editorial experience, and to cultivate their ability to edit scientific research.
The mentee’s responsibilities include:
- Proposing a Special Issue title and assisting the mentor in preparing a summary (around 200–400 words) and 3–10 keywords describing the background, importance, and goal of the Issue;
- Writing a brief promotion plan for the Special Issue;
- Preparing a list of scholars who may be interested in the Issue and personally e-mailing invitations on behalf of Guest Editors;
- Writing an editorial for the online Special Issue together with the mentor.
The mentor’s responsibilities include:
- Conducting a final check before the Special Issue is published online;
- Performing editorial control of the Special Issue and quality control of the publications, both of which must be carried out in a timely manner;
- Providing suggestions to younger scholars if they have any doubts or concerns regarding submissions;
- Organizing video calls with young scholars and the Editorial Office regularly to discuss problems and improvement suggestions for the Special Issue;
- Making and submitting decisions regarding submissions with the assistance of mentees.
Certificates and awards:
After the Special Issue closes, the Editorial Office will provide official certificates for all the mentors and early career researchers.
If you are interested in this opportunity, please send your Special Issue proposal to the Editorial Office of a journal you choose, and we will discuss the process (i.e., mentor collaboration, Special Issue topic feasibility analysis, etc.) in further detail. The full list of MDPI journals is as follows: https://www.mdpi.com/about/journals.
In addition to the new Special Issue Mentor Program, we will continue to welcome all Special Issue proposals focusing on hot research topics.
14 December 2022
"Thanks a Million!" – One Million Articles Published in MDPI Journals
MDPI has just become the first open access (OA) publisher to reach the milestone of one million articles published. That is one million articles freely available to all, to circulate and build upon! We are proud to share this special moment with the global scientific community.
This landmark has been reached thanks to the immeasurable support of more than 600,000 expert reviewers, 66,000 editorial board members and 6700 hard-working colleagues across MDPI’s global offices.
Within more than 25 years of publishing, our journals received 2.1 million manuscripts and generated 4.6 million peer review reports to get to one million papers published.
Reaching the milestone of one million articles published reinforces our mission to remove any existing barriers and to make scientific research accessible to all. Since its inception, MDPI’s goal has been to create reliable processes to make science open. This is a path towards facilitating the dissemination of novel insights in scientific communities.
Regular feedback from authors and reviewers shows that our service is greatly appreciated and needed. At the same time, the feedback helps us identify areas for further improvement.
As it stands, a significant share of published research findings remain closed access. More than half of the content published with the most well-known legacy publishers stays behind a paywall, and that is not including articles published in hybrid OA journals, or made available months or years after publication.
A new policy announced by the US administration in August 2022 requires that, as of January 2026, all US federally funded research be made freely and immediately available after publication. While the new policy does not mandate articles be published under an open access license, it is aligned with the open access movement in removing all barriers to research. Similarly, some of the most advanced research institutions in the world intend to have all funded research articles published in open access by 2025.
MDPI is proud to be the leading agent of the transition to open access.
"Thanks a Million" to all the contributors!
8 December 2022
MDPI Sustainability Foundation: New Look and Nominations for the 2023 Sustainability Awards Now Open
We are pleased to announce that the website of the MDPI Sustainability Foundation has been revamped! For the past couple of months, our UX UI team and front-end developers have been working hard to launch the website in time for the opening of the Sustainability Awards nominations.
The website is not the only thing that has had a remodeling. Indeed, the format of the Emerging Sustainability Leader Award (ESLA) has been updated. ESLA is now a competition open to individual researchers or start-ups founded by researchers under the age of 35. Nominee applications will go through 2 rounds of selection until the final 3 are decided. The finalists will then be invited to give pitch presentations during the Award Ceremony to win either first place (10,000 USD) or runner-up (2 x 5000 USD).
The World Sustainability Award, on the other hand, remains the same: a total prize money of 100,000 USD is up for grabs by senior individual researchers or groups of researchers from the international research community.
Nominations for both the World Sustainability Award and the Emerging Sustainability Leader award are now open! Check out our new website for more information on how to nominate.
29 November 2022
Editorial Board Members from the Journal of Clinical Medicine Featured in the 2022 Highly Cited Researchers List Published by Clarivate
Recently, ClarivateTM revealed its 2022 list of Highly Cited ResearchersTM—individuals at universities, research institutes and commercial organizations.
The scientists who were selected into this year’s list of Highly Cited Researchers have published highly cited papers in the 11-year period from January 2011 to December 2021, with citation frequency in the top 1% of academic subjects and the same year of publication in the Web of ScienceTM database. Based on Web of Science Citation data, 6,938 researchers from across the globe who have demonstrated a disproportionate level of significant and broad influence in their chosen field or fields over the last decade have been awarded Highly Cited Researcher 2022 designations. The list is truly global, spanning 69 countries or regions and spread across a diverse range of research sciences and social sciences.
According to statistics, eight members of the Editorial Board of the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) have been selected into the list of Highly Cited Researchers of Clarivate in 2022. They are being recognized for their high-quality scientific research achievements and outstanding contributions to professional fields. The JCM journal office sincerely congratulates all elected Editorial Board Members and hopes that they continue to have an academically productive relationship with the journal.
Name |
Affiliation |
Prof. Dr. Aldo Pietro Maggioni |
Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO), Italy |
Prof. Dr. Laurent Peyrin-Biroulet |
Universite de Lorraine, France |
Dr. Holger Thiele |
University of Leipzig, Germany |
Dr. Peng Huang |
Shenzhen University, China Mainland |
Dr. Francesco Landi |
Catholic University of the Sacred Heart, Italy |
Dr. Francesc Graus |
University of Barcelona, Spain |
Prof. Dr. Hans-Peter Hartung |
Heinrich Heine University Dusseldorf, Germany |
Prof. Dr. Antonio Vita |
University of Brescia, Italy |
22 November 2022
Journal of Clinical Medicine | Special Issue Mentor Program

We are pleased to announce the launch of a new initiative—the Special Issue Mentor Program.
This program will enable early career researchers (required to hold a Ph.D. in a related field) to gain experience editing a Special Issue in MDPI journals under the mentorship of our experienced Editorial Board Members or other experienced scientists. The mentor program will provide an excellent opportunity for early career scientists to cultivate their ability to edit and process scientific research.
The mentee’s responsibilities include:
- Proposing a Special Issue title and, with the assistance of the mentor, preparing a summary (around 200–400 words) and 3–10 keywords describing the background, importance, and goal of the Issue;
- Writing a brief promotion plan for the Special Issue;
- Preparing a list of scholars who may be interested in the Issue and personally e-mailing the invitations on behalf of Guest Editors;
- Writing an editorial for the online Special Issue together with the mentor.
The mentor’s responsibilities include:
- Conducting a final check before the Special Issue is published online;
- Performing editorial control of the Special issue and quality control of the publications in a timely manner;
- Providing suggestions to younger scholars if they have any doubts or concerns regarding submissions;
- Organizing video calls with young scholars and the Editorial office regularly to discuss problems and improvement suggestions for the Special Issue.
- Making and submitting decisions for the submissions under the assistance of mentees.
Certificates and Awards:
After the Special Issue closes, the Editorial Office will provide official certificates for all the mentors and early career researchers.
If you are interested in this opportunity, please send your Special Issue proposal to the Journal of Clinical Medicine Editorial Office ([email protected]), and we will discuss the process (i.e., mentor collaboration, Special Issue topic feasibility analysis, etc.) in further detail.
In addition to the new Special Issue Mentor Program, the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) will continue to welcome all Special Issue proposals focusing on hot research topics.
4 November 2022
Meet Us at the 27th Congress of the Chinese Pediatric Society, 15–18 December 2022, Changsha, China
MDPI will be attending the 27th Congress of the Chinese Pediatric Society, held in Changsha, China, from 15–18 December 2022.
The following MDPI journals will be represented:
- Children (leading journal);
- JPM;
- Medicina;
- Audiology Research;
- JCM;
- Healthcare;
- Diagnostics;
- Metabolites;
- Cancers;
- Nutrients.
If you plan on attending this conference, feel free to stop by our booth: #B67. Our delegates look forward to meeting you in person to answer any questions that you may have.
For more information about the conference, please see the following link: https://nccps2022.tiemeeting.com/CN.
21 October 2022
Meet Us at the 15th European Public Health Conference 2022, 9–12 November 2022, Berlin, Germany

MDPI will be attending the 15th European Public Health Conference 2022, held in Berlin, Germany, from 9 to 12 November 2022. The theme of Berlin 2022 is “Strengthening Health Systems: Improving Population Health and Being Prepared for the Unexpected”. This conference will aim to explore ways in which the public health community can rally around the principle of bringing about better population health. Meanwhile, the conference committee wants the discussions at the 15th EPH Conference to contribute to resilient health systems, universal health coverage (UHC), a well-trained and highly qualified clinical and public health workforce, and governance structures that take a stand and shape health systems globally.
During this conference, MDPI (at booth #13) will welcome researchers from different backgrounds to visit and share their latest ideas with us.
The following MDPI journals will be represented:
- IJERPH;
- Medicina;
- JCM;
- EJIHPE;
- Epidemiologia;
- Behavioral Sciences;
- Healthcare;
- Women;
- MPs;
- Nursing Report;
- COVID;
- Diseases;
- Data;
- Adolescents.
If you plan on attending this conference, feel free to stop by our booth at #13. Our delegates look forward to meeting you in person to answer any questions you may have.
For more information about the conference, please see the following link: https://ephconference.eu/index.php.
28 September 2022
Peer Review Week 2022 – Research Integrity: Creating and Supporting Trust in Research

Peer Review Week began 19 September 2022 under the theme of “Research Integrity: Creating and Supporting Trust in Research”. Through various blog articles, podcast, and webinar, we discussed this crucial subject throughout the week, celebrating the essential role peer review plays in maintaining research quality.
To begin, we held a Webinar on the topic. Professor Peter W. Choate and Dr. Emmanuel Obeng-Gyasi joined Dr. Ioana Craciun, one of MDPI’s scientific officers, for an in-depth discussion.
We invite you to view the event recording:
During the week, the MDPI Blog in a series articles highlighted how good Peer Review safeguards research integrity. The following topics were covered:
- Peer Review Week 2022
- Research Integrity
- What We’ve Learned About Peer Review Reports
- 4 Steps to the Perfect Peer Review Report
- How to Write the Perfect Peer Review Report: An Interview
- Inviting Great Peer Reviewers
In a new edition of Insight Faster, an MDPI podcast, we were delighted to talk to the co-chairs of the Peer Review Week committee, Jayashree Rajagopalan (Senior Manager of Global Community Engagement for CACTUS) and Danielle Padula (Head of Marketing and Community Development at Scholastica) to get their take on this year’s event and its related topics.
You can find the Podcast here.
We hope you enjoy the contents!
21 September 2022
Spanish Group for Cancer Immuno-Biotherapy (GÉTICA) Is Now an Affiliated Society Member of the Journal of Clinical Medicine
In September 2022, the Spanish Group for Cancer Immuno-Biotherapy (GÉTICA) chose the Journal of Clinical Medicine (ISSN: ISSN 2077-0383) as its preferred journal and became an affiliated society member. As part of this collaboration, all members of GÉTICA will benefit from a discount on the article processing charge (APC) when submitting articles to the Journal of Clinical Medicine.
GÉTICA is a Spanish non-profit association that was established in 2014 by and for clinicians as well as scientists in basic and/or translational research who are interested in tumor immunology and immunotherapies for cancer treatment. The overarching aims of GÉTICA are as follows:
1) to advance the research on and development of novel immunotherapies;
2) to promote the education of researchers and clinicians in these fields;
3) to foster public engagement by communicating the latest developments in cancer immunology and immunotherapy.
A further priority is to integrate other scientific societies and cooperative groups with GÉTICA, in order to establish a strong multidisciplinary and collaborative scientific environment that will help us to drive the field of cancer immunology forward and further the development of novel immunotherapies.
The Spanish Group for Cancer Immuno-Biotherapy (GÉTICA) is a professional organization whose functions are highly relevant to the scope of the Journal of Clinical Medicine.
We look forward to collaborating with GÉTICA and publishing state-of-the-art research from its members in this field.

8 September 2022
Meet Us at the 2022 CAGPO ACMOO 19th Annual Conference, 15–18 September 2022, Toronto, Canada

MDPI will be attending the 2022 CAGPO ACMOO Annual Conference, hosted by the 2022 CAGPO Annual Conference Committee, which will be held from 15 to 18 September 2022 in Toronto, Canada.
The CAGPO mission statement is to unify general practitioners in oncology, promote communication amongst general practitioners in oncology in tertiary care and primary care settings, act and speak as the recognized authority on behalf of and for the benefit of general practitioners in oncology and their interests, and promote the role of general practitioners in oncology within cancer centers and within the primary care setting. The conference is to address the learning needs of general practitioners in oncology (GPOs) and oncology-allied health attendees. During this meeting, we will address recent advancements in the standards of oncology care. Our speakers include GPOs, medical and radiation oncologists, as well as speakers from the disciplines of family medicine and clinical trials.
The following MDPI journals will be represented:
- Current Oncology (leading);
- Cancers;
- Medical Sciences;
- Pharmacy;
- Journal of Clinical Medicine;
- Cells;
- Onco.
If you are attending this conference, please feel free to start an on-site conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have.
For more information about the conference, please visit the following link: http://cagpo-annual-conference.ca, or contact the Current Oncology Editorial Office at [email protected].
5 August 2022
Meet Us at the European Society of Cardiology (ESC) Congress 2022, 26–29 August 2022, Online or On-Site in Barcelona, Spain

MDPI will be attending the European Society of Cardiology (ESC) Congress 2022, hosted by the European Society of Cardiology and the European Heart House, which will be held from 26 to 29 August 2022 online and on-site in Barcelona, Spain.
The spotlight of the congress is “Global Cardiovascular Health”, focusing on an inclusive approach to cardiovascular health that takes into account the differences in the prevalence, clinical manifestations, prevention strategies, diagnostic modalities, and management of cardiovascular disease around the world. The ESC Congress 2022 is built on a solid foundation that attracts worldwide cardiology leaders to present and exchange their knowledge and most important research results. It focuses on the best and latest science but also emphasizes the importance of innovation, introducing topics at the frontiers of cardiovascular medicine and science to the attendees.
The following MDPI journals will be represented:
- Journal of Clinical Medicine (leading);
- Healthcare;
- Journal of Cardiovascular Development and Disease;
- International Journal of Environmental Research and Public Health;
- Cancers;
- Tomography;
- Data;
- Hearts;
- International Journal of Translational Medicine;
- Medicina;
- Medicines;
- Journal of Personalized Medicine.
28 June 2022
2021 Impact Factors - Released
The 2021 citation metrics have been released in the Journal Citation Reports (JCR), and we’re pleased to announce the following results for MDPI journals:
Journal | Impact Factor | Rank | Category |
Antioxidants | 7.675 | Q1 | Food Science & Technology |
Biochemistry & Molecular Biology | |||
Chemistry, Medicinal | |||
Cells | 7.666 | Q2 | Cell Biology |
Nutrients | 6.706 | Q1 | Nutrition & Dietetics |
Cancers | 6.575 | Q1 | Oncology |
Pharmaceutics | 6.525 | Q1 | Pharmacology & Pharmacy |
International Journal of Molecular Sciences | 6.208 | Q1 | Biochemistry & Molecular Biology |
Q2 | Chemistry, Multidisciplinary | ||
Marine Drugs | 6.085 | Q1 | Chemistry, Medicinal |
Pharmacology & Pharmacy | |||
Biomolecules | 6.064 | Q2 | Biochemistry & Molecular Biology |
Batteries * | 5.938 | Q2 | Electrochemistry |
Energy & Fuels | |||
Materials Science, Multidisciplinary | |||
Viruses | 5.818 | Q2 | Virology |
Biosensors | 5.743 | Q1 | Chemistry, Analytical |
Instruments & Instrumentation | |||
Q2 | Nanoscience & Nanotechnology | ||
Journal of Fungi | 5.724 | Q1 | Mycology |
Q2 | Microbiology | ||
Nanomaterials | 5.719 | Q1 | Physics, Applied |
Q2 | Chemistry, Multidisciplinary | ||
Materials Science, Multidisciplinary | |||
Nanoscience & Nanotechnology | |||
Metabolites | 5.581 | Q2 | Biochemistry & Molecular Biology |
Foods | 5.561 | Q1 | Food Science & Technology |
Drones * | 5.532 | Q2 | Remote Sensing |
Remote Sensing | 5.349 | Q1 | Geosciences, Multidisciplinary |
Imaging Science & Photographic Technology | |||
Q2 | Remote Sensing | ||
Environmental Sciences | |||
Journal of Theoretical and Applied Electronic Commerce Research | 5.318 | Q2 | Business |
Antibiotics | 5.222 | Q1 | Pharmacology & Pharmacy |
Q2 | Infectious Diseases | ||
Pharmaceuticals | 5.215 | Q1 | Pharmacology & Pharmacy |
Q2 | Chemistry, Medicinal | ||
Biology | 5.168 | Q1 | Biology |
Fermentation | 5.123 | Q2 | Biotechnology & Applied Microbiology |
Toxins | 5.075 | Q1 | Toxicology |
Q2 | Food Science & Technology | ||
Bioengineering * | 5.046 | Q2 | Engineering, Biomedical |
Polymers | 4.967 | Q1 | Polymer Science |
Journal of Clinical Medicine | 4.964 | Q2 | Medicine, General & Internal |
Vaccines | 4.961 | Q2 | Immunology |
Medicine, Research & Experimental | |||
Molecules | 4.927 | Q2 | Chemistry, Multidisciplinary |
Biochemistry & Molecular Biology | |||
Microorganisms | 4.926 | Q2 | Microbiology |
Journal of Functional Biomaterials * | 4.901 | Q2 | Engineering, Biomedical |
Materials Science, Biomaterials | |||
Biomedicines | 4.757 | Q2 | Medicine, Research & Experimental |
Pharmacology & Pharmacy | |||
Biochemistry & Molecular Biology | |||
Plants | 4.658 | Q1 | Plant Sciences |
International Journal of Environmental Research and Public Health | 4.614 | Q1 | Public, Environmental & Occupational Health (SSCI) |
Q2 | Public, Environmental & Occupational Health (SCIE) | ||
Environmental Sciences (SCIE) | |||
Membranes | 4.562 | Q1 | Polymer Science |
Q2 | Engineering, Chemical | ||
Materials Science, Multidisciplinary | |||
Chemistry, Physical | |||
Pathogens | 4.531 | Q2 | Microbiology |
Catalysts | 4.501 | Q2 | Chemistry, Physical |
Toxics | 4.472 | Q2 | Toxicology |
Environmental Sciences | |||
Gels | 4.432 | Q1 | Polymer Science |
Journal of Cardiovascular Development and Disease | 4.415 | Q2 | Cardiac & Cardiovascular Systems |
Chemosensors | 4.229 | Q1 | Instruments & Instrumentation |
Q2 | Chemistry, Analytical | ||
Q3 | Electrochemistry | ||
Genes | 4.141 | Q2 | Genetics & Heredity |
Diagnostics | 3.992 | Q2 | Medicine, General & Internal |
Agronomy | 3.949 | Q1 | Agronomy |
Plant Sciences | |||
Land | 3.905 | Q2 | Environmental Studies |
Sustainability | 3.889 | Q2 | Environmental Sciences (SCIE) |
Environmental Studies (SSCI) | |||
Q3 | Green & Sustainable Science & Technology (SCIE) | ||
Q4 | Green & Sustainable Science & Technology (SSCI) | ||
Sensors | 3.847 | Q2 | Instruments & Instrumentation |
Chemistry, Analytical | |||
Engineering, Electrical & Electronic | |||
Materials | 3.748 | Q1 | Metallurgy & Metallurgical Engineering |
Q2 | Physics, Applied | ||
Physics, Condensed Matter | |||
Q3 | Materials Science, Multidisciplinary | ||
Chemistry, Physical | |||
Biomimetics * | 3.743 | Q2 | Engineering, Multidisciplinary |
Q3 | Materials Science, Biomaterials | ||
Tropical Medicine and Infectious Disease * | 3.711 | Q1 | Tropical Medicine |
Q2 | Parasitology | ||
Q3 | Infectious Diseases | ||
Lubricants * | 3.584 | Q2 | Engineering, Mechanical |
Fractal and Fractional | 3.577 | Q1 | Mathematics, Interdisciplinary Applications |
Water | 3.530 | Q2 | Water Resources |
Q3 | Environmental Sciences | ||
Micromachines | 3.523 | Q2 | Instruments & Instrumentation |
Physics, Applied | |||
Chemistry, Analytical | |||
Q3 | Nanoscience & Nanotechnology | ||
Journal of Personalized Medicine | 3.508 | Q2 | Medicine, General & Internal |
Health Care Sciences & Services | |||
Agriculture | 3.408 | Q1 | Agronomy |
Processes | 3.352 | Q2 | Engineering, Chemical |
Separations | 3.344 | Q2 | Chemistry, Analytical |
Magnetochemistry | 3.336 | Q2 | Chemistry, Inorganic & Nuclear |
Q3 | Chemistry, Physical | ||
Materials Science, Multidisciplinary | |||
Brain Sciences | 3.333 | Q3 | Neurosciences |
Buildings | 3.324 | Q2 | Construction & Building Technology |
Engineering, Civil | |||
Forests | 3.282 | Q1 | Forestry |
Energies | 3.252 | Q3 | Energy & Fuels |
Life | 3.251 | Q2 | Biology |
Coatings | 3.236 | Q2 | Materials Science, Coatings & Films |
Physics, Applied | |||
Q3 | Materials Science, Multidisciplinary | ||
Animals | 3.231 | Q1 | Agriculture, Dairy & Animal Science |
Veterinary Sciences | |||
Journal of Intelligence * | 3.176 | Q2 | Psychology, Multidisciplinary |
Fishes | 3.170 | Q1 | Marine & Freshwater Biology |
Q2 | Fisheries | ||
Healthcare | 3.160 | Q2 | Health Policy & Services (SSCI) |
Health Care Sciences & Services (SCIE) | |||
Inorganics * | 3.149 | Q2 | Chemistry, Inorganic & Nuclear |
Insects | 3.139 | Q1 | Entomology |
Atmosphere | 3.110 | Q3 | Meteorology & Atmospheric Sciences |
Environmental Sciences | |||
Current Oncology | 3.109 | Q3 | Oncology |
ISPRS International Journal of Geo-Information | 3.099 | Q2 | Geography, Physical |
Q3 | Computer Science, Information Systems | ||
Remote Sensing | |||
Diversity | 3.029 | Q2 | Biodiversity Conservation |
Ecology | |||
Tomography | 3.000 | Q3 | Radiology, Nuclear Medicine & Medical Imaging |
Current Issues in Molecular Biology | 2.976 | Q3 | Biochemistry & Molecular Biology |
Medicina | 2.948 | Q3 | Medicine, General & Internal |
Symmetry | 2.940 | Q2 | Multidisciplinary Sciences |
Horticulturae | 2.923 | Q1 | Horticulture |
Machines | 2.899 | Q2 | Engineering, Mechanical |
Engineering, Electrical & Electronic | |||
Systems * | 2.895 | Q2 | Social Sciences, Interdisciplinary |
Applied Sciences | 2.838 | Q2 | Engineering, Multidisciplinary |
Physics, Applied | |||
Q3 | Chemistry, Multidisciplinary | ||
Materials Science, Multidisciplinary | |||
Children | 2.835 | Q2 | Pediatrics |
Minerals | 2.818 | Q2 | Mining & Mineral Processing |
Mineralogy | |||
Geochemistry & Geophysics | |||
Universe | 2.813 | Q2 | Astronomy & Astrophysics |
Q3 | Physics, Particles & Fields | ||
Journal of Marine Science and Engineering | 2.744 | Q1 | Engineering, Marine |
Q2 | Oceanography | ||
Engineering, Ocean | |||
Entropy | 2.738 | Q2 | Physics, Multidisciplinary |
Fire * | 2.726 | Q2 | Forestry |
Q3 | Ecology | ||
Metals | 2.695 | Q2 | Metallurgy & Metallurgical Engineering |
Q3 | Materials Science, Multidisciplinary | ||
Electronics | 2.690 | Q3 | Engineering, Electrical & Electronic |
Computer Science, Information Systems | |||
Physics, Applied | |||
Crystals | 2.670 | Q2 | Crystallography |
Q3 | Materials Science, Multidisciplinary | ||
Aerospace | 2.660 | Q1 | Engineering, Aerospace |
Mathematics | 2.592 | Q1 | Mathematics |
Photonics | 2.536 | Q3 | Optics |
Actuators | 2.523 | Q2 | Instruments & Instrumentation |
Q3 | Engineering, Mechanical | ||
Veterinary Sciences | 2.518 | Q2 | Veterinary Sciences |
Behavioral Sciences * | 2.286 | Q3 | Psychology, Multidisciplinary |
Axioms * | 1.824 | Q2 | Mathematics, Applied |
For more information on Impact Factors and what it means to index academic journals, please visit our related blog posts.
* Journals given their first Impact Factor in 2022
Source: 2021 Journal Impact Factors, Journal Citation Reports TM (Clarivate, 2022)
20 June 2022
MDPI’s 2021 Young Investigator Awards in “Medicine & Pharmacology”—Winners Announced
MDPI’s Young Investigator Awards recognize promising junior researchers, acknowledge their contributions, and enhance communication among scientists. We are proud to present the winners for the year 2021 in the “Medicine & Pharmacology” category. The winners were selected by the journals’ editors.
We warmly congratulate the awarded young investigators for their outstanding contributions. MDPI will continue to provide support and recognition to the academic community.
- Jasper Fuk-Woo Chan, Queen Mary Hospital, Hong Kong
- Mateusz Maciejczyk, Medical University of Bialystok, Poland
- Matteo Lambertini, University of Genova, Italy
- Helen Rogers, Newcastle University, UK
- Amir Karami, University of South Carolina, USA
- Andrea Palermo, Campus Bio-Medico University, Italy
Journal of Personalized Medicine:
- Simone Di Franco, University of Palermo, Italy
- Catriona Hippman, University of Calgary, Canada
- Veeru Kasivisvanathan, University College London, UK
- Andrea Cortegiani, University of Palermo, Italy; University Hospital Policlinico Paolo Giaccone, Italy
- Qi Zhou, Purdue University, USA
20 June 2022
MDPI’s 2021 Travel Awards in “Medicine & Pharmacology”—Winners Announced
We are proud to recognize the winners of MDPI’s 2021 Travel Awards in the “Medicine & Pharmacology” category for their outstanding presentations and to present them with the prize.
MDPI journals regularly offer travel awards to encourage talented junior scientists to present their latest research at academic conferences in specific fields, which helps to increase their influence.
The winners mentioned below were carefully selected by the journal editors based on an outline of their research and the work to be presented at an academic conference.
We would like to warmly congratulate the Travel Awards winners for the year 2021 and wish them the greatest success with their future research endeavors. MDPI will continue to enhance communication among scientists.
- Soheil Saeedi, University of Zurich, Switzerland
- Shawn Alexander Hallett, University of Michigan, USA
- Claire Albert, Yale University, USA
- Raquel Filipa da Costa Viveiros, NOVA University of Lisbon, Portugal
- Patrick Jim Küppers, University Hospital Bonn, Germany
20 June 2022
MDPI’s 2021 Outstanding Reviewer Awards in “Medicine & Pharmacology”—Winners Announced
In order to acknowledge our reviewers, who so generously dedicate their time to reviewing papers, and demonstrate diligence, professionalism, and timeliness when reviewing manuscripts, MDPI journals regularly offer outstanding reviewer awards to scholars who participate in the peer-review process.
We are proud to recognize winners for the year 2021 in the “Medicine & Pharmacology” category for their outstanding contributions among extensive competition by presenting them with an Outstanding Reviewer Award.
We would like to take this opportunity to congratulate all of the winners on their achievement. MDPI will continue to provide support and recognition to the academic community.
- Antonio G. Solimando, University of Bari Aldo Moro, Italy
- Chenghui Li, University of Arkansas for Medical Sciences, USA
- Joaquim Carreras, Tokai University, Japan
- Pierfrancesco Franco, University of Turin School of Medicine, Italy
- Laurentiu Pop, University of Texas Southwestern Medical Center, USA
- Margaret Fitch, University of Toronto, Canada
- Caroline Mariano, BC Cancer Agency, Canada; University of British Columbia, Canada
- Naser Alsharairi, Griffith University, Australia
- Peter W. Choate, Mount Royal University, Canada
- Qin Xiang Ng, National University of Singapore, Singapore
- Giulio Francesco, Sapienza University of Rome, Italy
- Sebastian Schnaubelt, Medical University of Vienna, Austria
- Olga Kislitsina, Northwestern University, Northwestern Memorial Hospital, USA
Journal of Personalized Medicine:
- Onofrio Laselva, University of Foggia, Italy
- Ping-Hsun Wu, Kaohsiung Medical University, Taiwan
- Vladimir Vladimirov, Virginia Commonwealth University, USA
- Mauro Giuffrè, University of Trieste, Italy
- Erika Palmieri, National Cancer Institute at Frederick, USA
- Anjul Khadria, California Institute of Technology, Pasadena, USA
20 June 2022
MDPI’s 2021 Best Paper Awards in “Medicine & Pharmacology”—Winners Announced
The purpose of our Best Paper Awards is to promote and recognize the most impactful contributions published within MDPI journals.
The editors of each journal carefully selected reviews and research papers through a rigorous judging process based on criteria such as the scientific merit, overall impact, and the quality of presentation of the papers published in the journal last year.
We are honored to present the winners in the “Medicine & Pharmacology” category, who were selected amongst extensive competition, and congratulate the authors for their outstanding scientific publications.
MDPI will continue to provide support and recognition to the academic community.
by Eunice Ego Mgbeahuruike, Milla Stålnacke, Heikki Vuorela and Yvonne Holm
Antibiotics 2019, 8(2), 55; doi:10.3390/antibiotics8020055
by Bernardo Ribeiro da Cunha, Luís P. Fonseca and Cecília R. C. Calado
Antibiotics 2019, 8(2), 45; doi:10.3390/antibiotics8020045
by Zvi Artzi, Shiran Sudri, Ori Platner and Avital Kozlovsky
Dent. J. 2019, 7(1), 29; doi:10.3390/dj7010029
by Philipp Sahrmann, Cyrill Bettschart, Daniel B. Wiedemeier, Ahmed Al-Majid, Thomas Attin and Patrick R. Schmidlin
Dent. J. 2019, 7(4), 115; doi:10.3390/dj7040115
by Chantal Huisman and Helianthe Kort
Healthcare 2019, 7(1), 31; doi:10.3390/healthcare7010031
by Vijay Kumar Chattu, Soosanna Kumary Chattu, Deepa Burman, David Warren Spence and Seithikurippu R. Pandi-Perumal
Healthcare 2019, 7(1), 37; doi:10.3390/healthcare7010037
by Eija Könönen, Mervi Gursoy and Ulvi Kahraman Gursoy
Clin. Med. 2019, 8(8), 1135; doi:10.3390/jcm8081135
by Yueyuan Zhou, Yusuke Yamamoto, Zhongdang Xiao and Takahiro Ochiya
Clin. Med. 2019, 8(7), 1025; doi:10.3390/jcm8071025
by Tara K. Sigdel, Felipe Acosta Archila, Tudor Constantin, Sarah A. Prins, Juliane Liberto, Izabella Damm, Parhom Towfighi, Samantha Navarro, Eser Kirkizlar, Zachary P. Demko, Allison Ryan, Styrmir Sigurjonsson, Reuben D. Sarwal, Szu-Chuan Hseish, Chitranon Chan-On, Bernhard Zimmermann, Paul R. Billings, Solomon Moshkevich and Minnie M. Sarwal
Clin. Med. 2019, 8(1), 19; doi:10.3390/jcm8010019
by Borros Arneth
Medicina 2020, 56(1), 15; doi: 10.3390/medicina56010015
by Márió Gajdács, Marianna Ábrók, Andrea Lázár, and Katalin Burián
Medicina 2019, 55(7), 356; doi: 10.3390/medicina55070356
by Atheer Awad, Fabrizio Fina, Sarah J. Trenfield, Pavanesh Patel, Alvaro Goyanes, Simon Gaisford and Abdul W. Basit.
Pharmaceutics 2019, 11(4), 148; doi:10.3390/pharmaceutics11040148
by Constantin Mircioiu, Victor Voicu, Valentina Anuta, Andra Tudose, Christian Celia, Donatella Paolino, Massimo Fresta, Roxana Sandulovici and Ion Mircioiu
Pharmaceutics 2019, 11(3), 140; doi:10.3390/pharmaceutics11030140
9 June 2022
2021 CiteScores - Released

The 2021 citation metrics have been officially released in Scopus!
We are pleased to announce that 182 MDPI journals are included, of which:
● 21 journals received their first CiteScore.
● 85% of journals increased their CiteScore from 2020.
● 155 journals (85%) ranked above average, in at least one category.
The following 65 MDPI journals (36%) ranked among the top 25% of journals, in at least one category:
Journal |
CiteScore |
Quartile |
Category |
10.1 |
Q1 |
Genetics |
|
10.0 |
Q1 |
Biomedical Engineering |
|
8.1 |
Q1 |
Pharmacology, Toxicology and Pharmaceutics (miscellaneous) |
|
7.9 |
Q1 |
Electrical and Electronic Engineering |
|
7.9 |
Q1 |
Nutrition and Dietetics |
|
7.4 |
Q1 |
General Earth and Planetary Sciences |
|
7.2 |
Q1 |
Computer Science Applications |
|
6.9 |
Q1 |
Inorganic Chemistry |
|
6.9 |
Q1 |
Computer Networks and Communications |
|
6.7 |
Q1 |
General Biochemistry, Genetics and Molecular Biology |
|
6.6 |
Q1 |
General Chemical Engineering |
|
6.6 |
Q1 |
Health, Toxicology and Mutagenesis |
|
6.6 |
Q1 |
Infectious Diseases |
|
6.5 |
Q1 |
Food Science |
|
6.5 |
Q1 |
Civil and Structural Engineering |
|
6.4 |
Q1 |
Nature and Landscape Conservation |
|
6.4 |
Q1 |
Instrumentation |
|
6.1 |
Q1 |
Management Information Systems |
|
5.9 |
Q1 |
Chemistry (miscellaneous) |
|
5.7 |
Q1 |
Polymers and Plastics |
|
5.6 |
Q1 |
Engineering (miscellaneous) |
|
5.5 |
Q1 |
General Environmental Science |
|
5.5 |
Q1 |
Urban Studies |
|
5.4 |
Q2 |
Computer Networks and Communications |
|
5.3 |
Q1 |
Food Science |
|
5.3 |
Q1 |
Plant Science |
|
5.2 |
Q1 |
Ecology, Evolution, Behavior and Systematics |
|
5.2 |
Q1 |
General Engineering |
|
Journal of Open Innovation: Technology, Market, and Complexity |
5.1 |
Q1 |
Development |
5.0 |
Q1 |
Chemistry (miscellaneous) |
|
5.0 |
Q1 |
Control and Optimization |
|
5.0 |
Q1 |
Geography, Planning and Development |
|
5.0 |
Q1 |
Geography, Planning and Development |
|
4.9 |
Q1 |
Forestry |
|
4.9 |
Q1 |
Control and Optimization |
|
4.9 |
Q1 |
Soil Science |
|
4.8 |
Q1 |
General Earth and Planetary Sciences |
|
4.8 |
Q1 |
Mechanical Engineering |
|
4.8 |
Q1 |
Public Health, Environmental and Occupational Health |
|
4.8 |
Q1 |
Geography, Planning and Development |
|
International Journal of Environmental Research and Public Health |
4.5 |
Q1 |
Public Health, Environmental and Occupational Health |
4.5 |
Q1 |
Physical Therapy, Sports Therapy and Rehabilitation |
|
4.4 |
Q1 |
Mathematical Physics |
|
4.4 |
Q1 |
General Medicine |
|
4.3 |
Q1 |
General Mathematics |
|
4.2 |
Q1 |
Surgery |
|
4.1 |
Q1 |
Health Professions (miscellaneous) |
|
4.1 |
Q1 |
Plant Science |
|
4.0 |
Q1 |
General Engineering |
|
4.0 |
Q1 |
Forestry |
|
4.0 |
Q1 |
Education |
|
3.9 |
Q1 |
General Pharmacology, Toxicology and Pharmaceutics |
|
3.9 |
Q1 |
Applied Mathematics |
|
3.8 |
Q1 |
Development |
|
3.8 |
Q1 |
Architecture |
|
3.8 |
Q1 |
Metals and Alloys |
|
3.5 |
Q1 |
Communication |
|
3.4 |
Q1 |
General Social Sciences |
|
2.9 |
Q1 |
General Mathematics |
|
2.8 |
Q1 |
Analysis |
|
2.7 |
Q1 |
General Veterinary |
|
2.6 |
Q1 |
Algebra and Number Theory |
|
1.8 |
Q1 |
Conservation |
|
1.0 |
Q1 |
Religious Studies |
|
0.9 |
Q1 |
Philosophy |
Source: 2021 CiteScores™ (Elsevier)
13 May 2022
Journal of Clinical Medicine | Special Issue Development Program
We are pleased to announce a new project of Journal of Clinical Medicine (JCM, ISSN: 2077-0383)—Special Issue Development Program.
The program aims to provide early career scientists with the opportunity to develop a Special Issue and experience the academic editor's role under the mentorship of an experienced scientist.
What you will receive from the Special Issue Development Program:
- A Guest Editor certificate;
- A platform to collect papers on a certain topic;
- Guidance from experienced scientists from JCM;
- More editorial experience and the opportunity to enrich your resume.
If you are interested in this opportunity, please send your Special Issue proposal to the JCM Editorial Office ([email protected]) or submit the proposal at the following link: https://www.mdpi.com/journalproposal/sendproposalspecialissue/jcm. We will then discuss our potential collaboration and how the process works in detail.
In addition to the new Special Issue Development Program, JCM continues to welcome Special Issue proposals based on hot research topics.
22 April 2022
Meet the Editors | Interview with Prof. Marco Sebastiani— Section Editor-in-Chief of the Section “Immunology” in Journal of Clinical Medicine
1. Please briefly introduce yourself.
My name is Marco Sebastiani, professor of rheumatology at the University of Modena and Reggio Emilia. For many years, I’ve been working in some fields of rheumatology, such as rheumatoid arthritis, interstitial lung disease associated to rheumatic diseases, videocapillaroscopy in diagnosis and the management of connective tissue diseases, and cryoglobulinaemic vasculitis.
2. What attracted you to science editing?
Science-editing was a new work opportunity for me. It was a challenge to try to increase my expertise in other scientific fields.
3. The Journal of Clinical Medicine (JCM) is an open access journal. Can you explain your attitude toward open access? How do you think open access affects authors?
Open access is a good opportunity to increase the sharing and the diffusion of scientific progress. The authors can increase the visibility of their work. I frequently publish in open access journals, when I think that my work needs a large and rapid diffusion.
4. What are the current cutting-edge research areas in the field of immunology?
Immunology and rheumatology are experiencing a period of great research activity. The increase of knowledge in innate and acquired immunity, as well as in molecular mechanisms of inflammation, has allowed the discovery of new drugs and a better treatment of immune-mediated and inflammatory diseases. Moreover, in recent years, researchers have shown an increased interest in the lung’s involvement in rheumatic diseases; the development of new opportunities for treatment has induced research to search for new methods of screening and early diagnosis of interstitial lung disease.
5. What motivated you to join the JCM Editorial Board?
Journal of Clinical Medicine is a high-impact open access journal with an eminent Editorial Board. I accepted the opportunity to contribute to the journal and to collaborate with the other members of the Editorial Board with enthusiasm.
To work as a Section Editor-in-Chief of the Section “Immunology” is challenging, but rewarding, and it allows me to contribute to the development of the journal and keep up to date about all the activities of the journal.
6. How do you think COVID-19 affects medical research and publishing? Do you have any suggestions for the development of JCM during the epidemic period?
The appearance of the COVID-19 pandemic has determined a great increase in the research on this topic by researchers of many specialties, not only those with expertise in infectious disease and virology. The main side effect has been the stopping of many research projects in the first months of the pandemic. Now, COVID-19 continues to significantly impact the management of chronic and acute diseases; in this context, the interactions between the management of chronic diseases and the need for treatment and prophylaxis of SARS-CoV-2 infection can represent a topic to be explored in the coming months.
21 March 2022
Welcoming New Editorial Board Members of the Journal of Clinical Medicine
We are pleased to announce that four prominent academics have recently joined the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) Editorial Board. The new Editorial Board Members are as follows:
Name: Prof. Dr. Claudio Tondo
Affiliations: Department of Clinical Electrophysiology & Cardiac Pacing, Heart Rhythm Center, Centro Cardiologico Monzino IRCCS, Milan, Italy;
Department of Biochemical, Surgical and Dentist Sciences, University of Milan, Milan, Italy
Name: Dr. Barbara Bauce
Affiliation: Department of Cardio-Thoraco-Vascular Sciences and Public Health, University of Padua, Padua, Italy
Name: Prof. Dr. Chung Cheung Thomas Yau
Affiliation: Department of Medicine, The University of Hong Kong, Hong Kong, China
Name: Prof. Dr. Depei Wu.
Affiliations: National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China;
Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou 215123, China;
Department of Hematology, the First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Suzhou 215006, China
The commitment of these individuals to JCM is much appreciated, and we look forward to their contributions to the continued success of JCM.
Further details about the JCM Editorial Board can be found via the following link: https://www.mdpi.com/journal/JCM/editors.
27 December 2021
Recruiting Editorial Board Members for Journal of Clinical Medicine
Journal of Clinical Medicine (https://www.mdpi.com/journal/jcm; ISSN 2077-0383) is indexed by Science Citation Index Expanded (SCIE) with the Impact Factor of 4.242 (2020) and accepted for inclusion in Scopus. To secure the high-speed development of our journal in the near future, we are recruiting prestigious scholars from around the world to join our Editorial Board for the Sections that can be accessed at the following link: https://www.mdpi.com/journal/jcm/sections.
The main responsibilities of Editorial Board Members are as follows:
- Prechecking and making decisions for several (12 per year on average) manuscripts based on your area of expertise;
- Acting as, or recommending a Guest Editor for a Special Issue on a topic related to your research interests;
- Promoting JCM and increasing its visibility at related academic social media.
JCM is an international scientific open-access journal, providing a platform for advances in health care and clinical practices, a study of direct observation of patients, and general medical research. This multi-disciplinary journal is aimed at a wide audience of medical researchers and healthcare professionals, and it is indexed by the SCIE, PubMed, Scopus, and many other databases.
This position is open to experts in clinical medicine. To apply for this position (in one of our sections), recommend potential candidates, or request further information, please contact the JCM Editorial Office ([email protected])
27 December 2021
Welcoming New Editorial Board Members of Journal of Clinical Medicine
We are pleased to announce that three prominent academics have recently joined the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) Editorial Board for the Section “Cardiovascular Medicine”: Prof. Dr. Jeffrey L. Anderson, Prof. Dr. Jiguang Wang and Prof. Dr. Alun Huw Davies.
Name: Prof. Dr. Jeffrey L. Anderson
Affiliation: Intermountain Medical Center Heart Institute, Murray, UT, USA; Department of Internal Medicine, Division of Cardiology, University of Utah School of Medicine, Salt Lake City, UT, USA
Name: Prof. Dr. Jiguang Wang
Affiliation: Department of Cardiovascular Medicine, National Research Center for Translational Medicine, Centre for Cardiovascular Evaluations, Shanghai Key Laboratory of Hypertension, The Shanghai Institute of Hypertension, Shanghai, China; Department of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
Name: Prof. Dr. Alun Huw Davies
Affiliation: Academic Section of Vascular Surgery, Division of Surgery, Department of Surgery & Cancer, Imperial College London, Charing Cross Hospital, London W6 8RF, UK.
Their commitment to JCM is much appreciated, and we look forward to their contributions to the continued success of JCM.
Further details about the JCM Editorial Board can be found at the following link: https://www.mdpi.com/journal/JCM/editors.
22 November 2021
722 MDPI Editorial Board Members Receiving "2021 Highly Cited Researchers" Distinction
It is our great honor to congratulate the Editorial Board Members and Editors in MDPI's journals who have been distinguished as 2021 Highly Cited Researchers by Clarivate, according to Web of Science data. We herewith express our gratitude for the immense impact the named researchers continue to make on scientific progress and on our journals' development.
Clarivate's annual list of Highly Cited ResearchersTM identifies the most highly cited scientists for the past decade. Their impactful papers are among the top 1 per cent in the citation distribution of one or more of 22 fields analyzed in the "Essential Science Indicators", distinguishing them as hugely influential among their peers.
Abate, Antonio Abatzoglou, John T. Abbaszadeh, Mostafa Acharya, U. Rajendra Acharya, Viral V. Agarwal, Ravi P. Ahn, Myung-Ju Airoldi, Laura Ali, Imran Allakhverdiev, Suleyman I. Aluko, Rotimi E. Anasori, Babak Andersson, Dan I. Andes, David Anker, Stefan D. Apergis, Nicholas Ariga, Katsuhiko Arqub, Omar Abu Aschner, Michael Assaraf, Yehuda G. Astruc, Didier Atala, Anthony Atanasov, Atanas G. Atangana, Abdon Bahram, Mohammad Bakris, George L. Balandin, Alexander A. Baleanu, Dumitru Balsamo, Gianpaolo Bando, Yoshio Banks, William A. Bansal-Travers, Maansi Barba, Francisco J. Barros, Lillian Basit, Abdul W. Baskonus, Haci Mehmet Bassetti, Matteo Battino, Maurizio Bell, Jordana T. Bellomo, Nicola Benediktsson, Jon Atli Benelli, Giovanni Benjakul, Soottawat Bhatnagar, Amit Biddle, Stuart J. H. Biondi, Antonio Biondi-Zoccai, Giuseppe Bjarnsholt, Thomas Blaabjerg, Frede Blaschke, Thomas Blay, Jean-Yves Blumwald, Eduardo Blunt, John W. Boffetta, Paolo Bogers, Marcel Bonomo, Robert A. Bowman, David M.J.S. Boyer, Cyrille Brestic, Marian Brevik, Eric C. Buhalis, Dimitrios Burdick, Jason A. Byrd, John C. Cabeza, Luisa F. Cai, Xingjuan Cai, Jianchao Calhoun, Vince D. Calin, George Cao, Jinde Cao, Guozhong Carvalho, Andre F. Castellanos-Gomez, Andres Cerqueira, Miguel Ângelo Parente Ribeiro Chang, Jo-Shu Chang, Chih-Hao Chastin, Sebastien Chau, Kwok-wing Chemat, Farid Chen, Xiaobo Chen, YangQuan Chen, Jianmin Chen, Chaoji Chen, Min Chen, Qi Chen, Jun Chen, Xi Chen, Peng Chen, Yulin Chen, Bo Chen, Chen Chen, Zhi-Gang Chen, Wei-Hsin Chen, Gang Chen, Yongsheng Chen, Xiang Chen, Yimin Chen, Runsheng Chen, Lidong Chen, Shaowei Chen, Qian Chen, Yu Chen, Shuangming Chiclana, Francisco Cho, Sun Young Choi, Wonyong Chowdhary, Anuradha Choyke, Peter L. Cichocki, Andrzej Corella, Dolores Corma, Avelino Cortes, Javier Cortes, Jorge Costanza, Robert Crommie, Michael F. Cui, Yi Cui, Haiying Cui, Qinghua Cummings, Kenneth Michael Dai, Shifeng Dai, Sheng Daiber, Andreas Davis, Steven J. Dawson, Ted M. de la Fuente-Nunez, Cesar Decker, Eric Andrew Dekel, Avishai Demaria, Marco Deng, Yong Deng, Xiangzheng DePinho, Ronald A. Desneux, Nicolas Dimopoulos, Meletios-Athanasios Ding, Aijun Dionysiou, Dionysios D. Dokmeci, Mehmet Remzi Dolgui, Alexandre Dong, Fan Dou, Shi Xue Dou, Letian Du, Qian Du, Bo Dube, Shanta Rishi Dufresne, Alain Dummer, Reinhard Dupont, Didier Edwards, David Elaissari, Abdelhamid Elhoseny, Mohamed Ellahi, Rahmat Ellis, Erle C. ElMasry, Gamal Esteller, Manel Estévez, Mario Fabbro, Doriano Facchetti, Antonio Fan, Zhanxi Fang, Chuanglin Fasano, Alessio Fečkan, Michal Felser, Claudia Feng, Liangzhu Fensholt, Rasmus Ferdinandy, Péter Fernandez-Lafuente, Roberto Ferreira, Isabel C. F. R. Filippi, Massimo Fisher, Helen Fortino, Giancarlo Fosso Wamba, Samuel Franceschi, Claudio Fujita, Hamido Fujita, Masayuki Gai, Francesco Gaisford, Simon Galanakis, Charis M. Galluzzi, Lorenzo Galvano, Fabio Gan, Ren-You Gan, Lihua Gandomi, Amir H. Gao, Bin Gao, Feng Gao, Minrui Gao, Huijun Gao, Wei Gao, Huile Garbe, Claus Garcia, Hermenegildo Gasbarrini, Antonio Gasco, Laura Gautret, Philippe Geng, Yong Gerdts, Gunnar Geschwind, Daniel H. Ghadimi, Noradin Ghaffari, Roozbeh Ghamisi, Pedram Giampieri, Francesca Glick, Bernard R. Gnant, Michael Goel, Ajay Gogotsi, Yury Goldewijk, Kees Klein Gong, Jinlong Gong, Yongji Govindan, Kannan Granato, Daniel Grancini, Giulia Green, Douglas R. Grosso, Giuseppe Gu, Ke Guan, Cao Guastella, Adam J. Guerrero, Josep M. Gui, Guan Guizani, Mohsen Guo, Zaiping Gupta, Rangan Gutzmer, Ralf Haase, Dagmar Habibi-Yangjeh, Aziz Hagemann, Stefan Hagger, Martin Hamblin, Michael R. Hammoudeh, Shawkat Han, Heesup Hanes, Justin Harrison, Roy M. Hartung, Hans-Peter Hasanuzzaman, Mirza He, Jr-Hau He, Hongwen He, Jiaqing He, Debiao Henseler, Jörg Herrera, Francisco Herrera-Viedma, Enrique Hetz, Claudio Ho Kim, Jung Holmes, Elaine Hossain, Ekram Hsueh, Po-Ren Hu, Xiaosong Hu, Wenbin Huang, Jianping Huang, Hongwei Huang, Yu Huang, Jianying Huang, Peng Huang, Baibiao Huang, Shaoming Hubacek, Klaus |
Iqbal, Hafiz M. N. |
Saad, Fred |
The full list of 2021 Highly Cited Researchers can be accessed at the following webpage in the Web of ScienceTM https://recognition.webofscience.com/awards/highly-cited/2021/.
--- Highly Cited Researchers (HCR) is a Clarivate product.
16 November 2021
Topical Advisory Panel Established to Support Editorial Board
Academic editors play a crucial role in leading our journals and ensuring that each article undergoes a robust and timely peer-review. With the launch of Topics this year and addition of Topic Editors to our family of academic editors, we decided it would be a good time to restructure our academic boards, thus providing more clarity and support for each role. MDPI is pleased to announce the launch of a new position—Topical Advisory Panel Member, that will replace the previous position of Topics Board Member. The Topical Advisory Panel will be comprised of early career researchers eager to gain experience in editorial work.
The main responsibility of the new members of the Topical Advisory Panel is to regularly provide support to Guest Editors, Topic Editors, and Section Board Members. The responsibilities of the Topical Advisory Panel are available here: https://www.mdpi.com/editors.
Each year, the members’ performances are evaluated, and outstanding members are promoted to the Editorial Board by the Editor-in-Chief.
To qualify as a Topical Advisory Panel Member, applicants must:
- Have expertise and experience in the field related to the journal;
- Have received a Ph.D. in the last 10 years, approximately;
- Have at least 6-8 published papers in the last 5 years as first author or corresponding author;
- Currently hold an independent research position in academia or a government institute.
If you are interested in this role, please contact the editorial office by email.
We look forward to hearing from you soon.
25 October 2021
Open Access Week 2021 | It Matters How We Open Knowledge: Building Structural Equity, 25–31 October
Founded in 1996, MDPI was one of the first fully Open Access publisher. Over 25 years MDPI has grown to become the largest Open Access publisher globally, publishing over 160,000 articles across more than 350 journals in 2020. At the core, MDPI was founded in response to a pressing need of fast publication and inclusion. The scholar was set at the centre of the publication process for the first time. Acting as a service provider, rather than a product provider, MDPI exists to help scientists achive their objective to disseminate research results. At MDPI, we believe scientists deserve a better service from the publishing world.
The International Open Access Week (Open Access Week), founded by the SPARC (the Scholarly Publishing and Academic Resources Coalition) Alliance and student partners in 2008, has been successfully running for 13 years. As an advocate and pioneer of open access publishing, MDPI actively responds to the call of International Open Access Week. This year’s theme of “It Matters How We Open Knowledge: Building Structural Equity” highlights the Recommendation’s call for equitable participation from all authors and readers.
For the last 25 years, MDPI has been committed to disseminating open research. Here is a video showing MDPI’s Commitment to Equity, Inclusion and Diversity for More than 25 Years.
International Open Access Week is an important opportunity to catalyze new conversations, create connections across and between communities that can facilitate this co-design, and advance progress in the building of more equitable foundations for opening knowledge—discussions and actions that need to be continued, year in and year out. MDPI has always aimed to provide professional and efficient publishing services to scholars around the world.
Our mission is to make scientific research accessible to everyone; this year, we interview and hold discussions with open science ambassadors on how to build an equal and inclusive environment for open science. Academic editors help us collaborate with more institutions to advocate for open access ideas.
Besides this, our scientific community is a key driver of our success and MDPI’s remarkable growth. Despite the pandemic, we have prepared online conferences and workshops to gather scholars from different communities.
The Basel Sustainable Publishing online forum provides an equal opportunity for stakeholders and researchers from multi-cultural environments to exchange ideas and eliminate barriers to participation.
Conference date: 25 October 2021, online
Conference website: https://bspf2021.sciforum.net/
Main topics: MDPI discusses the current dilemma of open access science from various perspectives such as governments, libraries, and publishers, and related measures on how to change the status quo of discrimination from a global perspective.
We aim to support equality, inclusion, diversity, and accessibility in scholarly communications. We collaborate with universities and key laboratories and have scholarly communications with researchers, teachers, and students on open access workshops.
- 25 October 2021
Energies journal and Institute of Mechanics, Chinese Academy of Sciences
- 28 October 2021
Machines journal and State Key Laboratory of Traction Power, Southwest Jiaotong University
- 29 October 2021
Processes journal and Beijing Institute of Technology
- 29 October 2021
Coatings journal and Wuhan University of Technology
MDPI is committed to providing open access and high-quality publishing services for scholars and promoting rapid dissemination of academic achievements. We hope to promote the practices and policies of open access publishing and diversify the dissemination of academic achievements.
23 September 2021
2020 MDPI Top Reviewer Award—Winners Announced

Rigorous peer-review is the cornerstone of high-quality academic publishing. Over 369,916 scholars served as reviewers for MDPI journals in 2020. We are extremely appreciative of all those who made a contribution to the editorial process in this capacity. At the beginning of every year, journal editorial offices publish a list of all reviewers’ names to express our gratitude. In addition, this year, the MDPI Top Reviewer Award was announced, to recognize the very best reviewers for their expertise and dedication, and their high-quality, and timely review reports. We are pleased to announce the following winners of the 2020 MDPI Top Reviewer Award:
- Adriana Burlea-Schiopoiu;
- Alban Kuriqi;
- Álvaro González-Vila;
- Alessandro Alaimo;
- Alexey Beskopylny;
- Alexander Yu Churyumov;
- Alberto Fernández-Isabel;
- Andrea Mastinu;
- Antonios N. Papadopoulos;
- Anton Rassõlkin;
- Antonio Humberto Hamad Minervino;
- Arkadiusz Matwijczuk;
- Artur Słomka;
- Baojie He;
- Bartłomiej Potaniec;
- Bojan Đurin;
- Camilo Arturo Rodriguez Diaz;
- Carmelo Maria Musarella;
- Chiachung Chen;
- Chiman Kwan;
- Cristian Busu;
- Danil Pimenov;
- Dan-Cristian Dabija;
- Delfín Ortega-Sánchez;
- Demetrio Antonio Zema;
- Denis Butusov;
- Elena Lucchi;
- Gaurab Dutta;
- Livia Anastasiu;
- M. R. Safaei.
For more information about how to become a reviewer of MDPI journals, please see: www.mdpi.com/reviewers.
22 September 2021
MDPI Joins SDG Publishers Compact
UN's 17 Sustainable Development Goals (SDGs) are the blueprint to achieve a better and more sustainable future for all. In 2020 the SDG Publishers Compact was launched, aimed to inspire publishers and accelerate progress to achieve the 17 goals by 2030. Members of the programme are committed to support the publication of materials that will promote and inspire actions towards SDGs.
MDPI is an eager advocate of SDGs and has already been supporting the programme by creating Special Issues and publishing a series of books on SDGs prior to joining the Compact in 2021. MDPI's Sustainability Foundation initiated the World Sustainability Awards in 2016. We fully support UN's goals to promote sustainable actions that make the world a better place for all and, as part of its commitment, we will focus our actions on SDG10: Reduced Inequalities whilst promoting all 17 SDGs. For more details, please visit the programme’s website: https://www.un.org/sustainabledevelopment/sdg-publishers-compact/.
Joining this initiative was a unanimous decision. MDPI has in its core values the dissemination of science for all, breaking the wall between research access and under-represented members of the scientific community and the general population. To support this initiative further and continue to support under-represented scientists, MDPI will take a series of actions that will be announced once ready.
The first action MDPI takes is to nominate Dr. Liliane Auwerter as the coordinator of the programme. Dr. Auwerter studied Environmental Process Technology (UTFPR, Brazil), obtained her MSc degree in Water and Environmental Engineering (University of Surrey, UK) and in 2020 completed her PhD in self-healing low-friction materials for water transport (Imperial College London, UK), always focusing on diverse scientific projects that would potentially bring sustainability to industrial processes. As a student in Brazil, she engaged in volunteering activities focused on environmental education and took part in the Millennial Development Goals meetings held at the university.
For more information, please contact:
Dr. Liliane Auwerter
Scientific Officer
[email protected]
16 September 2021
Journal of Clinical Medicine | New Collaboration with European Independent Foundation in Angiology/Vascular Medicine (VAS)
We are pleased to announce that JCM (ISSN: 2077-0383) has established a new collaboration with the European Independent Foundation in Angiology/Vascular Medicine (VAS). It is a non-profit scientific organization that has been working on vascular diseases and their prevention for 30 years. Members can enjoy discounts for their submissions.
Other affiliated societies of JCM can be found at the following link: https://www.mdpi.com/journal/jcm/societies.
3 August 2021
Announcement on Japanese Consumption Tax (JCT)
This serves to announce to our valued authors based in Japan that value-added tax, or consumption tax will now be imposed on article processing fees and other service fees for all papers submitted, or resubmitted (assigned new paper IDs), effective from 15 August 2021. The change is in accordance with the Japanese "Act for Partial Revision of the Income Tax Act and Other Acts" (Act No. 9 of 2015), which includes a revision of consumption taxation on cross-border supplies of services such as digital content distribution.
For additional information from the National Tax Agency please see here ("Cross-border supplies of electronic services").
Contact: Setsuko Nishihara, MDPI Tokyo
16 July 2021
Journal of Clinical Medicine | New Collaboration with Japan Association for Clinical Engineers (JACE)
In July 2021, the Japan Association for Clinical Engineers (JACE) became affiliated with JCM, As part of this collaboration, all members of the JACE enjoy a discount on the article processing charge (APC) when submitting articles to the journal.
JACE was founded as a voluntary organization in February 1990. It has, through its role as an association for professionals specializing in the operation, maintenance, and inspection of life-support systems directly linked to human life, strived constantly to create a system in which patients can receive highly advanced engineering-based medical care safely with the effective use of limited medical resources. In a bid to accomplish its ocial mission, expand the duties, and raise the status of clinical engineers, it was approved as a public-interest corporation by the Ministry of Health, Labor, and Welfare (MHLW) on March 14, 2002.
The objective of this association is to contribute to the promotion and development of the nation’s medical care and welfare through the raising of professional ethics of clinical engineers, enhancement of their professional knowledge and skills, and improvement of reliability of equipment-based medical care and welfare, including life-support systems.
To aim at the global standard, JACE established “World Association for Clinical Engineers” or WACE (tentative name) and organized its first convention in Japan. For more information, please see: https://www.ja-ces.or.jp/.
30 June 2021
2020 Impact Factors - Released
The 2020 citation metrics have been officially released in the Journal Citation Reports (JCR)!
We are pleased to announce that 85 MDPI journals are included, of which:
- 10 journals received their first impact factor
- 96% of journals increased their impact factor from 2019
- 32 journals (38%) ranked among the top 25% of journals, in at least one category
Journal | Impact Factor | Rank | Category |
Cancers | 6.639 | Q1 | • Oncology |
Cells | 6.600 | Q2 | • Cell Biology |
Pharmaceutics | 6.321 | Q1 | • Pharmacology & Pharmacy |
Antioxidants | 6.313 | Q1 | • Food Science & Technology |
• Biochemistry & Molecular Biology | |||
• Chemistry, Medicinal | |||
Biomedicines | 6.081 | Q1 | • Medicine, Research & Experimental |
• Pharmacology & Pharmacy | |||
• Biochemistry & Molecular Biology | |||
International Journal of Molecular Sciences | 5.924 | Q1 | • Biochemistry & Molecular Biology |
Q2 | • Chemistry, Multidisciplinary | ||
Pharmaceuticals | 5.863 | Q1 | • Pharmacology & Pharmacy |
• Chemistry, Medicinal | |||
Journal of Fungi | 5.816 | Q1 | • Mycology |
• Microbiology | |||
Nutrients | 5.719 | Q1 | • Nutrition & Dietetics |
Biosensors | 5.519 | Q1 | • Chemistry, Analytical |
• Instruments & Instrumentation | |||
Q2 | • Nanoscience & Nanotechnology | ||
Marine Drugs | 5.118 | Q1 | • Chemistry, Medicinal |
• Pharmacology & Pharmacy | |||
Biology | 5.079 | Q1 | • Biology |
Nanomaterials | 5.076 | Q1 | • Physics, Applied |
Q2 | • Chemistry, Multidisciplinary | ||
• Materials Science, Multidisciplinary | |||
• Nanoscience & Nanotechnology | |||
Viruses | 5.048 | Q2 | • Virology |
Journal of Personalized Medicine | 4.945 | Q1 | • Medicine, General & Internal |
• Health Care Sciences & Services | |||
Metabolites | 4.932 | Q2 | • Biochemistry & Molecular Biology |
Biomolecules | 4.879 | Q2 | • Biochemistry & Molecular Biology |
Remote Sensing | 4.848 | Q1 | • Geosciences, Multidisciplinary |
Q2 | • Remote Sensing | ||
• Imaging Science & Photographic Technology | |||
• Environmental Sciences | |||
Gels * | 4.702 | Q1 | • Polymer Science |
Antibiotics | 4.639 | Q2 | • Infectious Diseases |
• Pharmacology & Pharmacy | |||
Toxins | 4.546 | Q1 | • Toxicology |
• Food Science & Technology | |||
Vaccines | 4.422 | Q2 | • Immunology |
• Medicine, Research & Experimental | |||
Molecules | 4.412 | Q2 | • Chemistry, Multidisciplinary |
• Biochemistry & Molecular Biology | |||
Foods | 4.350 | Q2 | • Food Science & Technology |
Polymers | 4.329 | Q1 | • Polymer Science |
Journal of Clinical Medicine | 4.242 | Q1 | • Medicine, General & Internal |
Toxics | 4.146 | Q2 | • Toxicology |
• Environmental Sciences | |||
Catalysts | 4.146 | Q2 | • Chemistry, Physical |
Microorganisms | 4.128 | Q2 | • Microbiology |
Membranes | 4.106 | Q1 | • Polymer Science |
Q2 | • Engineering, Chemical | ||
• Materials Science, Multidisciplinary | |||
• Chemistry, Physical | |||
Genes | 4.096 | Q2 | • Genetics & Heredity |
Fermentation * | 3.975 | Q2 | • Biotechnology & Applied Microbiology |
Journal of Cardiovascular Development and Disease * | 3.948 | Q2 | • Cardiac & Cardiovascular Systems |
Plants | 3.935 | Q1 | • Plant Sciences |
Life | 3.817 | Q2 | • Biology |
Diagnostics | 3.706 | Q2 | • Medicine, General & Internal |
Current Oncology | 3.677 | Q3 | • Oncology |
Materials | 3.623 | Q1 | • Metallurgy & Metallurgical Engineering |
Q2 | • Materials Science, Multidisciplinary | ||
• Chemistry, Physical | |||
• Physics, Applied | |||
• Physics, Condensed Matter | |||
Sensors | 3.576 | Q1 | • Instruments & Instrumentation |
Q2 | • Chemistry, Analytical | ||
• Engineering, Electrical & Electronic | |||
Pathogens | 3.492 | Q2 | • Microbiology |
Agronomy | 3.417 | Q1 | • Agronomy |
• Plant Sciences | |||
Chemosensors | 3.398 | Q2 | • Instruments & Instrumentation |
• Chemistry, Analytical | |||
Q3 | • Electrochemistry | ||
Land | 3.398 | Q2 | • Environmental Studies |
Brain Sciences | 3.394 | Q3 | • Neurosciences |
International Journal of Environmental Research and Public Health | 3.390 | Q1 | • Public, Environmental & Occupational Health (SSCI) |
Q2 | • Public, Environmental & Occupational Health (SCIE) | ||
• Environmental Sciences (SCIE) | |||
Tomography | 3.358 | Q2 | • Radiology, Nuclear Medicine & Medical Imaging |
Fractal and Fractional * | 3.313 | Q1 | • Mathematics, Interdisciplinary Applications |
Sustainability | 3.251 | Q2 | • Environmental Sciences (SCIE) |
• Environmental Studies (SSCI) | |||
Q3 | • Green & Sustainable Science & Technology (SCIE) | ||
• Green & Sustainable Science & Technology (SSCI) | |||
Water | 3.103 | Q2 | • Water Resources |
• Environmental Sciences | |||
Journal of Theoretical and Applied Electronic Commerce Research | 3.049 | Q3 | • Business |
Energies | 3.004 | Q3 | • Energy & Fuels |
Agriculture | 2.925 | Q1 | • Agronomy |
ISPRS International Journal of Geo-Information | 2.899 | Q2 | • Geography, Physical |
• Computer Science, Information Systems | |||
Q3 | • Remote Sensing | ||
Micromachines | 2.891 | Q2 | • Instruments & Instrumentation |
• Physics, Applied | |||
Q3 | • Chemistry, Analytical | ||
• Nanoscience & Nanotechnology | |||
Coatings | 2.881 | Q2 | • Materials Science, Coatings & Films |
• Physics, Applied | |||
Q3 | • Materials Science, Multidisciplinary | ||
Children | 2.863 | Q2 | • Pediatrics |
Processes | 2.847 | Q3 | • Engineering, Chemical |
Separations | 2.777 | Q3 | • Chemistry, Analytical |
Insects | 2.769 | Q1 | • Entomology |
Animals | 2.752 | Q1 | • Agriculture, Dairy & Animal Science |
• Veterinary Sciences | |||
Symmetry | 2.713 | Q2 | • Multidisciplinary Sciences |
Atmosphere | 2.686 | Q3 | • Meteorology & Atmospheric Sciences |
• Environmental Sciences | |||
Applied Sciences | 2.679 | Q2 | • Engineering, Multidisciplinary |
• Physics, Applied | |||
Q3 | • Chemistry, Multidisciplinary | ||
• Materials Science, Multidisciplinary | |||
Photonics | 2.676 | Q2 | • Optics |
Buildings * | 2.648 | Q2 | • Construction & Building Technology |
• Engineering, Civil | |||
Healthcare | 2.645 | Q2 | • Health Policy & Services (SSCI) |
Q3 | • Health Care Sciences & Services (SCIE) | ||
Minerals | 2.644 | Q2 | • Mining & Mineral Processing |
• Mineralogy | |||
• Geochemistry & Geophysics | |||
Forests | 2.634 | Q1 | • Forestry |
Crystals | 2.589 | Q2 | • Crystallography |
Q3 | • Materials Science, Multidisciplinary | ||
Entropy | 2.524 | Q2 | • Physics, Multidisciplinary |
Diversity | 2.465 | Q2 | • Biodiversity Conservation |
Q3 | • Ecology | ||
Journal of Marine Science and Engineering | 2.458 | Q2 | • Oceanography |
• Engineering, Marine | |||
• Engineering, Ocean | |||
Medicina | 2.430 | Q2 | • Medicine, General & Internal |
Machines * | 2.428 | Q2 | • Engineering, Mechanical |
Q3 | • Engineering, Electrical & Electronic | ||
Electronics | 2.397 | Q3 | • Engineering, Electrical & Electronic |
• Computer Science, Information Systems | |||
• Physics, Applied | |||
Fishes * | 2.385 | Q2 | • Fisheries |
• Marine & Freshwater Biology | |||
Metals | 2.351 | Q2 | • Metallurgy & Metallurgical Engineering |
Q3 | • Materials Science, Multidisciplinary | ||
Horticulturae * | 2.331 | Q1 | • Horticulture |
Veterinary Sciences * | 2.304 | Q1 | • Veterinary Sciences |
Universe | 2.278 | Q3 | • Physics, Particles & Fields |
• Astronomy & Astrophysics | |||
Mathematics | 2.258 | Q1 | • Mathematics |
Magnetochemistry | 2.193 | Q3 | • Chemistry, Inorganic & Nuclear |
• Chemistry, Physical | |||
• Materials Science, Multidisciplinary | |||
Current Issues in Molecular Biology | 2.081 | Q4 | • Biochemistry & Molecular Biology |
Actuators | 1.994 | Q3 | • Instruments & Instrumentation |
• Engineering, Mechanical | |||
Aerospace * | 1.659 | Q2 | • Engineering, Aerospace |
* Journals given their first Impact Factor in 2021
Source: 2020 Journal Impact Factors, Journal Citation Reports ® (Clarivate, 2021)
30 June 2021
Welcoming New Editorial Board Members of Journal of Clinical Medicine
We are pleased to announce that, up to now, 116 distinguished scholars have joined the JCM Editorial Board in this quarter, including the well-known Prof. Dr. Aldo Pietro Maggioni from the ANMCO Research Center of the Heart Care Foundation, Prof. Dr. Paolo P. Prandoni from the "Arianna Anticoagulazione" Foundation, Dr. Stefan Evers from the University of Münster, Prof. Dr. Ben Willem Mol from Monash University, Prof. Dr. Tobias Welte from Medizinische Hochaschule Hannover, Prof. Dr. Fabiola Atzeni from the University of Messina, Prof. Dr. Gianluca Aimaretti from Università del Piemonte Orientale, Prof. Dr. Eva Compérat from L’Assistance Publique-Hôpitaux de Paris and various other prominent academics.
You can access more information on our new members on the website: https://www.mdpi.com/journal/jcm/editors.
Their trust in JCM is much appreciated, and we look forward to their contributions to the journal.
28 April 2021
Book Builder—Compile a Customized E-Book from Your Favorite MDPI Open Access Content
MDPI Books recently released Book Builder, a new online tool to conveniently arrange, design and produce an eBook from any content published in MDPI journals. Book Builder offers two functions: on the one hand (1) Selections, available to every registered user of MDPI; on the other hand (2) Special Issue Reprints, which can be used exclusively by Guest Editors of Special Issues.
Selections
In just a matter of a few clicks, all users are now able to assemble books from MDPI articles and receive instantaneous feedback in the form of a fully produced and compiled book (PDF), which can be downloaded or ordered as print copy. Selections can include any paper published with MDPI, picking and combining content from different journals and special issues.
This way, the user may for example choose to compile an ebook focusing around a particular topic, or assemble articles from a group of others.
We invite you to make yourself familiar with the new tool! The Book Builder can be found here: https://www.mdpi.com/books/book_builder.
Special Issue Reprints
The Book Builder allows Guest Editors of MDPI journals to create a reprint from a successfully completed Special Issue or Topical Collection in book format. If you are a Guest Editor for an MDPI journal, you can use the new tool to create an PDF document which includes all articles published in the Special Issue as well as a book cover and table of contents.
For Special Issues containing a minimum of 5 articles, the Guest Editor can request its publication on the MDPI Book platform. Published reprints are assigned an ISBN and DOI.
In addition to the PDF copy of the Reprint Book, as a token of our gratitude, MDPI offers every Guest Editor one (1) complimentary print copy (via print-on-demand). All contributors benefit from a discount on orders of any additional print copies, to share with colleagues or libraries or others.
In line with our organization's values, MDPI Books publishes all content in open access, promoting the exchange of ideas and knowledge in a globalized world. MDPI Books encompasses all the benefits of open access—high availability and visibility, as well as wide and rapid dissemination. MDPI Books are distributed under the terms and conditions of the Creative Commons Attribution License, meaning as an author you retain the copyright for your work. In addition, with MDPI Books you can complement the digital version of your work with a high-quality printed counterpart.
If you are interested in editing a book volume or series, or have a monograph manuscript to be considered for publication, please submit your proposal online and look at our Information for Authors.
Contact: Laura Wagner, MDPI Books Manager (email)
15 April 2021
MDPI Celebrates Company Milestone With 25th Anniversary Page
"We exist to help scientists achieve their own objectives"

In June of this year, MDPI will celebrate the 25th anniversary of its foundation. To mark this significant milestone, we have created a 25th Anniversary page on our website that evokes the development of our company over the past quarter-century.
MDPI has been a pioneer of Open Access publishing ever since the concept was first created.
In a wide-ranging interview, our CEO Delia Mihaila reflects on the company’s 25th anniversary and its contribution to the world of scientific publishing.
Delia considers how MDPI has evolved since starting life in 1996 as a visionary ‘project’ run out of an apartment in Basel, Switzerland, by Dr. Shu-Kun Lin. A chemist who was passionate about the long-term preservation of rare chemical sample, Dr. Lin was determined to help scholars publish their findings as quickly as possible and make their research results available to as wide a readership as possible worldwide. That determination remains unchanged 25 years later.
Today, MDPI is an international organization with over 4,000 employees based on three continents and in ten countries, and ranks among the world's top four academic publishers.
MDPI's mission is to accelerate access to new scientific research, delivering insight faster for researchers worldwide. Read more here about the company's remarkable success story and what the Open Access publishing model can offer the global scientific community.
10 March 2021
Journal Selector: Helping to Find the Right MDPI Journal for Your Article
At MDPI, we strive to make your online publication process seamless and efficient. To achieve this, our team is continuously developing tools and features to make the user experience useful and convenient.
As the number of academic papers continues to grow, so does the need to analyze and work with them on a large scale. This prompted us to design a new feature aimed at helping researchers find journals that are relevant to their publication by matching their abstract topic. In this regard, we designed a similarity model that automatically identifies the most suitable academic journals for your paper.
We are pleased to introduce Journal Selector, a new feature that measures similarity in academic contexts. By simply entering the title and/or abstract into our Journal Selector, the author will see a list of the most related scientific journals published by MDPI. This method helps authors select the correct journals for their papers, highlighting the time of publication and citability.
The methodology is known as representation learning, where words are represented as vectors in hyperspace. Representation helps us differentiate between different concepts within articles, and in turn, helps us identify similarities between them.
We used an advanced machine learning model to better capture the semantic meanings of words. This helps the algorithm make better predictions by leveraging scientific text representation. In turn, this ensures high precision, helping authors decide which journal they should submit their paper to.
The goal is to support authors to publish their work in the most suitable journal for their research, as fast as possible, accelerating their career progress.
Contact: Andrea Perlato, Head of Data Analytics, MDPI (email)
9 February 2021
The First International Electronic Conference on Clinical Medicine

We are pleased to announce that the first International Electronic Conference on Clinical Medicine (ECCM), chaired by Prof. Dr. Emmanuel Andrès, from the University Hospital of Strasbourg, France, and Prof. Dr. Michael G. Hennerici, from the University of Heidelberg, Germany, will be held on 15–30 September 2021 at Sciforum (https://sciforum.net/conference/ECCM).
The conference will cover all the multidisciplinary aspects of clinical medicine. The topics of interest include, but are not limited to, the following:
Cardiology
COVID-19
Gastroenterology and Hepatopancreatobiliary Medicine
Oncology
Infectious Diseases
Pulmonology
Hematology
Neurology and Stroke Neurology
Stomatology
Clinical Psychology
Psychiatry
Obstetrics and Gynecology
Endocrinology and Metabolism
Nephrology and Urology
Epidemiology and Public Health
Orthopedics
Dermatology
Ophthalmology
Otolaryngology
Nuclear Medicine and Radiology
Pharmacology
Anesthesiology
Emergency Medicine
The conference will be completely free of charge, both to attend and, for scholars, to upload and present their latest work on the conference platform. Accepted abstract submissions will be published in the proceedings of the conference, and authors are invited to develop their abstracts into full manuscripts, which will be considered for publication in JCM, with a 10% discount on the APC. JCM is an open access journal, published semimonthly by MDPI, in the field of clinical medicine. The journal is indexed in the Science Citation Index Expanded (SCIE IF = 3.303) and other databases. Full texts are archived in PubMed Central (PMC).
Important Dates
- Abstract Submission: 31 May 2021
- Acceptance Notification: 14 June 2021
- Full Paper Submission: 12 July 2021
- Conference Open: 15–30 September 2021
For more information on ECCM, please visit the conference website (https://sciforum.net/conference/ECCM) or contact us by email ([email protected]).
29 January 2021
The Spanish Society of Hematology and Hemotherapy (SEHH) is Now an Affiliated Society Member of Hemato, JCM and Cells
In November 2020, the Spanish Society of Hematology and Hemotherapy (SEHH) became affiliated with Hemato, JCM and Cells. As part of this collaboration, all members of the SEHH enjoy a discount on the article processing charge (APC) when submitting articles to the journals.
The SEHH is a scientific society purposed with the promotion, development and dissemination of research advances in two specialist areas, Hematology and Hemotherapy. In particular, the SEHH focuses on their medical, scientific, organizational, care, teaching and research aspects. Hematology, as a specialty, covers all aspects related to the physiology of the blood and hematopoietic organs, the diagnosis and treatment of benign and malignant diseases of the blood, the study of the hemostasis and coagulation system, and all aspects related to transfusion medicine, including hematopoietic stem cell transplantation. The professional role of the hematologist covers all aspects of the practice.
With 61 years of history, the SEHH is today an organization that contributes significantly to science. At present, it holds a community of almost 2800 professionals, of which many are internationally recognized figures, who continually contribute to making hematology, globally, one of the most prestigious fields of Spanish medicine. The society considers that, in order to achieve optimal patient care, it is essential to have access to medical advances, promote research and have well-trained and highly qualified specialists in the management of hematological diseases.
The SEHH is a professional organization whose functions and research are highly relevant to the scope of Hemato, JCM and Cells. We look forward to collaborating with the SEHH and to publishing state-of-the-art research from its members.
29 December 2020
Editorial Board Members of JCM Named 2020 Highly Cited Researchers in Web of Science
It is our pleasure to announce that seven JCM Editorial Board Members have been listed as 2020 Highly Cited Researchers by Clarivate. This corresponds to being in the top 1% of the most cited researchers for that publication year.
Prof. Dr. Robert C. Cantu
1. Department of Neurology, Boston University Alzheimer’s Disease and CTE Centers, Boston University School of Medicine, Boston, USA;2. Department of Neurosurgery, Boston University School of Medicine, Boston, USA; Concussion Legacy Foundation, Boston, MA, USA;
3. Department of Neurosurgery, Emerson Hospital, Concord, USA
Interests: Neurosurgery; Spine Surgery; Sports Medicine; Concussion Care
Dr. Michael R. Hamblin
Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA 02114, USA
Interests: photodynamic therapy (PDT); low-level light therapy (LLLT); wound healing and infectious disease; atherosclerotic vulnerable plaque; anti-tumor immunity; photochemical mechanisms
Prof. Dr. Hans-Peter Hartung
Department of Neurology, Medical Faculty, Heinrich-Heine-University, Moorenstrasse 5, 40225, Düsseldorf, Germany
Interests: immune mediated neurological disroders; multiple sclerosis; NMOSD; immune encephalitides; immune neuropathies; Guillan Barre syndrome and CIDP
Prof. Dr. Gregory Y. H. Lip
1. Price-Evans Professor of Cardiovascular Medicine, University of Liverpool, United Kingdom2. Distinguished Professor, Aalborg University, Denmark
Interests: atrial fibrillation; hypertension; thrombosis and anticoagulation
Prof. Dr. Russel J. Reiter
Department of Cellular & Structural Biology, The UT Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX 78229-3900, USA
Interests: melatonin; free radicals of disease processes and aging; oxygen derivatives
Prof. Fred Saad
Centre Hospitalier de Université de Montréal, Montreal, Canada
Interests: Prostate cancer; biomarkers; novel therapeutics; castration resistant prostate cancer; GU cancers; metastases prevention
Dr. Allan H. Young
Centre for Affective Disorders, Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK
Interests: Bipolar disorder; treatment resistant depression; cognition; translational
The 2020 Highly Cited Researchers list has been announced by Web of Science at: https://recognition.webofscience.com/awards/highly-cited/2020/.
15 December 2020
MDPI adopts C4DISC principles to improve diversity and inclusion in scholarly communications
MDPI is proud to adopt the principles of the Coalition for Diversity & Inclusion in Scholarly Communications (C4DISC) to support building equity, inclusion, diversity, and accessibility in scholarly communications.
The C4DISC represents organizations and individuals working in scholarly communications and is focused on addressing issues of diversity and inclusion within the publishing industry.
MDPI’s Managing Editors encourage the Editors-in-Chief and Associate Editors to appoint diverse expert Editorial Boards. This is also reflective in our multi-national and inclusive workplace. We are proud to create equal opportunities without regard to gender, ethnicity, geographic location, sexual orientation, age, disability, political beliefs, religion, or socio-economic status. There is no place for discrimination in our workplace and editors of MDPI journals are to uphold these principles in high regard.
Representatives from C4DISC meet monthly, and have started to implement initiatives to shed light and improve on the lack of diversity in scholarly communications. Some of the initiatives include developing a joint statement of principles; conducting market research; providing training resources, best practices, toolkits, and documentation for our collective memberships; and establishing outreach programs, curricula, events, and publications.
The Coalition is committed to:
- eliminating barriers to participation, extending equitable opportunities across all stakeholders, and ensuring that our practices and policies promote equitable treatment and do not allow, condone, or result in discrimination;
- creating and maintaining an environment that respects diverse traditions, heritages, and experiences;
- promoting diversity in all staff, volunteers, and audiences, including full participation in programs, policy formulation, and decision-making;
- raising awareness about career opportunities in our industries to groups who are currently underrepresented in the workforce;
- supporting our members in achieving diversity and inclusion within their organizations.
14 December 2020
Article Layout and Templates Revised for Future Volumes
At MDPI we have slightly revised the layout for articles to be published in the 2021 Volume, starting at the end of December 2020. As of today, the article templates available for download on ‘Instructions for Authors’ pages have been updated.
The most noticeable change can be found on the first page of the article, where a left-hand column has been created to include the following front matter elements: (i) the recommended citation style for the article, (ii) the publishing history, (iii) as well as the Creative Commons Attribution license used (iv) a standard note regarding affiliations. At the same time, the extra spacing on the left means the authors’ affiliations are now more clearly set apart than before. Other front matter key elements such as journal logo, article type, article title, authors, abstract and keywords remain unchanged.
The blank column on the left runs through all pages in an article; as a result, the main text is slightly more condensed, which improve reader friendliness for smaller screens. Small figures/tables are aligned on the left with standard indenture, while large figures/tables are centered and covering the full width of the page. The revised layout was applied in the article pictured below, to serve as an example:
1) Information is displayed in the left information bar.
2) In the main text, there is a blank column on the left.
3) Small tables/figures are aligned on the left, large tables/figures are centered.
11 December 2020
2020 "Highly Cited Researchers" on MDPI Journal's Editorial Boards
We are pleased to acknowledge that many academic editors who have made an impact on MDPI journals as editorial board members, editors-in-chief, or section editors, are recognized as 2020 Highly Cited Researchers by Clarivate.
Highly Cited Researchers highlights the top 1% of researchers, by citations, in one or more of the 22 fields used in Clarivate Analytics Essential Science Indicators. We offer our congratulations to 279 academic editors of MDPI journals who were recognized as the most influential scholars in their fields in 2020.
Adams, Dave Agarwal, Ravi P. Ahn, Choon Ki Ahn, Myung-Ju Albrecht, Randy A. Andersson, Dan I. Anker, Stefan D. Apergis, Nicholas Ariga, Katsuhiko Artaxo, Paulo Balsamo, Gianpaolo Barba, Francisco J. Benediktsson, Jon Atli Benelli, Giovanni Bhatnagar, Amit Bialystok, Ellen Blaabjerg, Frede Blay, Jean-Yves Bogers, Marcel Bolton, Declan J. Boyer, Cyrille Brocca, Luca Bruix, Jordi Buhalis, Dimitrios Burdick, Jason A. Byrd, John C. Cabeza, Luisa F. Cabrerizo-Lorite, Francisco Javier Cai, Jianchao Calhoun, Vince D. Cantu, Robert C. Cerqueira, Miguel Chang, Jo-Shu Chau, Kwok-wing Chemat, Farid Chen, Jianmin Chen, Jun Chen, Min Chen, Shaowei Chen, Wei Chen, Wei-Hsin Chen, Xiaofeng Chen, Yangkang Chen, Zhi-Gang Chiclana, Francisco Corella, Dolores Cortes, Javier Cortes, Jorge Cummings, Kenneth Michael Dai, Shifeng Decker, Eric A. DePinho, Ronald A. Dimopoulos, Meletios-Athanasios Dincer, Ibrahim Du, Yihong Dupont, Didier Edwards, David Ellahi, Rahmat Ellis, Erle C. ElMasry, Gamal Esteller, Manel Estruch, Ramón Fang, Chuanglin Fasano, Alessio Fernandez-Lafuente, Roberto Ferreira, Isabel Fortino, Giancarlo Galluzzi, Lorenzo Galvano, Fabio Gandomi, Amir H. Gandomi, Amir H. Gao, Bin Gao, Feng Gao, Wei Garbe, Claus García, Hermenegildo Geschwind, Daniel H. Giampieri, Francesca Giralt, Sergio A. Glanz, Karen Goldewijk, Kees Klein Gössling, Stefan Govindan, Kannan Granato, Daniel Grosso, Giuseppe Grosso, Giuseppe Guerrero, Josep M. Haase, Dagmar Hagger, Martin S. Hamblin, Michael R. Han, Heesup Jankovic, Joseph Janotti, Anderson |
Jiang, Hai-Long Kalaji, Hazem M. Kalantar-Zadeh, Kourosh Kaner, Richard B. Karimi, Hamid Reza Kataoka, Kazunori Keesstra, Saskia Kepp, Oliver Kerminen, Veli-Matti Keyzers, Robert A. Khademhosseini, Ali Khan, Nafees A. Kim, Ki-Hyun Klemeš, Jiří Jaromír Klenk, Hans-Peter Konopleva, Marina Y. Krammer, Florian Krebs, Frederik C. Kroemer, Guido Kudo, Masatoshi Kurths, Juergen Kurzrock, Razelle Kuznetsov, Nikolay V. Kyrpides, Nikos C. La Vecchia, Carlo Lai, Yuekun Lam, James Lancellotti, Patrizio Lee, Sangmoon Leung, Victor C. M. Li, Jinghong Li, Yurui Lindahl, José M. Merigó Lip, Gregory Y. H. Loh, Xian Jun Long, Hualou Lund, Henrik Luo, Jingshan Luque, Rafael Lyons, Timothy W. Ma, Jun Ma, Wen-Xiu Ma, Yanming Maeda, Keisuke Makarova, Kira Mantovani, Alberto Martín-Belloso, Olga Martinoia, Enrico Marzband, Mousa Masclaux-Daubresse, Celine Masson, Patrick Mateos, María Victoria Mathiesen, Brian Vad Matyjaszewski, Krzysztof McArthur, Grant A. McCauley, Darren Medlock, Jolyon M. Melero, Ignacio Mezzetti, Bruno Miroshnichenko, Andrey E. Moran, Daniel Mueller, Lukas A. Mueller-Roeber, Bernd Naushad, Mu Nemeroff, Charles B. Nieto, Juan J. O'Donnell, Colm Ogino, Shuji Olabi, Abdul-Ghani O'Regan, Donal Orsini, Nicola Oswald, Isabelle P. Ozcan, Aydogan Pahl-Wostl, Claudia Pang, Huan Payne, James E. Peng, Shushi Perc, Matjaz Perez-Alvarez, Jose Angel Piquero, Alex R. Ploss, Alexander Postolache, Mihai Pradhan, Biswajeet Prinsep, Michele R. Qian, Dong Qu, Xiaogang Reiter, Russel J. Riahi, Keywan Richter, Andreas Rignot, Eric Robert, Caroline Ros, Emilio Rosell, Rafael |
Rosen, Marc A. |
The full list of 2020 Highly Cited Researchers can be accessed on https://recognition.webofsciencegroup.com/awards/highly-cited/2020/
--- Highly Cited Researchers (HCR) is a Clarivate product.
7 December 2020
Recruiting Editorial Board Members for JCM

JCM is recruiting Editorial Board Members for the following sections:
https://www.mdpi.com/journal/jcm/sections.
The main responsibilities of Editorial Board Members are as follows:
1) Making decisions on whether a manuscript can be accepted based on the reports we collect;
2) Reviewing a small number of papers each year;
3) Acting as or recommending a Guest Editor for a Special Issue on a topic related to your research interests;
4) Promoting JCM and increasing its visibility at related academic conferences.
Journal of Clinical Medicine (ISSN 2077-0383) is an international scientific open-access journal, providing a platform for advances in health care/clinical practices, the study of direct observation of patients, and general medical research. This multi-disciplinary journal is aimed at a wide audience of medical researchers and healthcare professionals. It is abstracted and indexed in the Science Citation Index Expanded in Web of Science and other databases, with citations available in PubMed, and is full-text archived in PubMed Central. The 2019 IF for JCM was 3.303.
This position is open to experts in clinical medicine. To apply for this position (in one of our Sections), recommend potential candidates, or request further information, please contact the JCM Editorial Office ([email protected]) or Lily Pei ([email protected]).
4 December 2020
JCM Free Webinar: Prediction of Preterm Birth in High Risk Pregnancies—06 December 2020

Preterm birth (PTB) remains one of the biggest challenges in contemporary obstetrics as it is associated with an increased risk of mortality as well as short- and long-term morbidity of the offspring. Many risk factors for PTB have been identified, including multiple gestation, placental insufficiency, cervical pathology and uterine factors, among others. As a result, many women are currently classified as at high risk for PTB. Accurate prediction of PTB is crucial as it can assist in selecting the optimal prevention measurements and counseling regarding the suitable antepartum follow up and the need for potential transfer to the appropriate facility in case of very high risk of PTB.
With a distinguished panel of leaders in this field, Professors Liran Hiersch, John Kingdom, Nathan Fox, Tal Biron-Shental and Ido Solt, this webinar will address aspects and perspectives on the prediction of PTB in various clinical scenarios.
Date: 6th December 2020 | 3:00 p.m. CET | 9:00 a.m. EST
Webinar ID: 862 1088 3441
Register for Free Here: https://clincialmed-4.sciforum.net/
Chair:
|
His main fields of interest include twin pregnancies, fetal growth and preterm birth. |
Dr. Liran Hiersch |
Speakers:
|
Presentation: Placenta Growth Factor: predicting placenta-mediated preterm delivery |
Dr. John Kingdom |
|
|
Presentation: Prediction and Prevention of Preterm Birth in Twins |
Dr. Nathan Fox |
|
|
Presentation: The correlation between telomere homeostasis and gestational length
|
Prof. Tal Biron-Shental |
|
|
Presentation: Is the vaginal microbiome a predictor of preterm birth? |
Dr. Ido Solt |
For any questions about the webinar, please contact us at [email protected].
2 November 2020
Current Oncology, Canada's Premier Oncology Journal, Published with MDPI from 2021
MDPI acquired Current Oncology (ISSN 1718-7729) in October 2020 from Multimed Publications Inc., who launched the title in 1994, as Canada’s first peer-reviewed journal in oncology.
Current Oncology features papers in all fields of cancer medicine, including radiation oncology, surgical oncology, medical oncology, pediatric oncology, pathology, and cancer rehabilitation and survivorship. It continues to be a trusted source for all members of the oncology community in Canada and abroad.
Coverage in indexing services includes MEDLINE (PubMed/National Library of Medicine), the Science Citation Index Expanded (Web of Science), Journal Citation Reports, Scopus (Elsevier), EMBASE (Elsevier), and more. Current Oncology's 2019 Impact Factor is 2.257, ranked 185/244 in the 'Oncology' category.
Previously published six times annually, normally with one or two additional supplements, MDPI will continue the schedule of bimonthly publications. The current volume of Current Oncology (v. 27) will be concluded at the end of 2020, at which point MDPI will take over publication of the journal, starting with Volume 28, at the beginning of 2021.
The goal is to greatly expand the journal's global reach, alongside MDPI's flagship Cancers journal, in order to become one of the world’s leading oncology journals.
Website: https://www.mdpi.com/journal/curroncol
Contact: Danica Jevtic, Marko Ristic
Current Oncology Editorial Office
2 November 2020
“JCM 2020 Outstanding Research Award” Winner Announcement
The JCM Outstanding Research Award was initiated to recognize outstanding research by authors of the journal that has had a significant international impact. The novelty and significance of research works were assessed by the JCM Editorial Board and reviewers along with consideration of the citations.
We are very pleased to announce that Dr. Robin Nicholas Thompson will be granted the JCM 2020 Outstanding Research Award for his contribution of using mathematical models to represent the epidemiological or evolutionary behavior of infectious disease outbreaks. The main aims are not only to generate forecasts of specific outbreaks but also to understand how diseases spread such that forecasts can be made, and control interventions can be planned with more precision.
His paper “Novel Coronavirus Outbreak in Wuhan, China, 2020: Intense Surveillance Is Vital for Preventing Sustained Transmission in New Locations” published in February 2020 (https://www.mdpi.com/2077-0383/9/2/498) was recognized as recommended reading by the World Health Organization.
Please join us in congratulating Dr. Thompson on receiving this award.
29 October 2020
JCM Free Webinar: Dry Eye 360- Looking at Dry Eye Disease from all Directions—3rd November 2020

Dry Eye Disease (DED) has gained recognition as a public health problem given its prevalence, morbidity, and cost implications. DED can have a variety of symptoms including blurred vision and ocular pain (dryness, burning aching) and a variety of signs including decreased tear production, corneal epithelial disruption, and rapid tear evaporation. However, it is well known that there is often a discrepancy between symptoms and signs of disease.
Date: 1.30pm (CET) | 06.30am (CDT)
Duration: Maximum 2 hours
Webinar ID: 961 1378 0758
Register for Free Here: https://sciforum.net/conference/JCM3
Chair:
![]() |
Presentation: DED from the outside- a discussion on the interaction between environmental exposures and the ocular surface, and their manifestation as DED. |
Associate Professor Anat Galor Guest Editor of “Dry Eye Syndrome: New Insights on Epidemiology and Management” |
Speakers:
![]() |
Presentation: DED from the inside- a discussion on systemic co-morbidities that may associated and drive disease. |
Professor Stephen C. Pflugfelder |
|
![]() |
Presentation: DED and the local neighborhood- a discussion on effects of the periocular skin and eyelids on the ocular surface and DED. |
Associate Professor Jennifer Craig |
For any questions about the webinar, please email [email protected].
20 August 2020
JCM Free Webinar: Advances in Preterm Delivery—24 September 2020

Preterm delivery (PTD; <37 weeks' gestation) complicates 5-13% of deliveries worldwide depending on the geographical and demographical characteristics of the population tested. Based on data from 184 countries, the global average preterm birth rate in 2010 was 11.1% giving a worldwide 14.9 million. It is the leading cause of perinatal morbidity and mortality as well as maternal morbidity. With a distinguished panel of Professors Eyal Sheiner, Gian Carlo Di Renzo, Shali Mazaki-Tovi and Nir Melamed, this webinar will address and share new perspectives on the prevention and monitoring of Preterm Delivery.
Date: 24 September 2020 | 1 pm (CEST) | 7 am (EDT) | 7 am (CST Asia)
Duration: Maximum 2 hours
Webinar ID: 856 8826 9334
Register for Free Here: https://sciforum.net/conference/ClinicalMed-2
Chair:
|
Presentation: Preterm delivery and other “placental” complications, and long-term maternal morbidity. |
Professor Dr. Eyal Sheiner Guest Editor of “Advances in Preterm Delivery” |
Speakers:
|
Presentation: Prevention of preterm birth: The evidence |
Prof. Dr. Gian Carlo Di Renzo |
|
|
Presentation: Bad rest or bed rest: efficacy and safety of decreased physical activity for the prevention of preterm birth.
|
Prof. Dr. Shali Mazaki-Tovi |
|
|
Presentation: Is there a role for serial monitoring of cervical length in twin pregnancies?
|
Prof. Dr. Nir Melamed |
For any questions about the webinar, please send an email to [email protected].
10 July 2020
Meet Us at the Society for Neurosciences’ 50th Annual Meeting (Neuroscience 2020), Washington, USA, 24–28 October 2020

MDPI will be attending the conference Neuroscience 2020, which will be hosted in Washington, USA, 24–28 October 2020.
SfN’s 50th annual meeting is the premier venue for the presentation of emerging science in the field of neurosciences, where one can learn from experts, forge collaborations with peers, explore new tools and technologies, and advance their career.
The following MDPI journals will be represented:
- Brain Sciences (leading journal)
- JCM
- Medicina
- Genes
- Children
- Cancers
- Behavioral Sciences
- Cells
- IJERPH
- Disease
- Biomedicines
- JPM
- Pathogens
- Healthcare
- IJMS
- Psych
- Pharmaceuticals
- Clocks&Sleep
- Jounal of Intelligence
- Pharmaceutics
If you are attending this conference, please feel free to stop by our booth (Booth #208). Our delegates look forward to meeting you in person, to answer any questions you may have. For more information about the conference, please visit:
10 July 2020
JCM: Five Experts in the Editorial Board Named 2019 "Highly Cited Researchers" in Web of Science
It is our pleasure to announce that five JCM Editorial Board Members have been listed as Highly Cited Researchers:
Prof. Fred Saad
Centre Hospitalier de Université de Montréal, Montreal, Canada
Interests: prostate cancer; biomarkers; novel therapeutics; castration resistant prostate cancer; GU cancers; metastases prevention
Prof. Dr. Gregory Y. H. Lip
1. Price-Evans Professor of Cardiovascular Medicine, University of Liverpool, United Kingdom
2. Distinguished Professor, Aalborg University, Denmark
Interests: atrial fibrillation; hypertension; thrombosis and anticoagulation
Prof. Dr. Laxmaiah Manchikanti
Pain Management Center of Paducah Associate Clinical, Anesthesiology and Perioperative Medicine, University of Louisville, 2831 Lone Oak Road, Paducah, KY 42003, USA
Interests: back pain; low back pain; opioids; spinal pain; chronic pain; interventional pain management
Dr. Michael R. Hamblin
Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA 02114, USA
Interests: photodynamic therapy (PDT); low-level light therapy (LLLT); wound healing and infectious disease; atherosclerotic vulnerable plaque; anti-tumor immunity; photochemical mechanisms
Prof. Dr. Russel J. Reiter
Department of Cellular & Structural Biology, The UT Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX 78229-3900, USA
Interests: melatonin; free radicals of disease processes and aging; oxygen derivatives
The 2019 Highly Cited Researchers list has been announced by Web of Science at:
https://recognition.webofsciencegroup.com/awards/highly-cited/2019/
9 July 2020
Open Access Agreement Between Jisc Collections and MDPI
We are delighted to announce the establishment of our Open Access agreement with Jisc Collections, which will allow UK institutions to benefit from access to article processing charge (APC) discounts and streamlined payment workflows.
All institutions participating in the agreement will also gain access to the MDPI online submission system where they can find full article metadata and pricing information for easy identification and additional transparency.
Eligible authors affiliated with the participating institutions are prompted to choose the corresponding Institutional Open Access Program (IOAP) when they submit an article via our online submission system.
About Jisc
Jisc's vision is for the UK to be the most digitally advanced education and research nation in the world. At its heart is the super-fast national research and education network, Janet, with built-in cyber security protection. Jisc also provides technology solutions for its members (colleges, universities and research centres) and customers (public sector bodies), helps members save time and money by negotiating sector-wide deals and provides advice and practical assistance on digital technology. Jisc is funded by the UK higher and further education and research funding bodies and member institutions.
For more information, contact [email protected].
About MDPI
MDPI is a publisher of fully peer-reviewed, Open Access journals with a focus on thorough and rapid editorial processing. Its aim is to ensure that high-quality research is verified and made available to the research community as quickly as possible. MDPI stands at the forefront of the Open Access movement, having launched its first online journal Molecules in 1996. Today, MDPI is a leader in Open Access publishing with over 250 journals across all research disciplines, and all content published under a Creative Commons Attribution License (CC BY).
For any questions about this agreement, please contact the MDPI IOAP team at [email protected].
29 June 2020
Updated Impact Factors Released in the Journal Citation Reports (Clarivate)
The updated citation metrics have been released in the Journal Citation Reports (JCR), published by Clarivate. The recent release of the JCR includes seventy-one MDPI titles. Out of these, 18 titles are newcomers, receiving a first Journal Impact Factor which is based on citation activity in 2019: Actuators, Agriculture, Biology, Biomedicines, Biosensors, Chemosensors, Children, Healthcare, Journal of Fungi, Journal of Personalized Medicine (JPM), Land, Life, Magnetochemistry, Membranes, Pharmaceuticals, Photonics, Separations and Toxics.
- Out of the previously listed journals, a total of 72 percent boast an increased Impact Factor.
- 25 journals are ranked among the top 25% of journals in at least one of the categories they are ranked for.
- Articles published in 2019 in MDPI journals account for approximately 17 percent of of articles published in gold Open Access journals covered in the Science Citation Index Expanded (SCIE) and Social Sciences Citation Index (SSCI).
First Impact Factors
Journal | Impact Factor | Rank | Category | Details |
Actuators | 1.957 | 31/64 (Q2) | • Instruments & Instrumentation | Link |
Agriculture | 2.072 | 25/91 (Q2) | • Agronomy | Link |
Biology | 3.796 | 19/93 (Q1) | • Biology | Link |
Biomedicines | 4.717 | 30/138 (Q1) 36/270 (Q1) |
• Medicine, Research & Experimental • Pharmacology & Pharmacy |
Link |
Biosensors | 3.240 | 24/86 (Q2) | • Chemistry, Analytical | Link |
Chemosensors | 3.108 | 16/64 (Q1) 27/86 (Q2) 13/27 (Q2) |
• Instruments & Instrumentation • Chemistry, Analytical • Electrochemistry |
Link |
Children | 2.078 | 50/128 (Q2) | • Pediatrics | Link |
Healthcare | 1.916 | 62/102 (Q3) 45/87 (Q3) |
• Health Care Sciences & Services (SCIE) • Health Policy & Services (SSCI) |
Link |
Journal of Fungi | 4.621 | 5/29 (Q1) 31/135 (Q1) |
• Mycology • Microbiology |
Link |
Journal of Personalized Medicine | 4.433 | 24/165 (Q1) 10/102 (Q1) |
• Medicine, General & Internal • Health Care Sciences & Services |
Link |
Land | 2.429 | 58/123 (Q2) | • Environmental Studies (SSCI) | Link |
Life | 2.991 | 26/93 (Q2) 109/267 (Q2) |
• Biology • Microbiology |
Link |
Magnetochemistry | 1.947 | 22/45 (Q2) 109/159 (Q3) 201/314 (Q3) |
• Chemistry, Inorganic & Nuclear • Chemistry, Physical • Materials Science, Multidisciplinary |
Link |
Membranes | 3.094 | 53/143 (Q2) 129/314 (Q2) 23/89 (Q2) |
• Engineering, Chemical • Materials Science, Multidisciplinary • Polymer Science |
Link |
Pharmaceuticals | 4.286 | 49/270 (Q1) | • Pharmacology & Pharmacy | Link |
Photonics | 2.140 | 48/97 (Q2) | • Optics | Link |
Separations | 1.900 | 53/86 (Q3) | • Chemistry, Analytical | Link |
Toxics | 3.271 | 32/92 (Q2) 92/265 (Q2) |
• Toxicology • Environmental Sciences |
Link |
Updated Impact Factors
Journal | Impact Factor | Rank | Category | Details |
Agronomy | 2.603 | 18/91 (Q1) 65/234 (Q2) |
• Agronomy • Plant Sciences |
Link |
Animals | 2.323 | 10/63 (Q1) 14/142 (Q1) |
• Agriculture, Dairy & Animal Science • Veterinary Sciences |
Link |
Antibiotics | 3.893 | 23/93 (Q1) 64/270 (Q1) |
• Infectious Diseases • Pharmacology & Pharmacy |
Link |
Antioxidants | 5.014 | 10/139 (Q1) 56/297 (Q1) 7/61 (Q1) |
• Food Science & Technology • Biochemistry & Molecular Biology • Chemistry, Medicinal |
Link |
Applied Sciences | 2.474 | 161/314 (Q3) 32/91 (Q2) 88/177 (Q2) 62/154 (Q2) |
• Materials Science, Multidisciplinary • Engineering, Multidisciplinary • Chemistry, Multidisciplinary • Physics, Applied |
Link |
Atmosphere | 2.397 | 48/93 (Q3) | • Meteorology & Atmospheric Sciences | Link |
Biomolecules | 4.082 | 98/297 (Q2) | • Biochemistry & Molecular Biology | Link |
Brain Sciences | 3.332 | 113/271 (Q2) | • Neurosciences | Link |
Cancers | 6.126 | 37/244 (Q1) | • Oncology | Link |
Catalysts | 3.520 | 65/159 (Q2) | • Chemistry, Physical | Link |
Cells | 4.366 | 70/195 (Q2) | • Cell Biology | Link |
Coatings | 2.436 | 10/21 (Q2) | • Materials Science, Coatings & Films | Link |
Crystals | 2.404 | 10/26 (Q2) 165/314 (Q3) |
• Crystallography • Materials Science, Multidisciplinary |
Link |
Diagnostics | 3.110 | 39/165 (Q1) | • Medicine, General & Internal | Link |
Diversity | 1.402 | 119/168 (Q3) | • Ecology | Link |
Electronics | 2.412 | 125/266 (Q2) | • Engineering, Electrical & Electronic | Link |
Energies | 2.702 | 63/112 (Q3) | • Energy & Fuels | Link |
Entropy | 2.494 | 33/85 (Q2) | • Physics, Multidisciplinary | Link |
Foods | 4.092 | 27/139 (Q1) | • Food Science & Technology | Link |
Forests | 2.221 | 17/68 (Q1) | • Forestry | Link |
Genes | 3.759 | 53/177 (Q2) | • Genetics & Heredity | Link |
Insects | 2.220 | 18/101 (Q1) | • Entomology | Link |
International Journal of Environmental Research and Public Health (IJERPH) | 2.849 | 58/193 (Q2) 32/170 (Q1) 105/265 (Q2) |
• Public, Environmental & Occupational Health (SCIE) • Public, Environmental & Occupational Health (SSCI) • Environmental Sciences (SCIE) |
Link |
International Journal of Molecular Sciences (IJMS) | 4.556 | 74/297 (Q1) 48/177 (Q2) |
• Biochemistry & Molecular Biology • Chemistry, Multidisciplinary |
Link |
ISPRS International Journal of Geo-Information (IJGI) | 2.239 | 31/50 (Q3) 18/30 (Q3) |
• Geography, Physical • Remote Sensing |
Link |
Journal of Clinical Medicine | 3.303 | 36/165 (Q1) | • Medicine, General & Internal | Link |
Journal of Marine Science and Engineering | 2.033 | 31/66 (Q2) | • Oceanography | Link |
Marine Drugs | 4.073 | 16/61 (Q2) | • Chemistry, Medicinal | Link |
Materials | 3.057 | 132/314 (Q2) | • Materials Science, Multidisciplinary | Link |
Mathematics | 1.747 | 28/324 (Q1) | • Mathematics | Link |
Medicina | 1.205 | 107/165 (Q3) | • Medicine, General & Internal | Link |
Metabolites | 4.097 | 95/297 (Q2) | • Biochemistry & Molecular Biology | Link |
Metals | 2.117 | 18/79 (Q1) 185/314 (Q3) |
• Metallurgy & Metallurgical Engineering • Materials Science, Multidisciplinary |
Link |
Micromachines | 2.523 | 56/92 (Q3) 23/64 (Q2) |
• Nanoscience & Nanotechnology • Instruments & Instrumentation |
Link |
Microorganisms | 4.152 | 37/135 (Q2) | • Microbiology | Link |
Minerals | 2.380 | 6/21 (Q2) 11/30 (Q2) |
• Mining & Mineral Processing • Mineralogy |
Link |
Molecules | 3.267 | 70/177 (Q2) 141/297 (Q2) |
• Chemistry, Multidisciplinary • Biochemistry & Molecular Biology |
Link |
Nanomaterials | 4.324 | 89/314 (Q2) 42/103 (Q2) |
• Materials Science, Multidisciplinary • Nanoscience & Nanotechnology |
Link |
Nutrients | 4.546 | 17/89 (Q1) | • Nutrition & Dietetics | Link |
Pathogens | 3.018 | 65/135 (Q2) | • Microbiology | Link |
Pharmaceutics | 4.421 | 44/270 (Q1) | • Pharmacology & Pharmacy | Link |
Plants | 2.762 | 58/234 (Q1) | • Plant Sciences | Link |
Polymers | 3.426 | 16/89 (Q1) | • Polymer Science | Link |
Processes | 2.753 | 59/143 (Q2) | • Engineering, Chemical | Link |
Remote Sensing | 4.509 | 9/30 (Q2) | • Remote Sensing | Link |
Sensors | 3.275 | 22/86 (Q2) 77/266 (Q2) 15/64 (Q1) |
• Chemistry, Analytical • Engineering, Electrical & Electronic • Instruments & Instrumentation |
Link |
Sustainability | 2.576 | 120/265 (Q2) 26/41 (Q3) 53/123 (Q2) 6/8 (Q3) |
• Environmental Sciences (SCIE) • Green & Sustainable Science & Technology (SCIE) • Environmental Studies (SSCI) • Green & Sustainable Science & Technology (SSCI) |
Link |
Symmetry | 2.645 | 29/71 (Q2) | • Multidisciplinary Sciences | Link |
Toxins | 3.531 | 21/92 (Q1) 34/139 (Q1) |
• Toxicology • Food Science & Technology |
Link |
Universe | 1.752 | 18/29 (Q3) 42/68 (Q3) |
• Physics, Particles & Fields • Astronomy & Astrophysics |
Link |
Vaccines | 4.086 | 57/158 (Q2) 50/138 (Q2) |
• Immunology • Medicine, Research & Experimental |
Link |
Viruses | 3.816 | 12/37 (Q2) | • Virology | Link |
Water | 2.544 | 31/94 (Q2) | • Water Resources | Link |
Source: Clarivate 2020, InCites Journal Citation Reports®.
5 June 2020
Journal of Clinical Medicine Reaches 5000 Articles Milestone

The Journal of Clinical Medicine (ISSN 2077-0383), an MDPI open access journal on health care, clinical practices, and general medical research, has passed another milestone by publishing its 5000th article since its inception in 2012.
JCM is now covered in the Science Citation Index Expanded in Web of Science and received an impact factor of 5.688 in 2018, which corresponds to a ranking of 15/160 (Q1) under the category ‘Medicine, General & Internal’.
JCM publishes original research covering the following non-exhaustive list of topical areas: Anesthesiology, Cardiology, Clinical Cytology, Clinical Neurology, Clinical Psychology, Dermatology, Emergency Medicine, Endocrinology & Metabolism, Epidemiology & Public Health, Gastroenterology & Hepatopancreatobiliary Medicine, Hematology, Immunology, Infectious Diseases, Molecular Diagnostics, Nuclear Medicine & Radiology, Nephrology & Urology, Obstetrics & Gynecology, Oncology, Ophthalmology, Orthopedics, Otolaryngology, Pharmacology, Psychiatry, Pulmonology, Vascular Medicine, Stomatology.
13 May 2020
COVID-19 Academic Resources Center

Since 1996, MDPI has been committed to supporting the research community by providing the latest research freely available and making relevant and useful research available as quickly as possible. The world is current experiencing a pandemic of COVID-19, and researchers are working extremely hard to understand it and find a cure.
The values MDPI holds strongly are particularly important at the moment, and we will continue to publish relevant, peer-reviewed research as quickly as possible in open access format. This means that it will immediately be available for researchers, health professionals, and the general public to read, distribute, and reuse. We believe that scientific advancements will be crucial to overcoming this pandemic, and will do everything we can to support researchers working looking for solutions.
COVID-19 Academic Resources Center contains a variety of